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Background: Self-management (SM) support for patients with chronic obstructive pulmonary disease
(COPD) is variable in its coverage, content, method and timing of delivery. There is insufficient evidence for
which SM interventions are the most effective and cost-effective.
Objectives: To undertake (1) a systematic review of the evidence for the effectiveness of SM interventions
commencing within 6 weeks of hospital discharge for an exacerbation for COPD (review 1); (2) a
systematic review of the qualitative evidence about patient satisfaction, acceptance and barriers to SM
interventions (review 2); (3) a systematic review of the cost-effectiveness of SM support interventions
within 6 weeks of hospital discharge for an exacerbation of COPD (review 3); (4) a cost-effectiveness
analysis and economic model of post-exacerbation SM support compared with usual care (UC) (economic
model); and (5) a wider systematic review of the evidence of the effectiveness of SM support, including
interventions (such as pulmonary rehabilitation) in which there are significant components of SM, to
identify which components are the most important in reducing exacerbations, hospital admissions/
readmissions and improving quality of life (review 4).
Methods: The following electronic databases were searched from inception to May 2012: MEDLINE,
MEDLINE In-Process and Other Non-Indexed Citations, EMBASE, Cochrane Central Register of Controlled
Trials (CENTRAL), and Science Citation Index [Institute of Scientific Information (ISI)]. Subject-specific
databases were also searched: PEDro physiotherapy evidence database, PsycINFO and the Cochrane
Airways Group Register of Trials. Ongoing studies were sourced through the metaRegister of Current
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Controlled Trials, International Standard Randomised Controlled Trial Number database, World Health
Organization International Clinical Trials Registry Platform Portal and ClinicalTrials.gov. Specialist abstract
and conference proceedings were sourced through ISI’s Conference Proceedings Citation Index and British
Library’s Electronic Table of Contents (Zetoc). Hand-searching through European Respiratory Society, the
American Thoracic Society and British Thoracic Society conference proceedings from 2010 to 2012 was
also undertaken, and selected websites were also examined. Title, abstracts and full texts of potentially
relevant studies were scanned by two independent reviewers. Primary studies were included if ≈90%
of the population had COPD, the majority were of at least moderate severity and reported on any
intervention that included a SM component or package. Accepted study designs and outcomes differed
between the reviews. Risk of bias for randomised controlled trials (RCTs) was assessed using the Cochrane
tool. Random-effects meta-analysis was used to combine studies where appropriate. A Markov model,
taking a 30-year time horizon, compared a SM intervention immediately following a hospital admission for
an acute exacerbation with UC. Incremental costs and quality-adjusted life-years were calculated, with
sensitivity analyses.
Results: From 13,355 abstracts, 10 RCTs were included for review 1, one study each for reviews 2 and 3,
and 174 RCTs for review 4. Available studies were heterogeneous and many were of poor quality.
Meta-analysis identified no evidence of benefit of post-discharge SM support on admissions [hazard ratio
(HR) 0.78, 95% confidence interval (CI) 0.52 to 1.17], mortality (HR 1.07, 95% CI 0.74 to 1.54) and most
other health outcomes. A modest improvement in health-related quality of life (HRQoL) was identified
but this was possibly biased due to high loss to follow-up. The economic model was speculative due to
uncertainty in impact on readmissions. Compared with UC, post-discharge SM support (delivered within
6 weeks of discharge) was more costly and resulted in better outcomes (£683 cost difference and 0.0831
QALY gain). Studies assessing the effect of individual components were few but only exercise significantly
improved HRQoL (3-month St George’s Respiratory Questionnaire 4.87, 95% CI 3.96 to 5.79).
Multicomponent interventions produced an improved HRQoL compared with UC (mean difference 6.50,
95% CI 3.62 to 9.39, at 3 months). Results were consistent with a potential reduction in admissions.
Interventions with more enhanced care from health-care professionals improved HRQoL and reduced
admissions at 1-year follow-up. Interventions that included supervised or unsupervised structured exercise
resulted in significant and clinically important improvements in HRQoL up to 6 months.
Limitations: This review was based on a comprehensive search strategy that should have identified most
of the relevant studies. The main limitations result from the heterogeneity of studies available and
widespread problems with their design and reporting.
Conclusions: There was little evidence of benefit of providing SM support to patients shortly after
discharge from hospital, although effects observed were consistent with possible improvement in HRQoL
and reduction in hospital admissions. It was not easy to tease out the most effective components of SM
support packages, although interventions containing exercise seemed the most effective. Future work
should include qualitative studies to explore barriers and facilitators to SM post exacerbation and novel
approaches to affect behaviour change, tailored to the individual and their circumstances. Any new trials
should be properly designed and conducted, with special attention to reducing loss to follow-up. Individual
participant data meta-analysis may help to identify the most effective components of SM interventions.
Study registration: This study is registered as PROSPERO CRD42011001588.
Funding: The National Institute for Health Research Health Technology Assessment programme.
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Plain English summary
Chronic obstructive pulmonary disease (COPD) is a lung condition that affects about 5% of adults.Patients develop cough and breathlessness, which gets worse over time, and many patients also have
‘flare-ups’, which can lead to being admitted to hospital for a few days. Patients should try to manage
their own health (self-manage) on a daily basis – exercising, eating more healthily, taking medications
properly and learning to recognise and self-treat their ‘flare-ups’ early. The aim is to avoid going to
hospital and to maintain better quality of life.
Guidelines recommend that general practitioners and nurses should support patients to self-manage but
there is insufficient information about how best to do so. As patients who have just left hospital are at a
high risk of being admitted again, one approach would be to introduce a programme of self-management
support at this point. However, it is unclear whether this would work or whether it would be efficient
financially for the NHS.
In this report, we drew together all available evidence and showed that self-management programmes
provided soon after leaving hospital might reduce future hospital admissions and improve patients’ quality
of life, but the results were inconclusive. However, if better research were undertaken, and programmes
were proven to reduce hospital admissions, the approach would be relatively cheap to implement.
We also explored which parts of self-management programmes were the most important, and found that
those that included a specific exercise plan appeared to be the most beneficial but it was difficult to be
sure about other aspects.
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Scientific summary
Background
Systematic reviews have shown that self-management (SM) interventions can lead to improved
health-related quality of life (HRQoL) and reduced hospital admissions. However, the content and delivery
of SM support varies considerably. There are unanswered questions about whether or not SM support
would be effective and cost-effective if started immediately after a hospital admission for an exacerbation,
and what is the most effective content and method of delivery of SM programmes.
Objectives
l To undertake a systematic review of the evidence for the effectiveness of SM interventions
commencing within 6 weeks of hospital discharge for an exacerbation of chronic obstructive
pulmonary disease (COPD) (review 1).
l To undertake a systematic review of the qualitative evidence about patient satisfaction, acceptance and
barriers to SM interventions (review 2).
l To undertake a systematic review of the cost-effectiveness of SM support within 6 weeks of hospital
discharge for an exacerbation of COPD (review 3).
l To undertake a cost-effectiveness analysis and economic model of post-exacerbation SM support
compared with usual care (UC) (economic model).
l To undertake a wider systematic review of the evidence of the effectiveness of SM support including
interventions [such as pulmonary rehabilitation (PR)] where there are significant components of SM, to
identify which components are the most important in reducing exacerbations, hospital admissions and
improving quality of life (review 4).
Methods
Systematic reviews
A comprehensive search strategy of the effectiveness of SM interventions was carried out. The following
electronic databases were searched from inception to May 2012, with no language restriction: MEDLINE,
MEDLINE In-Process and Other Non-Indexed Citations, EMBASE, Cochrane Central Register of Controlled
Trials (CENTRAL), and Science Citation Index [Institute of Scientific Information (ISI)]. Subject-specific
databases were also searched: PEDro physiotherapy evidence database, PsycINFO and the Cochrane
Airways Group Register of Trials. Ongoing studies were sourced through the metaRegister of Current
Controlled Trials, International Standard Randomised Controlled Trial Number database, World Health
Organization, International Clinical Trials Registry Platform Portal and ClinicalTrials.gov. Specialist abstract
and conference proceedings were sourced through ISI’s Conference Proceedings Citation Index and British
Library’s Electronic Table of Contents (Zetoc). Hand-searching through European Respiratory Society, the
American Thoracic Society and British Thoracic Society conference proceedings from 2010 to 2012 was
also undertaken, and selected websites were also examined.
Study selection was undertaken by two independent reviewers using predefined criteria. Full-text
manuscripts were obtained of all abstracts that were likely to meet these criteria.
For review 1, randomised controlled trials (RCTs) and relevant outcomes were included. For review 2, only
qualitative studies were included. For review 3, any cost-effectiveness study design was accepted. For the
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wider exploratory review (review 4), only RCTs were included and the primary outcomes were pre-specified
as HRQoL, hospital admissions and exacerbations.
Studies in which ≈90% of patients had COPD, and where the majority of the patients were moderately/severely
affected, were included. For reviews 1–3, patients must have been discharged from hospital with acute
exacerbation of their COPD within the previous 6 weeks. For review 4, there were no restrictions around
time period.
Self-management was defined as including disease education, medication management, smoking cessation
advice, action planning, breathing management, bronchial hygiene techniques, respiratory muscle training
(RMT), exercise, correct inhaler technique, advice about nutrition, stress management, relaxation and
attendance at patient support groups.
Risk of bias of the selected RCTs was assessed using the Cochrane Risk of Bias tool. The quality of the
qualitative study was assessed using the Critical Appraisal Skills Programme tool for qualitative evidence,
and the Drummond checklist was used to assess the cost-effectiveness study.
The results of each review were presented descriptively and in forest plots where appropriate. When
meta-analysis was undertaken, continuous outcome data were pooled using mean difference with
95% confidence intervals (CIs), and hazard ratios (HRs) with 95% CI for dichotomous events. Owing to the
expectation of high levels of heterogeneity, random-effects models were used throughout. The I2-statistic
was used to assess statistical heterogeneity between trials. To explore sources of heterogeneity, subgroup
analyses were undertaken. Prediction intervals were calculated to describe the range in which 95% of
the distribution of the effects lie. HRQoL measured by the St George’s Respiratory Questionnaire (SGRQ)
were reversed so that a positive result favoured the intervention group.
Economic model of cost–utility of post-discharge self-management support
A Markov model was developed to consider short-term risks of readmission and mortality, and long-term
natural history of COPD. The model compared a SM intervention immediately after a hospital admission
for an acute exacerbation with UC. Clinical effectiveness parameters for SM were derived from the clinical
effectiveness review, specifically the risk reduction in admissions. The model was speculative; thus, although
the clinical review was not conclusive, the model could assess the potential effect and the uncertainty
around this assumption. Resource use and costs associated with SM and usual treatment for COPD were
taken from a mixture of published and unpublished sources, and expert clinical advice. A clinical cohort of
1000 patients of mixed age, sex, smoking status and disease severity was modelled for a 30-year horizon.
Incremental costs and quality-adjusted life-years (QALYs) were calculated. Extensive sensitivity analyses were
carried out.
Results
Review of self-management post-discharge (review 1)
The search identified 13,355 citations, of which 836 full-text papers were assessed and 12 were included,
reporting 10 RCTs. The interventions included were very heterogeneous, ranging from an exercise-only
intervention to intensive integrated care at home. Studies generally had small sample sizes, frequently
high risk of bias with poor reporting, high loss to follow-up (particularly for the HRQoL outcomes) and
inappropriate analyses in some studies.
Meta-analysis identified no evidence of benefit of early SM support on admissions (HR 0.78, 95% CI 0.52
to 1.17; I2= 70.9%), mortality (HR 1.07, 95% CI 0.74 to 1.54; I2= 0%) and most other health outcomes.
A modest improvement in HRQoL was identified, but this was possibly biased owing to high loss to
follow-up in studies. However, the direction of effect for many outcomes (including admissions) favoured
the SM intervention.
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Review of qualitative studies reporting patient experience of self-management
post discharge (review 2)
Only one paper from Australia with a small qualitative component was included. Patients found that the
SM programme improved their communication with health-care professionals and access to resources.
Review of cost-effectiveness and costing studies post-discharge (review 3)
Only one trial from Spain met the criteria and was a hospital-at-home intervention with a substantial
SM component.
The cost analysis [using 2000 price data in euros (€)] found that the home hospitalisation intervention was
significantly less costly than conventional care (average cost per patient: €1255.12 vs. €2033.51; p= 0.003).
Economic model of self-management support post discharge
Owing to considerable uncertainty around the impact on readmissions and heterogeneity of the trial
results, the model-based analysis should be viewed as speculative and, therefore, only providing estimates
of the potential impact of a SM programme delivered in the post-exacerbation period.
The main drivers of the model were the effect on hospital readmissions, duration of the effect, and the
cost of a SM programme. The base-case analysis showed that, compared with UC, SM support (delivered
within 6 weeks of hospital discharge) was more costly but resulted in better outcomes, with a £683 cost
difference and a gain of 0.0831 QALYs. To be cost-effective, a SM programme, post admission for an
acute exacerbation, would need to cost no more than £2200 if the relative reduction in admissions was
consistent with a HR of 0.82. The sensitivity analysis suggested that SM support had a probability of 68%
of being cost-effective at a threshold incremental cost-effectiveness ratio of £20,000 per QALY,
demonstrating the uncertainty around the impact of SM on readmissions.
Review of effectiveness of different models and components of
self-management (review 4)
A total of 194 papers reporting 174 RCTs reported one of the three primary outcomes. The majority of
populations had moderate or severe COPD and recruited participants from secondary care. Trials were
generally small (47% had < 50 participants) and had short follow-up (45% up to 3 months). Most trials
(163, 96.6%) reported HRQoL, 42 (24.1%) reported hospital readmissions and only 20 (11.5%) reported
exacerbations. In the intervention groups, exercise was the most commonly reported component (76.9%),
followed by breathing techniques and management of dyspnoea (64.2%), and general education
about COPD and its management (47.2%). Seventy-three (31.9%) of the intervention arms had six or
more components; 38 (16.6%) were single components, with the vast majority of these being
exercise-only interventions.
Sequence generation and allocation concealment were adequate in 66 (37.9%) and 27 (15.5%) studies,
respectively. Owing to lack of blinding of participants of their allocation, HRQoL results were considered at
high risk of bias, except in trials with an active intervention or sham comparator. A frequent and significant
risk of bias was the reporting of the characteristics of only those who completed the study, rather than
those randomised.
Studies assessing the effect of individual components were few, but only exercise significantly improved
patient outcomes compared with UC, which was restricted to HRQoL in the short term (SGRQ at
3-months’ follow-up 4.87, 95% CI 3.96 to 5.79; I2= 0%). This is above the minimally clinically important
difference of four points for the SGRQ. Multicomponent (at least three individual components) SM
interventions were likely to be more effective than UC: at 9–12 months’ follow-up, SGRQ= 2.40 (95% CI
0.75 to 4.04; I2= 57.9%), hospital admissions HR= 0.79 (95% CI 0.60 to 1.05; I2= 62.6%). However, the
degree of heterogeneity suggests that there are important features of these interventions that need to be
established. Compared with UC, multicomponent SM interventions with supervised exercise (as in a PR
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programme) or structured unsupervised exercise (as in a home rehabilitation programme) appear effective.
SM programmes that provide an enhanced level of care and support (where there is proactive involvement
of health-care professionals) may reduce hospital admissions in the medium term (at 6 months: HR 0.78,
95% CI 0.62 to 0.99; I2= 55.1%) and improve HRQoL (SGRQ at 6 months= 4.05, 95% CI 2.23 to 5.87;
I2= 8.4%). The number of studies included in a range of other analyses which investigated modality of
exercise, RMT, duration of programme and person delivering the programme were too limited to provide
sufficient evidence to determine their effectiveness. No conclusive findings emerged from direct
comparisons between different SM interventions. Notably, there was no evidence that action plans were
effective by themselves.
Conclusions
This report provides a thorough evaluation of the available evidence from which to design future research
in this area. The reviews of the effectiveness of SM interventions immediately post admission for an
exacerbation revealed modest potential benefits to HRQoL, with no other statistically significant effects,
but with most other outcomes (excluding mortality) favouring the SM arm. There were no good qualitative
papers reporting patient experience of these early SM interventions and only one cost-effectiveness study.
A speculative economic model describes the assumptions required for such an intervention to be
cost-effective.
The wider exploratory review of SM interventions revealed that although some components of SM
interventions were associated with positive effects of HRQoL, such as structured exercise (either within a
supervised group or home based) enhanced care and multicomponent interventions, it was not possible to
establish the relative roles of individual components in reducing hospital admissions and improving HRQoL.
Implications for health care
The evidence is not consistent with recommending SM support be provided post discharge from hospital
after an acute exacerbation of COPD. However, the risk of readmission is so high that further research is
needed to establish whether or not some aspects of SM for some patients might be an effective approach.
It is difficult to recommend specific components that should be included in SM support interventions in
general. The evidence is most consistent with exercise being an important and effective component,
particularly in a supervised or structured unsupervised format. However, the evidence is insufficient to
establish the relative importance of other aspects.
Recommendations for research
1. Current interventions to support patient SM delivered post discharge cannot currently be recommended
because interventions are heterogeneous and methodology problematic, and, despite there being
potential benefit in terms of HRQoL, there is not enough good evidence to be sure that clinical
outcomes could be improved. Therefore:
i. High-quality studies should be undertaken among patients with COPD post discharge.
ii. This should include qualitative work to explore barriers and facilitators to SM when patients have
recently had an exacerbation, exploration of novel approaches to affect behaviour change and
exploration of approaches tailored to the individual and their circumstances.
iii. New approaches should be evaluated by properly designed and conducted trials, with special
attention to reducing loss to follow-up.
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2. Owing to the heterogeneity and complexity of interventions, it was not possible to unpick the most
important components of SM interventions in general, or to confirm whether they improve clinical
outcomes. It is clear that action plans alone do not seem to work in their present form, but that
structured exercise and more heavily supported interventions (which may not usually be defined as SM)
might work better. Therefore:
i. Further in-depth work using individual participant data (e.g. an individual participant data
meta-analysis) should be carried out to try to identify which are the most effective components of
interventions and identify patient-specific factors that may modify this. This work is ongoing by
other researchers.
ii. Future studies might try to identify the characteristics of patients who are more likely to be able to
self-manage and consider a more targeted approach.
iii. Further qualitative work is needed to explore patients’ barriers and facilitators to SM interventions.
iv. Novel approaches to influence behaviour change and to help patients manage or prevent
exacerbations should be explored, first using qualitative studies and then properly designed and
conducted RCTs.
v. Most trials include a mixture of components; more trials teasing out the individual elements either as
lone interventions, or with the addition of one component, would be useful.
3. Recommendations for the design and conduct of future RCTs of interventions to support patient SM:
i. In general new trials should adhere to modern standards of design, conduct and reporting in order
to reduce risks of bias, for example, blinding of outcome assessment, attempts to maximise follow-up
or methods to impute this, reporting of the characteristics of all randomised patients.
ii. The behaviour change theories and strategies that underpin COPD SM interventions need to be
better characterised and described.
iii. A clear framework for describing and classifying SM interventions and their comparators is required.
iv. Trials need to be adequately powered to detect a clinically relevant difference and long enough
to assess changing effects over time. There should be clear reporting of outcomes to include
self-efficacy, behaviour change and clinical outcomes, such as hospital admissions and exacerbations.
v. Given the wide range of HRQoL outcomes available, it would be useful to standardise their use
within COPD research and ensure that they are reported accurately within publications.
vi. Statistical analysis methods should be improved, in particular (1) analysis of HRQoL outcomes
should routinely adjust for baseline values to overcome baseline imbalance, account for correlation
between final score and baseline score, and increase statistical power; and (2) time-to-event
outcomes should be analysed using suitable analyses that allow for differential patient follow-up
and summarised using HRs (rather than odds ratios).
Study registration
This study is registered as PROSPERO CRD42011001588.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Background
Chronic obstructive pulmonary disease: definition, prognosis
and burden
Chronic obstructive pulmonary disease (COPD) is a long-term condition characterised by ‘persistent airflow
limitation that is usually progressive and associated with an enhanced chronic inflammatory response in
the airways and the lung to noxious particles and gases’.1 The most important cause of COPD is cigarette
smoking, although other risk factors are thought to be indoor and outdoor air pollution, occupational
exposures and diet.2 Over time, patients experience increasing breathlessness and more frequent
exacerbations of respiratory symptoms, leading to increasing disability, reduced quality of life (QoL) and
often repeated hospitalisations.1
Chronic obstructive pulmonary disease affects 5–10% of people worldwide,3 is rising in prevalence,4 and is
a leading cause of death.5 In the UK it is the second most common cause of emergency admissions,6
costing the NHS over £800M per year.7 Increasing recognition of the importance of this disease8,9
culminated in a new National Clinical Outcomes Strategy in 2011.6
Diagnosis and severity of chronic obstructive pulmonary
disease
A diagnosis of COPD is suspected among people with breathlessness or cough and is supported by
post-bronchodilator spirometry to confirm irreversible airflow obstruction.10 Although definitions of airflow
obstruction are inconsistent and controversial,11 National Institute for Health and Care Excellence (NICE)
guidance for COPD currently defines airflow obstruction when the ratio of forced expiratory volume in
1 second (FEV1) to forced vital capacity (FVC) is < 0.7 (i.e. FEV1/FVC< 0.7).10 Despite the requirement for
confirmation with spirometry, there are many people with a clinical diagnosis of COPD who do not meet
these spirometric criteria.12 Late-onset asthma, other comorbidities and difficulty obtaining spirometry data
may contribute to misdiagnoses.
Severity of airflow obstruction in the UK is graded using categories of FEV1 as a percentage of predicted
normal values of a healthy reference population (Table 1),10 although these definitions may vary across
countries, and have changed over time.
Severity of airflow obstruction does not necessarily reflect either the level of disability experienced or the
frequency of exacerbation and composite measures to capture the global impact of the disease have been
proposed.1 However, they are not yet widely used as the basis for treatment decisions. Most research
TABLE 1 Current UK categories of airflow limitation
Category FEV1% pred
Mild > 80
Moderate 50–79
Severe 30–49
Very severe < 30
FEV1% pred, forced expiratory volume in 1 second percentage predicted.
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studies evaluating treatments use FEV1% pred (forced expiratory volume in 1 second percentage predicted)
to select and describe patients. FEV1 is also often used as an outcome measure to describe prognosis
of patients, as are clinical measures (such as dyspnoea and exacerbations), global measures such as
health-related quality of life (HRQoL) and health service utilisation (e.g. hospital admissions).
Exacerbations of chronic obstructive pulmonary disease
Exacerbations or ‘flare-ups’ of COPD occur in approximately 50–60% of moderate/severe patients with
COPD, per year, in published cohorts and trials13,14 and similar rates are also observed in primary care
(unpublished data from the Birmingham COPD cohort study). They are a characteristic component of
disease progression, often requiring hospitalisation1 and are associated with long-term poor outcome.
Exacerbations are caused primarily by viral respiratory infections, particularly the common cold (associated
with about two-thirds of exacerbations).15 They result in worsening of a patient’s symptoms for several
days, this being more frequent during winter months.16
Approximately 15% of patients with COPD per year have exacerbations that are severe enough to lead
to hospital admission,7 which contributes to over half of the total direct costs of COPD to the NHS.7
Readmission for an exacerbation within 3 months is high at > 30%,17 as is 30-day mortality. Exacerbations
are often not independent events, and there are a group of people who are frequent exacerbators.18
Exacerbations are usually treated with an increase in usual medication, a course of antibiotics and/or steroids.10
Management of chronic obstructive pulmonary disease
In early-stage disease patients may not display or recognise their symptoms but, as the disease progresses,
varying degrees of cough, sputum, wheeze and dyspnoea1 may develop until eventually patients may
require long-term oxygen therapy.10 Other than the acute treatment of exacerbations, therapy is aimed at
reducing progression and managing symptoms and is primarily based around smoking cessation, inhaled
medications, pulmonary rehabilitation (PR) and, increasingly, more preventative disease management
approaches [including self-management (SM)].10
Management of long-term conditions in the UK
More than 15 million people in England are living with long-term conditions such as COPD, diabetes, heart
disease and asthma.19 Long-term conditions represent > 70% of hospital bed-days and more than half of
general practitioner (GP) consultations, and account for at least 70% of the total health and social care
budget.19 For patients, long-term conditions reduce QoL and ability to carry out daily tasks, as well as
contributing to premature mortality. In the past, treatment of people with long-term conditions would
have been more reactive. However, in 2004, the NHS Improvement Plan set out the plans for the future
care of these patients by focusing on avoiding admissions and caring for patients at the primary care level,
and encouraging patients to manage their own condition (SM).20
Patients access health-care professionals relatively infrequently and, therefore, in order to optimise their
health patients must be able to manage their own condition successfully on a daily basis. Support should
be available to help patients (and their families/carers) manage their own condition and make healthier
choices about their diet, physical activity and lifestyle.20 Since the NHS Improvement Plan was published,
this approach has been embedded in subsequent policy documents,21 which clearly emphasise the
important role of SM. However, it is clear that clinicians are often reluctant to take this approach and,
therefore, the support for patient SM is likely to be suboptimal.19
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Surveys indicate that > 90% of patients with long-term conditions would like to become more active
self-managers, although in many conditions report insufficient knowledge or support to do so.22
Self-management: definition and models
‘Self-management’ has been defined as the ability of a patient to deal with all that a chronic disease
entails, including symptoms, treatment, physical and social consequences and lifestyle changes.23 The exact
nature of SM will vary from condition to condition and person to person. Indeed, there is debate about the
interpretation of the goals of SM, which may differ between health-care professionals and patients, and
between countries and health-care systems.
There are many factors that may affect a patient’s ability to self-manage (e.g. severity, presence of
comorbidities, depression, education, psychological factors, ethnicity).24–27 One behavioural model that
describes SM is Patient Activation,28 which emphasises that patients should have the knowledge, skills and
confidence to manage their own health and health care. Interventions to promote SM should aim to
address each of these components.
Interventions to support self-management
Self-management support involves collaboration between the health-care professional and the patient so
that the patient acquires and demonstrates the knowledge and skills required to manage his/her medical
regimens, change their health behaviour, improve control of their disease and improve their well-being.29
Patient education alone is not sufficient; monitoring and assessment of progress is also essential. SM
interventions should teach skills that promote health behaviour modification with the aim of increasing
self-efficacy (the belief that one can successfully execute particular behaviours), thus improving clinical
outcomes, including adherence.30 Strategies to promote self-efficacy include personal experience and
practice, feedback and reinforcement, analysis of causes of failure and shared experience with successful
peers.30 Indeed, the established NHS Expert Patient Programme for managing chronic diseases is based on
Bandura’s theory of self-efficacy.31 Evaluations of SM programmes should therefore first assess patients’
self-efficacy, change in behaviour and then patient outcomes and health-care utilisation.
Self-management programmes can be delivered in a number of ways (e.g. series of workshops, written
material, by telephone, internet or a mixture) by various professionals or lay personnel, and can have
a range of components. Systematic reviews of SM programmes for long-term conditions have concluded
that such programmes tend to lead to small improvements in some outcomes for some chronic diseases
(but not all) and that further research is needed.32,33 More recently there have been some unsuccessful
high-profile trials in primary care settings,34–36 some of which suggest that only a subgroup of patients may
be able to self-manage.
Self-management of chronic obstructive pulmonary disease:
principles and current practice
Self-management for patients with COPD is complex and challenging.10,25 It requires patients to be able to
manage various facets of their condition on a daily basis, including understanding and taking their
medications appropriately with good inhaler technique, early recognition of exacerbations of symptoms
and early instigation of treatment during an exacerbation, receiving annual influenza vaccinations,
managing their breathlessness (including stress management/relaxation) to allow them to undertake
activities of daily living, bronchial clearance techniques, taking regular exercise to maintain their lung
function and exercise capacity, quitting smoking and maintaining a healthy diet.29,30,37
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In reality, the true extent to which patients manage these aspects is not well described but it is likely to be
suboptimal. A survey published in 2009 in Canada38 revealed that although patients felt that their knowledge
about the disease was good, in reality their knowledge of the causes of COPD, the consequences of not
adhering to their medication and how to manage exacerbations was inadequate. A small study in one GP
practice in the UK in 200439 indicated that only 48% of patients with COPD had discussed levels of
exercise with their GP/nurse and only 50% had spare antibiotics/steroids at home in case of exacerbations,
although > 80% reported understanding their inhalers, knowing what to do if they had an exacerbation
and having given up smoking.
Current self-management support for chronic obstructive
pulmonary disease in the UK
Self-management support for COPD is less well developed than in other long-term conditions both in the
UK and worldwide. NICE quality standards state that patients with COPD should have a comprehensive,
up-to-date personalised management plan, including information/educational material about the condition
and its management.40 NICE guidance also emphasises that patients at risk of having an exacerbation of
COPD should be given SM advice/treatment that encourages them to respond promptly to the symptoms
of an exacerbation.10 Other aspects of SM advice include promoting proactive behaviour change, such as
smoking cessation and increased exercise. However, the evidence about the exact nature and the
effectiveness and cost-effectiveness of potential components of a SM package is acknowledged to
be inadequate.10
A variety of tools are available, such as the ‘Living Well with COPD’ programme developed by the
Montreal Chest Institute and mentioned in the American Thoracic Society statement,30 materials provided
by the British Lung Foundation,41 and materials developed by individual hospitals/universities or private
health-care companies, but there is no one consistent recommended approach.6,10 Limited evidence
suggests that programmes are patchily provided and unlikely to be individualised.42 Qualitative studies in
the UK and elsewhere suggest that patients report a lack of SM support and a lack of understanding of
their condition.43,44
This heterogeneity is reflected in the literature describing trials of a wide variety of interventions. It is
accepted, however, that the optimum package of care is not known,10 and this fact is one of the premises
upon which this report is based.
There is considerable overlap between programmes that are defined as SM and other more complex
supervised programmes, such pulmonary rehabilitation (PR).37,45 PR is defined as ‘an evidence-based,
multidisciplinary, and comprehensive intervention for patients with chronic respiratory diseases who are
symptomatic and often have decreased daily life activities . . . programs involve patient assessment, exercise
training, education, nutritional intervention, and psychosocial support’.30 A continuum of support is now
recognised, which should, ideally, be personalised to reflect an individual patient’s needs, including disease
severity and other comorbidities.37,45
For this reason, in the second study within our evidence report, we have included trials of a wide range of
care packages including PR in order to identify which features of SM are most important, as long as they
involve one or more of the specified components of SM.
BACKGROUND
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Evidence for the effectiveness and cost-effectiveness of
self-management support for chronic obstructive pulmonary
disease: existing literature
Current literature on SM for COPD largely addresses the effectiveness of SM support when delivered to
patients in a stable state. There are now many trials and overlapping systematic reviews of interventions
(such as PR, integrated care), which include a SM component, although to varying degrees.46–50 A
Cochrane systematic review of SM education interventions48 (excluding studies on PR, updated in 2009)
identified 14 randomised controlled trials (RCTs) that showed that SM interventions delivered to patients
with COPD in the stable state could significantly reduce hospital admissions compared with usual care (UC)
[odds ratio (OR)= 0.64, 95% confidence interval (CI) 0.47 to 0.89], significantly improve some domains of
QoL and effect a small improvement in dyspnoea. However, many of the other results were inconclusive,
possibly because of the great heterogeneity in the populations studied, nature of the interventions,
outcomes measured and length of follow-up. The authors concluded that ‘data were still insufficient to
formulate clear recommendations regarding the form and contents of SM education programmes in
COPD . . . with a need for more large RCTs with long-term follow-up’.48
A systematic review of five trials on the effectiveness of action plans only (with only limited education)
found that although patients were significantly more likely to recognise exacerbations and initiate
treatment, there was no reduction in health-care utilisation, and they concluded that a more significant SM
approach might be needed.50 A further systematic review of COPD disease management programmes,49
including 10 trials and three before-and-after studies, indicated that such programmes (which often
include SM components) may decrease hospital admission and improve QoL, although further exploration
of the elements that bring the greatest benefit are needed.
A more recent systematic review of integrated disease management demonstrated a significant
improvement in QoL and respiratory admissions,47 and there are other recent systematic reviews of
breathing exercises,51 outreach nurses52 and exercise training.53 These reviews are significantly overlapping
in their inclusion but none of them comprehensively reviews all of the latest trials relating to SM
interventions/components or attempts to delineate the relative effectiveness of the different components.
One important factor that varies among the trials already reviewed48 is the nature of the populations
involved. It has been suggested that SM programmes should target those patients with more severe COPD
and frequent exacerbations in order to be beneficial.29,30 Patients who are admitted to hospital have a high
risk of readmission within 90 days.17 Thus a focus on patients who are currently hospitalised for COPD
(or recently discharged) could have the most potential for health gain and reduction in resource use. Data
on such interventions following hospitalisation (other than PR programmes) are limited.54
Rationale for evidence review
Although there is a plethora of RCTs published and increasing numbers of systematic reviews on different
aspects of SM support for COPD, results are conflicting about which of the many types of interventions,
and particularly which components, are the most effective.10 Furthermore, there remain significant
unanswered questions about the timing and delivery of SM support, particularly whether SM support
provided soon after discharge from hospital is effective or cost-effective.
In 2010, the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme
published a commissioning brief: supported SM for patients with moderate to severe COPD. It asked for a
wide systematic review of the literature, particularly focusing on patients, around or soon after discharge,
to answer: ‘What are the elements of supported SM that prevent readmission to hospital and adverse
outcomes?’ We report a series of systematic reviews and an economic model to address this question.
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Chapter 2 Aims and objectives
There were two main aims of this research project. The first was to undertake a systematic review ofthe effectiveness and cost-effectiveness of supported self-management among people with moderate
to severe chronic obstructive pulmonary disease who had recently been discharged from hospital
following an acute exacerbation of their condition, and to use this evidence to undertake a model-based
cost-effectiveness analysis from the UK NHS perspective. With a wider systematic review, we also planned
to identify the features and elements of self-management interventions that are most effective.
Each aim had specific objectives.
Aim 1
Among patients with chronic obstructive pulmonary disease at discharge, or recently discharged from
hospital within the last 6 weeks, to undertake:
l a systematic review of:
¢ the evidence for the effectiveness of self-management support evaluating health behaviour change,
self-efficacy, health service utilisation and patient-reported outcomes such as QoL (review 1)
¢ the qualitative evidence about patient satisfaction, acceptance and barriers to self-management
support (review 2)
¢ the cost-effectiveness of self-management support (review 3)
l a cost-effectiveness analysis and economic model of self-management support compared with usual
care (economic model).
Aim 2 (review 4)
Among patients with chronic obstructive pulmonary disease, at any time point, to:
l undertake a wider systematic review of the evidence of the effectiveness of self-management support
[including interventions (such as pulmonary rehabilitation) for which there are significant components
of self-management] in reducing exacerbations, hospital admissions/readmissions and improving QoL
l describe the features and elements of self-management interventions in relation to their effectiveness
by simple categorisation and tabulation
l perform subgroup analysis and meta-regression to explore features such as the effect of study quality,
population, setting and nature of intervention on the effectiveness of self-management interventions
compared with usual care
l use mixed-treatment comparison meta-analysis methods to explore which components or combinations
of components are most effective.
DOI: 10.3310/hta19360 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 36
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Jordan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
7
Structure of the report
The following chapters report separately on:
l Chapter 3: Aim 1 – clinical effectiveness review (review 1)
l Chapter 4: Aim 1 – qualitative evidence review (review 2)
l Chapter 5: Aim 1 – cost-effectiveness review (review 3)
l Chapter 6: Aim 1 – economic model
l Chapter 7: Aim 2 – review of effectiveness of components of self-management (review 4).
Each of the above chapters incorporates methods, results and discussion, and then, finally, Chapter 8 provides
an overall summary.
AIMS AND OBJECTIVES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
8
Chapter 3 A systematic review of the clinical
effectiveness of supported self-management
interventions delivered shortly after hospital
discharge: review 1
The aim of this chapter is to present the findings of a systematic review of the evidence for theeffectiveness of SM support evaluating health behaviour change, self-efficacy, health service utilisation
and patient-reported outcomes, such as quality of life (QoL).
Methods
A systematic review of published evidence of the effectiveness of interventions to support self-management
(SM) among patients with chronic obstructive pulmonary disease (COPD) who had recently been discharged
from hospital.
Definition of self-management used for this review
‘Self-management’ has been defined as the ability of a patient to deal with all that a chronic disease
entails, including symptoms, treatment, physical and social consequences and lifestyle changes.23 SM
interventions involve collaboration between the health-care professional and the patient so that the patient
acquires and demonstrates the knowledge and skills required to manage their medical regimens, change
their health behaviour, improve control of their disease and improve their well-being.29 This definition of
SM was used as a basis to devise a list of SM interventions/components that were considered for this
review (Table 2). Because SM interventions are so heterogeneous, we specifically chose to include all
possible aspects of SM to ensure completeness. However, we excluded interventions of smoking cessation
alone, as there is already good evidence of the benefits of smoking cessation in general, and a large
number of systematic reviews addressing the effectiveness of smoking cessation interventions (currently 60
Cochrane systematic reviews alone). Most evidence of the effectiveness of smoking cessation relates to
general populations, rather than people with a particular condition. Any study that included smoking
cessation as one component of a multicomponent package in people with COPD was included. Similarly,
there is already a systematic review of pulmonary rehabilitation (PR) at this time point;55 therefore, it was
not considered necessary to repeat it but rather use it for comparison.
Search strategy for effectiveness studies
A comprehensive search strategy was designed and conducted by an experienced information specialist.
The searches were kept broad to capture evidence to suit both aims.
Searches for relevant studies were conducted across the following bibliographic databases: MEDLINE,
MEDLINE In-Process and Other Non-Indexed Citations and EMBASE (via Ovid), Cochrane Central Register
of Controlled Trials (CENTRAL – Wiley) and Science Citation Index (Institute of Scientific Information).
Subject-specific databases were also searched: PEDro physiotherapy evidence database, PsycINFO (via Ovid) and
the Cochrane Airways Group Register of Trials. Ongoing studies were sourced through the metaRegister
of Current Controlled Trials, International Standard Randomised Controlled Trial Number database,
World Health Organization International Clinical Trials Registry Platform Portal and ClinicalTrials.gov.
Specialist abstract and conference proceedings were sourced through the Institute of Science Information’s
Conference Proceedings Citation Index and British Library’s Electronic Table of Contents (Zetoc).
Hand-searching through European Respiratory Society, the American Thoracic Society and British Thoracic
Society (BTS) conference proceedings from 2010 to 2012 was also undertaken, and selected websites
were also examined. No language restrictions or methodological filters were applied to the searches.
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TABLE 2 Interventions and/or components included or excluded as SM
Intervention/component Included/excluded Comments
Adherence to medication Include Education about taking treatment correctly, promoting adherence
Ambulatory oxygen Exclude Unless it concerns education or support to take prescribed
treatments such as ambulatory oxygen
Breathing techniques Include For example, pursed lip breathing
Bronchial hygiene techniques Include Mucus/airways clearance
Case management Exclude Unless elements of SM
Community matrons Exclude Unless elements of SM
Complementary therapies Exclude Exclude anything on acupuncture and massage, etc.
Early recognition of
symptoms/action plans
Include Must be self-monitoring, not external monitoring by external
agency, unless there is a teaching/training element (e.g. patient
being taught how to recognise the symptoms and act accordingly)
Education Include Any topics
Exercise Include Any type of exercise
Hospital at home Exclude Unless elements of SM
Inhaler technique Include Including assessment of inhaler technique
Integrated care Exclude Unless elements of SM
Nutritional programmes Include Include anything which encourages/helps people to maintain
good nutrition or modify their diet; exclude anything to do with
(proprietary) supplements, dietary programmes or trials of
effectiveness
Patient empowerment Include As recommended by patient advisory group
Relaxation Include Any types
Respiratory muscle training Include Including both inspiratory and EMT
Smoking cessation Exclude Unless as a component of a larger package (not as a single active
intervention)
Stress management Include Any types including counselling
Support groups Include As recommended by patient advisory group
Telecare Include Exclude if purely telemonitoring – not just about contact; include
if there is an encouragement/support component, e.g. help to
promote adherence to medication
EMT, expiratory muscle training.
SYSTEMATIC REVIEW 1
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Electronic database searching was carried out from inception to May 2012, and no updated searches were
undertaken beyond this time point. The search strategies used for electronic databases can be found in
Appendix 1; terms for COPD were combined with those for SM and, where possible, utilised appropriate
medical subject headings.
The citation lists of all included studies and any citations within relevant reviews were scanned for
additional relevant studies. Consultations with experts in the field through the investigators identified
additional relevant literature.
Reference Manager version 11 (Thomson ResearchSoft, San Francisco, CA, USA) was used to store and
manage all search results.
Study selection process
After removal of duplicates, titles and abstracts of the remaining search results were independently reviewed
by two reviewers. Full texts were obtained for papers meeting the inclusion criteria or when the abstract was
unclear. Full texts were then independently reviewed by two reviewers using detailed and piloted selection
criteria concerning study design, populations, interventions, comparators and outcomes for each review.
Any discrepancies were resolved by a third reviewer. Any non-English language papers were assessed, based
on titles and abstract, but when information was lacking or unclear, translators were used to decide final
inclusion. A reviewer worked alongside translators to avoid misinterpretation of the selection criteria. During
full-text screening, papers were categorised into their appropriate objectives or were excluded with reasons.
Selection criteria
The selection criteria for this review are summarised in Table 3.
Only primary studies were included. Studies concerning patients with moderate to severe COPD were
included, and those with patients with mild or very severe COPD were included only if the majority of the
study population was moderate/severe. A COPD study population of approximately 90% was required for
inclusion unless data on the subset of patients with COPD were provided separately. Studies were included
if the intervention was set within either a hospital or a community. Studies of any SM intervention/package
or components of SM interventions were included. For example, medication management, action plans,
exercise, inhaler technique and stress management (see Table 2). Comparators consisting of usual care (UC),
control/sham or other SM interventions were accepted.
Risk of bias assessment
All RCTs were assessed using the recommended and validated Cochrane Risk of Bias tool.56 The following
six domains were assessed: sequence generation, allocation concealment, blinding of personnel and
participants (by outcome), incomplete outcome data (by outcome), selective outcome reporting and other
potential threats to validity. Domains were judged as high risk of bias, low risk of bias and unclear risk of bias.
For trials with multiple papers, information from all of the studies was used to judge risk of bias. After a
piloting process, all studies were assessed by two independent reviewers with a third reviewer overseeing the
process. The GRADE57 framework was used to denote overall quality of evidence across studies for each of the
primary outcomes and also HRQoL, using a scoring system of 4 (high) to 1 (very low) quality. The findings
were summarised in a table, incorporating the results but also aspects that led to the final judgement.
Data extraction and manipulation
Approach
Data were extracted into piloted tables by the first reviewer with a second reviewer checking the extraction
and a third reviewer overseeing the process. The results of all studies were tabulated and described and
considered for combination in meta-analyses. Authors of included studies were contacted to clarify details
and provide additional data required for analyses.
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TABLE 3 Criteria for selecting studies
Study designs RCTs
Population Patients with moderate to severe COPD (defined clinically, with or without spirometry) recruited
specifically at discharge or up to 6 weeks post discharge for an acute exacerbation of their
condition (patients with mild or very severe COPD were included if they were a minority of the
population group)
Approximately 90% of patients in studies should have COPD
The setting could be either hospital or community
Intervention SM packages or important components of SM
Excluding trials of smoking cessation and PR
Comparator No intervention, UC, control/sham, other SM intervention
Primary outcomes Any of:
Health service outcomes and mortality
Primary care consultations
Hospital admissions
Readmissions
Duration of admissions
Mortality
Emergency department visits
Secondary outcomes Any considered but to include:
Behaviour change
Self-efficacy
Specific behaviours, e.g. increase in exercise/activity
Patient-reported outcomes
Exacerbations
HRQoL
Anxiety/depression
Patient satisfaction
Dyspnoea
Other
Lung function (FEV1 and FEV1/FVC)
SYSTEMATIC REVIEW 1
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Types of data extracted
The following types of data were extracted from all papers:
1. Study characteristics Including sample size, mean age, severity according to mean FEV1% pred, place
of recruitment, descriptions of intervention and control groups, outcomes, length of intervention and
length of follow-up. When multiple papers were derived from the same trial, study characteristics
were obtained from the original paper.
2. Study results Summary results from baseline and all follow-up times were extracted, including
treatment effects, p-values, confidence intervals (CIs), mean scores at follow-up and/or mean changes
in each group, numbers of events, hazard ratios (HRs), rates, loss to follow-up, etc. If multiple
interventions were considered in a study then data were extracted for each pair of interventions compared.
Data manipulation
In order to maximise and prepare the data for statistical analyses, a number of steps were taken:
l Lengths of intervention and follow-up were converted to weeks as a proportion of a 52-week year and
rounded to the nearest week.
l For continuous outcomes, for example QoL, reported mean difference (MD) estimates and 95% CIs
calculated from an analysis of covariance (ANCOVA) were preferred, as this method adjusts for baseline
imbalances. If not reported, the following methods were used in order of priority:
¢ MDs reported from an analysis of change scores
¢ MDs reported from an analysis of final scores
¢ MDs calculated indirectly by ourselves from other information (e.g. mean change score for each
group or the mean final score for each group).
If standard errors (SEs) were not reported directly, they were calculated from other information where
available (such as p-values, 95% CIs, number in each group) at the end of follow-up, and the standard
deviation (SD) of values in each group at the end of follow-up.
l For effect estimates for numbers of events over time, for example number of admissions or
exacerbations over follow-up, we preferentially used HRs (e.g. from a Cox regression analysis) because
they compare the rate of events over the whole follow-up period and account for individuals lost to
follow-up (censored). We used only first admissions, as it is not possible to combine different types of
measures (e.g. with mean number of admissions per patient) without making very strong assumptions,
and this was the most common measure. Where not reported, the following methods were used to
estimate the HR and its 95% CI indirectly, used in this priority order:
¢ Methods of Parmar et al.,58 which allowed indirect estimation of the HR and its CI from the
p-value, and the number of patients and outcomes in each group.
¢ If numbers of events and sample size were available, the method of Perneger59 was used. Where
there were zero cells then a continuity correction (1/sample size of the opposite group) was added
to each cell to allow HRs to be calculable.60
l Where necessary, MD results and loge HRs presented on the same plots were multiplied by –1 to
ensure that all estimates and intervals obtained related to the same direction of effect (e.g. that a MD
in HRQoL of < 0 meant the same thing in each study).
l To utilise more results on emergency department (ED) visits, reported mean numbers of visits during
follow-up were converted to rate of ED visit by assuming that all patients not lost to follow-up were
observed for the full duration of the trial.
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Forest plots
Results for each outcome were presented, where relevant, on a forest plot. Interventions were heterogeneous
across the studies so results were placed in subgroups most consistent with the intensity and duration of
support provided:
(a) more-supported SM package – six or more contacts or unspecified contacts but ≥ 6 weeks’ duration
(b) less-supported SM package – fewer than six contacts or unspecified contacts and < 6 weeks’ duration
(c) exercise-based intervention.
Within each of these subgroups, studies were displayed in order of length of follow-up except for QoL
outcomes, which were also grouped by questionnaire [St George’s Respiratory Questionnaire (SGRQ),
Chronic Respiratory (Disease) Questionnaire (CRQ), EuroQoL-5 Dimensions (EQ-5D)]. As there were multiple
follow-up points, it was decided that for each outcome, only data from the final follow-up period would
be displayed in the forest plot and used in any subsequent meta-analysis. The subgroups were specified
prior to inspection of the results to allow sensible exploration of the different types of interventions.
Meta-regression was not possible owing to the limited number of studies.
Meta-analyses
General approach
For each outcome the core group met to discuss whether or not meta-analysis was appropriate.
Meta-analysis was considered only when at least three studies were available.
All analyses were undertaken using Stata statistical software, version 12 (StataCorp LP, College Station, TX,
USA). When it was not appropriate to pool data, studies were displayed graphically in a forest plot but
without pooling.
Meta-analysis methods
A random-effects meta-analysis model was used to synthesise effect estimates across trials61 to account for
between-trial heterogeneity in intervention effects across the trials. MDs were pooled on the original scale,
but HRs were pooled on the loge scale.
Heterogeneity across studies was summarised using the I2-statistic (which gives the percentage of the
total variability in the data due to between-trial heterogeneity)62 and the tau-squared statistic
(the between-trial variance).61
When two or more interventions from the same study contributed to the same meta-analysis with the
same control group, an adjustment was required:
l For continuous outcomes, the SE of each estimate was inflated by first obtaining the pooled SD
(assuming equal variances) using the estimates of SE and sample size in each group. An inflated SE was
then calculated using the full sample size in the intervention group, and the sample size in the control
group divided by the number of comparisons it contributed to within the meta-analysis.
l For one study the same control group appeared twice or more in the analysis when using a HR outcome.
As the HRs for this study had been calculated using two-by-two tables,59 adjustment was made by
modifying the number of control events and the total sample size in the control group by dividing by the
number of comparisons in which that control group was incorporated. The modified two-by-two tables
were then used to calculate new HRs to be used in the meta-analyses where appropriate.59
Assessing publication bias
This was not possible as there were fewer than 10 studies for each of the outcomes.
Patient advisory group
A patient advisory group was established from local patients with COPD, chaired by Mr Michael Darby.
Meetings were held at the University of Birmingham, and the group provided advice on how COPD affected
their lives, their understanding of the importance of SM and different components, and their experiences of
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SM programmes. This assisted in the development of the definition of SM for the inclusion criteria of this
review. For example, they suggested the need for including peer support groups as an essential component.
They also commented on the plain English summary.
Results
Search results
Study identification and flow chart
Initial database searches identified 13,355 records, of which 836 remained after scanning titles and
abstracts using the inclusion/exclusion criteria (Figure 1). After the same criteria were applied to the full
papers, 12 papers reporting 10 trials were finally included in the review.63–74 Appendix 2 details the reasons
for exclusion at each stage. These were largely because patients were not recruited at the appropriate time
point during/after discharge. Overall, 5% of all full texts required arbitration by a third reviewer.
The inclusion of two trials was particularly difficult to assess.68,75 Both were comparing ‘hospital at home’
with UC and had substantial SM components. One trial75 was excluded because all patients were seen in
the ED then randomised to home compared with hospital (and therefore patients were not admitted at all
unless in the control group). In the second study,68 although patients were assessed in the ED, a substantial
proportion of patients in both arms were initially admitted and then discharged from hospital. The
difference between the two arms was (a) the proportion of patients requiring admissions and (b) the
intervention arm had ongoing SM support at home, whereas, once discharged, the control group had
usual primary care support. Thus, this trial was included.68
Conference abstracts meeting the inclusion criteria for this review are listed in Appendix 3. There were a
further four trials that were ongoing at the time of the search end date (see Appendix 4).
Characteristics of included studies
There were 10 RCTs (from 12 papers).63–74 One study69 had a limited qualitative element referring to
patient satisfaction, which will be discussed in the following chapter (see Chapter 4), and one study68
included a cost analysis, which is presented in Chapter 5. Table 4 details the characteristics of the RCTs.
Characteristics of included randomised controlled trials
Size, setting, recruitment
Randomised controlled trials ranged in size from 3373 to 46463 total participants. One66 was a cluster RCT,
based in 45 nursing homes. One paper was the 18-month follow-up of the original study,64,65 and one
paper72 referred to the Spanish centre of a European study.71
Participants were largely recruited in hospital during an exacerbation of COPD or at (or immediately after)
discharge. Two papers67,68 also included patients recruited at the ED who may not have been admitted
to hospital.
The definition of COPD for inclusion was generally based on a clinical diagnosis (except for Bucknall et al.,63
which also required patients to meet the spirometric criteria for airflow obstruction). One study70 included a
mixed population of patients with chronic lung disease, although 89% had COPD.
Patient exclusion from trials was usually based on inability to provide consent; terminal illness or extreme
comorbidities preventing inclusion in rehabilitation/exercise; or social conditions/lack of access to a
telephone. All of the studies were set among patients living at home except for the cluster RCT, which was
specifically based in nursing homes.66
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FIGURE 1 The selection process for clinical effectiveness studies.
SYSTEMATIC REVIEW 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
16
TA
B
LE
4
C
h
ar
ac
te
ri
st
ic
s
o
f
in
cl
u
d
ed
R
C
Ts
A
u
th
o
r,
ye
ar
,
co
u
n
tr
y,
st
u
d
y
d
es
ig
n
Po
p
u
la
ti
o
n
in
cl
u
si
o
n
cr
it
er
ia
Pa
rt
ic
ip
an
ts
In
te
rv
en
ti
o
n
(n
)
C
o
m
p
ar
at
o
r
(n
)
O
u
tc
o
m
es
Be
hn
ke
,
20
00
,6
4
G
er
m
an
y,
RC
T
In
cl
us
io
n:
Se
ve
re
C
O
PD
;
pa
tie
nt
s
ad
m
itt
ed
ow
in
g
to
ac
ut
e
ex
ac
er
ba
tio
n
Ex
cl
us
io
n:
U
ns
ta
bl
e
ca
rd
ia
c
di
se
as
e,
co
r
pu
lm
on
al
e
or
ot
he
r
co
m
or
bi
di
tie
s
pr
ev
en
tin
g
ex
er
ci
se
pa
rt
ic
ip
at
io
n,
e.
g.
or
th
op
ae
di
c
in
ab
ili
tie
s
or
pe
rip
he
ra
lv
as
cu
la
r
di
se
as
e
N
=
46
Re
cr
ui
te
d
in
ho
sp
ita
l4
–
7
da
ys
po
st
ho
sp
ita
la
dm
is
si
on
O
f
30
co
m
pl
et
er
s:
M
ea
n
ag
e
(y
ea
rs
)
(S
D
):
In
t:
64
.0
(1
.9
)
C
on
t:
68
.0
(2
.2
)
Se
x
(m
al
e)
n
(%
):
In
t:
12
(8
0.
0)
C
on
t:
11
(7
3.
3)
M
ea
n
FE
V
1%
pr
ed
(S
D
):
In
t:
34
.1
(7
.4
)
C
on
t:
37
.5
(6
.6
)
TR
A
IN
IN
G
(n
=
23
)
U
su
al
m
ed
ic
at
io
n
an
d
30
m
in
ut
es
da
ily
br
ea
th
in
g
ex
er
ci
se
s
Te
n-
da
y
ho
sp
ita
l-b
as
ed
tr
ai
ni
ng
in
cl
ud
in
g
da
ily
6-
m
in
ut
e
tr
ea
dm
ill
an
d
fiv
e
se
lf-
co
nt
ro
lle
d
w
al
ki
ng
se
ss
io
ns
Fo
llo
w
ed
by
6
m
on
th
s
in
di
vi
du
al
ly
ta
ilo
re
d
ho
m
e-
ba
se
d
w
al
ki
ng
pr
og
ra
m
m
e,
th
re
e
tim
es
a
da
y
D
ia
rie
s
of
ex
er
ci
se
Tw
o-
w
ee
kl
y
vi
si
ts
fo
r
3
m
on
th
s
th
en
m
on
th
ly
te
le
ph
on
e
ca
lls
fo
r
3
m
on
th
s
C
O
N
TR
O
L
(n
=
23
)
U
su
al
m
ed
ic
at
io
n
an
d
30
m
in
ut
es
’
da
ily
br
ea
th
in
g
ex
er
ci
se
s
Te
n-
da
y
ho
sp
ita
l-b
as
ed
tr
ai
ni
ng
,
in
cl
ud
in
g
da
ily
6-
m
in
ut
e
tr
ea
dm
ill
an
d
fiv
e
se
lf-
co
nt
ro
lle
d
w
al
ki
ng
se
ss
io
ns
A
dv
is
ed
to
pe
rf
or
m
ex
er
ci
se
at
ho
m
e
w
ith
ou
t
sp
ec
ifi
c
in
st
ru
ct
io
n
M
or
ta
lit
y
(6
m
on
th
s)
Q
oL
–
C
RQ
(3
an
d
6
m
on
th
s)
Ex
er
ci
se
ca
pa
ci
ty
:
6-
M
W
T
tr
ea
dm
ill
(1
,
2,
3
an
d
6
m
on
th
s)
D
ys
pn
oe
a:
Ba
se
lin
e/
Tr
an
si
tio
na
l
D
ys
pn
oe
a
In
de
x
(e
ve
ry
vi
si
t
po
st
di
sc
ha
rg
e)
Lu
ng
fu
nc
tio
n:
FE
V
1,
FV
C
,
TL
C
,
IT
G
V
,
D
LC
O
,
RV
(d
ay
s
0
an
d
11
,
3
an
d
6
m
on
th
s)
Bl
oo
d
ga
s
an
al
ys
is
,
BP
,
he
ar
t
ra
te
(d
ay
s
1
an
d
11
,
an
d
6
m
on
th
s)
co
nt
in
ue
d
DOI: 10.3310/hta19360 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 36
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Jordan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
17
TA
B
LE
4
C
h
ar
ac
te
ri
st
ic
s
o
f
in
cl
u
d
ed
R
C
Ts
(c
o
n
ti
n
u
ed
)
A
u
th
o
r,
ye
ar
,
co
u
n
tr
y,
st
u
d
y
d
es
ig
n
Po
p
u
la
ti
o
n
in
cl
u
si
o
n
cr
it
er
ia
Pa
rt
ic
ip
an
ts
In
te
rv
en
ti
o
n
(n
)
C
o
m
p
ar
at
o
r
(n
)
O
u
tc
o
m
es
Be
hn
ke
,
20
03
,6
5
G
er
m
an
y,
RC
T
In
cl
us
io
n:
Se
ve
re
C
O
PD
;
pa
tie
nt
s
ad
m
itt
ed
du
e
to
ac
ut
e
ex
ac
er
ba
tio
n
Ex
cl
us
io
n:
U
ns
ta
bl
e
ca
rd
ia
c
di
se
as
e,
co
r
pu
lm
on
al
e
or
ot
he
r
co
m
or
bi
di
tie
s
pr
ev
en
tin
g
ex
er
ci
se
pa
rt
ic
ip
at
io
n,
e.
g.
or
th
op
ae
di
c
in
ab
ili
tie
s
or
pe
rip
he
ra
lv
as
cu
la
r
di
se
as
e
N
=
46
Fo
llo
w
-u
p
of
26
of
30
pa
tie
nt
s
w
ho
ha
d
pa
rt
ic
ip
at
ed
in
th
e
Be
hn
ke
et
al
.6
4
6-
m
on
th
tr
ia
l
O
f
26
co
m
pl
et
er
s:
M
ea
n
ag
e
(y
ea
rs
)
(S
D
):
In
t:
64
.0
(7
.5
)
C
on
t:
69
.0
(6
.9
)
Se
x
(m
al
e)
n
(%
):
In
t:
11
(7
6)
C
on
t:
9
(7
5)
FE
V
1%
pr
ed
(S
D
):
In
t:
34
.9
(7
.1
)
C
on
t:
37
.5
(6
.9
)
TR
A
IN
IN
G
(n
=
23
)
U
su
al
m
ed
ic
at
io
n
an
d
30
m
in
ut
es
’
da
ily
br
ea
th
in
g
ex
er
ci
se
s
Te
n-
da
y
ho
sp
ita
l-b
as
ed
tr
ai
ni
ng
,
in
cl
ud
in
g
da
ily
6-
m
in
ut
e
tr
ea
dm
ill
an
d
fiv
e
se
lf-
co
nt
ro
lle
d
w
al
ki
ng
se
ss
io
ns
Ei
gh
te
en
-m
on
th
ho
m
e-
ba
se
d
tr
ai
ni
ng
pr
og
ra
m
m
e,
th
re
e
tim
es
a
da
y
fo
r
15
m
in
ut
es
ba
se
d
on
12
5%
of
6-
M
W
T
fo
r
3
m
on
th
s
an
d
th
en
ad
vi
se
d
to
co
nt
in
ue
re
gu
la
r
ex
er
ci
se
D
ia
rie
s
of
ex
er
ci
se
Tw
o-
w
ee
kl
y
vi
si
ts
fo
r
3
m
on
th
s
th
en
m
on
th
ly
te
le
ph
on
e
ca
lls
fo
r
3
m
on
th
s
C
O
N
TR
O
L
(n
=
23
)
U
su
al
m
ed
ic
at
io
n
an
d
30
m
in
ut
es
’
da
ily
br
ea
th
in
g
ex
er
ci
se
s
N
o
ex
er
ci
se
tr
ai
ni
ng
in
st
ru
ct
io
ns
in
ho
sp
ita
lo
r
ho
m
e
N
o
vi
si
ts
,
bu
t
di
d
re
ce
iv
e
m
on
th
ly
te
le
ph
on
e
ca
lls
Q
oL
:C
RQ
(6
,1
2,
18
m
on
th
s)
Ex
er
ci
se
ca
pa
ci
ty
:
6-
M
W
T
tr
ea
dm
ill
(6
,
12
,
18
m
on
th
s)
D
ys
pn
oe
a:
Bo
rg
Sc
al
e
at
re
st
;
Ba
se
lin
e/
Tr
an
si
tio
na
lD
ys
pn
oe
a
In
de
x
(6
,
12
,
18
m
on
th
s)
Lu
ng
fu
nc
tio
n:
FE
V
1,
V
C
,T
LC
,
IT
G
V
,D
LC
O
,R
V
(6
,1
2,
18
m
on
th
s)
H
os
pi
ta
la
dm
iss
io
ns
(6
-m
on
th
pe
rio
ds
fo
r
18
m
on
th
s)
A
ct
iv
ity
da
ta
(tr
ai
ni
ng
gr
ou
p
on
ly
)
(e
ac
h
m
on
th
)
In
ha
le
r
an
d
m
ed
ic
at
io
ns
us
e
SYSTEMATIC REVIEW 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
18
A
u
th
o
r,
ye
ar
,
co
u
n
tr
y,
st
u
d
y
d
es
ig
n
Po
p
u
la
ti
o
n
in
cl
u
si
o
n
cr
it
er
ia
Pa
rt
ic
ip
an
ts
In
te
rv
en
ti
o
n
(n
)
C
o
m
p
ar
at
o
r
(n
)
O
u
tc
o
m
es
Le
e,
20
02
,6
6
H
on
g
K
on
g,
cl
us
te
r
RC
T
In
cl
us
io
n:
C
O
PD
;a
ge
d
65
+
ye
ar
s;
pr
es
en
t
re
si
de
nt
s
of
pa
rt
ic
ip
at
in
g
nu
rs
in
g
ho
m
e;
at
le
as
to
ne
ad
m
is
si
on
in
pr
ev
io
us
6
m
on
th
s
Ex
cl
us
io
n:
Te
rm
in
al
ill
ne
ss
(n
ot
ex
pe
ct
ed
to
su
rv
iv
e
>
6
m
on
th
s)
C
om
m
un
ic
at
io
n
pr
ob
le
m
s
N
=
45
nu
rs
in
g
ho
m
es
N
=
11
2
pa
tie
nt
s
Pa
tie
nt
s
re
cr
ui
te
d
fr
om
th
e
ge
ria
tr
ic
un
its
of
tw
o
ho
sp
ita
ls
w
ith
m
ai
n
di
ag
no
si
s
of
C
O
PD
an
d
so
on
to
be
di
sc
ha
rg
ed
O
f
89
co
m
pl
et
er
s:
M
ea
n
(S
D
)
ag
e
(y
ea
rs
):
In
t:
81
.0
8
±
6.
03
C
on
t:
79
.6
8
±
6.
53
Se
x
(m
al
e)
n
(%
):
In
t:
27
(5
6.
3)
C
on
t:
20
(4
8.
8)
M
ea
n
FE
V
1%
pr
ed
(S
D
):
In
t:
30
.6
4
(1
0.
12
)
C
on
t:
31
.0
8
(1
3.
25
)
Se
ve
rit
y
n
(%
):
l
M
ild
(≥
50
%
)
In
t:
3
(6
.3
%
)
C
on
t:
4
(9
.8
%
)
l
M
od
er
at
e
(3
5–
49
%
)
In
t:
12
(2
5.
0%
)
C
on
t:
11
(2
6.
8%
)
l
Se
ve
re
(<
35
%
)
In
t:
33
(6
8.
8%
)
C
on
t:
26
(6
3.
4%
)
C
A
RE
SU
PP
O
RT
TO
N
U
RS
IN
G
H
O
M
E
(n
=
48
co
m
pl
et
er
s)
Su
pp
or
t
to
nu
rs
in
g
ho
m
e
st
af
f
pr
ov
id
ed
by
co
m
m
un
ity
nu
rs
es
V
isi
t1
:W
ith
in
1
w
ee
k
of
di
sc
ha
rg
e:
l
A
ss
es
sm
en
t
of
he
al
th
st
at
us
l
Pl
an
s
in
di
vi
du
al
is
ed
ca
re
l
Ed
uc
at
es
nu
rs
in
g
ho
m
e
st
af
f
l
Pr
ov
id
es
w
rit
te
n
in
fo
rm
at
io
n
sh
ee
ts
l
Te
ac
he
s
pa
tie
nt
s
ap
pr
op
ria
te
ca
re
pr
oc
ed
ur
es
(e
.g
.
dr
ug
an
d
di
et
re
gi
m
e,
br
ea
th
in
g
ex
er
ci
se
s,
us
e
of
in
ha
le
rs
)
W
ee
kl
y
vi
si
ts
by
sa
m
e
co
m
m
un
ity
nu
rs
e
fo
r
1
m
on
th
to
re
in
fo
rc
e
re
co
m
m
en
de
d
ca
re
an
d
ed
uc
at
io
n
M
on
th
ly
vi
si
ts
by
sa
m
e
nu
rs
e
to
pr
ov
id
e
on
go
in
g
su
pp
or
t
an
d
ed
uc
at
io
n
to
th
e
st
af
f
Be
tw
ee
n
vi
si
ts
an
d
as
ne
ce
ss
ar
y
co
m
m
un
ity
nu
rs
e
w
ou
ld
ad
di
tio
na
lly
pr
ov
id
e
ad
vi
ce
vi
a:
l
te
le
ph
on
e
l
vi
si
t
Th
is
m
ay
in
cl
ud
e
ad
vi
ce
on
ne
ed
fo
r
ED
vi
si
t
or
ad
m
is
si
on
If
re
ad
m
itt
ed
,
pr
ot
oc
ol
an
d
vi
si
ts
re
co
m
m
en
ce
d
on
di
sc
ha
rg
e
ba
ck
to
th
e
ho
m
e
C
O
N
TR
O
L
(n
=
41
co
m
pl
et
er
s)
U
su
al
co
m
m
un
ity
nu
rs
in
g,
e.
g.
w
ou
nd
/c
at
he
te
r
m
an
ag
em
en
t
H
os
pi
ta
lis
at
io
n
(6
m
on
th
s)
l
C
O
PD
re
ad
m
is
si
on
s
l
C
O
PD
ho
sp
ita
ld
ay
s
l
D
ay
s
to
fir
st
re
ad
m
is
si
on
ED
vi
si
ts
(6
m
on
th
s)
l
C
O
PD
ED
vi
si
ts
l
D
ay
s
to
fir
st
ED
vi
si
t
Fu
nc
tio
na
ls
ta
tu
s
(6
m
on
th
s)
:
Ba
rt
he
lI
nd
ex
Re
sp
ira
to
ry
st
at
us
(6
m
on
th
s)
:
FE
V
1%
pr
ed
Ps
yc
ho
lo
gi
ca
ls
ta
tu
s
(6
m
on
th
s)
:
G
H
Q
:
to
ta
la
nd
su
bs
ca
le
s
Pa
tie
nt
sa
tis
fa
ct
io
n
(6
m
on
th
s)
:
Th
irt
ee
n-
ite
m
Li
ke
rt
sc
al
e;
no
t
ad
m
in
is
te
re
d
to
co
nt
ro
la
rm
N
ur
si
ng
he
al
th
st
af
f
sa
tis
fa
ct
io
n
(1
m
on
th
):
El
ev
en
-it
em
Li
ke
rt
sc
al
e;
no
t
ad
m
in
is
te
re
d
to
co
nt
ro
la
rm
co
nt
in
ue
d
DOI: 10.3310/hta19360 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 36
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Jordan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
19
TA
B
LE
4
C
h
ar
ac
te
ri
st
ic
s
o
f
in
cl
u
d
ed
R
C
Ts
(c
o
n
ti
n
u
ed
)
A
u
th
o
r,
ye
ar
,
co
u
n
tr
y,
st
u
d
y
d
es
ig
n
Po
p
u
la
ti
o
n
in
cl
u
si
o
n
cr
it
er
ia
Pa
rt
ic
ip
an
ts
In
te
rv
en
ti
o
n
(n
)
C
o
m
p
ar
at
o
r
(n
)
O
u
tc
o
m
es
Eg
an
20
02
,6
9
A
us
tr
al
ia
,
RC
T
pl
us
qu
al
ita
tiv
e
el
em
en
t
(n
=
18
)
In
cl
us
io
n:
C
O
PD
;≥
18
ye
ar
s;
hi
st
or
y
of
ch
ro
ni
c
br
on
ch
iti
s
(w
ith
in
fe
ct
io
n)
,e
m
ph
ys
em
a,
ch
ro
ni
c
ob
st
ru
ct
io
n,
ch
ro
ni
c
as
th
m
a,
or
co
m
bi
na
tio
n;
ad
m
is
si
on
to
re
sp
ira
to
ry
un
it
be
d
w
ith
in
72
ho
ur
s
of
ho
sp
ita
la
dm
is
si
on
Ex
cl
us
io
n:
C
og
ni
tiv
e
fu
nc
tio
n
in
su
ff
ic
ie
nt
to
co
m
pl
et
e
qu
es
tio
nn
ai
re
N
=
66
Pa
tie
nt
s
ad
m
itt
ed
w
ith
C
O
PD
to
a
m
aj
or
pr
iv
at
e
ho
sp
ita
l;
re
cr
ui
te
d
du
rin
g
ad
m
is
si
on
M
ea
n
ag
e
(y
ea
rs
):
In
t:
67
.8
C
on
t:
67
.2
Se
x
(m
al
e)
n
(%
):
In
t:
12
(3
6)
C
on
t:
20
(6
0)
FE
V
1%
pr
ed
:
N
R
Se
ve
re
(F
EV
1
<
35
%
pr
ed
)
In
t:
19
(5
7.
6%
)
C
on
t:
19
(5
7.
6%
)
M
ild
/m
od
er
at
e
(F
EV
1
35
–
50
%
pr
ed
)
In
t:
14
(4
2.
4)
C
on
t:
14
(4
2.
4)
C
A
SE
M
A
N
A
G
EM
EN
T
(n
=
33
)
N
ur
si
ng
as
se
ss
m
en
t
an
d
re
vi
ew
:
co
m
pr
eh
en
si
ve
–
to
id
en
tif
y
ph
ys
ic
al
,
ps
yc
ho
lo
gi
ca
l,
so
ci
al
,s
pi
rit
ua
l,
re
so
ur
ce
ne
ed
s;
st
an
da
rd
is
ed
cl
in
ic
al
pa
th
w
ay
of
ca
re
du
rin
g
ho
sp
ita
la
dm
is
si
on
C
oo
rd
in
at
io
n
be
tw
ee
n
m
ed
ic
al
,
nu
rs
in
g
an
d
al
lie
d
he
al
th
pe
rs
on
ne
lb
y
ca
se
m
an
ag
er
C
oo
rd
in
at
ed
ca
se
m
an
ag
em
en
t
w
ith
pa
tie
nt
an
d
ca
re
r
ed
uc
at
io
n
on
m
an
ag
in
g
th
e
di
se
as
e,
m
ed
ic
at
io
n,
re
ha
bi
lit
at
io
n,
av
ai
la
bl
e
co
m
m
un
ity
se
rv
ic
es
an
d
ar
ra
ng
ed
di
sc
ha
rg
e
pl
an
ni
ng
Re
gu
la
r
te
le
ph
on
e
ca
lls
to
pa
tie
nt
an
d
ca
re
r
at
1
w
ee
k
an
d
6
w
ee
ks
U
C
(n
=
33
)
N
ur
si
ng
as
se
ss
m
en
t
(n
ot
cl
ea
r)
;
st
an
da
rd
is
ed
cl
in
ic
al
pa
th
w
ay
of
ca
re
du
rin
g
ho
sp
ita
la
dm
is
si
on
N
o
co
nt
ac
t
w
ith
ca
se
m
an
ag
er
,
no
ca
se
co
nf
er
en
ce
s
an
d
no
po
st
-d
is
ch
ar
ge
fo
llo
w
-u
p
H
os
pi
ta
lr
ea
dm
is
si
on
:
3
m
on
th
s
Q
oL
:
SG
RQ
an
d
Su
bj
ec
tiv
e
W
el
l-B
ei
ng
Sc
al
e:
1
an
d
3
m
on
th
s
So
ci
al
su
pp
or
t
su
rv
ey
:
1
an
d
3
m
on
th
s
A
nx
ie
ty
an
d
de
pr
es
si
on
:
H
A
D
S
(1
an
d
3
m
on
th
s)
Pa
tie
nt
sa
tis
fa
ct
io
n:
qu
al
ita
tiv
e
se
m
is
tr
uc
tu
re
d
in
te
rv
ie
w
w
ith
18
pa
rt
ic
ip
an
ts
,
3
m
on
th
s
SYSTEMATIC REVIEW 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
20
A
u
th
o
r,
ye
ar
,
co
u
n
tr
y,
st
u
d
y
d
es
ig
n
Po
p
u
la
ti
o
n
in
cl
u
si
o
n
cr
it
er
ia
Pa
rt
ic
ip
an
ts
In
te
rv
en
ti
o
n
(n
)
C
o
m
p
ar
at
o
r
(n
)
O
u
tc
o
m
es
H
er
m
iz
,
20
02
,6
7
A
us
tr
al
ia
,
RC
T
In
cl
us
io
n:
C
O
PD
;
30
–
80
ye
ar
s;
pa
tie
nt
s
at
te
nd
in
g
ho
sp
ita
lE
D
or
ad
m
itt
ed
w
ith
C
O
PD
Ex
cl
us
io
n:
Re
si
de
d
ou
ts
id
e
re
gi
on
;
in
su
ff
ic
ie
nt
En
gl
is
h
sk
ill
s;
re
si
de
nt
in
nu
rs
in
g
ho
m
e;
co
nf
us
ed
or
de
m
en
te
d
N
=
17
7
Pa
tie
nt
s
at
te
nd
in
g
ho
sp
ita
lE
D
or
ad
m
itt
ed
w
ith
C
O
PD
;
no
t
cl
ea
r
ex
ac
tly
w
he
n
re
cr
ui
te
d
bu
t
vi
si
t
1
oc
cu
rr
ed
1
w
ee
k
af
te
r
di
sc
ha
rg
e
M
ea
n
ag
e
(y
ea
rs
):
In
t:
67
.1
C
on
t:
66
.7
Se
x
(m
al
e)
,
n
(%
):
In
t:
41
(4
8.
8)
C
on
t:
43
(4
6.
2)
FE
V
1%
pr
ed
:
N
R
H
O
M
E
V
IS
IT
S
(n
=
84
)
Tw
o
ho
m
e
vi
si
ts
(c
om
m
un
ity
nu
rs
e)
V
is
it
1:
W
ith
in
1
w
ee
k
of
di
sc
ha
rg
e
l
A
ss
es
sm
en
t
of
he
al
th
st
at
us
an
d
pu
lm
on
ar
y
fu
nc
tio
n
l
Ed
uc
at
io
n
(v
er
ba
la
nd
w
rit
te
n)
on
di
se
as
e
l
A
dv
ic
e
on
sm
ok
in
g
ce
ss
at
io
n,
m
an
ag
em
en
t
of
A
D
L,
en
er
gy
co
ns
er
va
tio
n,
ex
er
ci
se
,
m
ed
ic
at
io
n,
he
al
th
m
ai
nt
en
an
ce
,
ea
rly
re
co
gn
iti
on
of
si
gn
s
th
at
re
qu
ire
m
ed
ic
al
in
te
rv
en
tio
n
l
C
ar
e
pl
an
se
nt
to
G
P
l
Re
fe
rr
al
to
se
rv
ic
es
/c
on
ta
ct
w
ith
G
P
if
ne
ce
ss
ar
y
V
is
it
2:
(1
m
on
th
po
st
di
sc
ha
rg
e)
Pr
og
re
ss
re
vi
ew
Pa
tie
nt
en
co
ur
ag
ed
to
re
fe
r
to
ed
uc
at
io
n
bo
ok
le
t
fo
r
gu
id
an
ce
U
C
(n
=
93
)
U
C
(G
P)
M
or
ta
lit
y
(3
m
on
th
s)
Re
ad
m
is
si
on
s
or
ED
vi
si
ts
(3
m
on
th
s)
G
P
co
ns
ul
ta
tio
ns
or
nu
rs
e
ho
m
e
vi
si
ts
(3
m
on
th
s)
G
P
pr
es
cr
ib
ed
dr
ug
s
G
P
ar
ra
ng
ed
fo
llo
w
-u
p
G
P
pr
ov
id
ed
pa
tie
nt
w
ith
ed
uc
at
io
n
G
P
pr
ov
id
ed
ca
re
r
w
ith
ed
uc
at
io
n
Q
oL
:
SG
RQ
(3
m
on
th
s)
Be
ha
vi
ou
r
ch
an
ge
(3
m
on
th
s)
l
Sm
ok
in
g
ha
bi
ts
l
Im
m
un
is
at
io
ns
l
K
no
w
le
dg
e/
un
de
rs
ta
nd
in
g
l
H
el
p-
se
ek
in
g
Pa
tie
nt
sa
tis
fa
ct
io
n
(3
m
on
th
s)
co
nt
in
ue
d
DOI: 10.3310/hta19360 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 36
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Jordan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
21
TA
B
LE
4
C
h
ar
ac
te
ri
st
ic
s
o
f
in
cl
u
d
ed
R
C
Ts
(c
o
n
ti
n
u
ed
)
A
u
th
o
r,
ye
ar
,
co
u
n
tr
y,
st
u
d
y
d
es
ig
n
Po
p
u
la
ti
o
n
in
cl
u
si
o
n
cr
it
er
ia
Pa
rt
ic
ip
an
ts
In
te
rv
en
ti
o
n
(n
)
C
o
m
p
ar
at
o
r
(n
)
O
u
tc
o
m
es
D
he
da
,
20
04
,7
3
U
K
,
RC
T
In
cl
us
io
n:
D
ia
gn
os
is
of
C
O
PD
;
fir
st
ad
m
is
si
on
of
C
O
PD
Ex
cl
us
io
n:
A
no
th
er
do
m
in
an
t
m
ed
ic
al
co
nd
iti
on
;
m
an
da
to
ry
re
as
on
fo
r
ho
sp
ita
lf
ol
lo
w
-u
p,
e.
g.
su
sp
ec
te
d
ca
nc
er
;
al
re
ad
y
un
de
r
ou
tp
at
ie
nt
fo
llo
w
-u
p;
re
fu
se
d
co
ns
en
t
N
=
33
Fi
rs
t
ad
m
is
si
on
of
C
O
PD
N
ot
cl
ea
r
w
he
n
re
cr
ui
te
d
bu
t
im
pl
ie
s
at
di
sc
ha
rg
e
(d
at
a
m
ay
be
co
m
pl
et
er
s
on
ly
–
no
t
cl
ea
r)
:
M
ea
n
ag
e
(y
ea
rs
)
(S
D
):
In
t:
68
.4
(5
.8
)
C
on
t:
71
.3
(8
.4
)
Se
x
(m
al
e)
n
(%
):
N
R
M
ea
n
FE
V
1%
pr
ed
(S
D
):
In
t:
44
.7
(2
1.
8)
C
on
t:
39
(1
1.
9)
D
is
ea
se
se
ve
rit
y
(B
TS
gu
id
el
in
es
)
In
t:
20
%
m
ild
,
20
%
m
od
er
at
e,
60
%
se
ve
re
C
on
t:
20
%
m
ild
,
27
%
m
od
er
at
e,
53
%
se
ve
re
H
O
SP
IT
A
L
O
U
TP
A
TI
EN
T
FO
LL
O
W
-U
P
(n
=
15
)
V
is
it
to
re
sp
ira
to
ry
nu
rs
e
an
d/
or
ch
es
t
ph
ys
ic
ia
n:
(n
=
4+
)
ov
er
6-
m
on
th
pe
rio
d
(3
,
6,
8,
12
or
16
w
ee
ks
)
l
Re
vi
ew
of
in
ha
le
r
te
ch
ni
qu
e
an
d
pe
ak
flo
w
di
ar
y
l
M
ed
ic
at
io
n
as
se
ss
m
en
t
l
Sm
ok
in
g
ce
ss
at
io
n
ad
vi
ce
l
A
dv
ic
e
ab
ou
t
nu
tr
iti
on
an
d
ex
er
ci
se
l
In
tr
od
uc
tio
n
to
pa
tie
nt
su
pp
or
t
gr
ou
p
PR
IM
A
RY
C
A
RE
FO
LL
O
W
-U
P
(n
=
18
)
V
is
it
pr
im
ar
y
ca
re
te
am
s
as
re
qu
ire
d
H
os
pi
ta
la
dm
is
si
on
s
(6
m
on
th
s)
Ex
ac
er
ba
tio
ns
(t
w
o
or
m
or
e)
(6
m
on
th
s)
Q
oL
:
SG
RQ
,
SF
-3
6
(6
m
on
th
s)
Lu
ng
fu
nc
tio
n:
FE
V
1
O
xy
ge
n
sa
tu
ra
tio
n
Ph
ar
m
ac
ol
og
ic
al
pr
es
cr
ip
tio
ns
:
ox
yg
en
,
ne
bu
lis
er
,
th
eo
ph
yl
lin
e,
br
on
ch
od
ila
to
rs
SYSTEMATIC REVIEW 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
22
A
u
th
o
r,
ye
ar
,
co
u
n
tr
y,
st
u
d
y
d
es
ig
n
Po
p
u
la
ti
o
n
in
cl
u
si
o
n
cr
it
er
ia
Pa
rt
ic
ip
an
ts
In
te
rv
en
ti
o
n
(n
)
C
o
m
p
ar
at
o
r
(n
)
O
u
tc
o
m
es
H
er
na
nd
ez
,
20
03
,6
8
Sp
ai
n,
RC
T
In
cl
us
io
n:
C
O
PD
ex
ac
er
ba
tio
n;
ab
se
nc
e
of
an
y
cr
ite
ria
fo
r
im
pe
ra
tiv
e
ho
sp
ita
lis
at
io
n
as
st
at
ed
by
th
e
BT
S
gu
id
el
in
es
Ex
cl
us
io
n:
N
ot
liv
in
g
in
th
e
ar
ea
or
ad
m
itt
ed
fr
om
a
nu
rs
in
g
ho
m
e,
lu
ng
ca
nc
er
an
d
ot
he
r
ad
va
nc
ed
ne
op
la
sm
,
ex
tr
em
el
y
po
or
so
ci
al
co
nd
iti
on
s,
se
ve
re
ne
ur
ol
og
ic
al
or
ca
rd
ia
c
co
m
or
bi
di
tie
s,
ill
ite
ra
cy
,
no
te
le
ph
on
e
N
=
22
2
Pa
tie
nt
s
w
ith
C
O
PD
ex
ac
er
ba
tio
n.
Re
cr
ui
te
d
at
em
er
ge
nc
y
ro
om
of
tw
o
te
rt
ia
ry
ho
sp
ita
ls
M
ea
n
ag
e
(y
ea
rs
)
(S
D
):
In
t:
71
(9
.9
)
C
on
t:
70
.5
(9
.4
)
Se
x
(m
al
e)
%
:
In
t:
96
.7
C
on
t:
97
M
ea
n
(S
D
)
FE
V
1
l(
%
pr
ed
):
N
R
at
ba
se
lin
e
H
O
M
E-
BA
SE
D
H
O
SP
IT
A
LI
SA
TI
O
N
(n
=
12
1)
A
ss
es
se
d
by
sp
ec
ia
lis
ed
te
am
in
em
er
ge
nc
y
ro
om
A
t
di
sc
ha
rg
e
St
an
da
rd
ph
ar
m
ac
ol
og
ic
al
tr
ea
tm
en
t
w
as
us
ed
in
ac
co
rd
an
ce
w
ith
na
tio
na
l
gu
id
el
in
es
N
on
-p
ha
rm
ac
ol
og
ic
al
tr
ea
tm
en
t,
2
ho
ur
,
in
cl
ud
in
g:
l
ed
uc
at
io
n
on
kn
ow
le
dg
e
of
di
se
as
e,
ad
he
re
nc
e
to
tr
ea
tm
en
t,
re
co
gn
iti
on
/p
re
ve
nt
io
n
of
tr
ig
ge
rs
of
ex
ac
er
ba
tio
ns
l
se
le
ct
io
n
of
ap
pr
op
ria
te
eq
ui
pm
en
t
l
sm
ok
in
g
ce
ss
at
io
n
l
pa
tie
nt
em
po
w
er
m
en
t
w
ith
A
D
L,
br
ea
th
in
g
ex
er
ci
se
s,
ex
er
ci
se
s,
nu
tr
iti
on
re
co
m
m
en
da
tio
ns
l
so
ci
al
is
at
io
n
an
d
ch
an
ge
s
in
lif
es
ty
le
H
om
e
vi
si
t
(1
ho
ur
)
by
nu
rs
e
w
ith
in
24
ho
ur
s
of
di
sc
ha
rg
e
D
ur
at
io
n
of
ho
m
e
ho
sp
ita
lis
at
io
n
de
te
rm
in
ed
by
nu
rs
e;
up
to
fiv
e
vi
si
ts
pe
rm
itt
ed
du
rin
g
8-
w
ee
k
pe
rio
d,
bu
t
no
lim
it
of
te
le
ph
on
e
co
nt
ac
t;
ac
tio
n
pl
an
re
vi
sit
ed
an
d
ed
uc
at
io
n
re
in
fo
rc
ed
Fa
ilu
re
w
as
ba
se
d
on
re
fe
rr
al
to
em
er
ge
nc
y
ro
om
or
m
or
e
th
an
fiv
e
nu
rs
e
vi
si
ts
re
qu
ire
d
U
C
(n
=
10
1)
St
an
da
rd
as
se
ss
m
en
t
by
ph
ys
ic
ia
n
in
em
er
ge
nc
y
ro
om
St
an
da
rd
ph
ar
m
ac
ol
og
ic
al
tr
ea
tm
en
t
N
o
po
st
-d
is
ch
ar
ge
fo
llo
w
-u
p
M
or
ta
lit
y
(2
m
on
th
s)
Re
ad
m
is
si
on
s
or
ED
vi
si
ts
(2
m
on
th
s)
H
os
pi
ta
lis
at
io
n:
ho
sp
ita
ld
ay
s
(2
m
on
th
s)
Q
oL
:
SG
RQ
an
d
SF
-1
2
sc
al
e
(2
m
on
th
s)
Lu
ng
fu
nc
tio
n:
FE
V
1,
FV
C
(2
m
on
th
s)
Pa
tie
nt
sa
tis
fa
ct
io
n
(2
m
on
th
s)
D
is
ea
se
kn
ow
le
dg
e
(2
m
on
th
s)
In
ha
le
r
te
ch
ni
qu
e
(2
m
on
th
s)
M
ed
ic
at
io
n
pr
es
cr
ip
tio
ns
an
d
ho
m
e
re
ha
bi
lit
at
io
n
(2
m
on
th
s)
C
os
ts
(2
m
on
th
s)
co
nt
in
ue
d
DOI: 10.3310/hta19360 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 36
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Jordan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
23
TA
B
LE
4
C
h
ar
ac
te
ri
st
ic
s
o
f
in
cl
u
d
ed
R
C
Ts
(c
o
n
ti
n
u
ed
)
A
u
th
o
r,
ye
ar
,
co
u
n
tr
y,
st
u
d
y
d
es
ig
n
Po
p
u
la
ti
o
n
in
cl
u
si
o
n
cr
it
er
ia
Pa
rt
ic
ip
an
ts
In
te
rv
en
ti
o
n
(n
)
C
o
m
p
ar
at
o
r
(n
)
O
u
tc
o
m
es
K
w
ok
,
20
04
,7
0
H
on
g
K
on
g,
RC
T
In
cl
us
io
n:
C
LD
(8
9%
ha
d
C
O
PD
);
60
+
ye
ar
s;
ha
vi
ng
at
le
as
t
on
e
ho
sp
ita
l
ad
m
iss
io
n
fo
r
C
LD
in
th
e
6
m
on
th
s
be
fo
re
in
de
x
ad
m
iss
io
n
Ex
cl
us
io
n:
Re
sid
ed
ou
ts
id
e
re
gi
on
;
co
m
m
un
ic
at
io
n
di
ff
ic
ul
tie
s;
no
fa
m
ily
ca
re
gi
ve
r;
re
sid
en
t
in
in
st
itu
tio
na
lc
ar
e;
te
rm
in
al
di
se
as
e
w
ith
lif
e
ex
pe
ct
an
cy
<
6
m
on
th
s
N
=
15
7
H
os
pi
ta
lis
ed
pa
tie
nt
s
w
ith
pr
in
ci
pa
ld
ia
gn
os
is
of
C
LD
re
cr
ui
te
d
fr
om
m
ed
ic
al
w
ar
ds
of
tw
o
ho
sp
ita
ls
w
ith
in
3
da
ys
of
ad
m
is
si
on
O
f
14
9
co
m
pl
et
er
s:
M
ea
n
ag
e
(y
ea
rs
)
(S
D
):
In
t:
75
.3
±
7
C
on
t:
74
.2
±
5.
7
Se
x
(m
al
e)
n
(%
):
In
t:
56
(7
3)
C
on
t:
55
(6
9)
M
ea
n
FE
V
1:
N
R
IN
TE
RV
EN
TI
O
N
(n
=
77
)
A
co
m
m
un
ity
nu
rs
e
V
is
it
1:
Be
fo
re
di
sc
ha
rg
e:
l
pr
ov
id
e
he
al
th
co
un
se
lli
ng
(d
ru
g
co
m
pl
ia
nc
e,
in
ha
le
r
te
ch
ni
qu
e,
di
et
ar
y
ad
vi
ce
as
re
qu
ire
d)
l
en
co
ur
ag
e
to
co
nt
ac
t
nu
rs
e
w
he
n
th
ey
de
ve
lo
pe
d
m
ed
ic
al
pr
ob
le
m
s
vi
a
te
le
ph
on
e
ho
tli
ne
V
is
it
2:
(7
da
ys
’
po
st
-d
is
ch
ar
ge
ho
m
e
vi
si
t)
l
Re
vi
ew
co
nd
iti
on
l
G
iv
e
he
al
th
co
un
se
lli
ng
–
re
in
fo
rc
e
dr
ug
an
d
di
et
re
gi
m
e,
pr
ov
id
e
ad
vi
ce
on
m
od
ifi
ca
tio
ns
of
ho
m
e
en
vi
ro
nm
en
t
to
av
oi
d
irr
ita
nt
s
or
ph
ys
ic
al
da
ng
er
,
en
co
ur
ag
e
ph
ys
ic
al
ex
er
ci
se
l
Pr
ov
id
e
ps
yc
ho
so
ci
al
su
pp
or
t
l
A
rr
an
ge
so
ci
al
an
d
he
al
th
se
rv
ic
es
l
En
co
ur
ag
e
us
e
of
ho
tli
ne
w
he
n
sy
m
pt
om
s
ar
os
e
W
ee
kl
y
ho
m
e
vi
si
ts
fo
r
4
w
ee
ks
an
d
m
on
th
ly
th
er
ea
ft
er
fo
r
up
to
6
m
on
th
s
to
m
on
ito
r
ch
an
ge
s
in
ph
ys
ic
al
co
nd
iti
on
,r
ei
nf
or
ce
he
al
th
co
un
se
lli
ng
,
an
d
en
co
ur
ag
e
ho
tli
ne
us
e
if
ne
ce
ss
ar
y
U
C
(n
=
80
)
Ro
ut
in
e
fo
llo
w
-u
p
by
sa
m
e
m
ed
ic
al
te
am
s
So
m
e
pa
tie
nt
s
re
ce
iv
ed
ho
m
e
vi
si
t
if
re
fe
rr
ed
H
os
pi
ta
lr
ea
dm
is
si
on
s
(4
w
ee
ks
,
6
m
on
th
s)
Pe
rio
d
of
ho
sp
ita
lis
at
io
n
(b
ed
-d
ay
s)
ED
vi
si
ts
(6
m
on
th
s)
Ps
yc
ho
so
ci
al
sc
or
es
:
Lo
nd
on
H
an
di
ca
p
Sc
al
e,
G
H
Q
sc
or
e,
M
ul
tid
im
en
si
on
al
H
ea
lth
Lo
cu
s
of
C
on
tr
ol
Sc
al
es
(6
m
on
th
s)
Ex
er
ci
se
ca
pa
ci
ty
:
6-
M
W
T
(6
m
on
th
s)
M
or
ta
lit
y
(6
m
on
th
s)
C
ar
e
bu
rd
en
(6
m
on
th
s)
:
C
os
t
of
C
ar
e
In
de
x
SYSTEMATIC REVIEW 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
24
A
u
th
o
r,
ye
ar
,
co
u
n
tr
y,
st
u
d
y
d
es
ig
n
Po
p
u
la
ti
o
n
in
cl
u
si
o
n
cr
it
er
ia
Pa
rt
ic
ip
an
ts
In
te
rv
en
ti
o
n
(n
)
C
o
m
p
ar
at
o
r
(n
)
O
u
tc
o
m
es
W
on
g,
20
05
,7
4
H
on
g
K
on
g,
RC
T
In
cl
us
io
n:
D
ia
gn
os
is
of
C
O
PD
;
al
er
t
an
d
or
ie
nt
at
ed
;
co
nt
ac
ta
bl
e
by
te
le
ph
on
e
Ex
cl
us
io
n:
D
is
ch
ar
ge
d
to
an
ol
d-
ag
e
ho
m
e;
se
rio
us
al
co
ho
lo
r
dr
ug
ab
us
e
or
ps
yc
hi
at
ric
di
se
as
e;
di
ag
no
se
d
w
ith
IH
D
,
m
us
cu
lo
sk
el
et
al
di
so
rd
er
s
or
ot
he
r
di
sa
bl
in
g
di
se
as
es
th
at
m
ay
lim
it
re
ha
bi
lit
at
io
n;
dy
in
g
an
d/
or
un
ab
le
to
pr
ov
id
e
in
fo
rm
ed
co
ns
en
t
N
=
60
A
t
di
sc
ha
rg
e
fr
om
m
ed
ic
al
de
pa
rt
m
en
t
of
ac
ut
e
ca
re
ho
sp
ita
l
M
ea
n
ag
e
(y
ea
rs
)
(S
D
):
73
.6
(7
.8
)
Se
x
(m
al
e)
n
(%
):
47
(7
8.
3)
FE
V
1%
pr
ed
:
N
R
TE
LE
PH
O
N
E
FO
LL
O
W
-U
P
(n
=
30
)
St
ru
ct
ur
ed
,
in
di
vi
du
al
is
ed
ed
uc
at
io
na
l
an
d
su
pp
or
tiv
e
te
le
ph
on
e
fo
llo
w
-u
p
pr
og
ra
m
m
e
de
liv
er
ed
by
a
re
sp
ira
to
ry
nu
rs
e
Ba
se
d
on
Ba
nd
ur
a’
s
th
eo
ry
of
se
lf-
ef
fic
ac
y3
1
l
G
oa
l-s
et
tin
g
an
d
pa
tie
nt
ed
uc
at
io
n
in
cl
ud
in
g:
¢
m
an
ag
em
en
t
of
dy
sp
no
ea
an
d
en
er
gy
-s
av
in
g
te
ch
ni
qu
es
¢
ve
rb
al
pe
rs
ua
si
on
(m
ed
ic
at
io
n
ad
he
re
nc
e)
¢
st
re
ss
m
an
ag
em
en
t
te
ch
ni
qu
es
(r
el
ax
at
io
n,
br
ea
th
in
g
te
ch
ni
qu
es
)
Tw
o
te
le
ph
on
e
co
nt
ac
ts
on
da
ys
3–
7
an
d
da
ys
14
–
20
w
ith
ea
ch
ca
ll
la
st
in
g
10
–
20
m
in
ut
es
RO
U
TI
N
E
C
A
RE
(n
=
30
)
U
C
H
ea
lth
se
rv
ic
e
ut
ili
sa
tio
n:
ED
,
ou
tp
at
ie
nt
,
ad
m
is
si
on
s
(1
,
3
m
on
th
s)
Se
lf-
ef
fic
ac
y:
M
od
ifi
ed
C
hi
ne
se
C
O
PD
Se
lf-
Ef
fic
ac
y
Sc
al
e
fo
r
dy
sp
no
ea
(d
ay
35
)
co
nt
in
ue
d
DOI: 10.3310/hta19360 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 36
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Jordan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
25
TA
B
LE
4
C
h
ar
ac
te
ri
st
ic
s
o
f
in
cl
u
d
ed
R
C
Ts
(c
o
n
ti
n
u
ed
)
A
u
th
o
r,
ye
ar
,
co
u
n
tr
y,
st
u
d
y
d
es
ig
n
Po
p
u
la
ti
o
n
in
cl
u
si
o
n
cr
it
er
ia
Pa
rt
ic
ip
an
ts
In
te
rv
en
ti
o
n
(n
)
C
o
m
p
ar
at
o
r
(n
)
O
u
tc
o
m
es
C
as
as
,
20
06
,7
1
Sp
ai
n,
RC
T
In
cl
us
io
n:
C
O
PD
;
ho
sp
ita
l
ad
m
is
si
on
>
48
ho
ur
s
du
e
to
ex
ac
er
ba
tio
n
Ex
cl
us
io
n:
N
ot
liv
in
g
in
he
al
th
-
ca
re
ar
ea
;s
ev
er
e
co
m
or
bi
d
co
nd
iti
on
s;
lo
gi
st
ic
al
lim
ita
tio
ns
du
e
to
po
or
so
ci
al
co
nd
iti
on
s,
e.
g.
no
te
le
ph
on
e
ac
ce
ss
;
ad
m
itt
ed
to
nu
rs
in
g
ho
m
e
N
=
15
5
(n
=
11
3,
Ba
rc
el
on
a;
n
=
42
,
Le
uv
en
)
Re
cr
ui
te
d
im
m
ed
ia
te
ly
af
te
r
ho
sp
ita
ld
is
ch
ar
ge
fr
om
tw
o
te
rt
ia
ry
ho
sp
ita
ls
(B
ar
ce
lo
na
,
Le
uv
en
)
M
ea
n
ag
e
(y
ea
rs
)
(S
D
):
In
t:
70
(9
)
C
on
t:
72
(9
)
Se
x
(m
al
e)
n
(%
):
In
t:
50
(7
7)
C
on
t:
79
(7
8)
M
ea
n
FE
V
1%
pr
ed
(S
D
):
In
t:
43
(2
0)
C
on
t:
41
(1
5)
IN
TE
G
RA
TE
D
C
A
RE
(n
=
65
)
Fo
ur
-p
ar
t
in
te
gr
at
ed
ca
re
:
1.
C
om
pr
eh
en
si
ve
as
se
ss
m
en
t
of
pa
tie
nt
2.
Ed
uc
at
io
n
se
ss
io
n
on
SM
(2
ho
ur
s)
(d
is
ea
se
kn
ow
le
dg
e,
sm
ok
in
g
ce
ss
at
io
n,
pr
om
ot
io
n
of
ph
ys
ic
al
ac
tiv
ity
,
nu
tr
iti
on
al
ad
vi
ce
,
in
st
ru
ct
io
ns
on
ot
he
r
no
n-
ph
ar
m
ac
ol
og
ic
al
tr
ea
tm
en
t,
m
ed
ic
at
io
n
ad
m
in
is
tr
at
io
n,
te
ac
hi
ng
SM
st
ra
te
gi
es
to
co
pe
w
ith
fu
tu
re
ex
ac
er
ba
tio
n)
3.
In
di
vi
du
al
ly
ta
ilo
re
d
ca
re
pl
an
:
l
Ba
rc
el
on
a:
1×
jo
in
t
vi
si
t
by
sp
ec
ia
lis
ed
nu
rs
e
an
d
pr
im
ar
y
ca
re
te
am
l
Le
uv
en
:
re
gu
la
r
ho
m
e
G
P
vi
si
ts
us
in
g
st
an
da
rd
gu
id
el
in
es
4.
W
ee
kl
y
te
le
ph
on
e
ca
lls
fo
r
1
m
on
th
.
Te
le
ph
on
e
ca
lls
at
3
m
on
th
s
an
d
9
m
on
th
s
w
ith
no
ed
uc
at
io
n
5.
A
cc
es
s
to
th
e
sp
ec
ia
lis
t
nu
rs
e
at
th
e
ho
sp
ita
lt
hr
ou
gh
IC
T
pl
at
fo
rm
in
cl
ud
in
g
w
eb
-b
as
ed
ca
ll
ce
nt
re
.
C
ou
ld
tr
ig
ge
r
a
vi
si
t
N
ot
e
th
at
th
er
e
is
so
m
e
in
co
ns
is
te
nc
y
w
ith
G
ar
ci
a-
A
ym
er
ic
h7
2
U
C
(n
=
90
)
U
C
:
H
os
pi
ta
lp
hy
si
ci
an
de
ci
de
d
on
ou
tp
at
ie
nt
co
nt
ro
lr
eg
im
e.
St
an
da
rd
pr
ot
oc
ol
fo
r
ph
ar
m
ac
ol
og
ic
al
pr
es
cr
ip
tio
n
an
d
in
-h
os
pi
ta
lt
re
at
m
en
t
Ph
ys
ic
ia
n
vi
si
t
ev
er
y
6
m
on
th
s
M
or
ta
lit
y
(6
,
12
m
on
th
s)
H
os
pi
ta
la
dm
is
si
on
s
(1
2
m
on
th
s)
H
ea
lth
-c
ar
e
re
so
ur
ce
ut
ili
sa
tio
n
(1
2
m
on
th
s)
:
in
cl
ud
es
G
P
co
ns
ul
ta
tio
ns
SYSTEMATIC REVIEW 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
26
A
u
th
o
r,
ye
ar
,
co
u
n
tr
y,
st
u
d
y
d
es
ig
n
Po
p
u
la
ti
o
n
in
cl
u
si
o
n
cr
it
er
ia
Pa
rt
ic
ip
an
ts
In
te
rv
en
ti
o
n
(n
)
C
o
m
p
ar
at
o
r
(n
)
O
u
tc
o
m
es
G
ar
ci
a-
A
ym
er
ic
h,
20
07
,72
Sp
ai
n
(s
ub
se
t
of
C
as
as
et
al
.71
),
RC
T
In
cl
us
io
n:
C
O
PD
;
ad
m
itt
ed
be
ca
us
e
of
an
ep
is
od
e
of
ex
ac
er
ba
tio
n
re
qu
iri
ng
ho
sp
ita
lis
at
io
n
fo
r
>
48
ho
ur
s
Ex
cl
us
io
n:
N
ot
liv
in
g
in
th
e
he
al
th
-c
ar
e
ar
ea
or
liv
in
g
in
a
nu
rs
in
g
ho
m
e;
lu
ng
ca
nc
er
or
ot
he
r
ad
va
nc
ed
m
al
ig
na
nc
ie
s;
lo
gi
st
ic
lim
ita
tio
ns
du
e
to
po
or
so
ci
al
co
nd
iti
on
s,
ill
ite
ra
cy
or
no
te
le
ph
on
e
ac
ce
ss
;
ex
tr
em
el
y
se
ve
re
ne
ur
ol
og
ic
al
or
ca
rd
io
va
sc
ul
ar
co
m
or
bi
di
tie
s
N
=
11
3
Re
cr
ui
te
d
im
m
ed
ia
te
ly
af
te
r
di
sc
ha
rg
e
fr
om
on
e
te
rt
ia
ry
ho
sp
ita
l
O
f
62
co
m
pl
et
er
s:
M
ea
n
ag
e
(y
ea
rs
)
(S
D
):
In
t:
72
(1
0)
C
on
t:
73
(9
)
Se
x
(m
al
e)
n
(%
):
In
t:
16
(8
0.
0)
C
on
t:
37
(9
0)
FE
V
1%
pr
ed
:
N
R
D
es
cr
ib
ed
as
‘s
ev
er
e’
IN
TE
G
RA
TE
D
C
A
RE
(n
=
44
)
Fo
ur
-p
ar
t
in
te
gr
at
ed
ca
re
:
1.
C
om
pr
eh
en
si
ve
as
se
ss
m
en
t
of
pa
tie
nt
2.
Ed
uc
at
io
n
se
ss
io
n
on
SM
(2
ho
ur
)
(d
is
ea
se
kn
ow
le
dg
e,
sm
ok
in
g
ce
ss
at
io
n,
pr
om
ot
io
n
of
ph
ys
ic
al
ac
tiv
ity
,
nu
tr
iti
on
al
ad
vi
ce
,
in
st
ru
ct
io
ns
on
ot
he
r
no
n-
ph
ar
m
ac
ol
og
ic
al
tr
ea
tm
en
t,
m
ed
ic
at
io
n
ad
m
in
is
tr
at
io
n,
te
ac
hi
ng
SM
st
ra
te
gi
es
to
co
pe
w
ith
fu
tu
re
ex
ac
er
ba
tio
n)
;
w
rit
te
n
in
fo
rm
at
io
n
pr
ov
id
ed
an
d
ed
uc
at
io
n
on
sk
ill
s
to
id
en
tif
y
de
te
rio
ra
tio
n
an
d
ad
vi
se
d/
ta
ug
ht
to
ca
ll
th
e
ca
ll
ce
nt
re
if
si
gn
s
an
d
sy
m
pt
om
s
in
di
ca
tiv
e
of
cl
in
ic
al
de
te
rio
ra
tio
n;
ca
ll
to
sp
ec
ia
lis
t
nu
rs
e
ge
ne
ra
te
d
ad
vi
ce
or
ho
m
e
vi
si
t
as
ne
ce
ss
ar
y
3.
In
di
vi
du
al
ly
ta
ilo
re
d
ca
re
pl
an
(d
ev
is
ed
by
nu
rs
e
ca
se
m
an
ag
er
an
d
pr
im
ar
y
ca
re
te
am
);
jo
in
t
vi
si
t
m
ad
e
w
ith
in
72
ho
ur
s
of
di
sc
ha
rg
e
re
ga
rd
in
g
co
m
or
bi
di
tie
s
an
d
so
ci
al
su
pp
or
t;
w
ee
kl
y
te
le
ph
on
e
ca
lls
1
m
on
th
,
on
e
fu
rt
he
r
ca
ll
at
m
on
th
s
3
an
d
9
to
re
in
fo
rc
e
SM
4.
A
cc
es
s
to
th
e
sp
ec
ia
lis
t
nu
rs
e
at
th
e
ho
sp
ita
lt
hr
ou
gh
IC
T
pl
at
fo
rm
in
cl
ud
in
g
w
eb
-b
as
ed
ca
ll
ce
nt
re
U
C
(n
=
69
)
U
C
M
or
ta
lit
y
(6
an
d
12
m
on
th
s)
Q
oL
:
SG
RQ
,
EQ
-5
D
(6
an
d
12
m
on
th
s)
D
ys
pn
oe
a:
M
RC
(6
an
d
12
m
on
th
s)
Tr
ea
tm
en
t
ad
he
re
nc
e
an
d
in
ha
le
r
te
ch
ni
qu
e:
M
ed
ic
at
io
n
A
dh
er
en
ce
Sc
al
e,
In
ha
le
r
A
dh
er
en
ce
Sc
al
e
an
d
ob
se
rv
at
io
n;
m
ed
ic
at
io
n
us
e
(6
an
d
12
m
on
th
s)
M
ed
ic
at
io
ns
an
d
ox
yg
en
th
er
ap
y
(6
an
d
12
m
on
th
s)
Lu
ng
fu
nc
tio
n
–
FE
V
1,
FV
C
,
Pa
O
2,
Pa
C
O
2
(6
an
d
12
m
on
th
s)
V
ac
ci
na
tio
n
up
ta
ke
(in
flu
en
za
,
pn
eu
m
oc
oc
ca
l):
6
an
d
12
m
on
th
s
Pa
tie
nt
sa
tis
fa
ct
io
n
(6
an
d
12
m
on
th
s)
Sm
ok
in
g
(6
an
d
12
m
on
th
s)
Ex
er
ci
se
(6
an
d
12
m
on
th
s)
K
no
w
le
dg
e:
ab
ou
t
di
se
as
e
an
d
id
en
tif
ic
at
io
n/
tr
ea
tm
en
t
of
ex
ac
er
ba
tio
ns
BM
I
co
nt
in
ue
d
DOI: 10.3310/hta19360 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 36
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Jordan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
27
TA
B
LE
4
C
h
ar
ac
te
ri
st
ic
s
o
f
in
cl
u
d
ed
R
C
Ts
(c
o
n
ti
n
u
ed
)
A
u
th
o
r,
ye
ar
,
co
u
n
tr
y,
st
u
d
y
d
es
ig
n
Po
p
u
la
ti
o
n
in
cl
u
si
o
n
cr
it
er
ia
Pa
rt
ic
ip
an
ts
In
te
rv
en
ti
o
n
(n
)
C
o
m
p
ar
at
o
r
(n
)
O
u
tc
o
m
es
Bu
ck
na
ll,
20
12
,6
3
U
K
,
RC
T
In
cl
us
io
n:
Pa
tie
nt
s
w
ith
C
O
PD
ad
m
itt
ed
to
ho
sp
ita
l
w
ith
ac
ut
e
ex
ac
er
ba
tio
n;
FE
V
1
<
70
%
pr
ed
an
d
FE
V
1/
FV
C
<
0.
7
Ex
cl
us
io
n:
H
ist
or
y
of
as
th
m
a
or
le
ft
ve
nt
ric
ul
ar
fa
ilu
re
;
ac
tiv
e
m
al
ig
na
nt
di
se
as
e;
ev
id
en
ce
of
co
nf
us
io
n
or
po
or
m
em
or
y
N
=
46
4
D
ur
in
g
or
sh
or
tly
af
te
r
ho
sp
ita
la
dm
is
si
on
;
si
x
ac
ut
e
ho
sp
ita
ls
an
d
co
nt
rib
ut
in
g
ho
sp
ita
ls
w
ith
el
ig
ib
le
pa
tie
nt
s;
au
gm
en
te
d
by
re
vi
ew
of
pa
tie
nt
s
at
te
nd
in
g
PR
an
d
ch
ec
ki
ng
fo
r
ev
id
en
ce
of
ho
sp
ita
la
dm
is
si
on
M
ea
n
ag
e
(y
ea
rs
)
(S
D
):
69
.1
(9
.3
)
Se
x
(m
al
e)
n
(%
):
17
0
(3
7%
)
SU
PP
O
RT
ED
SM
(n
=
23
2)
Lo
ng
-t
er
m
tr
ea
tm
en
t
op
tim
is
ed
,
in
ha
le
r
te
ch
ni
qu
es
ch
ec
ke
d,
of
fe
re
d
ap
pr
op
ria
te
sm
ok
in
g
ce
ss
at
io
n
ad
vi
ce
an
d
PR
Sy
m
pt
om
da
ily
di
ar
ie
s
Su
pp
or
te
d
SM
by
nu
rs
es
tr
ai
ne
d
in
‘s
el
f-
re
gu
la
tio
n
th
eo
ry
’;
th
is
ai
m
s
to
em
po
w
er
pa
tie
nt
s
to
m
an
ag
e
C
O
PD
by
im
pr
ov
ed
kn
ow
le
dg
e
an
d
un
de
rs
ta
nd
in
g
of
th
e
di
se
as
e
an
d
sk
ill
s
to
m
on
ito
r
sy
m
pt
om
s
an
d
ca
rr
y
ou
t
ap
pr
op
ria
te
ac
tio
ns
,
su
ch
as
al
te
rin
g
tr
ea
tm
en
t
ea
rly
in
ea
rly
st
ag
es
of
an
ex
ac
er
ba
tio
n
U
C
(n
=
23
2)
Lo
ng
-t
er
m
tr
ea
tm
en
t
op
tim
is
ed
,
in
ha
le
r
te
ch
ni
qu
es
ch
ec
ke
d,
of
fe
re
d
ap
pr
op
ria
te
sm
ok
in
g
ce
ss
at
io
n
ad
vi
ce
an
d
PR
Sy
m
pt
om
da
ily
di
ar
ie
s
U
C
:
co
nt
in
ui
ng
m
an
ag
em
en
t
by
G
P,
ho
sp
ita
lc
lin
ic
ia
ns
or
bo
th
M
or
ta
lit
y
(1
2
m
on
th
s)
H
os
pi
ta
la
dm
is
si
on
w
ith
ex
ac
er
ba
tio
n
of
C
O
PD
(1
2
m
on
th
s)
Su
cc
es
sf
ul
SM
(in
iti
at
in
g
tr
ea
tm
en
t
du
rin
g
ex
ac
er
ba
tio
n)
(1
2
m
on
th
s)
Q
oL
:
SG
RQ
,
EQ
-5
D
(6
an
d
12
m
on
th
s)
A
nx
ie
ty
/d
ep
re
ss
io
n
–
H
A
D
S
(6
an
d
12
m
on
th
s)
Se
lf-
ef
fic
ac
y
–
C
O
PD
Se
lf
Ef
fic
ac
y
Sc
al
e
(6
an
d
12
m
on
th
s)
SYSTEMATIC REVIEW 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
28
A
u
th
o
r,
ye
ar
,
co
u
n
tr
y,
st
u
d
y
d
es
ig
n
Po
p
u
la
ti
o
n
in
cl
u
si
o
n
cr
it
er
ia
Pa
rt
ic
ip
an
ts
In
te
rv
en
ti
o
n
(n
)
C
o
m
p
ar
at
o
r
(n
)
O
u
tc
o
m
es
M
ea
n
FE
V
1%
pr
ed
(S
D
):
40
.5
(1
3.
6)
SM
m
at
er
ia
lb
as
ed
on
‘L
iv
in
g
W
el
l
w
ith
C
O
PD
pr
og
ra
m
m
e’
C
on
te
nt
in
cl
ud
ed
:
l
D
is
ea
se
kn
ow
le
dg
e
l
Ev
en
ts
th
at
le
d
to
ho
sp
ita
l
ad
m
is
si
on
l
N
at
ur
e
of
ex
ac
er
ba
tio
ns
l
Re
co
gn
is
in
g
ea
rly
si
gn
s
of
an
ex
ac
er
ba
tio
n
l
M
an
ag
in
g
fu
tu
re
ex
ac
er
ba
tio
ns
an
d
m
on
ito
rin
g
si
gn
s
an
d
sy
m
pt
om
s
l
H
ow
dr
ug
s
w
or
k
l
Re
in
fo
rc
em
en
t
of
se
lf-
m
an
ag
em
en
t
be
ha
vi
ou
rs
l
SM
pl
an
l
Fo
ur
40
-m
in
ut
e
in
di
vi
du
al
tr
ai
ni
ng
se
ss
io
ns
de
liv
er
ed
at
ho
m
e
ev
er
y
2
w
ee
ks
fo
r
2
m
on
th
s
pl
us
ho
m
e
vi
si
ts
at
le
as
t
ev
er
y
6
w
ee
ks
th
er
ea
ft
er
fo
r
10
m
on
th
s
6-
M
W
T,
6-
M
in
ut
e
W
al
k
Te
st
;
A
D
L,
ac
tiv
iti
es
of
da
ily
liv
in
g;
BM
I,
bo
dy
m
as
s
in
de
x;
BP
,
bl
oo
d
pr
es
su
re
;
C
on
t,
co
nt
ro
l;
D
LC
O
,
di
ff
us
in
g
ca
pa
ci
ty
of
th
e
lu
ng
fo
r
ca
rb
on
m
on
ox
id
e;
G
H
Q
,
G
en
er
al
H
ea
lth
Q
ue
st
io
nn
ai
re
;
G
P,
ge
ne
ra
lp
ra
ct
iti
on
er
;
H
A
D
S,
H
os
pi
ta
lA
nx
ie
ty
an
d
D
ep
re
ss
io
n
Sc
al
e;
IC
T,
in
fo
rm
at
io
n
co
m
m
un
ic
at
io
n
te
ch
no
lo
gy
;
IH
D
,
is
ch
ae
m
ic
he
ar
t
di
se
as
e;
In
t,
in
te
rv
en
tio
n;
IT
G
V
,
in
tr
at
ho
ra
ci
c
ga
s
vo
lu
m
e;
M
RC
,
M
ed
ic
al
Re
se
ar
ch
C
ou
nc
il;
n/
a,
no
t
ap
pl
ic
ab
le
;
N
R,
no
t
re
po
rt
ed
;
Pa
C
O
2,
pa
rt
ia
la
rt
er
ia
lc
ar
bo
n
di
ox
id
e
te
ns
io
n;
Pa
O
2,
pa
rt
ia
la
rt
er
ia
l
ox
yg
en
te
ns
io
n;
SF
-1
2,
Sh
or
t
Fo
rm
qu
es
tio
nn
ai
re
-1
2
ite
m
s;
SF
-3
6,
Sh
or
t
Fo
rm
qu
es
tio
nn
ai
re
-3
6
ite
m
s;
RV
,
re
si
du
al
vo
lu
m
e;
TL
C
,
to
ta
ll
un
g
ca
pa
ci
ty
.
DOI: 10.3310/hta19360 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 36
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Jordan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
29
Description of included patients
Mean age of participants was similar across the included RCTs (66–74 years), except in the cluster RCT
based in nursing homes,66 where the mean age was approximately 80 years. Sex distribution, however,
was variable across studies (ranging from 37% to 97% males). Where reported, severity of disease was
similar with mean FEV1 ranging from approximately 31% to 42% of predicted values. Most patients were
described as having moderate or severe COPD.
Description of self-management interventions and comparators
Interventions were varied and have been described in full in Table 4. Figure 2 provides a summary diagram
of the included RCTs, with interventions grouped into three categories:
(a) ‘More supported’ Six or more contacts or ≥ 6 weeks’ duration if contacts not specified. This
category included:
– large RCT in the UK of supported SM (based on the Living Well with COPD materials) for 12 months,
compared with UC63
– RCT in Spain/The Netherlands of integrated care including supported SM for 12 months,71,72
compared with UC
– RCT in Hong Kong70 of a community nurse-supported discharge programme, including SM support,
with weekly visits for 4 weeks and then monthly, with additional telephone hotline and a total
follow-up of 6 months, compared with UC
– small RCT in the UK73 of hospital outpatient visit-based SM support over 16 weeks with total
6 months’ follow-up, compared with UC
– cluster RCT in Hong Kong66 of support by community nurses to nursing home staff and patients with
a supported SM component, weekly visits for 1 month and thereafter monthly visits for a total of
6 months, compared with UC.
(b) ‘Less supported’ Fewer than six contacts or < 6 weeks’ duration if contacts not specified. Including:
– RCT in China of telephone-based SM (based on Bandura’s theories of self-efficacy31), with
two telephone calls before week three and total follow-up for 3 months, compared with UC74
– RCT in Australia of SM support provided by two visits after 1 week and 1 month, with total
3 months’ follow-up, compared with UC67
– RCT in Spain of home-based hospitalisation, including SM education and action plans, reinforced
during up to five home-visits and telephone contacts over an 8-week period, compared with UC68
– RCT in Australia of case management with SM support with review and two telephone calls
and follow-up for 3 months in total, compared with UC.69
(c) ‘Exercise-only intervention’ Home-based exercise-only interventions:
– small RCT of home-based exercise, supervised regularly for 3 months and with 6-month64 and
18-month65 follow-up, compared with general exercise advice.
Description of comparators
Comparators were ‘UC’ [often with little description but focused on usual GP management] except for the
exercise trials,64,65 for which the control group had some initial exercise training in hospital and were then
advised to perform exercise at home.
Range of outcomes reported
All included trials measured at least one of the primary outcomes. Mortality was reported in six
trials;63,64,67,68,70–72 hospital admissions (measured in multiple ways) in all 10 trials;63–74 and other health-care
utilisation in six trials.66–68,70–72,74
Of the secondary outcomes, HRQoL was assessed in seven trials63–68,71–73 and was provided as an overall
score as well as subdomains. The most common score was the SGRQ.
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Exacerbations were reported in only one trial.73 Self-efficacy was measured in two trials;63,74 behaviour
change in four trials;63,67,68,72 anxiety/depression in five trials;63,66,69,70 exercise capacity in two trials;64,65,70
dyspnoea in two trials;64,65,72 and lung function in five trials.64–66,68,72,73
Patient satisfaction with the intervention was described in five trials,66–68,72 one of which is described in full
in the next chapter, as it involved qualitative interviews.69 Costs were described in one trial,68 but no trials
described days lost from work.
Quality of included randomised controlled trials
Risk of bias evaluations are presented in Table 5 and are described as high, low or unclear risk for each
aspect of potential bias.
More supported
( > 6 contacts or unspecified
contacts / > 6 weeks’ duration)
                 Kwok 200470
• Community nurse-based 
   care/SM
• Weekly visits for 4 weeks then
   monthly plus telephone hotline
• Outcomes:
      Dheda 200473
• Visits to respiratory
   nurse/physician
   > 4 times
• Outcomes:
Usual
care
M A H
Primary outcomes
Mortality Admissions Other health-care
utilisation
Secondary outcome
HRQoL
M A H
Q
A Q
6 months
(n = 157)
6 months
and 18 months
(n = 46)
12 months
(n = 155/113)
6 months
(n = 122),
45 homes
6 months
(n = 33)
12 months
(n = 464)
3 months
(n = 66)
3 months
(n = 177)
3 months
(n = 60)
2 months
(n = 222)
        Bucknall 201263
• Supported SM
• Living well with COPD
• Multiple visits
• Outcomes:
M A Q
Casas 200671 and
Garcia-Aymerich 200772
• Integrated care
• Several home visits
• Outcomes:
M A H Q
M A Q
• Home-based exercise
• Regular visits
• Outcomes:
• Home-based care/SM
• Up to five visits over 8 weeks plus
   telephone contact
• Outcomes:
Less supported
(< 6 contacts or unspecified contacts/
< 6 weeks’ duration)
M A H Q
M A H Q
A H
A H
      Hermiz 200267
• Home-based care/SM
• Two visits
• Outcomes:
                  Lee 200266
• Care and SM support to nursing
   home staff/patients
• 4 × weekly visits, then monthly
• Outcomes:
        Wong 200574
• Telephone-based
   self-management
• Two contacts
• Outcomes:
Exercise
Usual care differs
significantly from other studies
Hernandez 200368            
• Case management
• Two contacts by telephone
• Outcomes:
A Q
Egan 200269
Behnke 200064
and Behnke 200365
FIGURE 2 Study characteristics of the included RCTs.
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TABLE 5 Risk of bias assessment of included trials
Sources of
bias
aBehnke 200064 aBehnke 200365 Egan 200269 Hermiz 200267 Lee 200266
Hernandez
200368
1. Sequence
generation
Unclear:
Randomly
allocated but
method not
described
Unclear:
Randomly allocated
but method not
described
Low:
Stratified and then
random number
tables
Unclear:
‘Simple
randomisation’ at
one site and
permutated block
at another
Unclear:
Intervention and
control nursing homes
matched by
readmission rates and
stratified into high,
medium, low risk.
Randomised in pairs
but details not given
Low:
Computer-
generated
random numbers
in 1 : 1 or
2 : 1 ratio
2. Allocation
concealment
Unclear:
Insufficient
information
Unclear:
Insufficient
information
Unclear:
Insufficient
information
Unclear:
Insufficient
information
Unclear:
Insufficient
information
Unclear
Although
described as
‘blindly assigned
to groups’
3. Blinding of
outcomes
a. Hospital
admissions
n/a Low Low Low Low Low
b. ED visits n/a n/a n/a n/a Low Low
c. Primary care
consultations
n/a n/a n/a Low
Available from GP
n/a n/a
d. Mortality Low n/a n/a Low n/a Low
e. Patient-
reported
outcomes
HRQoL: high
Dyspnoea: high
Patient not blinded
HRQoL: high
Patient not blinded
HRQoL: high
Anxiety and
depression: high
Patient not blinded
HRQoL: high
Behaviour
change: high
Patient
satisfaction: high
Patient not
blinded
Psychological status:
high
Patient satisfaction:
high
Patients not blinded
HRQoL: high
Patient
satisfaction: high
Investigator
administrating
questionnaire
blinded but patient
not blinded
f. Other
outcomes of
interest
Lung function:
unclear
No information
provided but
interviews
conducted by the
physicians managing
the care so unlikely
to be blind
Exercise capacity:
low risk because
assessor gave no
encouragement
Lung function:
unclear
No information
provided, but
interviews conducted
by the physicians
managing the care so
unlikely to be blind
Exercise capacity: low
risk because assessor
gave no
encouragement
n/a n/a Lung function: unclear
Not known whether or
not assessors were
blinded
Lung function:
unclear
Not known
whether or not
assessors were
blinded
4. Incomplete
outcome
data
Outcomes only
provided on
completers
14/23 (61%) in
intervention arm
12/23 (52%) in
control arm
Ignoring deaths,
11% loss to
follow-up,
although reasons
not provided for
withdrawals
Outcomes only
provided on
completers (79.5%
overall)
Insufficient reporting of
attrition/exclusions
Implies that the
only attrition
during 8-week
period was due to
death
Dheda 200473 Kwok 200470 Wong 200574
bCasas 200671
bGarcia-Aymerich
200772 Bucknall 201263
Unclear:
Randomly allocated
but method not
described
Low:
‘Random number
table’
Low:
‘Research
randomiser’
Low:
Computer-generated
random numbers
Low:
Computer-generated
random numbers
Low:
Computer-generated
sequence using
permuted blocks and
minimisation
Unclear:
Insufficient
information
Unclear:
Insufficient
information
Unclear:
Insufficient
information
Unclear:
Although described as
‘blindly assigned to
groups’
Unclear:
Although described as
‘blindly assigned to
groups’
Low:
Treatment group
allocation were
obtained by
telephone after
baseline assessment
had been made
Low Low Low Low n/a Low
n/a Low Low n/a n/a n/a
n/a n/a n/a Low n/a n/a
n/a Low n/a Low Low Low
HRQoL: high
Patients not blinded
GHQ score: high
Patients not blinded
Self-efficacy: high
Patients not blinded
although assessors
blinded
n/a High
HRQoL; dyspnoea;
treatment adherence/
inhaler technique;
vaccine uptake; patient
satisfaction; smoking;
exercise; knowledge
High
HRQoL; anxiety
and depression;
self-efficacy
Patients not blinded
Lung function: unclear
Not known whether
or not assessors were
blinded
Exacerbations: unclear
No information
Exercise capacity: low
Assessors were blinded
n/a Unclear
Lung function
No information
provided on blinding
n/a
Most outcomes only
provided on
completers (89%)
Low: all participants
accounted for,
3.3% dropout;
missing values
replaced by group
mean
continued
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TABLE 5 Risk of bias assessment of included trials (continued )
Sources of
bias
aBehnke 200064 aBehnke 200365 Egan 200269 Hermiz 200267 Lee 200266
Hernandez
200368
a. Hospital
admissions
n/a High Unclear Low
89% followed up
High Unclear
b. ED visits n/a n/a n/a n/a High Unclear
c. Primary care
consultations
n/a n/a n/a Low:
89% followed up
n/a n/a
d. Mortality Low n/a n/a Low:
100% followed
up
Low
e. Other High:
Withdrawals
reported;
outcomes provided
only on completers
(65% in each arm)
High High:
Other than deaths,
12% loss to-follow-
up, although
reasons/
characteristics not
provided for
withdrawals
Data not provided
for all participants
Low:
89% followed up
HRQoL: unclear
5. Selective
outcome
reporting
Unclear:
Protocol not
identified
Unclear
Protocol not
identified
Mention of
collection of GP
consultations and
exacerbations, but
not reported
Unclear:
Protocol not
identified
Unclear:
Protocol not
identified
Unclear:
Protocol not identified
Unclear:
Protocol not
identified
Other
comments
Methodology of
lung function
measurement not
given
Table of
characteristics
provided only on
completers
Baseline differences
for age, CRQ,
lung function and
6-MWT
Table of
characteristics only
provided on
completers
Clear imbalance of
gender at baseline,
and possibly other
characteristics
Outcome data very
difficult to
interpret as
change provided
between interim
time points only
Study design
problematic
Although a cluster
design analysis does
not take this into
account
Unknown validity of
satisfaction
questionnaire
Methodology of FEV1
measurement not
given
Baseline
differences with
respect to
smokers, oxygen
therapy, although
comparable to
disease severity
(FEV1% pred)
Short follow-up
period
Outcome
assessment not
clear; percentage
not always correct
Lung function
analyses not
adjusted for
baseline
6-MWT, 6-Minute Walk Test; GHQ, General Health Questionnaire; ITT, intention to treat; n/a, not applicable;
SEM, standard error of the mean.
a Behnke et al.64 and Behnke et al.65 refer to the same trial.
b Casas et al.71 and Garcia-Aymerich et al.72 refer to subgroups of the same trial.
Dheda 200473 Kwok 200470 Wong 200574
bCasas 200671
bGarcia-Aymerich
200772 Bucknall 201263
Unclear:
Unclear follow-up rate
Low:
89% followed up
Low:
97% followed up
Low n/a Low
Low
89% followed up
Low
97% followed up
n/a n/a n/a
n/a n/a Low:
97% followed up
Low:
Withdrawals reported;
other than deaths
<10% lost
n/a n/a
n/a Low n/a Low Low Low
HRQoL: high
Lung function: high
66.7% followed up in
intervention arm and
83.3% followed up in
control arm
Withdrawals reported
but no information on
characteristics
reported and, not
accounted for in
analysis
Exercise capacity: high
77% took part due to
loss to follow-up and
mobility problems
Low:
97% followed up
n/a High:
High loss to follow-up
(other than deaths,
14.2% lost)
Reasons for
withdrawals reported
but analyses
undertaken only on
completers
Lost to follow-up
appeared more
severely affected than
completers
High:
HRQoL; self-efficacy;
anxiety and
depression high loss
to follow-up; only
61% completed
questionnaires at
6 months
Non-completers had
greater morbidity
and worse baseline
self-efficacy, and
more likely to be in
the control arm
Unclear:
Protocol not identified
Unclear:
Protocol not identified
Unclear:
Protocol not
identified
High:
Data not available for
HRQoL
Unclear:
Protocol not identified
Unclear:
Protocol not
identified
Very small study
Methods of outcome
assessment not
described
Numerical data not
available for lung
function
Rather limited
information provided
throughout
One patient excluded
from analysis owing to
visiting GP (not ITT)
No table of
characteristics
Confusion over SEM
or SD
Three subjects in
control were
undergoing PR
Change in sample
size calculation
External validity
of Chinese
Self-Efficacy Scale
Gender may not be
very well balanced
across arms
Differences in text and
Table 2 for differences
in rate of admissions
Not well balanced
on previous
hospitalisations, and
receipt of influenza
vaccination
No description of lung
function test methods
Intervention arm
seemed to have higher
number of admissions
in the previous year
and possibly worse
SGRQ score
DOI: 10.3310/hta19360 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 36
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Jordan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
35
In general, the quality of reporting and conduct of the included studies was low, with some very small,
poorly conducted studies.64,65,73 Out of the 10 RCTs,63–74 appropriate methods of randomisation (e.g.
computer random number generator) were used in six trials63,68–72,74 suggesting a low risk of bias, although
methods were unclear in the remaining four.64–67,73 Allocation concealment was insufficiently described in
all except the largest most recent trial,63 which used a central telephone method of allocation to reduce
the risk of bias.
Blinding of patients and health-care personnel would not have been appropriate for this type of SM
and similar such interventions; therefore, the results of any patient-reported outcomes or non-blinded,
investigator-assessed outcomes would be potentially subject to bias. In this review, the important
patient-reported outcomes were consistently judged to be subject to high risk of bias across all of the
trials, including HRQoL, dyspnoea, anxiety and depression, self-efficacy, patient satisfaction and
behaviour change.
Measurements of lung function and exercise capacity both rely on assessors’ encouragement and could be
subject to bias if not blinded. It was usually unclear whether or not investigators were blind to treatment
when assessing lung function, although when measured, exercise capacity was judged to have low risk
of bias because either the assessors were blind70 or it was explicitly stated that they did not provide
encouragement.64,65 In general, conduct of outcome measurement were frequently poorly described, with
standards and conduct of lung function testing particularly unclear.64,65,68,72
However, assessment of hospital admissions, other health-care utilisation and mortality would be likely to
have a low risk of bias (either self-reported or obtained from records), as concluded for most of the
included trials.
The most obvious flaw in the conduct of some of the included studies was the lack of completeness in
follow-up, which was considerably < 70% in some trial arms and would be likely to bias most clinical
measures and HRQoL (and other questionnaire) outcomes in particular,63–65,73 and any other questionnaire/
clinical measures. This was even discussed by the authors of the largest, most recent trial with only 61% of
randomised patients with HRQoL reported at follow-up,63 who concluded that the data were therefore
unreliable. Several of the studies64,65 reported characteristics of only the completing participants rather than
all randomised participants, or gave no table of characteristics at all.73 This weakens any attempt to assess
baseline imbalance and any bias introduced at this stage.
As is usual, it was difficult to assess selective outcome reporting without availability of protocols. In
addition, outcome data were unclearly analysed in several studies,64–66,69,73 and the older studies (pre 2005)
were often limited in their description of methods in general. There were signs of baseline imbalance
between arms in some studies, which was not addressed in the analyses.65 The best conducted and
reported trials tended to be the most recent.63,70–72,74
Primary outcomes
All-cause mortality: no evidence of effect
Six trials63,64,67,68,70–72 contributed mortality results (Figure 3 and Appendix 5). There was a wide range of
event rates across the trials. Despite the general heterogeneity of interventions, there was no statistical
heterogeneity and the overall results indicated that there was no evidence of effect on mortality (HR 1.07,
95% CI 0.74 to 1.54). Using the GRADE system, we would judge that this is moderate-quality evidence
(Table 6).
Hospital admissions: no evidence of effect
Seven trials63,65,67,68,70,71,73 contributed data to the admissions results (Figure 4 and Appendix 6). The results
of three trials66,69,74 could not be included in the combined results because they reported mean number of
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TABLE 6 GRADE summary of findings for main outcomes
Outcome Control risk
Intervention
risk Results
No. of
participants
(trials)
Quality
rating Comments
Mortality 56/598 59/581 1.15
(95% CI 0.79 to 1.67)
1179 (6) +++;
moderate
Outcome
measurement
likely to be
unbiased
I2= 0%
Generally, low risk
of bias except
allocation
concealment
rarely mentioned
Hospital
admissions
259/621 211/596 0.78
(95% CI 0.52 to 1.17)
1217 (7) ++; low Outcome
measurement
problematic in
some trials due to
loss to follow-up
I2= 70.9%
Wide CIs crossing
line of no effect
Some study
results based on
completers only
ED visits n/a n/a Not combined
RR ranged from 0.27
to 1.06
932 (5) ++; low Unclear methods
of randomisation
and allocation in
two trials
Follow-up was
generally short
and results
inconsistent
GP consultations n/a n/a Not combined
No significant effects
332 (2) +; very low Very little
information
HRQoL n/a n/a SGRQ 3.84-point
improvement (95% CI
1.29 to 6.40 points)
845 (6) +; very low Biased follow-up –
enormous loss to
follow-up
Outcome
measurement
likely to be biased
I2= low
n/a, not applicable to report as combined values not computed; RR, rate ratio.
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admissions rather than first admission and one69 also did not provide sufficient information to calculate
a SE.
Overall, statistical heterogeneity was high (I2= 70.9%), and subdividing by level of support explained only a
fraction of this. Estimates are provided by level of SM support, although there was no evidence of any
effect for the non-exercise-based interventions and substantial remaining heterogeneity.
One of the studies that may have contributed to the remaining heterogeneity in the non-exercise-based
studies is the small study of 33 participants by Dheda et al.,73 which was poorly reported, had signs of
inadequate randomisation and very high loss to follow-up, especially in the intervention arm. This study73
had the most extreme results in its category.
The trial of home-based exercise65 demonstrated a large relative reduction on the rate of first admission
(HR 0.17, 95% CI 0.05 to 0.66), although this trial was very small and these results were based only on
participants who completed the study (< 60% of those randomised), and thus would also be subject to
high risk of bias. Furthermore, although subgrouping by intervention category was an a priori identified
analysis, care must be taken in the interpretation of results due to multiple comparisons being performed.
The evidence above was judged to be of low quality according to GRADE (see Table 6).
General practitioner consultations: no evidence of effect
Two trials reported GP-related health-care activity (see Appendix 7).67,71 Neither trial reported any evidence
of differences between physician contacts, drug prescriptions or amount of education provided between
the intervention arm and the control arm. Note that one trial67 reported mean number of visits, although it
is likely that median values would be more appropriate. The evidence was of very low quality (see Table 6).
Emergency department visits: no evidence of effect
The effect on ED visits is displayed in Figure 5 (see Appendix 8), for which five trials66–68,70,72 contributed
data. Four trials66,68,70,74 reported mean visits per patient and two67,68 reported first visit. The two trials with
a longer follow-up of 6 months66,70 failed to demonstrate any evidence of an effect on ED visits. This
evidence was also of low quality (see Table 6).
Secondary outcomes
Health-related quality of life: consistent with improvement although
potential bias
Six trials63–66,67,68,72,73 contributed data on HRQoL using the SGRQ, the CRQ or the EQ-5D (Figure 6
and Appendix 9). The data from one study69 could not be used as they reported median change only.
Five trials63,67,68,72,73 used the SGRQ, two trials63,72 reported the EQ-5D and one trial64 the CRQ.
Overall, SM interventions resulted in an improvement of 3.84 (95% CI 1.29 to 6.40) points on the SGRQ
scale compared with control (close to the minimal clinically important difference of four points), although
follow-up (where reported) ranged from about 25% to 83% across studies, and, therefore, this result
should be treated with caution and contributed to the overall judgement that this evidence was of very
low quality (see Table 6). In particular, the study by Dheda et al.,73 which produced the most extreme
results, had many methodological flaws.
Exercise capacity: possible effect with exercise-based intervention only
Two trials64,65,70 reported on exercise capacity (see Appendix 10). For the study by Behnke et al.,64 we
analysed results from the longest follow-up time point (18 months). At this point, the home exercise
programme showed strong statistical evidence of a large benefit compared with exercise advice only
(MD in treadmill distance in 6 minutes= 355.0m, 95% CI 269.2m to 440.9m). Note that this trial was
likely to be biased, as only completing participants were described, and the trial had a loss to follow-up
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of > 40%. In neither trial was the substantial baseline imbalance taken into account, which would have
exaggerated the effect size. In contrast, the trial of nurse-supported discharge in Hong Kong retained
nearly 90% of its patients, and there was no statistical evidence of a difference after 6 months in mean
distance walked compared with the UC arm (MD 24m, 95% CI –7.1m to 55.1m).
Lung function: no evidence of effect
Data from four trials64–66,68,72 were plotted (see Appendix 11). Three trials provided results on raw FEV1
values (Figure 7),64,65,68,72 and two trials the effect on percentage predicted FEV1 (Figure 8).65
,66 There was no
evidence of any effect from any of the individual trial results, and it was not deemed appropriate to pool
the individual trials due to the small number of studies and heterogeneity of outcomes, follow-up time and
methods of analysis. The findings are in agreement with the fifth trial73 which reported no evidence of
effect on FEV1 but did not provide data. Again, the proportion of patients followed up across the trials was
very variable.
Anxiety and depression: possible improvement in scores
Four trials (see Appendix 12)63,66,69,70 reported on psychological health outcomes; however, only two trials63,66
contributed to the analysis on anxiety (Figure 9) because one trial69 reported only median changes and the
other70 did not provide separate results for anxiety. Although there were data on less than half of the
sample in the larger study,63 the intervention group had a mean reduction of 1.06 points (95% CI 0.04 to
2.08 points) in the ‘anxiety’ component of the Hospital Anxiety and Depression Scale (HADS) score compared
with the control group, and the other trial66 demonstrated a mean reduction of 1.5 points (95% CI 0.62 to
2.38 points) in the ‘anxiety and insomnia’ component of the General Health Questionnaire (GHQ) relative to
the control group.66
One of the above trials66 also showed some evidence of a reduction in depression score (MD –1.0, 95% CI
–1.97 to –0.03), although follow-up rates were not reported, whereas there was no evidence of effect in
the larger trial63 (Figure 10).
Exacerbations: no evidence of effect
Only one small, poor-quality trial73 of hospital outpatient follow-up (n= 33) reported on exacerbations. This
study reported that there were ‘fewer patients with two or more exacerbations within a six-month period
(2 v. 3) in the intervention group but the small numbers precluded meaningful statistical analysis’.
Dyspnoea: possible effects in exercise trial
Two RCTs64,65,70 reported effects on dyspnoea (see Appendix 13) reporting a variety of different measures.
The Behnke trial64,65 of home-based exercise reported effects at 1, 2, 3, 6, 12 and 18 months using the
Baseline/Transitional Dyspnoea Index and the ‘dyspnoea’ domain of the CRQ questionnaire. Significant
improvements in dyspnoea score in the intervention arm were observed throughout the trial, with all
measures. However, > 45% of the 46 original patients had dropped out by the end of the follow-up period.
A trial of integrated care72 also reported dyspnoea among 62 of 113 completers using the Medical
Research Council (MRC) dyspnoea scale, finding no evidence of effect after 12 months (MD between
two arms –0.38, 95% CI –1.1 to 0.34).
Behaviour change: improvement in knowledge but inconsistent evidence of
effects on behaviour
Three trials67,68,72 reported effects of the intervention on a range of health behaviours (see Appendix 14).
None of the studies used validated questionnaires.
All three trials67,68,72 reported significantly better knowledge about the disease and how to recognise and
treat exacerbations among patients receiving the SM intervention, and two trials68,72 reported significantly
better adherence to inhaler treatment and inhaler technique. This was not matched by improvements
in smoking behaviours or uptake of vaccines. Effects on physical activity were inconsistent.
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Self-efficacy: inconsistent effects
Two trials63,74 reported effects on self-efficacy (see Appendix 15). Significant improvements in self-efficacy
were observed in the trial74 of a community nurse-supported discharge programme in Hong Kong after
3 months (p= 0.009), which was most marked in the physical exertion and weather/environment domains.
Despite a high loss to follow-up, a much larger and more intensive trial63 of supported SM reported no
evidence of improvement in self-efficacy after 12 months.
Patient satisfaction: inconsistent results
Four trials66–68,72 reported effects on patient satisfaction with the intervention using different questionnaires
(often with little detail provided; see Appendix 16). Two66,68 of the trials66–68,72 indicated increased
satisfaction with their care compared with the control arm. However, loss to follow-up was generally high.
Discussion
Key results
Despite a rigorous search we identified only 10 RCTs63–74 that evaluated the effectiveness of interventions
providing SM support to patients shortly after being discharged from hospital with an acute exacerbation
of their COPD.
Few of the trials had consistently low risk of bias. Many studies were small and suffered from inadequate
reporting and high loss to follow-up, particularly affecting patient-reported outcomes such as HRQoL.
Although the participants seemed relatively homogeneous, interventions were very heterogeneous,
with some trials67–69,74 providing low-intensity, short-term support of 2–3 months and others63 a very
intensive package lasting for 12 months.
Overall, there was limited evidence of effect on health-related behaviours and outcomes. There was some
evidence of improvement in patient knowledge, treatment of exacerbations and inhaler technique,68,69,73
but there was inconsistent evidence of effect on other health-promoting behaviours68,73 or on
self-efficacy.64,75
In terms of health outcomes, the most consistent effects were observed on patients’ QoL, with an overall
improvement with data from five trials63,67,68,72,73 of 3.8 points on the SGRQ score (close to the minimally
clinically important difference of four points). Notably, though, this estimate should be treated with
caution because, although reaching statistical significance, there was substantial and differential loss to
follow-up in both arms, which could bias the results in favour of a positive effect. The authors of the
largest trial63 indicated, themselves, that the results from their trial could be unreliable. The reduction in
anxiety exhibited in two trials,63,66 however, supports some potential effect on patients’ psychological
health (although it is not clear whether or not this would be clinically important).
An important outcome for these patients is whether the SM package had any effect on subsequent
hospital admissions. We were able to use data that reported time to first all-cause admission. Despite
subdividing by intensity of intervention, we were unable to explain the substantial heterogeneity observed,
but, overall, there was no clear evidence of effect on hospitalisation (HR 0.78, 95% CI 0.52 to 1.17;
I2= 71%). Post hoc inspection of the data suggested a possibility of a greater effect with the
exercise-based intervention but would require more data to be explored in depth. It is possible, however,
that the effects on admissions would be diluted because we extracted admissions due to any cause
(although in our analysis the majority were for respiratory causes).
There was no apparent evidence of effect on mortality and no clear patterns with duration of intervention.
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In general, the most positive results across the outcomes were observed in the small trial of home-based
exercise64,65 but, given the multiple methodological limitations of the trial in terms of reporting and
analysis, the results have to be interpreted with caution.
How this fits with other literature
This is the first systematic review that addresses the effectiveness of SM support provided to patients with
COPD soon after hospital discharge. The only other review related to this time point is a Cochrane review
of PR,76 which identified nine trials and showed significant reduction in hospital admissions [pooled odds
ratio (OR) 0.22, 95% CI 0.08 to 0.58], over 25 weeks and mortality (OR 0.28, 95% CI 0.10 to 0.84) over
107 weeks. Effects of PR on HRQoL were well above the minimal important difference when measured by
the CRQ and the SGRQ total score (MD –9.88, 95% CI –14.40 to –5.37). However, in common with
our review, trials were small and methodologically inadequate, and, although loss to follow-up was not
discussed or assessed in the risk of bias section, a large proportion did not complete the rehabilitation.
There was also significant heterogeneity across many of the outcomes. The authors discussed the
possibility of publication bias and possible overestimate of effect with small trials but suggested this would
not account for the whole effect. The results would fit with our tentative observation that trials with an
exercise component might be more effective.
The majority of the studies and reviews of SM support are set among patients who have COPD in a stable
state. Our results, although showing few significant effects, are consistent with some of the other
systematic reviews. For example, a systematic review of SM education48 showed evidence of a significant
reduction in respiratory admissions (OR 0.64, 95% CI 0.47 to 0.89; n= 8 RCTs) and a significant mean
improvement of 2.6 points (95% CI 0.2 to 5.0 points) on the SGRQ score (n= 7 trials). A review of PR46
reported an overall mean improvement in SGRQ score of 6 points (95% CI 3 to 9 points; n= 6 trials) and
a review of integrated disease management47 found a similar improvement in HRQoL: SGRQ 3.71 points
(95% CI 1.6 to 5.8 points; n= 13); CRQ 1.02 points (95% CI 0.67 to 1.36 points; n= 4) and respiratory
admissions (OR 0.68, 95% CI 0.47 to 0.99; n= 7) and a similar lack of effect on mortality. Conversely,
a review of action plans found little evidence of benefit on HRQoL or health-care utilisation.50
In the last couple of years, and particularly since the completion of our searches, there have also been
a number of individual trials and commentaries that question whether patients are actually able to
self-manage.34,36,77,78 Two of these among patients with COPD35,62 identify a group of successful
self-managers in post hoc exploratory analyses. The first of these63 is included in our review but no other
studies have explored these subgroups so we were unable to examine this point further.
Strengths and weaknesses
A strength of this review was the comprehensive search and selection process, which made it unlikely that
we would have missed relevant studies. In addition, we followed Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidance with respect to study selection, data extraction, risk of bias
assessment, reporting and analysis.
The main limitation relates to the paucity of evidence and methodological weaknesses of many of the
available studies, which limits our conclusions, and the heterogeneous nature of the interventions that
makes comparisons hard and conclusions difficult to draw. The particular problems with these studies,
especially the older ones, include generally inadequate reporting of important items, particularly methods
of randomisation and limited data on baseline characteristics. Many studies were small, with data reported
only for participants completing the trial and had substantial loss to follow-up of > 30% in some arms,
which is likely to bias all self-reported items and HRQoL in particular. There was a lack of information
about the assessment of some outcomes, especially lung function measurements and analyses were often
unclear or inappropriate. In addition, the admission results were reported in several different ways, for
example first admission, mean admissions, etc. Although ideally we would like to be able to capture all of
this information – especially as some patients may have multiple admissions – current methodologies are
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inadequate to do so. We chose rate of first admission because there were more data available; however,
it is unclear how the effect of the interventions would vary if all admissions could be considered.
With the limited number of trials it was not possible to assess publication bias, but it is possible that
because of the small size of the studies showing positive effects this would be a potential problem.
Another issue is that of generalisability, as only two RCTs63,73 were set in the UK health-care setting.
Studies in China and other areas of Europe may not necessarily be relevant; the feasibility and effectiveness
of different types of support may be dependent on both financial and practical issues in individual settings.
With the limited data available it was not possible to explore the effect of different settings.
Implications for research and practice
It is difficult to recommend any type of SM support to be provided immediately after discharge with the
evidence available as there is no clear evidence of effect across most of the outcomes. This conclusion is in
contradiction to the current recommendations in the COPD discharge care bundle.79 Notwithstanding,
the point estimate is consistent with ≈20% reduction in admissions which has been observed in other
systematic reviews.
However, to move forward with this area of research, there should be:
l more in-depth work to explore the needs/views of patients with regard to SM support after a recent
discharge from hospital before designing novel interventions aimed at behaviour change
l an adequate standard of reporting ensured in future trials, and they should be conducted to modern
standards with an adequate number of participants
l a clear framework for describing and classifying SM interventions and their comparators
l an exercise component included in future studies
l clear reporting of outcomes to include self-efficacy, behaviour change and clinical outcomes, including
separate reporting of COPD-related and all-cause admissions
l consideration that patients may be too ill at this point (both physically and psychologically) to take up
the more rigorous parts of SM interventions until they are in a more stable state; the difficulty in
recruitment and retention in the included studies bears this out.
Conclusions
l Self-management support delivered shortly after an acute exacerbation may have some benefit in terms
of HRQoL and possibly admissions but the evidence is thin and unconvincing.
l Exercise may play an important role but there are not enough data to explore this.
l Any future trials should address issues of bias, particularly loss to follow-up, but this may be inherent in
the nature of the intervention and the fact that patients are still trying to recover from an exacerbation.
l The evidence is not in support of SM interventions to be put into practice for patients with COPD at,
or recently after, hospital discharge.
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Chapter 4 A systematic review of the qualitative
evidence about patient satisfaction, acceptance and
barriers to supported self-management interventions
delivered shortly after hospital discharge: review 2
The aim of this chapter is to present the findings of a systematic review of the qualitative evidence aboutpatient satisfaction, acceptance and barriers to self-management (SM) support.
Methods
A systematic review of published evidence of the qualitative evidence about patient satisfaction,
acceptance and barriers to SM support programmes among patients with chronic obstructive pulmonary
disease (COPD) recently discharged from hospital.
Definition of self-management
As described for review 1 and tabulated in Table 2.
Search strategy
A comprehensive search strategy was undertaken as described as for review 1. The search was broad and
covered many databases and no study design filters were applied. Search terms related to qualitative
evidence included ‘patient-centred’ and ‘patient focus’.
Study selection process
As described for review 1.
Selection criteria
Selection criteria were as described for review 1, with the difference of two elements: study design and
outcomes. Only qualitative study designs (interviews and focus groups) were sought and outcomes relating
to patient satisfaction, acceptance and barriers to SM were assessed.
Study quality, data extraction and synthesis
Study quality was assessed using the Critical Appraisal Skills Programme (CASP) checklist for qualitative
research.80 As well as extracting data related to study and patient characteristics, any quotes, key themes
and concepts identified were extracted. As outlined in the protocol, an interpretive analysis
(meta-ethnography)81 was planned if findings allowed. This involved looking for similarities (reciprocal
translation), differences (refutational translation) or creating a line of argument using concepts proposed in
included primary studies. However, as only one study described a small element of qualitative interviewing,
this was not undertaken.
Results
Search results
Figure 11 outlines the flow of included studies. One of the included randomised controlled trials (RCTs)69
from review 1 had a limited qualitative element referring to patient satisfaction and was therefore included
in this review. There was also one ongoing study (see Appendix 4).
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Relevant ongoing 
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FIGURE 11 Selection process for qualitative studies.
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Characteristics of included study
The included trial was a trial of nursing-based case management among 66 patients in Australia admitted
to hospital with COPD. The intervention comprised SM support with review and two telephone calls and
follow-up for 3 months in total, compared with usual care.69 A subgroup of 18 patients and their carers
from both arms of the trial were interviewed in more depth using semistructured interviews focusing on
issues associated with patients and caregiver satisfaction with care. The interviews were recorded, and
then transcribed and coded to identify themes. These interviews revealed that patients were very satisfied
with their care in hospital and, for those in the intervention arm, ongoing contact with the community
nurse was very helpful in improving their access to resources and communication with the health
professionals. For those in the control arm, those with family support or medical contact were satisfied but
those without were not. Table 7 describes the patient and caregiver quotes in relation to case managers.
Quality of included studies
Table 8 presents an assessment of the quality of this study. The aims of the study were not very clear from
the outset, which means that it was difficult to assess which methodology would be appropriate. It was
possible to infer that patients’/carers’ views and satisfaction with the intervention would be sought, which
would mean that these semistructured qualitative interviews would be appropriate. However, although the
authors mentioned that patients were selected to maximise variability, the only factor that they mention is
about representing both intervention and control groups.
There is mention of the home setting, although not the justification for it, but they do not mention a topic
guide, any modification of the methods, details of any interviewer biases, how the themes were identified
or whether or not saturation was reached. Thus, the findings are really not very valuable.
TABLE 7 Patient and caregiver quotes from included qualitative study
Context Quotation
The caregiver of a patient in the control group
without support – such as extensive family,
medical support from health-care professionals
It is absolutely hopeless
A patient from the intervention group who
received a CM talking about benefits of having
a CM
I became more involved with (the CM) and it was good to know
that she cared . . . kept on your hammer all the time . . . So I think
that . . . it will give some peace of mind to the patients, you know.
The big thing is to know what is happening
A patient from the intervention group
commenting on benefits that a CM provides
(The CM) made me aware of things that were available that I didn’t
bother to want to know about before
A caregiver of a patient of the intervention group
commenting on benefits that a CM provides
(The CM) helped me organize (a nebulizer); she pointed out a lot of
things to me, different things that should be done (for the patient)
CM, case manager.
Source: quotes taken from study by Egan et al.69
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TABLE 8 Risk of bias assessment of included qualitative study using CASP checklist for qualitative research
CASP checklist questions Judgement and comments/quotes
Was there a clear statement of the aims of the
research?
Unclear
Aims of the RCT made clear
Authors state a lot of focus is around economic outcomes rather than
patient-focused outcomes; no clear aim relating to qualitative research
Is a qualitative methodology appropriate? Unclear
This is an RCT which has both quantitative and qualitative
analyses
Unclear as the research goal is not clearly stated although they mention
focusing on issues to do with patient and caregiver satisfaction
Was the research design appropriate to address
the aims of the research?
Unclear
Very little detail of qualitative methodology reported, although
semistructured interviews seem appropriate
Was the recruitment strategy appropriate to the
aims of the research?
Unclear
Participants were selected to maximise variability and to
represent both intervention and control groups
Variability not detailed; subgroup of 18 patients from RCT selected for
qualitative
Were the data collected in a way that addressed
the research issue?
Unclear
Audiotaped interviews
Patient interviews – semistructured
Patients and caregivers interviewed at home
No topic guide, no mention of any modifications during study, no
justifications for setting for data collection
Has the relationship between researcher and
participants been adequately considered?
Unclear
No details of biases; not clear who led interviews
Have ethical issues been taken into
consideration?
Unclear
‘The study received ethical clearance from the participating hospital’ –
This is in reference to the RCT; no other details regarding ethics
Was the data analysis sufficiently rigorous? Unclear
Not enough detail to permit judgement
All interviews, including those with the respiratory physicians
were audiotaped then transcribed and coded to identify
recurring themes and patterns
Is there a clear statement of findings? Unclear
Not particularly adequate
Based on the qualitative interviews, all patients were very
satisfied with their care in hospital
How valuable is the research? Not very valuable as it stands with limited details
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Discussion
Key results
A comprehensive search of the literature revealed only one RCT69 with a limited qualitative aspect and
limited conclusions.
Strengths and weaknesses
The search strategy was broad, conducted across several databases and with no study design filters
applied. Additionally, reviewers adhered to a systematic methodology with two independent reviewers
assessing studies for inclusion and exclusion against a prespecified selection criteria; therefore, it was
unlikely that any relevant qualitative evidence will have been overlooked. However, after a thorough
search and identification process, only one study69 was included.
How this fits with the findings of the effectiveness review (review 1)
Unfortunately, the included study69 only gave scant information regarding the qualitative aspects, and it is
difficult to be sure of the true purpose of the interviews and how they were actually conducted. The
study,69 however, reported that patients who received a case manager were very satisfied with their care,
and were made aware of resources available to them and how to use them. Those in the control arm
without family support were more concerned about their situation, although those in the control arm with
family support seemed reasonably satisfied. This reflects the evidence from the quantitative studies for
which the evidence was inconsistent (two studies66–68,72 showed better satisfaction with the intervention
and two did not) but does not really gain much further insight.
Conclusions
There is almost no qualitative evidence about patients’ views on SM support programmes that are
delivered post discharge, and, given that the quantitative evidence reveals uncertainty about the
effectiveness of such interventions in their current form, it is therefore a potential area of research need.
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Chapter 5 A systematic review of the
cost-effectiveness of supported self-management
interventions delivered shortly after hospital
discharge: review 3
The aim of this chapter is to present the findings of a systematic review of the cost-effectiveness ofself-management (SM) interventions delivered post discharge in patients with chronic obstructive
pulmonary disease (COPD) compared with usual care (UC).
Methods
A systematic review of the literature was conducted to identify all published studies assessing the
cost-effectiveness of SM interventions delivered to patients with COPD within 6 weeks of hospital
discharge following an acute exacerbation.
Search strategy
A comprehensive search strategy was undertaken by an experienced information specialist from inception
to May 2012. Three electronic databases were searched: MEDLINE and EMBASE via Ovid and Cochrane
NHS Economic Evaluation Database (Wiley). Searches were not limited by date nor were any language
restrictions applied. The search strategies used for each database can be found in Appendix 17.
Relevant literature from the clinical effectiveness searches were also identified and included for review,
if they had not already been captured in the searches for cost-effectiveness.
Reference Manager version 11 was used to store and manage all references.
Study selection process
The inclusion and exclusion criteria outlined below were used to select studies. A two-stage review process
was applied by two independent reviewers: first, screening titles and abstracts, and then reviewing full
papers. Discrepancies were resolved by a third reviewer with expertise/knowledge in the field of
health economics.
Selection criteria
Study design
Full and partial economic studies, costing studies and costing models were included.
Population
Studies including patients admitted to hospital with an acute exacerbation of COPD, who were recruited
at the point of discharge or within 6 weeks after discharge were included (see Chapter 3, Methods).
Intervention
Any SM programme, package or intervention including adherence to medication, inhaler technique,
breathing techniques, exercise, education and support groups among others. Pulmonary rehabilitation was
not included for this review.
Comparator
Comparators considered were UC, other SM interventions or no intervention.
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Outcomes
Cost-related outcomes included health service utilisation, hospital admissions and readmissions, duration of
admissions, ED visits, days lost from work, drug utilisation and cost-effectiveness. Effectiveness outcomes
were as reported for the clinical effectiveness review (see Chapter 3).
Risk of bias assessment
Risk of bias of included studies was assessed using the Drummond checklist, as suggested in the Cochrane
Handbook.56 Risk of bias assessment was undertaken by two reviewers independently, one of whom had
expertise in the field of health economics.
Data extraction
Study characteristics and results were extracted independently by two reviewers. Meta-analysis was not
considered appropriate for this review because of the paucity of evidence.
Results
Search results
Figure 12 outlines the study identification process. A total of 1611 references were imported into
Reference Manager, and 240 duplicates were removed automatically and manually. Overall, 1131 titles
and abstracts were screened, with 129 articles being identified for full-text review. Only one study68 met
the inclusion criteria for this review, which also formed part of the clinical effectiveness review. A further
four studies met initial inclusion criteria but were ongoing and so have been listed in Appendix 4.
A number of other studies (n= 27) were identified as potentially useful to inform the independent
economic analysis (see Chapter 6). These studies included relevant primary or secondary data on the cost
or utilisation of health care associated with SM in patients with COPD; however, the intervention was not
delivered to patients in hospital at the point of discharge or within 6 weeks of hospital discharge. Data
from some of these studies were used to estimate the costs of SM in the model (see Chapter 6).
Characteristics of included studies
The single included trial by Hernandez et al.68 was conducted in two tertiary hospitals in Barcelona, Spain,
with a total sample size of 222 patients: 121 patients were randomised to the home hospitalisation group
and 101 were randomised to conventional care. The hospital-at-home intervention included four phases:
assessment by a specialist team during admission to the emergency room; treatment at discharge; home
hospitalisation with follow-up; and assessment after 8-week follow-up. Specific SM components
implemented as part of the hospital-at-home service included 2 hours of the following delivered at the
point of discharge and later reinforced during home visits (along with action plan reinforcement):
l education on disease, adherence to medication and recognition/prevention of triggers of exacerbations
l selecting appropriate equipment at home and training on the correct administration of
pharmacological therapy
l smoking cessation
l patient empowerment for daily life activities, including hygiene, dressing, household tasks, leisure
activities, breathing exercises and skeletal muscle activity
l nutrition recommendations
l socialisation and changes in lifestyle.
The following outcomes were reported: mortality, readmissions or ED visits, hospitalisation, HRQoL, lung
function, patient satisfaction, disease knowledge, inhaler technique, medication prescriptions, and home
rehabilitation and costs.
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FIGURE 12 Selection process for cost-effectiveness studies.
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Quality of included studies
The details of a cost analysis economic evaluation68 were described and are summarised in Table 9.
The research question was stated with reasons for its importance as well as for the rationale for the
intervention and control under comparison. A public insurer perspective was taken but not justified;
however, the limitations of taking this viewpoint were highlighted. The source of effectiveness estimates
was stated and details of the design and results of the effectiveness study were provided. Outcome
measures were clearly outlined and quantities of resource use (per patient) were given separately from unit
costs. Details of direct and indirect costs were provided with nurse home visits, prescriptions, telephone
calls and transport being calculated directly and inpatient hospital stay, emergency room visits, outpatient
visits, primary care consultations and social support visits being calculated indirectly. Costs incurred by
patients or carers were not considered. Currency and price data were reported using 2000 price data
(euros); however, no details were provided regarding any price adjustments for inflation or currency
conversions. The time horizon for the study was 1 year; thus, discount rates were not applied. Tariff prices
were applied to resource-use data that were collected to calculate an average annual health-care cost per
patient in both arms. Although differences in both costs and outcomes were reported, they did not
conduct a full economic evaluation by presenting the relative cost-effectiveness. As the costs for the
intervention were lower and outcomes better, this study68 suggests the intervention dominated UC.
Sensitivity analyses, and the details thereof, were discussed only briefly.
TABLE 9 Summary of study included in cost-effectiveness review
Author Hernandez et al.68
Date 2003
Type of economic evaluation Cost analysis
Currency used Euros (€)
Year to which costs apply 2000
Perspective used Public insurer
Comparators Home hospitalisation compared with conventional care
Source(s) of effectiveness data Clinical effectiveness data from RCT
Source(s) of resource-use data Based on data from RCT
Sources of unit cost data Directly calculated from data from trial, as well as indirectly calculated from
tariffs for patients with COPD in a public insurance company
Modelling approach used Not applicable
Summary of effectiveness results Mortality: HR= 0.59 (95% CI 0.19 to 1.85)
First ED visit: HR= 0.41 (95% CI 0.20 to 0.85)
All ED visits: HR= 0.44 (95% CI 0.24 to 0.79)
Hospital admission: HR= 0.71 (95% CI 0.40 to 1.24)
QoL: MD= 4.50 (95% CI 0.66 to 8.34)
Lung function: MD= 0.20 (95% CI –0.04 to 0.44)
Summary of cost-effectiveness results Intervention dominates UC
Sensitivity analysis Intervention dominates UC when resources released by the intervention
were 75% or 50% of the average cost
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Cost-effectiveness
As only one study met inclusion criteria for this review, no meta-analysis was undertaken; instead, the cost
analysis results from the included study68 are reported.
Costs were reported for the following outcomes (categories) following an 8-week follow-up period:
length of hospital stay, emergency room visits (excluding visits that required further hospital admission),
outpatient visits, primary care consultations, social support visits, home visits by nurse, prescriptions,
telephone calls (both to the nurse from the patient and from the nurse to the patient) and transport costs.
Details of the costs reported for each outcome are provided in Table 10.
The cost analysis found the home hospitalisation intervention to be significantly less costly than
conventional care (average cost per patient: €1255.12 vs. €2033.51; p= 0.003). Hospital stay, emergency
room visits, outpatient and social support visits were at a greater cost per patient for the conventional care
group than for the home hospitalisation group, with the difference for hospital stay and emergency room
visits reaching significance (p< 0.001 and p= 0.01, respectively). Prescription costs were significantly
higher in the intervention group than in the control group (cost per patient: €217.21 vs. €172.06;
p= 0.001). Primary care visits were also greater in the intervention group, although the difference was not
reported to be statistically significant.
A sensitivity analysis based on resources for home hospitalisation at 50% and 75% of the average cost per
patient (to capture intervention costs in the longer term) was undertaken. Cost savings in favour of home
hospitalisation were conserved across each assumption.
TABLE 10 Costs associated with home hospitalisation and conventional care
Resource-use item
Cost per patient (€)
p-valueaHome hospitalisation Conventional care
Inpatient hospital stay 941.40 1795.47 < 0.001
Emergency room visits 10.31 24.59 0.01
Outpatient visits 5.49 22.04 –
Primary care physician visits 8.19 7.57 –
Prescriptions 217.21 172.06 0.001
Nurse home visits 41.94 – –
Social support visits 1.62 2.19 –
Telephone calls 20.99 – –
Transport 7.97 9.59 –
Average cost (€) per patient (95% CI) 1255.12 2033.51 0.003
CI, confidence interval.
a Non-parametric Mann–Whitney U-test.
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Discussion
Summary of results
A comprehensive search strategy identified one study68 that met the inclusion criteria for this review.
The overall quality of the study was high, with some issues related to reporting. Meta-analysis was not
possible. The study68 revealed that home hospitalisation is less costly than conventional care [£1041.75 vs.
£1687.81 (conversion rate €1 = £0.83)].
How this fits with other literature
One relevant study82 published after the search strategy had been completed was subsequently identified.
Xin Lie et al.82 developed a Markov model to evaluate the impact of a hypothetical exacerbation
management programme that could detect the risk of exacerbation and divert the risk of hospitalisation. In
patients without prior history of exacerbation, they estimated that this would result in savings of US$2900
per patient over 12 years, and in higher-risk patients – with a history of one or two exacerbations per
year – this estimate increased to US$16,000 per patient.
Strengths and limitations
This is the first systematic review of the cost-effectiveness literature of SM interventions for patients who
have recently been discharged from hospital after an acute exacerbation of COPD. The methods used
throughout this cost-effectiveness review were systematic. A comprehensive search strategy was
undertaken and the results were reviewed independently by two reviewers, including a health economist.
The recommended quality assessment checklist was used.
It should be noted that the patients in this study were recruited from the emergency room rather than
after discharge post hospital admission, which may or may not cause variations in the applicability of the
results. A scarcity of evidence of the cost-effectiveness of SM interventions was evident. The identified
study included the cost of implementing a hospital-at-home programme with components of SM, thus the
SM components reflect only a proportion of the costs and cost savings incurred.
Implications for research
There is a need for more economic evaluations, alongside randomised controlled trials, specifically
addressing patients who have recently been discharged from an inpatient hospital admission stay after an
acute exacerbation of COPD, and who have been treated with SM interventions or components of SM,
such as education, action plans, breathing techniques, relaxation and stress management amongst others.
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Chapter 6 Economic evaluation
Methods
This section provides a detailed description of the economic model that was developed and used to
evaluate the cost-effectiveness (cost–utility) of self-management (SM) support delivered within 6 weeks of
hospital discharge compared with usual care (UC) in a patient population with chronic obstructive
pulmonary disease (COPD) who have been admitted for an exacerbation. The evidence for the
effectiveness of SM programmes (see Chapter 3) demonstrated that there was considerable uncertainty for
the outcome measures of mortality, quality of life (QoL) and admissions. The model presented here
considers the potential impact of reduced admissions due to a SM programme, in terms of costs, mortality
and QoL. However, owing to the uncertainty around the point estimate of reduction in admission and
the considerable heterogeneity between studies, this effect must be considered with some caution.
Therefore, the economic model should be viewed as speculative, with the aim of estimating the potential
cost–utility of SM if it is truly effective at reducing hospital admissions for exacerbations.
Model description
A Markov decision model, built in TreeAgePro 2014 (TreeAge Software, Inc., Williamstown, MA, USA)
was structured to consider short-term increased risks of readmission and mortality, and the long-term
natural history of the disease, taking into account exacerbations, increasing COPD severity and mortality
(Figure 13). This structure was an adapted version of other COPD Markov models83 with health states linked
to GOLD (Global Initiative for Chronic Obstructive Lung Disease) severity. It incorporated additional health
states to capture the higher risks reported in patients immediately after discharge in audits of patients
admitted to hospital.84 The model had a time cycle of 1 month and a lifetime time horizon (30 years) was
used. All costs and outcomes were considered from a NHS perspective for a price year of 2012.
Post admissions Stable
GOLD 2
Stable
GOLD 3
Stable
GOLD 4
Stable
GOLD 2
Post admission
month 3
GOLD 3
Post admission
month 3
GOLD 2
Post admission
month 2
GOLD 3
Post admission
month 2
GOLD 2
Post admission
month 1
GOLD 3
Post admission
month 1
GOLD 4
Post admission
month 3
GOLD 4
Post admission
month 2
GOLD 4
Post admission
month 1
Dead
FIGURE 13 Markov model structure.
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Severity of COPD was defined according to the GOLD classification. GOLD stage 2 was defined as having a
forced expiratory volume in 1 second (FEV1) of ≥ 50%, < 80% predicted; GOLD stage 3, a FEV1 of ≥ 30%,
< 50% predicted; and GOLD stage 4, a FEV1 of < 30% predicted. GOLD stage 1 (mild COPD) was
excluded, as < 16% of patients admitted to UK hospitals with COPD had a FEV1 of ≥ 80% predicted.
A patient started in the model in one of three health states representing their first month post admission,
taking into account their current GOLD severity stage. Those who continued to recover without further
exacerbations moved to health states to represent the second and third month of recovery, again related
to their GOLD stage. Within this 3-month recovery period, a patient could die from COPD or other causes
or have a further exacerbation requiring readmission, which could be fatal. If the patient survived, they
were discharged to restart the 3-month recovery period in a ‘first month post-admission’ health state.
The patient pathway within each post-admission health state (Figure 14) was similar for each month and
severity stage. The post-admission health states allowed the model to consider the immediate increased
risk of readmission and COPD-related mortality for 3 months after discharge. Once a patient survived
3 months of recovery with no readmissions, they moved into a stable health state for their GOLD stage.
Once in the stable GOLD stage 2, 3 or 4, a patient could remain in that health state, deteriorate to the
next more severe health state, have an exacerbation or die. An exacerbation could be moderate (managed
in primary care) or severe (admitted to hospital). Patients who recovered from moderate exacerbations
either remained in the same health state or deteriorated. Severe exacerbations could result in death, and
surviving patients moved to the relevant ‘first month post-admission’ health state. It was assumed that no
patients could improve into a better GOLD stage health state. Figure 15 illustrates the patient pathway in a
stable health state.
Base-case cohort
For the base-case analysis, the characteristics of the cohort were taken from the 2011 report by the
European Audit84 of UK patients with COPD admitted to hospital (Table 11). The proportions of men and
current smokers were assumed to remain constant. The baseline distribution of patients entering the
model was 35% in GOLD stage 2, 35% in GOLD stage 3 and 30% in GOLD stage 4.
Estimation of model parameters
This section outlines the assumptions applied, and sources used, to populate the base-case,
usual-care arm.
Transition probabilities within post-admission health states
Published data on exacerbation rates in patient cohorts who had been admitted to hospital demonstrated
an elevated risk of readmission and mortality immediately after discharge.84,85 In addition, exacerbation
rates and severity of exacerbations increased with disease severity. The risk of a mild or moderate
exacerbation was not considered in the post-admission health states.
Live
Die
Dead
Continued
recovery
Post-admission
GOLD 2 month 1
Live
Readmitted
Dead
Die during admission
Stay the same
Post-admission GOLD 2 month 2
Post-admission GOLD 2
month 1
Post-admission GOLD 3
month 1
Post-admission GOLD 3 month 2
Stay the same
Deteriorate
Deteriorate
FIGURE 14 Pathways within post-admission states.
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The majority of the transition probabilities for post-admission health states were obtained from the
European Audit84 and are reported in Table 12. Risks of readmission and mortality were the same for each
of the three post-admission months and did not differ by GOLD stage. Post-admission COPD-related
mortality and readmission risks were assumed to be evenly distributed over the 3-month period.
Age- and sex-specific all-cause mortality rates were obtained from Office for National Statistics life tables
and adjusted to avoid double counting of COPD-related mortality. Appendix 18 lists the COPD adjusted
all-cause mortality rates applied in the economic model. Age- and smoking-related disease progression
rates were obtained from a published model86 (see Appendix 19). All annual rates were converted to
monthly probabilities.
Transition probabilities within stable health states
The patient pathways for each GOLD stage health state were assumed to be the same (see Figure 15);
however, the probabilities, costs and utilities differed by COPD severity. The probability of progressing to a
more severe GOLD stage was not assumed to vary by exacerbation history; thus, the transition probabilities
for movement between stable health states were the same as those described above.
The probabilities for exacerbations and hospitalisations were obtained from the TORCH (TOwards a
Revolution in COPD Health)85 and ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive
Surrogate Endpoints)13 studies, respectively. Patients who survived, exacerbation free, for the 3-month
TABLE 11 Base-case characteristics
Characteristic Median or %
Age (median) 72
Sex (% male) 47.4
Smoking status (% current smokers) 39.4
GOLD stage (%): 2; 3; 4 35; 35; 30
Source: European Audit 2012.84
TABLE 12 Mortality and exacerbation risks applied in post-admission states
Definition Probability Beta distributiona
COPD-related death during admissionb
Men 0.050 α= 118, β= 2243
Women 0.051 α= 133, β= 2490
90-day COPD-related death post admissionb
Men 0.047 α= 104, β= 2097
Women 0.049 α= 120, β= 2324
90-day COPD-related readmissionb
Men 0.323 α= 705, β= 1496
Women 0.295 α= 721, β= 1723
a A beta distribution is a family of continuous probability distributions defined on the interval (0,1) denoted by α and β,
where ‘α’ is the number of successes in a trial and ‘β’ is the number of failures.
b Mortality and readmission rates were adjusted to include only those for which the primary cause was COPD or
respiratory failure. These were not differentiated by GOLD stage in the post-admission health states.
Source: European Audit 2012.84
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post-admission period were assumed to have exacerbation and hospitalisation rates similar to those
reported in stable cohorts for each severity stage. As the exacerbation rates from the TORCH trial85 were
reported by type of treatment, assumptions were required in the model regarding the proportion of
patients on each type of treatment in each GOLD stage health state. These proportions were obtained
from unpublished data collected from a cohort of UK patients with COPD who were recruited as part of
BLISS (Birmingham Lung Improvement Studies) in the West Midlands. Exacerbation rates were then
weighted by the proportion of patients on each treatment in each GOLD stage severity group. As the
TORCH study85 did not report the proportion actually admitted to hospital for an exacerbation, this was
obtained from the ECLIPSE study.13
The base-case proportions on each type of treatment, annual exacerbation rates and the proportion
resulting in a hospital admission are reported in Tables 13 and 14. Probabilities for inpatient mortality,
all-cause mortality and disease progression are as described previously for the post-admission states.
Estimate for effectiveness of self-management support
Data and assumptions regarding the effectiveness of SM were based on the results of the review
presented in Chapter 3. As previously highlighted, although evidence suggested a potential reduction
in readmissions, there was considerable uncertainty around the point estimate of effect as the
95% CI crossed 1 (see Chapter 3, Hospital admissions: no evidence of effect). The HR used for the
base-case model was the weighted ratio of the more intense SM interventions. Two alternative HRs
reported were subsequently applied in a one-way sensitivity analysis. The estimate of effect was applied to
all monthly probabilities for readmission for severe exacerbation in the SM strategy in the model
(Table 15).
TABLE 13 Proportion of each type of treatment and exacerbation rate
Severity stage
Treatment type
Othera ICS LABA ICS/LABA
GOLD 2
Proportion on treatment (%) (BLISS) 42.92 0.02 6.31 50.75
Annual exacerbation rate (TORCH)85 0.82 0.68 0.71 0.57
GOLD 3
Proportion on treatment (%) (BLISS) 26.27 0.85 5.08 67.80
Annual exacerbation rate (TORCH)85 1.24 0.99 1.08 0.91
GOLD 4
Proportion on treatment (%) (BLISS) 16.28 4.65 2.33 76.74
Annual exacerbation rate (TORCH)85 1.79 1.53 1.40 1.54
ICS, inhaled corticosteroids; LABA, long-acting beta-agonist; ICS/LABA, combined therapy (combined ICS and LABA).
a Patients may have been on other treatments, such as long-acting muscarinic antagonists (LAMAs) and short-acting
muscarinic antagonists (SAMAs).
TABLE 14 Exacerbation and hospitalisation rates applied in stable health states
Severity stage Overall weighted exacerbation rate85
Proportion of exacerbations hospitalised13
% Beta distributions
GOLD 2 0.68 11 α= 104, β= 841
GOLD 3 1.00 25 α= 225, β= 675
GOLD 4 1.57 54 α= 158, β= 135
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Although the effectiveness estimate was estimated over a short period of time in the trials, the model
assumed that the effect of the SM intervention would last for 2 years.
The results of the review indicated no evidence of higher all-cause mortality associated with SM, as the HR
reported was very close to 1. As the model takes into account a reduced risk of readmission, which leads
to improved survival, no further adjustment to mortality was undertaken.
Estimation of quality-adjusted life-years
Utility values were required for all health states and exacerbation events, and were combined with information
on survival in order to calculate quality-adjusted life-years (QALYs). The model health states were based on
COPD severity defined by GOLD stages 2–4. Utility values for these health states were calculated from
unpublished data collected from the BLISS cohort. Utility scores for GOLD stages 2–3 were derived from the
EQ-5D-5L (a revised version of the EQ-5D questionnaire). The five dimensions (mobility, self-care, usual
activities, pain and discomfort, and anxiety and depression) have five levels, compared with the older version,
which used three levels. The addition of two more levels may have made the EQ-5D more sensitive to
differences in health states and avoid ceiling effects.87
The EQ-5D-5L was completed by 917 participants enrolled in the BLISS study, with a confirmed diagnosis
of COPD, at GOLD stage 2, 3 or 4, and converted to utility scores using the interim crosswalk value set for
a UK population reported by EuroQoL.88 Data from this cohort were deemed suitable for stable health
states in the model for two reasons. First, participants were not recovering from an exacerbation at the
time of questionnaire completion, therefore the utility scores were expected to reflect QoL in the stable
condition. Second, > 80% of patients in each GOLD stage had been admitted to hospital at least once in
the past year, therefore presenting a population who suffered exacerbations. EQ-5D-5L responses were
converted to utility scores and are reported in Table 16.
The utility scores were compared with values applied in other COPD models that defined health states by
GOLD severity stage. The utility values obtained from the BLISS cohort study were similar to those reported
in other studies.83,89–91 Data on utility loss suffered immediately after a moderate or severe exacerbation
were extracted from previously published models; however, estimates varied greatly and the evidence
underpinning these was poor.83,89,92–94 It was assumed that there was a loss of utility for 1 month for
moderate exacerbations and a utility loss for 3 months for severe exacerbations due to full recovery taking
a longer period of time.95–97 However, in line with other studies, the utility loss for severe exacerbations
TABLE 15 Adjusted HRs applied to admissions for the SM strategy
Analysis HR 95% CI Meta-analysis inclusion criteria
Base case 0.83 0.50 to 1.36 Review 1: More supported SM interventions
One-way sensitivity
analysis
Low 0.96 0.49 to 1.90 Review 1: Less supported SM interventions
High 0.78 0.52 to 1.17 Review 1: All studies, including those with an exercise
component
Source: outcomes reported in Chapter 3 (review 1).
TABLE 16 Utility scores for stable GOLD health states
Descriptor GOLD 2 GOLD 3 GOLD 4
Sample size (n) 650 229 38
Mean utility score (SE) 0.7041 (0.0102) 0.6765 (0.0174) 0.6014 (0.0415)
SE, standard error.
Source: BLISS cohort study (unpublished data).
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was assumed to be greatest in the first month, with improvement in QoL in the second and third months
post admission.
The utility loss estimate of 15% for moderate exacerbation and 50% for severe exacerbation was obtained
from Rutten-van Mölken et al.89 This was applied to the mean utility score across all three severity stages
(as opposed to each individually) to ensure that the utility loss suffered in stage 2 or 3 was not greater
than loss experienced by stage 4 patients. The mean utility score found in the BLISS cohort across stages
2–4 was 0.693; therefore, a moderate exacerbation was assumed to result in a loss of 0.104 QALYs for
1 month and a severe exacerbation was assumed to result in a 0.346 loss of QALYs in the first month,
reducing to a loss of 0.173 QALYs for months 2 and 3. A summary of all the utilities applied in the
base-case analysis is provided in Table 17.
The review presented in Chapter 3 found evidence that SM may have a positive impact on QoL; however,
the results were highly uncertain. As the model takes into account reduced rates of readmissions in the SM
strategy, which leads to reduced loss of QoL, no further utility gains were applied in the model.
Resource use and costs
The resource use considered within the model was broadly concerned with the SM intervention, primary
and secondary health-care professional contacts, and pharmacotherapy. Health-care contacts for each
GOLD severity group were estimated with reference to National Institute of Health and Care Excellence
(NICE) guidelines and expert opinion. Use of pharmacotherapy was estimated from data provided by the
BLISS cohort. Unit costs were primarily obtained from NHS Reference costs98 and Unit Costs of Health and
Social Care.99 When appropriate, unit costs were inflated to 2012 prices using NHS Health Index inflation
rates. Annual costs were divided by 12 to derive a monthly cost. Moderate and severe exacerbations were
treated as additional one-off costs and assumed to be the same, irrespective of the underlying GOLD stage.
Routine health-care visits
It is recommended by NICE10 that stable patients with COPD are followed up at least once a year and
those with very severe COPD at least twice a year, with rapid access to hospital assessment as necessary.
Based on these guidelines it was assumed that patients at GOLD stages 2, 3 and 4 would attend 1, 2 and
2.5 assessments per year, respectively, and that spirometry tests were conducted once per year in GOLD
stage 2 and twice in GOLD stage 3 and 4 patients. As follow-up arrangements in primary or secondary
care were not specified within the guidelines, an even split between both types of services was assumed
for each severity group.
The cost of follow-up and spirometry in secondary care were obtained from NHS Reference Costs.98 Costs
for follow-up in primary care were based on the cost of a home visit by a community nurse, as published
by the Personal Social Services Research Unit (PSSRU)99 and the cost of spirometry was extracted from a
costing document published by NHS Commissioning Support for London.100 Additional health-care costs
TABLE 17 Utility scores including loss of quality of life with exacerbations
Severity of COPD
Base case
GOLD 2 GOLD 3 GOLD 4
Stable conditiona 0.7041 0.6765 0.6014
Moderate exacerbation 0.6001 (1 month) 0.5725 (1 month) 0.4974 (1 month)
Severe exacerbation 0.3581 (first month) 0.3305 (first month) 0.347 (first month)
0.5311 (months 2 and 3) 0.5035 (months 2 and 3) 0.4284 (months 2 and 3)
a Source: BLISS cohort; assumptions extracted from Rutten-van Mölken et al.89 and applied to mean scores obtained
from BLISS.
DOI: 10.3310/hta19360 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 36
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Jordan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
69
included were the provision of annual influenza vaccinations, home oxygen therapy and the cost of
prescribing. As the median age of the population was > 70 years, it was assumed that 75%101 of patients
in each severity group received the vaccination at the current estimated cost of £6.21.101 The average
number of days and cost of home oxygen therapy received in each severity group was obtained from
estimates reported in Hertel et al.,92 derived from expert opinion.
Smoking cessation advice and pulmonary rehabilitation are also recommended by NICE as UC for patients
with COPD.10 However, these costs were assumed to be the same for both strategies, thus cancelling each
other out, and were omitted from the model.
The total annual costs of health-care visits in GOLD stages 2, 3 and 4 were estimated to be £180, £332
and £453, respectively. A summary of the assumptions and reference costs applied to derive these
estimates is provided in Table 18.
Routine pharmacotherapy
The NICE guidance is not prescriptive for each GOLD stage, and suggests that the number and type of
treatments prescribed should be determined by patient symptoms and response. Therefore, the model
utilised data from the previously described BLISS cohort for the proportion of patients on each line of
therapy, by GOLD stage (Table 19).10 As 100% of patients were reported to be on an inhaled short-acting
β2-agonist (SABA), assumptions on the number of delivery devices in each severity stage were made by
clinical experts. Drug reference costs reported by NICE 2011102 (Table 20) were compared with current unit
costs listed on the NHS Drug Tariff database103 in 2014. Most of the drug prices were consistent with those
listed in the NICE 2011 report; however, some were higher and some were lower.102 As there did not
appear to be a consistent drug inflation rate during this period (2011–14), it was not appropriate to inflate
the 2011 prices or deflate the 2014 prices to estimate the costs in 2012 prices, thus the prices listed in
the NHS Drug Tariff database103 for 2014 were applied. Annual and monthly costs were calculated by
applying the same unit cost to annual costs reported by NICE. When there was more than one drug in
each treatment class, an overall average cost was applied.
TABLE 18 Annual routine health-care utilisation and costs by GOLD stage
Health care GOLD 2 GOLD 3 GOLD 4 Unit cost (£) Source
Secondary care
follow-up
0.5 visit 1 visit 1.25 visits 139 NHS Reference Costs 2010/11,98
inflated to 2012
Primary care
follow-up
0.5 visit 1 visit 1.25 visits 57 PSSRU 2012;99 hourly cost of a
community nurse home visit
Secondary care
spirometry
0.5 test 1 test 1 test 52 NHS Reference Costs 2010–11,98
inflated to 2012 prices
Primary care
spirometry
0.5 test 1 test 1 test 18 North Central London costing
report for a community-led
COPD pathway100
Influenza vaccination 75% uptake 75% uptake 75% uptake 6.21 Department of Health 2011101
Oxygen therapy 0 days 1.22 days 6.08 days 15 Hertel et al.92
Prescription costs per
consultation (£)
42.70 (assuming one per annum) PSSRU 201299
Annual cost (£) 180.20 331.88 453.40
Monthly cost (£) 15.02 26.12 37.78
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TABLE 19 Proportion on type of pharmacotherapy and monthly cost by severity
Severity stage
Assumed no. of SABAs
used per month
Proportion on type of pharmacotherapy
SABA ICS LABA Combinationa LAMA SAMA
GOLD 2 (n= 599) 1 1.00 0.04 0.06 0.51 0.46 0.05
GOLD 3 (n= 216) 2 1.00 0.01 0.05 0.68 0.62 0.04
GOLD 4 (n= 37) 2.5 1.00 0.05 0.02 0.77 0.65 0.05
Monthly cost (£) GOLD stage 2 43.72
GOLD stage 3 60.91
GOLD stage 4 67.57
ICS, inhaled corticosteroids; LABA, long-acting beta-agonist; LAMA, long-acting muscarinic antagonist; SAMA, short-acting
muscarinic antagonist.
a Combination therapy whereby two or more types of pharmacotherapy were prescribed.
TABLE 20 Unit costs of pharmacotherapy
Class
Drug formulation
and dose
Price (£)
per pack
(NICE 2011)102
Price (£)
per pack
(NHS 2012)103
Annual
cost (£)
estimated
by NICE102
Annual cost
in 2012
prices (£)
Monthly
cost (£)
SABA Salbutamol 100 µg metered
inhalation (generic)
3.52 3.31 25.70 24.17 2.01
Terbutaline 500 µg metered
inhalation (Bricanyl®,
AstraZeneca)
6.92 6.92 101.03 101.03 8.42
SABA average cost 5.22
ICS Beclometasone 250 µg metered
inhalation (generic)
18.74 12.31 34.20 22.45 1.87
SAMA Ipratropium 20 µg metered
inhalation (Atrovent®,
Boehringer Ingelheim)
5.05 5.05 27.65 27.65 2.30
LABA Salmeterol 25 µg metered
inhalation (Serevent)
29.26 29.26 356.00 356.00 29.67
LAMA Tiotropium 18 µg inhalation
capsule (Spiriva)
32.49 33.50 395.30 407.58 33.97
LABA
and ICS
Budesonide 200 µg+ formoterol
6 µg metered inhalation
(Symbicort® turbohaler,
Astrazeneca)
38.00 11.84+ 24.80 462.33 445.78 37.15
Budesonide 400 µg+ formoterol
12 µg metered inhalation
(Symbicort turbohaler)
38.00 13.86+ 30.06 462.33 534.36 44.53
Fluticasone propionate
500 µg+ salmeterol 50 µg
metered inhalation (Seretide®
accuhaler, Allen & Hanburys Ltd)
40.92 40.92 497.86 497.92 41.49
LABA+ ICS average cost 41.06
ICS, inhaled corticosteroids; LABA, long-acting beta-agonist; LAMA, long-acting muscarinic antagonist; SAMA, short-acting
muscarinic antagonist.
Source: NICE 2011102 and NHS Drug Tariff database.103
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Cost of exacerbations
Moderate exacerbations were assumed to be predominantly managed in primary care through GP
appointments, with a proportion attending accident and emergency (A&E) without admission. As no data
were found on the split between GP and A&E visits, assumptions were derived from expert opinion reported
in Hertel et al.,92 which assumed that two out of three patients would see a GP, and one out of three patients
would attend A&E. Prescribed additional medication for a moderate exacerbation was assumed to be a
course of prednisolone (5mg tablets, six times per day for 5 days) and antibiotics when exacerbations were
associated with a history of purulent sputum (NICE10). The total cost of treating a moderate exacerbation was
estimated to be £114, and a breakdown of how this cost was calculated is presented in Table 21.
The majority of severe exacerbations were assumed to be managed in hospital but 20% were assumed
to be managed through hospital-at-home or early discharge schemes. The 2011 NICE102 costing study
estimated the average cost of a COPD hospital admission to be £1978. These costs were not inflated as
the NHS tariff prices98 applied appeared similar to those listed in 2012. No data were available on the
tariffs for hospital-at-home or early discharge schemes; however, a UK-based cost analysis estimated the
costs incurred in a similar scheme to be £1653 in 2009 prices,104 inflated to £1769 for 2012. Following
discussion with our clinical experts, it was assumed that 20% of those who suffered an exacerbation
requiring admission accessed the non-inpatient type of service.
Guidance from NICE also recommends that patients should be followed up after discharge therefore this cost
was included in the average cost of a severe exacerbation and was assumed to include one follow-up visit,
30% seen by a community nurse, 30% attending a GP appointment and 40% attending an outpatient
appointment. The total cost of managing a severe exacerbation was estimated to be £2053 (Table 22).
TABLE 21 Cost of moderate exacerbation
Resource-use item
% requiring
resource Unit cost (£) Source of cost estimate
GP visit (12 minutes) 66.7 44.40 PSSRU99
A&E visit without admission 33.3 112.00 PSSRU99
Prednisolone (5-mg tablets,
six times per day for 5 days)
100 0.11 NHS Drug Tariff database103
Amoxicillin (Amoxil®, GlaxoSmithKline)
(500-mg capsules, three times a day for 5 days)
100 0.09 NHS Drug Tariff database103
Prescription costs per consultation 100 42.70 PSSRU99
Estimated cost (£) of moderate exacerbation 114.28
TABLE 22 Cost of severe exacerbation
Resource-use item
Proportion
requiring
resource (%) Unit cost (£) Source
Average cost of COPD hospital stay 80 1978 NICE 2011102
Average cost of hospital-at-home programme 20 1769 Bakerley et al.,104 inflated to
2012 prices
Community nurse follow-up 30 57 PSSRU99
GP follow-up (12-minute visit) 30 44 PSSRU99
Outpatient appointment follow-up 40 139 NHS tariff prices98
Estimated cost (£) of severe exacerbation 2053
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Cost of self-management
The cost of providing a SM programme to patients with COPD post discharge was estimated with reference
to the activities described in a sample of studies selected from review 1 in Chapter 3. Studies were chosen
to reflect different levels of intensity of SM. The estimated cost of delivering a SM programme of low,
moderate/high and high intensity is detailed in Tables 23–25. The costs estimated for Wong et al.74 and
Bucknall et al.63 were estimates based on the resource use described.
TABLE 23 Cost estimates for low-intensity SM
Description of activity
Resource
required Unit cost (£)
Total cost per
patient (£) Source
Two 10- to 20-minute telephone
calls within 4 weeks of discharge;
each telephone call was assumed
to take 45 minutes of staff nurse
time, taking into account missed
calls and processing information
before and after
Staff nurse time 43 64.50 Hour of staff nurse time
(PSSRU 201299)
A senior nurse specialist
supervised this service; this was
15 minutes of time per patient
Senior staff
nurse time
81 20.25 Hour of senior nurse specialist
(PSSRU 201299)
Total cost 84.75
Source: Wong et al.74
TABLE 24 Resource use and cost of moderate- to high-intensity SM
Description of activity
Resource
required Unit cost (£)
Total cost per
patient (£) Source
Two 1-hour one-to-one education
sessions by specialist respiratory
nurse
Specialist nurse 91 182 Hour of clinical nurse specialist
patient contact time (PSSRU 201299)
Care plan development, sharing
plan with primary care team
(30 minutes of nurse specialist and
30 minutes of community nurse
time)
Specialist nurse 58 50 Hour of clinical nurse specialist and
community nurse (PSSRU 201299)
Community
nurse
42
One follow-up by respiratory care
team including respiratory
specialist, GP, nurse and social
worker (30 minutes of each
health-care professional’s time)
Specialist nurse
home visit
91 2440 Hour of specialist nurse home
visit time; hour of GP home visiting
time; hour of community nurse
time; hour of social worker for
adult services time (PSSRU 201299)
GP home visit 282
Community nurse 61
Social worker 54
Four weekly telephone calls in the
first month (10 minutes per call, plus
10 minutes follow-up administration)
Specialist nurse 58 77.33 Hour of clinical nurse specialist
time (PSSRU 201299)
Two follow-up telephone calls
(10 minutes per call, plus 10 minutes’
follow-up administration)
Specialist nurse 58 38.67 Hour of clinical nurse specialist
time (PSSRU 201299)
0.03 telephone calls per patient
triggered through access to
specialist case manager via
telephone service (20 minutes
each)
Specialist nurse 58 0.58 Hour of clinical nurse specialist
time (PSSRU 201299)
0.05 follow-up home visits per
patient triggered by telephone calls
Specialist nurse 91 3.05 Hour of home visit by community
nurse (PSSRU 201299)
Total cost 597.13
Source: Casas et al.71
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Calculated costs were compared with estimates of other SM programmes that are targeted at patients
with COPD but not delivered at discharge (see Appendix 20).The majority of SM programmes cost
between £500 and £600, and are therefore similar to the estimate of the SM programme described
by Casas et al.;71 thus this was chosen for the base case for the moderate- to high-intensity programme.
Sensitivity analyses were conducted to evaluate the cost-effectiveness of SM assuming low- and
high-intensity programmes and are outlined in the sensitivity analysis subsection.
Assessment of cost-effectiveness
The incremental analysis was designed to generate the cost per additional QALY gained for SM delivered
within 6 weeks of discharge when compared with UC in a cohort of patients with COPD. In summary, the
key assumptions for the base case were as follows:
l The starting cohort was assumed to be aged 72 years, 47.4% male with 39.4% current smokers
(see Chapter 6, Base-case cohort).
l The starting distribution of COPD severity was 35% GOLD stage 2, 35% GOLD stage 3 and 30%
GOLD stage 4 (see Chapter 6, Base-case cohort).
l Mortality and readmission risks during admission and immediately after discharge were taken from the
European Audit84 and applied for 3 months’ post-admission (see Chapter 6, Transition probabilities
within post-admission health states).
l Long-term exacerbation, hospitalisation risk and disease progression were taken from large cohort
studies of three years or more (see Chapter 6, Transition probabilities within stable health states).
l The estimate for reduction in risk of admission with SM was taken from moderate- to high-intensity
programmes (see Chapter 6, Estimate for effectiveness of self-management report).
l Utility values were obtained from the BLISS cohort and an estimate was applied for the utility loss
associated with exacerbation (see Chapter 6, Estimation of quality-adjusted life-years).
l The cost of UC was estimated with reference to pharmacotherapy use amongst the BLISS cohort, best
practice guidance, expert opinion and NHS reference prices (see Chapter 6, Resource use and costs).
l The cost of SM was estimated to be £597, incurred in the first month and the effect was assumed to
last for 2 years (see Chapter 6, Cost of self-management).
Where available, data were entered into the model as distributions so as to fully incorporate the
uncertainty around parameter values in order that a probabilistic sensitivity analysis could be undertaken.
Beta distributions were applied to the proportion on different treatments and accessing services in primary
and secondary care; they were also applied to annual exacerbation rates and the proportion resulting in
hospital admissions, as well as the risk reduction expected in the SM arm. Normal distributions were
applied to utilities and utility losses. The probabilistic sensitivity analysis was run with 1000 simulations, and
cost-effectiveness planes and acceptability curves were produced.
TABLE 25 Estimated cost of high-intensity SM
Description of activity
Resource
required Unit cost (£)
Total cost per
patient (£) Source
Four 40-minute training sessions at home
from study nurse (each visit is 60 minutes
community nurse specialist time)
Community
nurse
61.00 244.00 Hour of community nurse
home visiting time
(PSSRU 201299)
Seven home visits every 6 weeks for
12 months (each visit takes an hour of
community nurse specialist time)
Community
nurse
61.00 427.00 Hour of community nurse
home visiting time
(PSSRU 201299)
Total cost 671.00
Source: Bucknall et al.63
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Sensitivity analysis
Additional model runs were undertaken to determine the impact of changing key parameters on the
model results. Those parameters for which the incremental cost-effectiveness ratio (ICER) was
demonstrated to be particularly sensitive to change were explored in more detail. The following analyses
were undertaken:
1. The time horizon was varied, changing from the base-case assumption of 30 years to 6 months,
2 years, 10 years and 20 years.
2. The effect of SM on admissions was varied by substituting the base-case HR of 0.83 (95% CI 0.50 to
1.36) with two alternative HRs reported in Chapter 3. This included a HR derived from a meta-analysis
of two low-intensity programmes of 0.96 (95% CI 0.49 to 1.90) and a meta-analysis that included
exercise interventions representing a high-intensity programme of 0.78 (95% CI 0.52 to 1.17).
3. The duration of effect was tested for the base-case moderate-high-intensity SM programme, assuming
the effect lasted for only (1) 6 months and (2) the lifetime of the cohort (see Chapter 6, Duration
of effect).
4. The cost of SM was tested applying a low estimate of £85 and a high estimate of £671 (see Chapter 6,
Cost of self-management).
5. An alternative set of utility scores obtained from Borg et al.83 were applied (higher utility scores for
GOLD stages 2 and 3, lower utility scores for GOLD stage 4 and a proportional deduction in utility for
each severity stage lasting for 1 month in both moderate or severe exacerbation); see Table 26 (see also
Utility values for chronic obstructive pulmonary disease).
6. Subgroup analysis was conducted to test if the decision rules changed if targeted at different
subpopulations. This was tested by assuming that (1) all patients were GOLD stage 2; (2) all patients
were GOLD stage 3; (3) all patients were GOLD stage 4; (4) there were different start ages; (5) all of the
cohort were male; (6) all of the cohort were female; (7) all were smokers; (8) and all were non-smokers
(see Chapter 6, Subgroup analysis).
7. Two scenario analyses were conducted: scenario 1 applied the highest estimate of effect 0.78 (95% CI
0.52 to 1.17) and the highest estimate of SM costs, £671; scenario 2 applied the lowest estimate of
effect 0.96 (95% CI 0.49 to 1.90) and the lowest estimate of costs of £85 (see Chapter 6,
Scenario analysis).
TABLE 26 Alternative utility values applied in one-way sensitivity analysis
Sensitivity analysis 1
Stable condition 0.7551 0.7481 0.5493
Moderate exacerbation 0.6418 (1 month) 0.6359 (1 month) 0.4669 (1 month)
Severe exacerbation 0.378 (1 month) 0.374 (1 month) 0.2747 (1 month)
Assumptions on proportion effect for utility loss during exacerbation taken from Rutten-van Mölken89 and applied to mean
utilities found in Borg et al.83
DOI: 10.3310/hta19360 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 36
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Jordan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
75
Results
Base-case analysis
The base-case results presented in Table 27 show that, compared with UC, SM (delivered within 6 weeks
of discharge) was more costly and resulted in better outcomes, with a £683 cost difference and gain of 0.0831
QALYs. The ICER was £8218 per QALY gained – well below the threshold values of £20,000–30,000 per QALY
gained as recommended by NICE.10
Results from the probabilistic sensitivity analysis are shown in the cost-effectiveness plane in Figure 16, which
shows the distribution of 1000 resampled cost–effect difference pairs. The probabilistic sensitivity analysis
clearly shows that SM is the more expensive strategy; however, the effectiveness is less certain, with a number
of points indicating that SM may give fewer QALYs. The cost-effectiveness acceptability curve in Figure 17
shows that the intervention has a 68% probability of being cost-effective at £20,000 per QALY gained and
71% at a £30,000 threshold.
TABLE 27 Base-case results
Strategy
Mean
cost (£)
Cost
difference (£)
Mean
QALYs
QALY
difference
ICER
(£/QALY)
Probability cost-effective at a
specified threshold (%)a
£20,000/QALY £30,000/QALY
UC 18,872 5.767
SM 19,556 683 5.850 0.0831 8218 68 71
a Refers to the proportion of samples drawn from the probabilistic sensitivity analysis that could be considered
cost-effective, based on what NICE is willing to pay for an additional QALY gained.
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Sensitivity analysis
Alternative model time horizon
Table 28 presents the results of the model when varying the time horizon of the model. At a short time
horizon of 6 months, when the intervention has been effective for 6 months, the ICER was £52,487 –
above the NICE thresholds for cost-effectiveness; however, this is unlikely to represent a realistic time
frame. At 2 years, the ICER reduces to £5954 as a result of most of the additional cost of implementing a
SM programme being offset by savings from a reduction in hospital admissions. This changes over time, as
higher costs are incurred in the surviving arm as a result of lower mortality. The probability of SM being
cost-effective at £20,000/QALY remains > 62% beyond 2 years but no longer dominates UC.
Alternative hazard ratios for readmissions in the self-management strategy
Owing to the considerable uncertainty around the effectiveness estimate (HR) for readmissions, this model
parameter was expected to be the biggest driver of the cost-effectiveness results. To test this, two
alternative HRs reported in the meta-analysis for review 1 were applied in the model and the results are
shown in Table 29. The first alternative HR applied was a higher estimate of the effect. This was derived
from a meta-analysis that included SM interventions with an exercise component. Applying the higher
estimate of effect, the ICER decreased to £6249, and the likelihood of SM being cost-effective at a
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FIGURE 17 Base-case cost-effectiveness acceptability curve.
TABLE 28 Sensitivity analysis: alternative model time horizons
Time
horizons Cost difference (£)
QALY
difference
ICER
(£/QALY)
Probability cost-effective
at £20,000/QALY (%)
Probability cost-effective
at £30,000/QALY (%)
6 months 175 0.0033 52,487 32 39
2 years 95 0.0160 5954 62 65
10 years 489 0.0624 7838 65 72
20 years 664 0.0812 8180 68 71
Base case
(30 years)
683 0.0831 8218 68 71
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threshold value of £20,000 per QALY increased to 82%. The second alternative HR applied was a lower
estimate of effect derived from a meta-analysis of two low-intensity SM programmes. This increased the
ICER to £38,265. This was above the threshold value of £30,000/QALY and hence the probability of SM
being cost-effective at £30,000/QALY reduced to 45%.
Figure 18 illustrates the relationship between changing the point estimates of the HR and the mean ICER.
At values of < 1 the ICERs are positive, and at all values of < 0.95 the ICERs are below the threshold of
£30,000 per QALY. As the HR approaches 0.5, the ICER decreases and the benefits increase. At all values
of > 1, SM is a less favourable option. If SM has no effect or increases the risk of hospital admission, it is
dominated by UC (negative ICERs in Figure 18) hence why the ICER drops sharply. As the ratio increases to
1.5 the ICER decreases as UC becomes less cost-effective due to lower mortality in the UC arm. The 95% CIs
for all three reported estimates crossed 1.
Duration of effect
Table 30 presents the results applying different assumptions regarding the duration of effect of SM
support. In the base case it was assumed that the effect of SM would last for 2 years. The values were
varied in the sensitivity analysis from 6 months to 30 years. When a shorter duration of effect was applied,
the ICER increased and the probability of SM being cost-effective decreased. Conversely, applying a higher
duration of effect decreased the ICER and increased the likelihood of SM being cost-effective.
Figure 19 illustrates the relationship between changing the duration of effect and the ICER. At between
6 and 24 months the ICERs drop sharply and the decision rule changes. Most of the studies identified
in the effectiveness review were short term in nature, resulting in uncertainty on the duration of this effect.
Cost of self-management
The impact of changing the cost of SM is presented in Table 31. Applying the high estimate of £671
increases the ICER to £9257 and the probability of SM being cost-effective at a threshold of £20,000 per
QALY is similar at 69%. Applying the low estimate of £85 decreases the ICER to £1033 and increases the
probability that SM is cost-effective at a threshold of £20,000 per QALY to 76%.
Figure 20 shows the relationship between SM costs and the ICER. At all values for the cost of SM between
£50 and £2200 the ICER is below a willingness-to-pay threshold of £30,000. At costs above £2200 the
mean ICER in the base-case scenario is not cost-effective.
Utility values for chronic obstructive pulmonary disease
The effect of applying alternative utility scores and assumptions is shown in Table 32, demonstrating that
QALYs are gained in both strategy arms, irrespective of the changes in utility values for stable health states
and utility loss associated with exacerbation changes. Therefore, there is little impact on QALY differences
between strategies, and all estimates of the utility values for stable and exacerbating health states give
similar results.
TABLE 29 Sensitivity analysis: alternative HRs for admissions in SM support
HR Cost difference (£)
QALY
difference
ICER
(£/QALY)
Probability
cost-effective
at £20,000/
QALY (%)
Probability
cost-effective
at £30,000/
QALY (%)
Base case (0.83, 95% CI
0.50 to 1.36)
683 0.0831 8218 68 71
High estimate (0.78, 95% CI
0.52 to 1.17)
676 0.1082 6249 82 84
Low estimate (0.96, 95% CI
0.49 to 1.90)
703 0.0184 38,265 41 45
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TABLE 30 Sensitivity analysis: alternative durations of effect
Duration of
effect
Cost
difference (£)
QALY
difference
ICER
(£/QALY)
Probability cost-effective
at £20,000/QALY (%)
Probability cost-effective
at £30,000/QALY (%)
Base case (2 years) 683 0.0831 8218 68 71
High estimate:
30 years
383 0.2876 1333 77 77
Low estimate:
6 months
686 0.0414 16,570 55 63
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FIGURE 18 Sensitivity analysis: relationship between HR for readmissions and ICER. a, Illustration of how the ICER
changes by varying the HR between 0.5 and 1.5; and (b) magnification of how the ICER changes within the
boundaries of a threshold of plus or minus £30,000 per QALY.
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FIGURE 19 Sensitivity analysis: relationship between ICER and duration of effect of SM. (a) Illustration of how the ICER
changes between 10 months and 30 years; and (b) magnification of how the ICER changes between 3 and 25 months.
TABLE 31 Sensitivity analysis: alternative assumptions for cost
Cost of SM (£) Cost difference (£)
QALY
difference
ICER
(£/QALY)
Probability
cost-effective at
£20,000/QALY (%)
Probability
cost-effective at
£30,000/QALY (%)
Low estimate: 85 86 0.083 1033 76 77
High estimate: 671 768 0.0831 9257 69 69
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Subgroup analysis
GOLD severity stage
Table 33 presents the ICERs when assuming that only one GOLD stage severity group entered the model.
The mean difference (MD) in QALYs gained between SM and UC increased in more severe groups. The
lowest ICER is £3323 per QALY gained in GOLD stage 4, with a 73% likelihood that SM is cost-effective at
£20,000 per QALY. There is greater uncertainty around the cost-effectiveness of SM in patients entering
the model at GOLD stage 2 or 3, with the probability of being cost-effective at £20,000 per QALY 64% or
62%, respectively.
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FIGURE 20 Relationship between cost of SM and ICER.
TABLE 32 Sensitivity analysis: alternative utility values and assumptions
Analysis Cost difference (£)
Mean QALYs
QALY difference ICER (£/QALY)SM+UC UC
Base case 683 5.850 5.767 0.083 8218
Values obtained in Borg et al.83 680 6.126 6.044 0.082 8304
TABLE 33 Subgroup analysis: alternative GOLD stage cohorts
Cohort
enter at:
Mean cost (£)
Cost
difference (£)
Mean QALYs
QALY
difference
ICER
(£/QALY)
% cost-effectiveness at:
SM UC SM UC
£20,000/
QALY
£30,000/
QALY
GOLD 2 15,835 15,245 591 7.437 7.367 0.069 8511 64 68
GOLD 3 21,078 19,989 1089 5.783 5.697 0.086 12,629 62 68
GOLD 4 22,120 21,803 317 4.078 3.983 0.0955 3323 73 75
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Age
The starting age of the model cohort was varied and results are presented in Table 34. The probability of
SM being cost-effective does not change by age but the ICERs are lower in the older cohort. Therefore,
although the ICERs are different for different start ages, the decision rules are similar at all start ages and
the probability of being cost-effective is similar.
Gender
The results for separate male and female cohorts are shown in Table 35. There was very little difference in
the ICERs or probability of SM being cost-effective when targeted at solely men or women.
Smoking status
Table 36 presents the results for current smokers and ex-/non-smokers. Again, there was very little
difference in the ICERs or probability of SM being cost-effective when targeted at only smokers or
ex-smokers.
Scenario analysis
Table 37 presents the results of the scenario analysis. The first scenario applied the highest effect on
reducing admissions (HR 0.78) and the highest cost estimate of SM (£671). The second scenario applied
the lowest effect (HR 0.96) and the lowest estimate of the cost of SM (£85). This suggests that the
likelihood of SM being cost-effective is greater in the higher cost, higher-effect scenario, relative to the
lower-cost, lowest-effect scenario, but still < £20,000 per QALY.
TABLE 34 Subgroup analysis: alternative cohort start ages
Start age
(years)
Mean cost (£)
Cost
difference (£)
Mean QALYs
QALY
difference
ICER
(£/QALY)
% cost-effectiveness at:
SM (£) UC (£) SM UC
£20,000/
QALY
£30,000/
QALY
55 28,747 27,738 1009 8.5814 8.464 0.1174 8591 66 71
85 10,409 10,045 364 3.1137 3.0681 0.0456 7980 67 71
TABLE 35 Subgroup analysis: male and female cohorts
Gender Cost difference (£) QALY difference
ICER
(£/QALY)
% cost-effectiveness at:
£20,000/QALY £30,000/QALY
Male 642 0.0814 7895 70 73
Female 725 0.085 8534 68 71
TABLE 36 Subgroup analysis: cohorts of smokers and ex-smokers
Smoking status Cost difference (£) QALY difference
ICER
(£/QALY)
% cost-effective at:
£20,000/QALY £30,000/QALY
Smoker 679 0.0829 8188 67 71
Ex-/non-smoker 679 0.0829 8189 67 71
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Discussion
Key results
This is the first economic model to consider the cost-effectiveness of SM support compared with UC in
patients with COPD within 6 weeks of discharge from hospital admission for an exacerbation. Owing to
the considerable uncertainty on the impact on readmissions, and the heterogeneity of the trial results, this
model-based analysis should be viewed as speculative, and therefore providing only estimates of the
potential impact of a SM programme.
The base-case model results suggested that SM support was a cost-effective intervention at the threshold
at which NICE is willing to pay at £20,000 per QALY gained, if the assumption that the provision of SM
support leads to a reduction in hospital admissions is met. The impact of reduced readmissions in the
model led to lower mortality and morbidity from severe exacerbations over the long term. There were
fewer costly hospital admissions, and intervention costs were relatively low compared with the cost of
a readmission.
The probabilistic sensitivity analysis, which considers parameter uncertainty in the model, suggested that
SM had a probability of 68% of being cost-effective at a threshold of £20,000/QALY, demonstrating the
uncertainty around the impact of SM on readmissions. The remaining probability, when SM was not
cost-effective, was due to the intervention potentially having worse outcomes while being more costly.
Furthermore, the one-way sensitivity analyses undertaken were informative in highlighting the key drivers
of the model results. As expected, cost-effectiveness was affected by the estimate of effect on
readmissions, duration of effect and cost of a SM programme. The base case considered the intervention
to have an impact for 2 years; however, the data from trials were collected only over the short term, for
example 6 months. The results demonstrated that if the effect lasts for only 6 months then at a threshold
of £20,000 per QALY gained the SM support was unlikely to be cost-effective. Currently, the model
suggests that as long as the cost of the intervention is < £2200 then it is likely to be cost-effective;
however, this threshold value will drop if the intervention is less effective.
Subgroup analysis, changing by considering different cohorts with regards to gender, age or smoking
status, found no evidence of effect on the overall result. There was some evidence that SM might be more
cost-effective in GOLD stage 4 patients. This is most likely to be due to a higher baseline risk of
exacerbation and a higher proportion of exacerbations resulting in hospital admission. Therefore, a risk
reduction is likely to have a greater effect.
TABLE 37 Scenario analysis: alternative combinations of cost and effect of SM on admission
Scenario Cost difference (£)
QALY
difference
ICER
(£/QALY)
% cost-effectiveness at:
£20,000/QALY £30,000/QALY
Cost applied: £671,
HR applied: (0.78)
758 0.108 7007 78 81
Cost applied: £85,
HR applied: (0.96)
107 0.018 5832 54 55
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Strengths and limitations
A key strength of this analysis is that this is the first economic model to consider the cost-effectiveness of
SM in this particular patient group and illustrates the key variables that impact on the results. Although no
good-quality, long-term data currently exist on the effectiveness of SM, a model structure exists for
reanalysis once additional data become available.
The model structure applied was a further strength of this study. It is a modified version of previously
published decision models whereby additional post-admission health states were added to incorporate
emerging evidence on the higher risks in patients with COPD immediately after discharge.13 This was
thought to be particularly important for measuring costs and outcomes in this model, as the patient
population were assumed to receive the intervention within 6 weeks of discharge.
Although there are concerns about the effectiveness estimates, robust data were included in the model to
represent the natural history of the condition. The risks applied in the first 3 months were obtained from the
UK cohort included in the European Audit84 of patients with COPD admitted to hospital. The model also
captures long-term outcomes by disease severity, applying data on long-term exacerbation risks, mortality
and disease progression from large longitudinal studies – TORCH85 and ECLIPSE.13 This study also applies
patient-level utility data obtained from a representative sample of UK patients (unpublished data obtained
from BLISS cohort). Finally, although there was a great deal of uncertainty around effectiveness data and
assumptions applied to this model, distributions were applied to reflect this uncertainty. The probabilistic
sensitivity analysis was also supplemented by a one-way sensitivity analysis of all key parameters, thus
demonstrating which parameters were mostly likely to influence decisions to implement SM.
There are a number of caveats when considering the results of this economic model. Most importantly,
this is a speculative decision model and therefore can be considered as indicative of only the potential
cost-effectiveness of SM. As highlighted in the clinical effectiveness and cost-effectiveness review, there is
a dearth of high-quality evidence on the long-term costs and outcomes associated with this intervention.
This model was based on this weak evidence of effect and thus incorporates considerable uncertainty
when assumptions from the literature and estimates from clinical experts were applied in the absence of
better-quality data.
In addition to the uncertainty around the effect of SM, there was also some uncertainty around
parameters and assumptions applied in the base case for UC. Although the model was able to reflect
mortality and readmission risks in the first 3 months after discharge, it was assumed that after those
3 months, those who were not readmitted would move to a stable health state. It is unclear if this really
reflects natural history or if the risk of readmissions and mortality remain higher beyond 3 months among
those with recent history of exacerbation. Similarly, the data extracted from the TORCH85 and ECLIPSE13
studies represent average exacerbation and hospitalisation rates in stable COPD cohorts over a 3-year
period and these data were applied over a 30-year time horizon. In reality this may change over time.
The model highlights a number of areas in which further research is required. Crucially, further evidence is
needed on the effectiveness of SM support to confirm if it is indeed cost-effective and with greater
certainty. Longer-term evidence beyond 6 months is also required. Follow-up data on cohorts of patients
admitted to hospital is needed to provide better estimates of long-term outcomes. A review of costs
applied of other SM programmes in patients with COPD suggests that the cost of implementing SM
support are likely to range somewhere between £8568 and £671.63 Although more research is required to
develop more accurate cost estimates for implementing SM programmes in this cohort, this is unlikely to
change the outcome of this analysis. Finally, better data are required on utility values in COPD populations,
particularly the utility loss associated with exacerbation.
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Although outside the scope of this report – in light of the uncertainty around the effectiveness and
cost-effectiveness of the intervention – it would be beneficial for a value of information analysis to be
undertaken in the future. Value of information analysis allows a comparison of the potential benefits of
additional research with the costs of further investigation. The value of any further research is based on
how much this extra information will reduce the overall decision uncertainty.
Summary
l Currently, there is no published evidence on the cost-effectiveness of SM compared with UC in patients
with COPD who have recently been discharged from hospital.
l This is the first economic model to attempt to estimate the cost-effectiveness of SM in this
patient group.
l This speculative model indicates that SM is cost-effective if it is assumed that the intervention has a
small positive effect on reducing admissions for a minimum of 6 months.
l The model has a number of limitations, the most important related to the large amount of uncertainty
around the effectiveness estimate driving the model results.
l The analysis highlights the importance of conducting further research on the effect and duration
of effect of the SM intervention delivered post discharge to allow a more robust analysis of
cost-effectiveness.
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Chapter 7 A systematic review to identify the
features and elements of self-management support
interventions that are most effective: review 4
The aim of this chapter is to present the findings from a broad systematic review to assess theeffectiveness, and identify the most effective components, of self-management (SM) interventions.
Methods
A systematic review of the evidence of effectiveness of interventions to support SM among patients with
chronic obstructive pulmonary disease (COPD), at any time point, to identify the features and elements
that are most effective.
Definition of self-management
As described for review 1 and tabulated in Table 2.
Search strategy
A comprehensive search strategy described as for review 1. Only citation lists of relevant reviews were
examined for additional relevant studies.
Study selection process
As described for review 1.
Selection criteria
In contrast with the first review, owing to the likely high volume of relevant studies, the selection criteria
included only RCTs and a more limited range of outcomes (Table 38). Although RCTs purely of smoking
cessation were excluded, trials described as ‘pulmonary rehabilitation (PR)’ were included, as many PR trials
include components of SM and aim to enable participants to self-manage their condition after the PR
programme ends. Furthermore, many interventions describe supported SM with a supervised structured
exercise programme, which is similar to PR. There is a large overlap of intervention content even with
different definitions and we wanted to include as complete a range of evidence as possible.
Risk of bias assessment
As for review 1, all of the RCTs were assessed using the Cochrane Risk of Bias tool.56 Assessment was
limited to primary outcomes. All studies were assessed by one independent reviewer, with a second
reviewer independently checking at least 10% of studies, and a third reviewer overseeing the
complete process.
Data extraction
Approach
Data extraction of study characteristics was undertaken by a single reviewer, except for key fields such as
sample size, duration of intervention and duration of follow-up, which were extracted in duplicate on to a
piloted table of characteristics. The components of interventions were mapped by a single reviewer after
the research team had each mapped 30 studies and discussed discrepancies and component definitions/
criteria. For the results, data were extracted only from papers that reported any of the three primary
outcomes (QoL, hospital admissions/readmissions or exacerbations). The reporting in papers of secondary
outcomes (mortality, anxiety, depression, exercise capacity, lung function, health-care utilisation, ED visits
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and breathlessness) was documented but the results were not extracted. Owing to high volume, one
reviewer extracted all of the data on to piloted tables using Microsoft Excel version 2010 (Microsoft
Corporation, Redmond, WA, USA), with at least 10% of the extracted data being checked by a statistician.
If necessary any differences were resolved via discussion with a third reviewer. When relevant data were
lacking or unclear, authors were contacted via e-mail.
Types of data extracted
As described for review 1.
Data manipulation
As described for review 1.
Analyses
Owing to a large volume of literature, only those papers that reported any one of the three primary
outcomes were taken forward for further analyses:
(a) HRQoL scores including subdomain scores
(b) numbers of/time to first hospital admissions/readmissions
(c) numbers of/time to first exacerbation/s.
Papers with secondary, but no primary, outcomes were tabulated only.
TABLE 38 Selection criteria for review 4
Study designs RCTs
Population Any patients with moderate to severe COPD (defined clinically with or without spirometry)
including those in the stable state (patients with mild or very severe COPD were included if
they were a minority of the population group)
> 90% of patients in studies had COPD
The setting could be either hospital or community
Intervention SM packages, larger packages of care that included a significant component of SM (e.g. PR) or
important components of SM
Excluding trials of smoking cessation
Comparator
(where appropriate)
No intervention, usual care, control/sham, other SM intervention
Primary outcomes Exacerbations
Hospital admissions/readmissions
HRQoL
Secondary outcomes Mortality
Anxiety, depression
Exercise capacity
Lung function
Health service utilisation
ED visits
Dyspnoea
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Analyses consisted of mapping and description of the features and elements of the interventions from the
included papers; presentation of the results of various combinations and comparisons of components on
forest plots; meta-analysis of the data where appropriate; meta-regression; and subgroup analysis to
explore heterogeneity.
Description of the features and elements of self-management interventions
by simple categorisation and tabulation
To describe the features and elements of SM interventions, a mapping process was undertaken whereby
interventions were broken down into a visual representation of components (defined in Table 39).
Components included disease knowledge/education, exercise, breathing techniques, smoking cessation
TABLE 39 Definitions of components of SM
Component Broad inclusion/definition
Disease knowledge Education about disease, disease management, treatments, SM, chronic illness, activities of daily life,
end of life, self-care tips, travel and COPD
SM unspecified SM education/skills
RMT IMT, EMT (pressure, threshold, resistance devices)
Action planning Managing exacerbations, coping plan, management of COPD symptoms, recognising when to
call a doctor
Breathing
management and
techniques
Breathing exercises, breathing retraining, respiratory biofeedback, managing breathlessness and
coping with triggers for breathlessness, t’ai chi, vocal exercises
Smoking cessation Advice, counselling, groups, interventions to help reduce/quit smoking as required
Medication/
adherence
Information about medication and adherence, promoting adherence (pharmacological or
non-pharmacological)
Bronchial hygiene
techniques
Postural drainage/coughing technique
Nutrition Advice, counselling, groups, supplements as required
Psychological
intervention
Psychosocial support, cognitive–behavioural therapy, cognitive training, relaxation
(including exercises, e.g. progressive muscle relaxation), stress management, general goal-setting,
mood disturbance, handling emotions (how to cope with the disease), psychosocial problems
associated with respiratory disability, self-talk and panic control, health, qigong
Preventative Avoiding exacerbations, pollution and environmental hazards, managing infections, personal hygiene
Inhaler technique
and use
Assessing inhaler technique, teaching correct use and handling of inhalers
Energy
conservation
Pacing and good posture, home modifications and ADL, work simplification
Support groups/
patient
empowerment
Peer support self-help groups/networks, e.g. Breathe Easy, developing confidence to negotiate with
clinicians
Exercise Strength Upper limb, lower limb strength/resistance exercises
Aerobic Cycling, walking, stair climbing as aerobic/endurance exercises
Other Flexibility and balance exercises, sham training, unspecified exercises
Enhanced access/
care
Access to health professionals, access to call centre/hotline, health professional home visits and/or
telephone support
Other Any miscellaneous uncommon components, e.g. sleep or other symptom control
Usual care Usual medications and visits to GP or routine secondary care
ADL, activities of daily living; EMT, expiratory muscle training; IMT, inspiratory muscle training; RMT, respiratory muscle
training.
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and inhaler technique among others. Each component was subdivided into either an information element
only or a support/training element. All treatment arms of the trials were mapped in this way. The numbers
of components within intervention and control arms were identified.
Exploring significant components of self-management interventions in
reducing exacerbations, hospital admissions/readmissions and improving
quality of life
Planned analyses and comparisons
To explore the effectiveness of different SM components (or groups of components), a series of
18 analyses were planned (Table 40) in collaboration with the steering group to ensure clinical relevance.
The analysis plan was developed prior to collation of any of the data and followed two main objectives:
To:
i. explore clinically relevant interventions
ii. avoid repeating any recent high-quality systematic review, such as a Cochrane review.
TABLE 40 Analyses planned to explore the effectiveness of SM components and interventions
Intervention Comparator
1. Multicomponent interventions UC/control
2. Addition of one component
3. Exercise-only interventions UC/control/sham intervention
4. Enhanced care
5. Multicomponent interventions with supervised exercise UC/control
6. Multicomponent interventions with structured unsupervised exercise UC/control
7. Multicomponent interventions with exercise counselling only UC/control
8. Multicomponent interventions without an exercise element UC/control
9. Multicomponent interventions including an exercise component consisting of
aerobic and strength training
UC/control
10. Strength and aerobic exercise training Aerobic training only
11. Endurance/aerobic training Strength/resistance training
12. Upper limb and lower limb training Lower limb training only
13. Interval training Continuous training
14. IMT or EMT UC/control/sham intervention
15. More sessions/longer-duration interventions Fewer sessions/shorter duration
interventions
16. Hospital-based interventions Home-based interventions
17. Pharmacist-delivered interventions
18. Maintenance programme post PR No maintenance programme post PR
EMT, expiratory muscle training; IMT, inspiratory muscle training; UC, usual care.
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We explored the effectiveness of any single component interventions that were delivered either alone or as
part of a wider package for which the only difference between the two arms was this single component. A
multicomponent SM package was included in many analyses and we defined multicomponent as including
three or more relevant components. The definition of three components was used because most exercise
programmes would require some discussion of managing breathlessness. From a clinical perspective it
seemed likely that some interventions would describe both components and others only the
exercise component.
To avoid repeating current systematic reviews, we chose not to explore the effectiveness of integrated care
but instead explored the effects of ‘enhanced care’. We defined ‘enhanced care’ to be interventions that
gave patients access to additional contact with health-care professionals through regular telephone contact
or visits. This is distinct from integrated care, which required delivery by a multidisciplinary team.
The effectiveness of exercise-only interventions was explored by examining different combinations of
exercise (e.g. strength, aerobic, and combined strength and aerobic exercises). The inclusion of these
different modes of exercise is important for professionals developing and delivering SM and rehabilitation
programmes for COPD. Exercise as part of multicomponent packages was categorised into groups of
supervised exercise (which mirrors PR), unsupervised exercised (mirroring home-based rehabilitation
programmes) and exercise education only.
As well as the components, we were also interested in delivery mechanisms. These were discussed and
agreed by the steering group before any analyses were undertaken. We considered that the location of
the intervention was an important delivery issue, for example hospital or centre-based compared with a
home-based programme and the duration or intensity of programmes to be important delivery issues also.
To explore these questions we sought trials that had direct comparisons.
Post hoc analyses were decided upon after mapping the content of the SM intervention components. Post
hoc analyses included an exploration of the effectiveness of interventions delivered by pharmacists and the
effectiveness of maintenance programmes post PR.
Presentation on forest plots
For each analysis, the first stage involved presenting extracted study results on forest plots alongside key
study characteristics so that the wider team could determine whether it was sensible to perform
meta-analysis. For each intervention, the effectiveness across each outcome was presented. Data were
presented in forest plots when there were ≥ 10 studies. As there were multiple follow-up points, results
were divided into three time periods: up to and including 3 months; above 3 months to 6 months;
and beyond 6 months since the start of the study. If a study had more than one follow-up point within
each time period, the latest follow-up within the period was used.
All forest plots were then ordered according to the number of components in the intervention arm,
followed by the length of follow-up and then alphabetically by author name.
Owing to a large volume of different QoL measures used, only data from the disease-specific total
SGRQ and CRQ were included in the forest plots. In this review, SGRQ is presented on a reversed scale
(i.e. higher scores are better).
For QoL data, the numbers of patients followed up were displayed, as well as baseline differences between
intervention and control arms, and whether or not ANCOVA was used to adjust for the baseline value.
For plots of HRs, details were also displayed of whether or not the effect size was used directly from data
within the trials or whether or not they were estimated using other available data.
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Meta-analysis methods
As described for review 1, but in addition to the summary estimate and its 95% confidence interval (CI),
each random-effects analysis was also summarised by reporting a 95% prediction interval. This predicts
how the effectiveness of the intervention could vary from the average in different circumstances, for
example for different contexts, populations and lengths of follow-up.62,105 This is important to ascertain
whether the intervention is likely to work in the majority of settings, or whether – due to unexplained
heterogeneity – the intervention may work well in some settings but work less well (or not at all) in other
settings. Prediction intervals were calculated where there were five or more studies per analysis and were
tabulated separately from the forest plots.
Assessing publication bias
For each meta-analysis containing ≥ 10 studies, the likelihood of publication bias was investigated through
the construction of funnel plots and Egger’s test for ‘small-study effects’, i.e. the tendency for smaller
studies to provide more positive findings. It is important to note that when heterogeneity exists,
publication bias may be one of a number of reasons for any small-study effects identified. The restriction
of 10 studies was due to the low power of identifying small-study effects with few studies.106
Meta-regression and subgroup or sensitivity analyses
For each meta-analysis, if there were sufficient numbers of studies (at least 10 per meta-analysis),
meta-regression was considered to explore whether the following prespecified variables explained any of
the heterogeneity: severity of disease in the study population, length of intervention, number of
components of intervention and study quality.
Mixed-treatment comparisons
Although mixed-treatment comparison meta-analyses were planned, the assumptions to undertake the
analysis were not considered to have been met. In particular, the large heterogeneity in follow-up time,
the included patient population and the study design suggested that the consistency assumption required
was unlikely to be sensible.107 Therefore, no mixed-treatment comparisons were explored.
Patient advisory group
See review 1 for details.
Search results
Included studies
From 13,355 identified titles, 836 full papers were obtained and 283 papers were finally included. Of
these, 174 RCTs from 194 papers reported one of the three primary outcomes: HRQoL, hospital
admissions/readmissions and exacerbations (Figure 21). A total of 89 papers reported outcomes other than
our three primary outcomes and are listed in Appendix 21 alongside the secondary outcomes that they
reported. Overall, 553 papers were excluded (see Appendix 2 for full list with reasons for exclusion).
Arbitration by a third reviewer was required for 5% of all full texts. In total, 40 ongoing studies were
identified as relevant (see Appendix 4).
Within the 174 trials with primary outcomes several studies had multiple arms. Thus there were
229 comparisons of interventions compared with usual care (UC), control or another active intervention.
Characteristics of studies
The study and population characteristics of the 174 included RCTs with relevant primary outcomes are
summarised in Appendix 22.
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(n = 40)
FIGURE 21 Summary of the selection process for clinical effectiveness studies.
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Country/setting/recruitment
The majority of the trials were set in high-income countries, with 33 (19%) from the USA and 21 (12.1%)
from the UK. However, trials were set in 31 different countries, including eight from China, six from
Hong Kong, three from India and two from the Republic of Korea. A breakdown is given in Table 41.
TABLE 41 Setting of SM trials
Country n %
USA108–140 33 19.0
UK63,73,141–159 21 12.1
Australia67,69,160–170 13 7.5
Spain68,171–180 12 6.9
The Netherlands181–190 10 5.8
Canada191–198 8 4.6
China74,199–205 8 4.6
Germany64,206–211 7 4.0
Hong Kong66,70,212–215 6 3.4
Sweden216–221 6 3.4
Denmark222–226 5 2.9
New Zealand227–231 5 2.9
Brazil232–235 4 2.3
Turkey236–239 4 2.3
India240–242 3 1.7
Italy75,243,244 3 1.7
Austria245,246 2 1.1
Belgium247,248 2 1.1
France249,250 2 1.1
Ireland251,252 2 1.1
Israel253,254 2 1.1
Norway255,256 2 1.1
Switzerland257,258 2 1.1
Taiwan259,260 2 1.1
Japan261,262 2 1.1
Argentina263 1 0.6
Egypt264 1 0.6
Greece265 1 0.6
Jordan266 1 0.6
Korea267 1 0.6
Republic of Korea268 1 0.6
Spain and Belgium70 1 0.6
Venezuela269 1 0.6
Note
‘n’ refers to number of trials.
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Size
The sample size of the 174 included trials ranged from 10 to 743 [median 53, interquartile range (IQR)
38–100]. Trials were generally small with 81 (46.6%) trials including < 50 participants, 47 (27.0%) with
50–99 participants, 34 (19.5%) with 100–199 participants, and 12 (6.9%) with ≥ 200 participants
(Table 42).
Population characteristics
Table 43 summarises the characteristics of the populations in the trials. The characteristics reported were
frequently of those who completed the trial rather than those who were randomised.
The mean age of the participants was between 52 and 80 years, with the majority of trials (72%)
reporting a mean age of between 60 and 69 years. The proportion of male participants ranged from 15%
to 100%. In the trials that provided data on the gender of the participants, males tended to be in the
majority. Thirty-four trials66,67,69,70,74,111,112,118,127,133,136,142,144,151–153,168,185,192,195,199,201–205,209,210,212,214,218,238,264,270–272
did not report the FEV1% pred but reported the proportions within severity groups. Of the trials that did
provide these data, the mean FEV1% pred of the trial participants ranged from 26.3% to 69.0%.
More than half of trials had a population mean in the 30–59% range, which is equivalent to GOLD
stage 3 – severe COPD.
Recruitment of participants was mainly from secondary care or PR programmes.
TABLE 42 Number of participants in included studies
Size of trial n %
< 25 13 7.5
25–49 68 39.1
50–74 29 16.7
75–99 18 10.3
100–149 23 13.2
150–199 11 6.3
200+ 12 6.9
Note
‘n’ refers to number of trials.
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TABLE 43 Characteristics of the populations of included studies
Characteristic n (%)
Age (mean, years)
50–59 11 (6.3)
60–69 111 (63.8)
70–79 29 (16.7)
80+ 1 (0.5)
NR 22 (12.6)
Males (n, %)
1–25 4 (2.3)
26–50 36 (20.7)
51–75 62 (35.6)
75–100 51 (29.3)
NR 21 (12.1)
FEV1% pred (mean)
50–79 44 (25.3)
30–49 90 (51.7)
< 30 5 (2.9)
NR 35 (20.1)
Recruited from:
Secondary care inpatient 15 (8.6)
Secondary care outpatient/unspecified 83 (47.7)
ED 1 (0.5)
PR programme/referred 21 (12.1)
Primary care 9 (5.2)
Primary and secondary care 3 (1.7)
Community 3 (1.7)
Primary or secondary care and advertisement 18 (10.3)
NR/unclear 21 (12.1)
NR, not reported.
Note
‘n’ refers to number of studies.
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Follow-up of trial participants
Length of follow-up ranged from 4 weeks to 2 years from the start of the intervention. In 78 (44.8%),
follow-up was ≤ 3 months, in 120 (69.0%) it was ≤ 6 months and in 174 (94.3%) it was ≤ 1 year. Twelve
trials65,116,155,166,172,182,190,248,271,273–277 had follow-up of > 1 year (Table 44).
Time from the end of intervention (delivery of last element of SM support) to last follow-up varied considerably
(see Table 44). A total of 106 (60.9%) of the trials reported follow-up data only at the end of the intervention
period (details provided within appendices). Only 18 trials111,121,141,161,166,170,172,192,195,198,210,213,217,229,250,251,270,271,276–279
(10.9%) reported a follow-up of > 6 months after the end of the intervention.
Interventions
The interventions were very heterogeneous. They included structured group-based PR programmes; more
limited one-to-one educational SM interventions delivered in an outpatient setting or at a patient’s home,
sometimes with telephone follow-up; integrated disease management with multidisciplinary input and
often some element of monitoring by health professionals; exercise-only interventions (with some
dyspnoea management) and respiratory muscle training (RMT) using threshold devices. Within these
various broad categories, there was a range of individual SM components, including some that might
be less traditionally part of SM, such as qigong, t’ai chi and singing. Appendix 23 provides detailed
descriptions of the intervention and comparator groups with intensity and frequency of
interventions delivered.
Description of self-management components in intervention and comparator arms
Within the arms of the 174 trials we categorised 15 types of components (plus other and unspecified).
In the intervention groups exercise was the most commonly reported component (76.9%), followed
by breathing techniques and management of dyspnoea (64.2%), and general education about COPD
and its management (47.2%). Details of the numbers of individual components for the intervention and
comparator groups are shown in Table 45. Appendix 24 displays which components were present within
the intervention and comparator groups of each study.
TABLE 44 Duration of follow-up and time from end of intervention to follow-up
Time to last follow-up n (studies) %
Time to last follow-up (weeks)
≤ 13 76 43.7
14–26 40 23.0
27–52 44 25.3
> 52 12 6.9
Unclear 2 1.1
Time from end of intervention to last follow-up (weeks)
0 106 60.9
≤ 13 27 15.5
14–26 16 8.6
27–52 14 8.0
> 52 4 2.3
Unclear 7 4.0
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Up to 13 different SM components were included in any one of the intervention arms, and up to 11 in any
one of the comparator groups (Table 46). Seventy-three (31.9%) of the intervention arm interventions had
six or more components. In the intervention group, 38 (16.6%) were single components with the vast
majority of these being exercise-only interventions. In contrast, the majority of the comparators had two or
fewer described components [167 (72.9%)], with 34.9% not providing any detail about the SM education
or support provided to the comparator group as part of UC (see Table 46).
The content of the components of the intervention are shown according to the total number of
components in the intervention in Table 47. Of the single-component interventions, 25 of 38 (65.8%)
were exercise only, 9 of 38 (23.7%) were RMT and three (7.9%) were breathing exercises. In the two- and
three-component interventions, exercise is frequently combined with breathing/dyspnoea management
and disease knowledge. Overall, the most common components were exercise [176 (76.9%) of studies],
breathing techniques and dyspnoea management [147 (64.2%)], disease knowledge [108 (47.2%)] and
psychological interventions [77 (33.6%)].
In those interventions with six or more components, the most common components were exercise
[69 (94.5%) of studies], breathing techniques and dyspnoea management [66 (90.4%)], disease
knowledge [65 (89.0%)] and medication advice [60 (82.5%)]. Notably, smoking cessation was mentioned
in only 38 (52.1%) of the interventions with six or more components.
Figure 22 displays the range of different interventions included.
TABLE 45 Self-management components reported in the interventions and comparator groups
Component
Intervention (no. of studies) Comparator (no. of studies)
n (%) n (%)
Exercise 176 (76.9) 96 (41.9)
Breathing techniques/dyspnoea management 147 (64.2) 52 (22.7)
Disease knowledge 108 (47.2) 68 (29.7)
Psychological including relaxation and stress
management
77 (33.6) 34 (14.8)
Medication advice 77 (33.6) 43 (18.8)
Nutrition advice 51 (22.3) 28 (12.2)
Enhanced access 50 (21.8) 15 (6.6)
Action planning for self-treating exacerbations 43 (18.8) 9 (3.9)
Smoking cessation advice/support 44 (19.2) 18 (7.9)
Inhaler technique 36 (15.7) 19 (8.3)
Bronchial hygiene/secretion clearance techniques 30 (13.1) 16 (7.0)
Unspecified 24 (10.5) 9 (3.9)
RMT 32 (14.0) 11 (4.8)
Energy conservation 22 (9.6) 7 (3.1)
Other 18 (7.9) 5 (2.2)
Preventative measures to avoid infection 18 (7.9) 11 (4.8)
COPD support groups 7 (3.1) 3 (1.3)
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Duration of the intervention
The duration of the intervention was measured to the last behavioural or supportive contact and ranged
from 1 day to 2 years (Table 48). A total of 114 trials (58.8%) reported interventions of ≤ 3 months’
duration, with nine trials (4.6%) being longer than 1 year. Five trials71,72,117,142,215,255,280,281 did not report an
intervention duration or had a variable duration intervention (see Appendix 23).
174 trials with 200
intervention arms
Single component
(n = 46)
Two components
(n = 39)
Multicomponent
(n = 115)
Delivered
in group
(n = 18)
No
exercise
(n = 2)
No
exercise
(n = 2)
No
exercise
(n = 6)
Exercise
(n = 16)
Delivered
individually/
unclear
mode
(n = 28)
Delivered
individually/
unclear
mode
(n = 20)
• 12 case-management
• 1 early discharge
• 1 hospital at home
Delivered
in group
(n = 19)
Delivered
in group
(n = 57)
Group-based
pulmonary
rehabilitation
(n = 68)
Delivered individually/
unclear mode
(n = 58)
FIGURE 22 Range of interventions included across 174 trials.
TABLE 48 Duration of intervention
Intervention duration (weeks) No. of studies %
< 1 2 1.1
4 19 10.9
5–8 59 33.9
9–13 34 19.5
14–26 29 16.7
27–52 22 12.6
53–104 4 2.3
NR/variable duration 5 2.9
NR, not reported.
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Mode of delivery of the intervention
The majority of the interventions were delivered by nurses and respiratory physiotherapists. Half of the
interventions had a group-based component; 63 (36.2%) were entirely group based; and an additional 24
(13.8%) had a group component followed by individual support. In 20 studies the mode of delivery was
unclear. Details of the mode of delivery are in Table 49 and in the detailed characteristics of intervention
table in Appendix 23.
Comparator arms
There were 141 comparisons (from 127 trials) of an intervention compared with UC or a control group
that was not an active intervention. The UC arm was frequently not described; in other cases it was the
standard primary and/or secondary care for people with COPD.
A total of 107 comparisons (from 85 trials) were of two active interventions. Details are provided in
Appendix 23.
Primary outcome measures
Most trials (163, 96.6%) reported HRQoL; 42 (24.1%) reported hospital admissions or readmissions and
only 20 (11.5%) reported exacerbations.
Other outcome measures reported
The included studies reported a wide range of outcomes; 12 reported mortality, 103 dyspnoea, 34 anxiety
and 41 depression outcomes. Exercise capacity was reported in 135 studies and lung function in 92
studies. Health service utilisation was reported in 41 trials and ED visits in 29 trials. The details of which
trial reported which outcomes are displayed in Appendix 25.
Risk of bias of included studies
Table 50 summarises the risk of bias. Details of the risk of bias assessment for all of the included studies
are tabulated in Appendix 26.
Reporting of the method of generating the randomisation sequence was generally poor, with only
71 (36%) of the trials providing adequate information. Where reported, the randomisation method was
adequate to produce a low risk of bias. Similarly, the majority of studies [146 (84%)] did not provide
sufficient information about allocation concealment to be able to determine the risk of bias. We
considered the risk of bias for self-reported HRQoL to be high unless the participant was blinded to the
intervention, either by randomisation to an active intervention in each study arm, or through a sham
intervention. This resulted in a high rate of categorisation of high risk of bias for this outcome measure
[117 (63%)].
TABLE 49 Mode of delivery of SM interventions
Mode of delivery n (studies) %
Group based 63 36.2
Individual 63 36.2
Mixed: group and one to one 24 13.8
Remote (internet/telemonitoring) 4 2.3
Unclear 20 11.5
Total 174 100.0
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We also assumed that reporting of hospital admission would be unlikely to be influenced by knowledge of
allocation; thus, the majority of trials reporting this outcome were categorised as at low risk of bias for this
outcome. Loss to follow-up was frequently high, and authors often failed to adequately account for those
with missing outcome data or did not describe their characteristics. Relatively few trials reported that
they had published a protocol or were registered on a clinical trials database, so only 63 (30%) were
categorised as at low risk of bias of selective outcome reporting; however, in most cases all the outcome
measures described in the methods were reported in the results section.
A significant other potential cause of bias was due to authors reporting in the abstract the numbers
completing the trial rather than randomised and the characteristics of only those who completed the trial.
Furthermore, baseline imbalances (e.g. caused by small sample sizes) were not routinely adjusted for
in statistical analyses, and thus differences at follow-up (e.g. in QoL) might (partly) be due to
baseline differences.
Effectiveness results
Appendix 25 gives an overall summary of direction of effects for each trial for reference purposes.
The following sections refer to the results of specific analyses described previously in Table 40.
All trials
Figures 23–26 plot the outcomes at all reported time points for all trials for HRQoL measured by the
SGRQ and the CRQ, hospital admission and exacerbations. These results have not been combined by
meta-analysis due to the heterogeneity of the interventions and comparators.
The trials were ordered by the number of components, and upon visual inspection there does not appear
to be any relationship between the size of the effect and the number of components. For HRQoL, many
trials reported a large difference between the intervention and comparator group at baseline and, when
present, this was rarely adjusted for in the analysis using ANCOVA.
At the last follow-up point, 11 of 56 (19.6%) resulted in a statistically significant reduction in hospital
admissions and 4 of 28 (14.3%) a statistically significant reduction in exacerbations. A total of 22 of 87
(25.3%) comparisons showed a statistically significant improvement in total SGRQ score, 16 of 41 (39.0%)
in total CRQ, 10 of 24 (41.7%) on the physical components of the Short Form questionnaire-36 items
(SF-36) but only 2 of 21 (9.5%) on the mental component of the SF-36. For individual components, the
CRQ ‘dyspnoea’ and ‘mastery components had the highest proportions of reported significant
improvements (26.4% and 25.8%, respectively).
TABLE 50 Summary of risk of bias
Risk of bias Low, n (%) High, n (%) Unclear, n (%) Total
Sequence generation 66 (37.9) 0 (0) 108 (62.1) 174
Allocation concealment 27 (15.5) 1 (0.6) 146 (83.9) 174
Blinding of HRQoL outcome 34 (19.5) 117 (62.7) 23 (13.2) 174
Blinding of admission outcome 44 0 1 45
Incomplete outcome data 46 (26.4) 83 (47.7) 45 (25.8) 174
Selective outcome reporting 55 (31.6) 2 (1.1) 117 (67.2) 174
Other biases 44 (25.3) 86 (49.4) 44 (25.3) 174
Note
‘n’ refers to number of studies.
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Multicomponent interventions compared with usual care
Health-related quality of life
Multicomponent interventions were defined as those with three or more components. Forty-one trials
reporting 44 interventions compared with UC reported usable total SGRQ or CRQ results; 31 trials reported
hospital admissions, of which 18 could be used in meta-analysis; and 12 trials reported exacerbations of
which three could be used in the meta-analysis (see Appendix 25).
The meta-analysis findings are reported for three time periods: up to and including 3 months, greater than
3 months but up to 6 months (hereafter described as 3–6 months) and greater than 6 months.
For SGRQ followed up to 3 months, most trials reported a greater improvement from baseline to follow-up
in favour of the intervention group.68,121,142,144,148,149,161,186,194,213,214,221,226,227,237–239,257 The summary meta-analysis
result reveals that on average the multicomponent arm had a SGRQ score of 6.50 points (95% CI 3.62 to
9.39 points) higher than the UC arm. However, this is the average of a distribution of trial effects and this
distribution is wide due to high heterogeneity (I2= 82.4%). The prediction interval reports the range
in which 95% of the distribution of the effects lies. The majority of the interval is > 0 and thus mainly in
favour of multicomponent interventions; however, it does overlap zero (95% CI –4.66 to 17.67) indicating
that the interventions are not always effective. At the longer follow-up point of 3–6 months, the estimate
of the average effect was 4.47 points on the SGRQ (95% CI 1.93 to 7.02 points; I2= 79.6%) and at
> 6 months it was 2.40 points (95% CI 0.75 to 4.04 points; I2= 57.9%), both favouring the intervention
group. There is some suggestion that the size of the effect was smaller as follow-up was longer, but loss to
follow-up was also a more significant problem at the longest follow-up point, which may have biased the
effect estimate. The upper boundary of the prediction intervals also lowers with the longer follow-up time.
There were fewer trials reporting the CRQ. At all three time points the estimate of the average effect was
in favour of the intervention group, suggesting that, on average, multicomponent SM interventions were
more effective than UC at up to 6 months’ follow-up. However, heterogeneity was high and the prediction
intervals at all three time points included zero. The results for HRQoL are summarised in Figures 27 and 28
and Table 51.
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Hospital admissions
The results of 18 studies63,65,67,68,70,71,73,120,140,142,148,160,168,212,213,227,266,270 of multicomponent interventions
compared with UC which reported hospital admissions have been analysed; eight with follow-up at
≤ 3 months,67,68,70,120,148,160,212,227 four with follow-up to 6 months;70,73,160,266 and eight with follow-up
at ≥ 1 year.63,65,71,140,142,168,213,270 Although the summary HRs from meta-analysis favoured the intervention
groups at all three follow-up periods, there was much uncertainty leading to only weak statistical evidence
of an effect and heterogeneity was high at follow-up times of > 3 months. Details are given in Figure 29
and Table 52.
Exacerbations
Exacerbations were reported in an analysable format by only four studies.73,182,213,284 The multicomponent
interventions had no evident effect – details in Figure 30 and Table 52. At the last follow-up point, only 2
of 12 studies that reported exacerbations reported a statistically significant effect in favour of the
multicomponent SM intervention.140,172
TABLE 51 Health-related quality-of-life outcomes for multicomponent interventions vs. UC
Outcome Time frame
No. of studies
(comparisons) Summary MD (95% CI) I2 (%) 95% prediction interval
SGRQ ≤ 3 months 18 6.50 (3.62 to 9.39) 82.4 –4.66 to 17.67
> 3 to ≤ 6 months 14 (15) 4.47 (1.93 to 7.02) 79.6 –4.71 to 13.65
> 6 months 16 2.40 (0.75 to 4.04) 57.9 –2.38 to 7.17
CRQ ≤ 3 months 7 0.40 (0.01 to 0.79) 75.7 –0.84 to 1.64
> 3 to ≤ 6 months 5 1.02 (0.05 to 1.98) 93.2 –2.66 to 4.70
> 6 months 3 1.21 (–0.47 to 2.88) 96.2
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Summary: multicomponent interventions
Evidence of effectiveness of multicomponent interventions on HRQoL, but considerable uncertainty for hospital
admissions and exacerbations.
Exploring specific individual components of self-management interventions
We aimed to explore the effectiveness of specific individual components of SM interventions by examining
the trials for which there was a difference in one component between intervention and control arms.
Action plans
Four trials170,188,229,231 reported the addition of an action plan to a SM package. There was no difference in
the average effect on HRQoL of the arms including action plans compared with the comparator groups
(SGRQ 0.43, 95% CI –1.69 to 2.54; I2= 0%) (Figure 31).
McGeoch et al.229 further undertook 1-year follow-up of people who were given an action plan and
reported no effect on hospital admissions (HR 0.97, 95% CI 0.33 to 2.89) (Figure 32). At 6 months’
follow-up, a large trial by Trappenburg et al.188 found no additional effect of action plans on exacerbations
(HR 1.12, 95% CI 0.77 to 1.62) (Figure 33).
Breathing techniques
Two trials235,240 reported breathing training or techniques. On average, the breathing training groups had
a SGRQ score that was 5.0 points (95% CI 4.06 to 5.94 points) higher than the comparison groups.
Although the trials were of a small size, the heterogeneity was low (I2= 0%). Van Gestal et al.208 reported
no difference in the CRQ at 4 weeks’ follow-up (0.17, 95% CI –0.09 to 0.43 points) (Figure 34; see also
Figure 31).
Distraction auditory therapy during exercise
Bauldoff et al.108 reported no significant difference in SGRQ between the group with distraction auditory
therapy and a group with an exercise intervention only (see Figure 31).
TABLE 52 Multicomponent interventions vs. UC: hospital admissions and exacerbations
Outcome Time frame No. of studies Summary HR (95% CI) I2 (%) 95% prediction interval
Admissions ≤ 3 months 8 0.94 (0.73 to 1.20) 0.0 0.69 to 1.28
> 3 to ≤ 6 months 4 0.56 (0.22 to 1.42) 77.8 –
> 6 months 8 0.79 (0.60 to 1.05) 62.6 0.36 to 1.77
Exacerbations ≤ 3 months 1 3.01 (0.31 to 28.96) n/a –
> 3 to ≤ 6 months 2 1.01 (0.59 to 1.74) 0.0 –
> 6 months 2 1.09 (0.77 to 1.53) 37.4 –
n/a, not applicable.
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Exercise techniques/dyspnoea management
We did not include the exercise-only interventions in this analysis, as these have been separately analysed
and are described in the next section. This analysis investigates the effect of adding exercise to other
SM components.
Two trials141,225 reported HRQoL using the SGRQ, with an average effect of 8.20 points (95% CI –2.28 to
18.67 points). The trial by Petersen et al.225 was small (n= 19), with a difference at baseline not accounted
for and short follow-up. Three trials141,204,272 reported the CRQ with the exercise group achieving an
average of 0.71 points (95% CI –0.30 to 1.73 points) more improvement than the comparison group
(see Figures 31 and 34).
A small trial by Moore et al.,271 which investigated exacerbations, reported no evidence of a reduction at
6 weeks’ follow-up (see Figure 33).
Patient support groups
Brooks et al.193 investigated the effect of the addition of a patient support group to a multicomponent SM
package, but although only half of the participants completed the trial, no difference in HRQoL was found
at 1-year follow-up (SGRQ 1.40, 95% CI –4.14 to 6.94) (see Figure 31).
Exercise-only interventions compared with usual care or a
sham intervention
We further examined the effect of individual components by reviewing trials in which exercise was a single
component. The exercise could be supervised or unsupervised, but there were no other SM components.
Eight trials64,183,207,212,240,248,252,282 reported the effects of exercise-only interventions on HRQoL, with no other
SM components in a way through which the data could be incorporated in the meta-analyses. The four
trials183,212,240,252 with five comparator groups, which reported SGRQ at up to 3 months, reported a
significant benefit from the exercise-only intervention (4.87 points, 95% CI 3.96 to 5.79). The prediction
interval (3.39–6.36) provides strong evidence that exercise-only interventions are effective in improving the
SGRQ score at up to 13 weeks’ follow-up. Only Gohl et al.207 reported the SGRQ at 1-year follow-up with
a large but non-significant effect in favour of exercise, although the sample size was very small with only
19 participants. Three trials64,248,282 reported the CRQ outcome, although all had low rates of follow-up, so
results must be interpreted with caution. At 3 months’ follow-up there was a modest effect in favour of
the exercise group but not statistically significant, and at 6 months there was a larger, non-significant
effect, with a high level of heterogeneity. Details are shown in Figures 35 and 36, and Table 53.
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Chan et al.212 compared t’ai chi and exercise to UC in separate comparisons and reported no effects on
hospital admission rates (Figure 37). Behnke et al.64 undertook follow-up at the end of an 18-month
exercise-only intervention and showed a significantly lower hospital admission rate in the intervention
group (3/14) compared with 9 of 12 in the UC group (HR 0.17, 95% CI 0.05 to 0.64). In addition,
Hernandez et al.282 reported no statistical difference in admission rates between the exercise group and
comparator at last follow-up. A small trial by Murphy et al.252 reported exacerbations at 3 and 6 months,
with a suggestion of lower rates, but participant numbers were very small (HR at 3 months 0.02, 95% CI
0.00 to 28.17; HR at 6 months 0.34, 95% CI 0.07 to 1.77) (Figures 37 and 38). Chan et al.212 reported no
difference on exacerbations between groups at 3 months’ follow-up.
Summary: individual components
For individual components we are limited by insufficient evidence. There is no evidence of effectiveness of action
plans, there was only one trial193 of support groups showing no difference when added to a multicomponent
package; breathing management and techniques may have a positive effect.
There is strong evidence that exercise-only interventions increase HRQoL in the short-term, but limited evidence
on hospital admissions and exacerbations.
Enhanced care
We wanted to explore the general effects of providing support to patients over just giving simple
information approaches, which we termed ‘enhanced care’. It included regular telephone contact to
reinforce information or behaviour change techniques, provided encouragement or included scheduled
home visits for assessment with reinforcement or encouragement.
Fifteen studies63–65,67,71,72,110,120,140,155,180,188–190,192,193,206,251,270,271,283 provided information in the form of the total
SGRQ or CRQ and were included in the meta-analyses. Only three studies67,120,193 reported the SGRQ at
3 months’ follow-up with very heterogeneous results; estimate of average effect was 1.27 points (95% CI
–4.28 to 6.82 points, I2= 73.8). At 3–6 months’ and 12 months’ follow-up the enhanced-care arm had a
higher SGRQ score than the UC arm – details are given in Figure 39 and Table 54. The estimates of the
average CRQ at the three follow-up times all favoured the enhanced-care arm but were not statistically
significant and heterogeneity was very high (Figure 40).
TABLE 53 Health-related quality of life and admissions outcomes for exercise-only interventions compared with UC
or a sham intervention
Outcome Time frame No. of trials (comparisons) Summary MD (95% CI) I2 (%)
SGRQ ≤ 3 months 4 (5) 4.87 (3.96 to 5.79) 0
> 6 months 1 8.50 (–2.29 to 19.29) n/a
CRQ ≤ 3 months 2 0.70 (–0.07 to 1.47) 68.6
> 3 to ≤ 6 months 2 1.17 (–0.35 to 2.69) 92.5
Summary HR (95% CI)
Admissions ≤ 3 months 1 (2) 1.12 (0.29 to 4.36) 0
Exacerbations ≤ 3 months 1 0.02 (0.00 to 28.17) n/a
> 3 to ≤ 6 months 1 0.34 (0.07 to 1.77) n/a
n/a, not applicable.
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TABLE 54 Outcomes for enhanced interventions compared with UC/SM package
Outcome Time frame
No. of studies
(comparisons)
Summary MD
(95% CI) I2 (%) 95% prediction interval
SGRQ ≤ 3 months 3 1.27 (–4.28 to 6.82) 73.8 –
> 3 to ≤ 6 months 4 3.09 (1.28 to 4.90) 0.0 –
> 6 months 7 4.05 (2.23 to 5.87) 8.4 1.00 to 7.10
CRQ ≤ 3 months 4 0.54 (–0.18 to 1.26) 87.5 –2.18 to 8.12
> 3 to ≤ 6 months 3 0.93 (–0.49 to 2.35) 95.5 –3.40 to 8.28
> 6 months 2 0.85 (–1.12 to 2.82) 82.1 –
Summary HR (95% CI)
Admissions ≤ 3 months 4 1.05 (0.67 to 1.66) 38.3 –
> 3 to ≤ 6 months 2 0.75 (0.20 to 2.86) 93.2 –
> 6 months 10 0.78 (0.62 to 0.99) 55.1 0.40 to 1.54
Exacerbations > 3 to ≤ 6 months 2 1.11 (0.76 to 1.60) 0.0
> 6 months 1 1.00 (0.68 to 1.46) n/a
n/a, not applicable.
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On average, enhanced care had a similar risk of hospital admission at 3 and 6 months (Figure 41 and
Table 54), but a lower risk at 1 year or longer (HR 0.78, 95% CI 0.62 to 0.99). However, there was
moderate heterogeneity at 1 year and the prediction interval showed that the intervention would
frequently not be effective in lowering hospital admissions. Seven studies did not provide data that could
be included in the meta-analyses,69,74,136,140,180,188,251 of which three also reported a statistically significant
reduction in hospital admissions at 1-year follow-up.140,180,251
Only three trials155,188,206 were included in the meta-analyses for exacerbations with no evidence of any
effect of enhanced care on risk of exacerbation (Figure 42). Four other trials120,140,180,251 reported
exacerbation rates at last follow-up, one140 of which reported a statistically significant reduction.
Summary: enhanced care interventions
Positive effect on HRQoL, particularly at medium-/longer-term follow-up. There may be a reduction in hospital
admissions with longer-term follow-up, but there is considerable heterogeneity. There is insufficient evidence to
establish the effect on exacerbations.
The contribution of exercise to multicomponent self-management packages
The following analyses explore the contribution of exercise and its mode of delivery as a contributor to the
heterogeneity. Multicomponent interventions:
l with a supervised exercise element compared with UC
l a structured, unsupervised exercise element compared with UC
l exercise counselling only compared with UC
l without an exercise element compared with UC.
Multicomponent interventions with a supervised exercise element compared
with usual care
Trials were included in this category if the exercise component of a larger package of care was directly
supervised. The majority were group, centre-based interventions (generally referred to as PR).
Health-related quality of life
Of the 47 trials that reported HRQoL, 26 trials (27 interventions) reported disease-specific HRQoL using
the total SGRQ or CRQ (see Appendices 13 and 27). Findings are similar to those for multicomponent
interventions overall, with the largest estimate of the average effect in SGRQ at up to 3 months’ follow-up
(7.75, 95% CI 3.49 to 12.01) points. There was no difference in average effect between the intervention
and UC arms in SGRQ at follow-up of > 6 months. Heterogeneity was very high for most outcomes and
follow-up times and loss to follow-up variable. Small but significant improvements in the CRQ were
seen at 3 and 6 months’ follow-up favouring the SM group. Details are given in Figures 43 and 44 and
Table 55.
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Hospital admissions
We were able to combine the reports of hospital admission rates in six trials.65,148,160,192,212,213,227 Although the
trend was for the average effect on admission rates to be lower in the intervention arms, this was not a
significant effect at any of the follow-up time points (Figure 45). Four other trials172,182,212,213 reported hospital
admissions at last follow-up; only one reported a statistically significant reduction in hospital admissions.172
Exacerbations
Three trials182,206,213 reported exacerbation rates in such a way that a HR could be computed; heterogeneity
was low or moderate but no evidence of effect was observed (Figure 46 and Table 55). Two additional
trials172,212 reported exacerbations at last study follow-up, with Güell et al.172 reporting a statistically
significant reduction in favour of the intervention group.
Multicomponent interventions with a structured, unsupervised exercise
element compared with usual care
Trials were included in this category if they provided detail about a structured home exercise programme
including duration and proposed frequency of exercise within a larger package of care. These were
home-based interventions.
Of the eight trials186,251,255,262,264,270,283,284 that reported HRQoL, five used the total SGRQ186,251,255,262,270 and
one the CRQ.283 On average, the multicomponent SM package with structured unsupervised exercise had a
larger improvement in SGRQ at 3–6 months’ follow-up than UC [3.59 points (95% CI 1.28 to 5.91 points;
I2= 0%)]. However, by 1-year follow-up there was no evidence of effect: SGRQ 0.80 points (95% CI –1.03
to 2.63 points; prediction interval –2.39 to 3.99). Only one trial283 reported the CRQ at 8 weeks’ follow-up
(0.61, 95% CI –0.18 to 1.41 points) (Figures 47 and 48, and Table 56).
TABLE 55 Outcomes for multicomponent interventions with supervised exercise
Outcome Time frame
No. of studies
(comparisons) Summary MD (95% CI) I2 (%)
95% prediction
interval
SGRQ ≤ 3 months 14 7.75 (3.49 to 12.01) 80.1 –8.25 to 23.75
> 3 to ≤ 6 months 6 6.57 (3.24 to 9.90) 77.6 –3.66 to 16.79
> 6 months 4 1.13 (–2.81 to 5.08) 0 –
CRQ ≤ 3 months 7 0.43 (0.03 to 0.83) 77.8 –0.86 to 1.72
> 3 to ≤ 6 months 6 1.02 (0.19 to 1.86) 92.0 –1.95 to 3.99
> 6 months 3 1.21 (–0.47 to 2.88) 95.2 –
Summary HR (95% CI)
Admissions ≤ 3 months 4 0.78 (0.54 to 1.14) 0.0 –
> 3 to ≤ 6 months 1 0.55 (0.25 to 1.18) n/a –
> 6 months 2 0.47 (0.08 to 2.60) 83.8 –
Exacerbations > 3 to ≤ 6 months 2 0.99 (0.56 to 1.75) 0 –
> 6 months 2 1.09 (0.77 to 1.53) 37.5 –
n/a, not applicable.
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Of the four trials182,255,262,270 that reported hospital admissions at last follow-up, two182,270 reported a
statistically significant reduction in the intervention group. A HR could be calculated for only one trial,270
which reported a significant reduction in hospital admissions (HR 0.55, 95% CI 0.35 to 0.87)
(Figure 49).270 Moore et al.,284 who had only 27 participants (and wide CIs), reported exacerbations
(HR 3.01, 95% CI 0.31 to 28.96) (see Figure 50). An additional two trials192,251 reported no significant
difference in exacerbations at last follow-up point.
Multicomponent interventions with exercise counselling only compared with
usual care
Seven trials67,72,73,140,170,180,266 reported disease-specific HRQoL using total SGRQ or CRQ following
multicomponent interventions that included advice about increasing exercise. There were no significant
effects on the SGRQ in the combined analyses at any of the three follow-up points and heterogeneity was
high (Figure 51 and Table 57). Two trials72,180 had large differences in the SGRQ score at baseline that were
not accounted for, and three trials72,73,140 had low or imbalanced follow-up rates.
Eight trials reported hospital admissions,67,70,71,73,75,140,168,266 of which one168 was not included in the
meta-analyses. There were no significant effects on admissions at any of the three follow-up points, and
heterogeneity was high at the 6- and 12-month follow-up points. Details are given in Figure 52 and
Table 57.
Only Dheda et al.73 reported exacerbation rates at 6 months’ follow-up in a form enabling a HR to be
calculated, with no difference between study arms (Figure 53). Three other trials140,180,266 reported
exacerbations at 6 months265 or a year,140,180 with Rice et al.140 reporting a significant reduction in
exacerbations at 1 year.
Multicomponent interventions without an exercise element compared with
usual care
We included five trials63,112,120,185,256 of multicomponent interventions that did not include exercise or even
advice about exercise as a component in the meta-analyses.
Although the estimates of average effects of QoL (SGRQ) at all three follow-up points were in
the direction favouring the intervention, none was statistically significant and heterogeneity was high
(Figure 54 and Table 58).
TABLE 56 Outcomes for multicomponent interventions with structured, unsupervised exercise
Outcome Time frame No. of studies Summary MD (95% CI) I2 (%)
SGRQ > 3 to ≤ 6 months 4 3.59 (1.28 to 5.91) 0.0
> 6 months 5 0.80 (–1.03 to 2.63) 2.3
CRQ ≤ 3 months 1 0.61 (–0.18 to 1.41) n/a
Summary HR (95% CI)
Admissions > 6 months 1 0.55 (0.35 to 0.87) n/a
Exacerbations ≤ 3 months 1 3.01 (0.31 to 28.96) n/a
n/a, not applicable.
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TABLE 57 Outcomes for multicomponent interventions with exercise counselling only compared with UC
Outcome Time frame No. of studies Summary MD (95% CI) I2 (%)
SGRQ ≤ 3 months 1 1.32 (–2.97 to 5.61) n/a
> 3 to ≤ 6 months 3 1.87 (–4.43 to 8.18) 71.2
> 6 months 4 3.88 (–1.39 to 9.14) 74.6
Summary HR (95% CI)
Admissions ≤ 3 months 2 1.40 (0.93 to 2.11) 0
> 3 to ≤ 6 months 3 0.52 (0.13 to 2.09) 81.0
> 6 months 3 0.79 (0.50 to 1.26) 67.9
Exacerbations > 3 to ≤ 6 months 1 1.0 (0.17 to 5.98) n/a
n/a, not applicable.
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Results were combined for two trials that reported hospital admission rates at 3–6 months.63,142 Neither
reported a statistically significant reduction in admissions (Figure 55). Three other trials112,136,142 that
reported hospital admissions at last follow-up did not find any significant difference between study groups.
Koff et al.120 reported no significant difference in exacerbations at 3 months’ follow-up.
Summary: role of exercise in multicomponent interventions
l Multicomponent interventions with supervised exercise compared with UC have a positive effect on HRQoL
and positive trend for hospital admissions but not reaching statistical significance.
l For multicomponent interventions with structured, unsupervised exercise there is evidence of effectiveness
on HRQoL in the medium term, but insufficient evidence for hospital admissions and exacerbations.
l For interventions with advice to increase exercise in an unstructured manner there were few trials, but no
evidence of overall effect on HRQoL, hospital admissions or exacerbations.
l There were limited numbers of studies of multicomponent interventions without any exercise counselling.
There is some evidence that they may lead to short-term improvements in HRQoL, but there was
inconclusive evidence for hospital admissions.
TABLE 58 Health-related quality of life and admission outcomes for multicomponent interventions without
exercise advice or support
Outcome Time frame No. of studies Summary MD (95% CI) I2 (%)
SGRQ ≤ 3 months 3 4.65 (–1.45 to 10.74) 82.0
> 3 to ≤ 6 months 2 2.75 (–3.24 to 8.74) 0
> 6 months 3 3.73 (–0.99 to 8.44) 81.1
Summary HR (95% CI)
Admissions ≤ 3 months 1 0.32 (0.03 to 3.03) n/a
> 6 months 2 0.99 (0.76 to 1.30) 0
n/a, not applicable.
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Self-management interventions including an exercise component consisting
of aerobic and strength training
Given the possible influence of exercise, we further explored the effect of different types of exercise
interventions by first examining the effects of interventions that include both aerobic and strength training.
The summary meta-analysis result indicates that, on average, the combined aerobic/strength exercise arm
has a SGRQ score of 7.80 points higher than the UC arm (95% CI 2.82 to 12.79 points). However, this is
the average of the distribution of intervention effects and this distribution was wide as a result of high
heterogeneity (I2= 81.5%). The prediction interval, in which 95% of the distribution of the effects occur,
is –10.60 to 26.21, which is mainly in favour of the intervention, but also indicates that the intervention
is not always effective. At the mid follow-up point of 3–6 months, the estimate of the average effect
was 3.76 points on the SGRQ (95% CI 2.13 to 5.39 points; I2= 0%) favouring the intervention group.
However, at > 6 months there was no evidence of effect (Figure 56 and Table 59). The CRQ results
favoured the intervention group up to 6 months’ follow-up (Figure 57).
We identified six trials148,154,160,213,227,270 reporting hospital admissions but at no follow-up time point was the
average effect significantly in favour of the intervention arm (Figure 58 and Table 59).
Similarly, the average effects of the four trials reporting exacerbations,154,182,213,284 showed no evidence of
effect of aerobic and strength training (Figure 59).
Summary: strength and aerobic exercise interventions
Favourable effect on HRQoL and hospital admissions (although not statistically significant). No evidence of
effect on exacerbations.
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TABLE 59 Outcomes for combined strength and aerobic exercise interventions compared with UC
Outcome Time frame
No. of studies
(comparisons) Summary MD (95% CI) I2 (%) 95% prediction interval
SGRQ ≤ 3 months 13 7.80 (2.82 to 12.79) 81.5 –10.60 to 26.21
> 3 to ≤ 6 months 6 3.76 (2.13 to 5.39) 0.0 1.45 to 6.07
> 6 months 6 0.27 (–1.47 to 2.01) 0.0 –2.20 to 2.74
CRQ ≤ 3 months 4 0.27 (0.00 to 0.53) 0 –
> 3 to ≤ 6 months 2 0.55 (0.02 to 1.09) 32.1 –
> 6 months 1 0.10 (–0.50 to 0.70) 70.1 –
Summary HR (95% CI)
Admissions ≤ 3 months 4 0.67 (0.42 to 1.09) 23.1 –
> 3 to ≤ 6 months 1 0.55 (0.25 to 1.18) n/a –
> 6 months 2 0.75 (0.41 to 1.37) 68.2 –
Exacerbations ≤ 3 months 2 0.80 (0.11 to 5.83) 65.4 –
> 3 to ≤ 6 months 1 1.01 (0.57 to 1.79) n/a –
> 6 months 2 1.09 (0.77 to 1.53) 37.4 –
n/a, not applicable.
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Strength and aerobic exercise training compared with aerobic training only
To investigate the effect of strength training, we evaluated the effects of studies reporting the addition of
strength training over aerobic training. Two trials reported this comparison at 3 months’ follow-up.233,246
On average combined training has a SGRQ 4.23 points (95% CI –8.75 to 17.22 points) higher than
aerobic training alone, but this effect is not statistically significant (Figure 60).
Summary: strength training
Limited evidence from only two trials;233,246 no evidence of effect.
DOI: 10.3310/hta19360 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 36
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Jordan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
159
Le
n
g
th
 o
f
fo
llo
w
-u
p
(w
ee
ks
)
Le
n
g
th
 o
f
in
te
rv
en
ti
o
n
(w
ee
ks
)
B
as
el
in
e
d
if
fe
re
n
ce
(i
n
te
rv
en
ti
o
n
–
co
n
tr
o
l)
N
o
. o
f
co
m
p
o
n
en
ts
St
u
d
y
In
te
rv
en
ti
o
n
n
(e
n
d
)/
n
(s
ta
rt
) 
(%
)
C
o
n
tr
o
l
n
(e
n
d
)/
n
(s
ta
rt
) 
(%
)
A
N
C
O
V
A
M
ea
n
 d
if
fe
re
n
ce
(i
n
te
rv
en
ti
o
n
– 
co
n
tr
o
l)
 (
95
%
 C
I)
M
ea
n
 d
if
fe
re
n
ce
 (
ef
fe
ct
 s
iz
e  
>
 0
 f
av
o
u
rs
 in
te
rv
en
ti
o
n
)
1 1
Fo
llo
w
-u
p
 1
3 
w
ee
ks
 o
r 
le
ss
12
12
12
12
12
.8
D
o
u
ra
d
o
 2
00
92
33
 B
V
o
n
b
an
k 
20
12
24
6  
B
–5
.0
N
o
N
o
11
/1
4 
(7
9)
12
/1
2 
(1
00
)
13
/1
9 
(6
8)
12
/1
2 
(1
00
)
4.
23
 (
–8
.7
5 
to
 1
7.
22
)
6.
00
 (
–7
.6
5 
to
 1
9.
65
)
–1
2.
50
 (
–5
4.
52
 t
o
 2
9.
52
)
–2
0
–1
0
0
10
20
To
ta
l (
I2
 =
 0
.0
%
, p
 =
 0
.4
12
)
FI
G
U
R
E
60
H
ea
lt
h
-r
el
at
ed
q
u
al
it
y-
o
f-
lif
e
(S
G
R
Q
)
o
u
tc
o
m
es
fo
r
st
re
n
g
th
an
d
ae
ro
b
ic
ex
er
ci
se
tr
ai
n
in
g
in
te
rv
en
ti
o
n
s
vs
.a
er
o
b
ic
ex
er
ci
se
o
n
ly
.D
o
u
ra
d
o
20
09
2
3
3
B
=
st
re
n
g
th
tr
ai
n
in
g
an
d
lo
w
-i
n
te
n
si
ty
g
en
er
al
tr
ai
n
in
g
vs
.l
o
w
-i
n
te
n
si
ty
g
en
er
al
tr
ai
n
in
g
;
V
o
n
b
an
k
20
12
2
4
6
B
=
st
re
n
g
th
an
d
en
d
u
ra
n
ce
tr
ai
n
in
g
vs
.
en
d
u
ra
n
ce
tr
ai
n
in
g
.
SYSTEMATIC REVIEW 4
NIHR Journals Library www.journalslibrary.nihr.ac.uk
160
Endurance training compared with strength/resistance training
To explore which of the strength or endurance training was more effective we examined trials directly
comparing both. Four trials reported HRQoL for this comparison (Figures 61 and 62).216,233,246,247 At none of
the follow-up points was there any evidence of a significant difference in average effect (Table 60). Only
one trial reported hospital admission rates, which showed no evidence of effect (HR 0.68, 95% CI 0.22 to
2.13) (Figure 63).247
Summary: endurance training compared with strength/resistance training
Limited evidence; no evidence of effect.
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TABLE 60 Health-related quality of life and admissions outcomes for endurance training compared with strength/
resistance training
Outcome Time frame No. of studies Summary MD (95% CI) I2 (%)
SGRQ ≤ 3 months 3 0.14 (–7.30 to 7.58) 0
> 3 to ≤ 6 months 1 0.90 (–11.65 to 13.45) n/a
> 6 months 1 1.30 (–7.02 to 9.62) n/a
CRQ ≤ 3 months 1 0.0 (–0.90 to 0.90) n/a
Summary HR (95% CI)
Admissions ≤ 3 months 1 0.68 (0.22 to 2.13) n/a
n/a, not applicable.
DOI: 10.3310/hta19360 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 36
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Jordan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
163
Le
n
g
th
 o
f
fo
llo
w
-u
p
(w
ee
ks
)
Le
n
g
th
 o
f
in
te
rv
en
ti
o
n
(w
ee
ks
)
H
R
d
ir
ec
tl
y
re
p
o
rt
ed
N
o
. o
f
co
m
p
o
n
en
ts
St
u
d
y
In
te
rv
en
ti
o
n
to
ta
l
In
te
rv
en
ti
o
n
ev
en
ts
C
o
n
tr
o
l
to
ta
l
C
o
n
tr
o
l
ev
en
ts
H
R
 (
95
%
 C
I)
H
R
 (
ef
fe
ct
 s
iz
e 
>
 1
 f
av
o
u
rs
 in
te
rv
en
ti
o
n
)
Fo
llo
w
-u
p
 1
3 
w
ee
ks
 o
r 
le
ss
5
24
7
24
N
o
12
12
1
Sp
ru
it
 2
00
22
47
0.
68
 (
0.
22
 t
o
 2
.1
3)
0.
25
0.
50
1
2
5
10
FI
G
U
R
E
63
A
d
m
is
si
o
n
o
u
tc
o
m
es
fo
r
en
d
u
ra
n
ce
tr
ai
n
in
g
vs
.
st
re
n
g
th
/r
es
is
ta
n
ce
ex
er
ci
se
tr
ai
n
in
g
.
SYSTEMATIC REVIEW 4
NIHR Journals Library www.journalslibrary.nihr.ac.uk
164
Upper and lower limb training compared with lower limb training only
This analysis aimed to explore the addition of upper limb training, which trains accessory respiratory
muscles. Only one trial263 of 48 participants reported the CRQ immediately post intervention at 8 weeks
with no evidence of effect (–0.21, 95% CI –0.85 to 0.42) (Figure 64).
Summary: upper limb training
Limited evidence from one trial263 only; no evidence of effect.
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Interval compared with continuous exercise
We explored whether interval or continuous exercise training was more effective. In a direct comparison,
three trials reported the CRQ at ≤ 3 months (Figure 65).124,257,265 There was no evidence of a difference
in average effect of interval exercise compared with continuous exercise interventions (CRQ –0.14,
95% CI –0.32 to 0.04; I2= 0%) (see Figure 65).
Summary: interval training compared with continuous training
Limited evidence; no evidence of effect.
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Inspiratory or expiratory muscle training compared with usual care or a
sham intervention
Four trials163,184,253,254 reported RMT compared with a UC or sham intervention. Two small trials253,254
reported the SGRQ at three follow-up points but with wide CIs around a non-significant effect. Two small
trials163,184 reported the CRQ immediately post intervention at 5 and 8 weeks, with an average CRQ
score of 0.44 points (95% CI –0.27 to 1.15) higher than UC, indicating a non-statistically significant
improvement in HRQoL. Only one trial253 reported hospital admissions, with a non-significantly lower HR in
the RMT arm (HR 0.77, 95% CI 0.34 to 1.72) (Figures 66–68 and Table 61).
Summary: inspiratory/expiratory muscle training
Limited evidence. Some evidence of potential effect on HRQoL in mid to longer term.
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Direct comparison of more sessions/longer duration with
shorter programmes
This analysis investigated the effect of longer programmes: 7 weeks’ duration compared with 4 weeks’
duration,144 additional exercise sessions following a course of PR224 or two compared with one repeat PR
sessions.244 It did not investigate the intensity of exercise undertaken within a session. There is no evidence
that longer programmes or more sessions lead to improved SGRQ scores or reduced exacerbations
(Figures 69–71 and Table 62).
Summary: more sessions/longer-duration interventions
Limited evidence; no evidence of effect.
TABLE 61 Health-related quality of life and admissions outcomes for inspiratory and expiratory muscle training
compared with UC/sham
Outcome Time frame No. of studies Summary MD (95% CI) I2 (%)
SGRQ ≤ 3 months 2 1.95 (–10.23 to 14.12) 0
> 3 to ≤ 6 months 2 7.95 (–3.75 to 19.64) 0
> 6 months 2 10.10 (–1.38 to 21.59) 0
CRQ ≤ 3 months 2 0.80 (–0.27 to 1.15) 69.8
Summary HR (95% CI)
Admissions ≤ 3 months 1 0.77 (0.34 to 1.72) n/a
n/a, not applicable.
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Hospital compared with home location
Four trials reported disease-specific HRQoL outcomes in hospital with or without home locations compared
with a home-based programme (Table 63).64,169,177,198 There was no evidence of an average effect that
differed between the comparison groups in HRQoL at any of the follow-up points except for one small trial
at 6 months’ follow-up64 (Figures 72 and 73). In Maltais et al.198 both groups received a 4-week outpatient
supervised educational package, while the exercise component was either hospital- or home-based.
Summary: hospital-based compared with home-based interventions
Limited evidence; no evidence of effect.
TABLE 62 Health-related quality of life and exacerbations for longer/more sessions compared with shorter/fewer
sessions programmes
Outcome Time frame No. of studies Summary MD (95% CI) I2 (%)
SGRQ ≤ 3 months 2 0.08 (–3.59 to 3.74) 0.0
> 3 to ≤ 6 months 2 –2.01 (–5.77 to 1.74) 0.0
> 6 months 2 –2.46 (–5.42 to 0.50) 0.0
Summary HR (95% CI)
Exacerbations > 3 to ≤ 6 months 1 0.09 (0.00 to 55.93) n/a
n/a, not applicable.
TABLE 63 Health-related quality of life and admissions outcomes for hospital compared with home
SM interventions
Outcome Time frame No. of studies Summary MD (95% CI) I2 (%)
SGRQ ≤ 3 months 2 –0.25 (–4.58 to 4.09) 28.2
> 3 to ≤ 6 months 1 3.00 (–4.94 to 10.94) n/a
> 6 months 2 –1.94 (–5.26 to 1.38) 15.6
CRQ ≤ 3 months 2 0.33 (–1.09 to 1.75) 93.7
> 3 to ≤ 6 months 1 1.95 (1.33 to 2.57) n/a
n/a, not applicable.
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Delivery by pharmacists
We aimed to explore any effects by professional delivering care. The majority of interventions were
delivered by nurses or physiotherapists. Three trials136,251,266,285 had a SM intervention delivered by a
pharmacist with a UC comparator. Of these, two trials251,266 reported the SGRQ, with a higher average
effect in favour of the pharmacist-led intervention at 6 months (2.74, 95% CI –1.54 to 7.03; I2= 30.3%),
but this was not statistically significant (Figure 74). At 1-year follow-up, Khdour et al.251 reported a
non-significant difference of 3.80 SGRQ points in favour of the pharmacist-led intervention (95% CI –1.95
to 9.55 points). Jarab et al.266 reported a significant reduction in hospital admissions at 6 months (HR 0.26,
95% CI 0.07 to 0.93) (Figure 75).
Summary: delivery by pharmacists
Insufficient evidence; no evidence of effect.
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Maintenance programme post pulmonary rehabilitation compared with
no maintenance programme
No combined analyses were possible for this analysis. Romagnoli et al.244 found no evidence of effect on
HRQoL from a maintenance programme following PR at 4, 26 or 52 weeks (Figure 76). At 2 years’
follow-up, Sridhar et al.155 reported a significantly greater CRQ score (2.04, 95% CI 0.37 to 3.71) but no
effect on hospital admissions (HR 1.11, 95% CI 0.65 to 1.91) or exacerbations (HR 1.00, 95% CI 0.68 to
1.46) (Figures 77–79).
Summary: maintenance programme post rehabilitation
Limited evidence; no evidence of effect.
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Exploring heterogeneity using meta-regression
Meta-regression was used to explore the effects of risk of bias within studies, the average severity of COPD
in the participants, the number of intervention components and the duration of the intervention. The last
analysis is also clearly related to the follow-up time point. No clear pattern emerged. Although at up to
3 months’ follow-up the trials of all multicomponent interventions with generally low risk of bias have a
significantly higher SGRQ score than trials at higher risk of bias, this effect was not seen at any other time
point or for subgroups of interventions. Similarly, increasing numbers of components were associated with
significant improvements of SGRQ in analyses of all multicomponent interventions, but a small but
opposite effect was seen for the effect of enhanced SM on hospital admissions. For multicomponent
interventions, the population with severe COPD had a reduced improvement in SGRQ compared with
those with moderate or less severe COPD. Inconsistent results were observed for length of follow-up
(Tables 64 and 65).
Publication bias
We present funnel plots of the analyses, which included at least 10 studies (see Appendices 28–33). The
asymmetric distribution apparent in several of the plots is suggestive of publication bias, with an Egger’s
test for asymmetry showing p< 0.1 in five of the six analyses with ≥ 10 trials. These patterns are consistent
with an absence of smaller studies with negative outcomes. This would be consistent with biases observed
in other literatures, particularly in the context of a comprehensive search of the literature such as the one
carried out here. Although the publication bias is thus a genuine concern, the asymmetry may also be due
to systematic associations between sample size and other heterogeneous characteristics that impact
on outcome.
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TABLE 64 Meta-regression of a range of SM interventions on the SGRQ
Category Follow-up Coefficient 95% CI p-value
All multicomponent interventions
Low risk of biasa ≤ 3 months 9.86 6.91 to 12.80 < 0.001
Severe populationb –3.84 –5.85 to –1.83 < 0.001
No. of components 1.36 0.89 to 1.84 < 0.001
Length of intervention (weeks):c
14–26 – – –
27+ –10.16 –20.74 to 0.41 0.060
Low risk of biasa > 3 to ≤ 6 months –0.95 –5.52 to 3.62 0.684
Severe populationb –1.97 –7.00 to 3.06 0.443
No. of components –0.51 –1.07 to 0.05 0.074
Length of intervention (weeks):c
14–26 4.40 0.24 to 8.55 0.038
27+ –0.21 –4.27 to 3.85 0.918
Low risk of biasa > 6 months –0.10 –3.81 to 3.60 0.957
Severe populationb –2.90 –4.69 to –1.10 0.002
No. of components –0.26 –0.81 to 0.29 0.358
Length of intervention (weeks):c
14–26 4.48 –3.81 to 12.78 0.289
27+ 1.76 0.22 to 3.30 0.025
Multicomponent interventions with supervised exercise
Low risk of biasa ≤ 3 months 6.27 –1.37 to 13.91 0.108
Severe populationb 1.70 –10.21 to 13.62 0.779
Number of components 1.19 –0.70 to 3.08 0.218
Length of intervention (weeks):c
14–26 – – –
27+ –11.60 –22.11 to –1.09 0.031
Interventions including an exercise component consisting of aerobic and strength training
Low risk of biasa ≤ 3 months 6.21 –2.19 to 14.62 0.148
Severe populationb 2.08 –8.09 to 12.24 0.689
Number of components 0.60 –1.15 to 2.36 0.501
Length of intervention (weeks):c
14–26 – – –
27+ –12.31 –21.94 to –2.68 0.012
a Reference is higher risk of bias.
b Reference is less severe population.
c Reference is intervention length of ≤ 13 weeks.
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Discussion
We report the findings of a large systematic review that has explored the components and delivery of
SM interventions in order to try to identify the optimal mode of delivery and make-up of such interventions.
Key results
Overall we found that:
l There were a large number of relevant trials with our primary outcomes of interest but the majority
were small, short term (≤ 3 months) and poorly reported.
l Almost half of the trials suffered from incomplete outcome reporting, which was likely to be an
important source of bias for the HRQoL results in particular.
l Interventions were very heterogeneous and usually multicomponent.
l Exercise was the most common component, but other common components were breathing
management techniques and general education about COPD and its management.
l Overall, the nature and results of the studies were so heterogeneous it was not appropriate to combine
them all together.
l Studies assessing the effect of individual components were few but, from the evidence available, only
exercise significantly improved patient outcomes, but this was restricted to HRQoL in the short term.
l Multicomponent interventions (with three or more components) produced combined effects which
suggested that HRQoL was improved compared with UC. However, there was much statistical
heterogeneity that could not be explained by length of follow-up. The results were also consistent with
a potential reduction in admissions but, again, data were heterogeneous and the CIs crossing the line of
no effect. Further exploration using meta-regression techniques indicated that the results could have
been affected by the likely bias introduced in the study, the disease severity of the populations and the
number of components in the interventions, although across time points, these findings were not stable.
l Subgroups of the multicomponent studies revealed that interventions with more enhanced care and
support were effective in improving HRQoL and reducing admission rates among the studies of
≥ 6 months’ duration.
l Furthermore, multicomponent interventions that included supervised exercise, or an unsupervised but
structured exercise element, resulted in significant and clinically important improvements in HRQoL
up to 6 months, although data were sometimes heterogeneous. There was insufficient evidence to
comment on other outcomes.
l Further exploration of exercise did not reveal which type of exercise was more effective or whether
duration/intensity was important.
l Insufficient evidence was available to assess the effect of delivery of SM type of health professional.
TABLE 65 Meta-regressions of enhanced care interventions on hospital admissions
Category Follow-up Coefficient 95% CI p-value
Enhanced care
Low risk of biasa > 6 months 0.17 –0.34 to 0.68 0.513
Severe populationb –0.27 –1.02 to 0.49 0.492
No. of components –0.08 –0.14 to –0.01 0.020
Length of intervention (weeks):c
14–26 – – –
27+ 0.39 –0.27 to 1.04 0.244
a Reference is higher risk of bias.
b Reference is less severe population.
c Reference is intervention length of ≤ 13 weeks.
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Comparison of findings with other reviews
Contents of self-management interventions
Through mapping the SM interventions and their individual components we are able to show the huge
range of interventions, with differing components, delivered either as brief information/education or in a
more supported manner. Exercise was the most frequent component and the most common component
of single/two-component interventions. A recent systematic review by Stoilkova et al.286 has mapped
educational programmes in COPD management only, including studies published in the English language.
This reported that over half of educational interventions had ≥ 10 topics incorporated within a programme.
We took a much broader approach to defining SM, searching for studies that might include any of the
relevant aspects of SM. Although we also found that a high proportion of trials evaluated multicomponent
interventions, about one-fifth were single component, usually exercise only.
Role of behaviour change strategies
From the descriptions of interventions it was frequently not clear to what extent techniques for behaviour
change were used in the SM education and support. Most intervention descriptions had no description of
underlying behavioural change theory or the individual behaviour change strategies used. Some papers
described using self-regulation theory, or Bandura’s Social Learning Theory;31 others described strategies
such as self-monitoring, goal-setting, action planning and the use of biofeedback. The use of Abraham
and Michie’s287 taxonomy of behaviour change to underpin the descriptions of the SM interventions would
enable their relative contributions to be ascertained. Education is an important element of COPD SM
interventions, with almost half of the studies in this review including this component. However, education
as directly imparted provision of information is generally not effective by itself.288 Information is effective
when accompanied by active, behavioural strategies, and it is not clear to what extent these have been
included within the interventions included in this review. Dishman et al.289 identified that knowledge alone
did not predict behaviour change, but that self-efficacy is an important cognitive determinant of change,
showing that people have at least acquired the confidence and belief that they can self-manage their
COPD. Trials that used action planning for an exacerbation generally failed to measure self-efficacy to
determine whether they increased self-efficacy for identification of an exacerbation and confidence with
commencing treatment. Given that action planning has not been found to be effective,50 it is vital to
explore the mechanisms by which it is proposed to work, to establish whether any lack of effect is due
to a failure to commence treatment as a result of lack of confidence.
Behavioural change techniques that have been shown to be most effective in the promotion of physical
activity and healthy eating in the general population may also be beneficial to encourage physical activity
and exercise in people with COPD.290 The technique associated with most effects was being prompted
to self-monitor behaviour. Other techniques that appeared to be effective when combined with
self-monitoring were prompting intention formation, goal-setting and providing feedback on performance.
These would all be achievable as part of a SM intervention for people with COPD.
Results of effectiveness of self-management interventions
Overall the effect on HRQoL of multicomponent SM interventions was positive, with an average effect size
of greater than four points on the SGRQ, which is considered to be the minimal clinically important
difference. The effect of SM on admissions and exacerbations was less clear, possibly as a result of fewer
trials in the analyses. Our plan was to explore the expected high levels of heterogeneity to try to identify
formats of SM for COPD that looked particularly promising in terms of HRQoL and health service utilisation
outcomes. These analyses were developed by the wider project steering group and aimed to have a clinical
coherence. We decided not to repeat analyses that were the subject of recent Cochrane systematic reviews.
We have no evidence from our analyses that SM interventions with more components are better than
those with fewer. The results from the meta-regression provided inconsistent results in relation to the risk
of bias of the study, severity of the population’s COPD and number of components.
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Role of specific components of self-management
There were few studies that evaluated either single components of SM compared with UC, or the addition
of an individual component to a wider package of care. The exploration of single component interventions
is important, as it may be the case that it is easier for participants to focus on a single component better
than a multicomponent intervention.
Action plans
A Cochrane systematic review investigated the effect of action plans with a brief educational component
compared with UC.50 There was no effect on HRQoL, emergency room visits, general practitioner
consultations or hospital admissions, but participants in the action plan group had more treatments for
exacerbations. Our review did not identify any additional studies addressing this SM strategy alone.
Action planning was a component in over half of the multicomponent interventions.
Smoking cessation interventions
Smoking cessation was a surprisingly low proportion of the SM components (in < 20% of interventions);
however, this may be a result of people with COPD being referred out to a separate smoking cessation
service, rather than including it as part of a SM programme. It is possible that the inclusion of smoking
cessation within SM programmes may be a source of heterogeneity, which we have not explored. In a
systematic review of smoking cessation interventions for COPD five studies were included.291 There were
no comparisons of psychological interventions compared with no interventions. Direct comparisons of two
active psychosocial interventions showed no significant difference, but a combination of a psychosocial and
pharmacological intervention compared with no treatment showed sustained cessation.
Exercise-only interventions
We have reported the effects of exercise-only/exercise with dyspnoea management interventions compared
with UC. At follow-up of ≤ 3 months the average effect of exercise only was –4.87 (95% CI –5.79 to
–3.96) SGRQ points in favour of the intervention but, because of small numbers of trials reporting HRQoL
with a longer follow-up or admissions or exacerbations, we do not have evidence of an effect after this
short period. All but one of these trials included supervised exercise, so we were unable to explore the role
of direct supervision compared with unsupervised home-based exercise in the absence of other
SM components.
Effect of multicomponent interventions
In the wide range of multicomponent SM interventions and settings evaluated, our meta-analysis indicates
that overall (on average) multicomponent SM interventions have a positive effect on HRQoL. Our summary
estimates were larger than the minimal clinically important difference for SGRQ at follow-up to 6 months
for the multicomponent interventions and at all follow-up points for the CRQ.292 However, we did find
considerable heterogeneity, making it hard to establish which particular interventions and which particular
settings work best. Our findings are similar to those of a systematic review by Effing et al.,48 who evaluated
the effectiveness of SM education compared with UC. Effing et al.48 included 14 trials, with considerable
overlap with our analysis but they excluded trials of PR. Effing et al.48 reported a smaller improvement on
the SGRQ (2.6, 95% CI 0.02 to 5.0) than we found, but did report a significant reduction in respiratory
admissions, which did not agree with our findings.
Integrated disease management
Several systematic reviews have addressed the effectiveness of disease management.47,49 This has been
defined by Schrijvers293 as ‘Disease management consists of a group of coherent interventions designed to
prevent or manage one or more chronic conditions using a systematic, multidisciplinary approach and
potentially employing multiple treatment modalities. The goal of chronic disease management is to identify
persons at risk for one or more chronic conditions, to promote SM by patients and to address the illness or
conditions with maximum clinical outcome, effectiveness and efficiency regardless of treatment setting(s)
or typical reimbursement patterns’. The most recent review is a Cochrane review by Kruis et al.47 The
Cochrane review47 included 26 trials and reported a difference of 3.71 points on the SGRQ (95% CI 1.6 to
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5.8 points) in favour of the intervention group, a reduction in respiratory admissions (OR 0.68, 95% CI
0.47 to 0.99) and a reduction in all-cause admissions up to 12 months (OR 0.62, 95% CI 0.36 to 1.07).
There was no effect on exacerbations. Given this recent review, we have not repeated this analysis in
this report.
Enhanced care
Our definition of enhanced care included proactive telephone calls from a respiratory health-care
professional and helplines available to patients or visits from health-care professionals, all as a means to
reinforce information/techniques/strategies and encourage behaviour change. The interventions were
generally delivered by a respiratory nurse or physiotherapist/physiologist. This has not been addressed in
other systematic reviews. We have identified improvements in HRQoL and reduced hospital admissions
after 6 months of follow-up, suggesting that these enhancements should be considered further. The
analyses had high levels of heterogeneity, so further exploration of the individual components would
be useful.
Role of exercise alone or within larger self-management packages
Group-based self-management with supervised exercise as part of a multicomponent
self-management intervention
Our analysis of SM interventions with supervised exercise is similar to that of Lacasse et al.’s46 Cochrane
review of PR programmes. Although the Lacasse et al. review46 included six trials in their analysis of total
SGRQ, we included 18, and found a similar effect size at our follow-up points up to 6 months, but an
attenuated effect after one year follow-up. We had higher heterogeneity than that reported by Lacasse
et al.,46 which may reflect our wider inclusion criteria. We have been able to extend the Lacasse review by
reporting hospital admissions and exacerbations; however, the number of trials in these analyses was low
(five and three, respectively) and no significant effects were seen.
Multicomponent self-management without supervised exercise
We undertook subgroup analyses to explore the effect of the level of supervision and amount of exercise
advice and support in multicomponent SM interventions. The unsupervised exercise was structured in
terms of frequency, duration and intensity, but did not take place in a centre or group setting. Although
we identified an average effect on the SGRQ at 3 months that was significant, evidence of effect in the
longer term was absent. Interventions that included exercise advice only or no exercise at all (as part of a
multicomponent intervention) had no evidence of effectiveness.
To further explore the role of exercise we investigated the effect of strength and aerobic exercise training
compared with UC. These interventions all included at least one other SM component with the exercise.
This showed significantly higher HRQoL scores, but no effect on hospital admissions and exacerbations.
In a systematic review, Zainuldin et al.294 explored intensity of leg training and type of training (interval
compared with continuous). Three trials compared higher-intensity training with lower-intensity training
but the pooled effect showed no significant difference between the groups on 6-Minute Walk Distance.
HRQoL and hospital admissions/exacerbations were not reported. There was no significant difference
between the interval and continuous training groups in the eight included studies, for any of the
outcomes, including HRQoL.294 In our study we also found no difference between interval and
continuous training.
Role of aerobic and resistance exercise
To unpick the relative contributions of resistance (strength) and aerobic exercise on HRQoL, hospital
admissions and exacerbations, we undertook direct comparisons. Only two trials233,246 directly compared
resistance and aerobic exercise with aerobic exercise only, with no difference in average HRQoL between
the exercise arms. No trials reported hospital admissions.
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Four trials compared endurance with resistance exercise showing no effect of HRQoL or hospital
admissions.216,233,246,247
Respiratory muscle training
Two main groups of interventions came under this category. Sívori et al.263 compared upper limb exercises
to UC, with no significant effect on HRQoL. Our findings are similar to those of Costi et al.,295 who
reported the HRQoL outcomes individually for three trials, all of which found no significant difference.
We identified a large number of trials that evaluated inspiratory muscle training (IMT) and expiratory
muscle training (EMT) using threshold devices (20 trials: see Appendix 27). These either had UC or sham
devices (set at the lowest setting for resistance) as the comparison group. Only four trials163,184,253,254
reported disease-specific HRQoL using the SGRQ or CRQ and one trial253 reported hospital admissions.
We did not identify any evidence of effectiveness of RMT on these outcomes.
Our findings can be compared with those of systematic reviews of IMT compared with UC,296 and IMT or
IMT plus PR compared with other rehabilitation interventions.297 Geddes et al.296 had only two trials that
compared IMT to sham treatment and reported the total CRQ (weighted MD 0.33, 95% CI 0.19 to 1.47).
The review by O’Brien et al.297 reported only the individual subscales for the CRQ, but found a significantly
greater improvement in the dyspnoea subscale for the exercise-only interventions than the interventions
that included IMT (CRQ dyspnoea 1.94, 95% CI 1.01 to 2.88).
Interventions delivered by particular professional groups
Three trials136,251,266,285 reported SM interventions by pharmacists. We hypothesised that the
multicomponent interventions that they delivered would have a particular focus on medication
management, which was a component of all three trials. The combined effects on HRQoL were not
significant, but Jarab et al.266 reported a significant reduction in hospital admissions at 6 months’
follow-up.
Other systematic reviews have reported the effects of interventions delivered by physiotherapists298 and
of outreach nursing.52 The review of outreach nursing52 has considerable overlap with the concept of
integrated disease management. Wong et al.52 reported a significant improvement in HRQoL, but no effect
on mortality or hospital admissions.
How the evidence fits with other long-term conditions
All our included trials took a patient-based approach in which the SM was delivered to patients in the form
of group-based or individual education and other support. A large UK-based cluster randomised trial
(WISE: Whole System informing self-management engagement),34 published after our search was
completed, sought to support primary care practitioners to embed SM support into their everyday practice.
The trial recruited 1634 patients with COPD in primary care but did not find statistically significant
improvements in self-efficacy, generic HRQoL or shared decision-making. The authors cited difficulties with
implementation in a ‘real’ primary care setting with an unselected group of patients.
Recent studies of note since our searches were undertaken
A recent trial34 was halted prematurely after interim analysis identified a higher mortality rate in the group
that received the SM intervention. The intervention failed to increase knowledge or use of antibiotics as
part of action planning, but the findings are otherwise unexplained. An analysis of mortality rates across all
of the included studies in our review might help identify whether this was an outlying result.
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Strengths and limitations
Strengths
This is the largest systematic review of SM for COPD, with 174 trials reporting our three outcomes in
229 comparisons. We had no exclusions by language or publication date and included 12 trials that were
reported in a language other than English. The review was undertaken with two people independently
selecting titles, abstracts and full papers for inclusion/exclusion, with a third person reviewing and deciding
on papers where there was a disagreement, and group discussion about papers and interventions that
were difficult to categorise. We used an extensive data extraction form to extract directly and – when not
reported – indirectly calculate statistical results for the intervention effects of interest. This allowed us to
incorporate a larger number of studies in the meta-analysis than previous reviews, especially with regard
to HRs.
Many of our subgroup analyses cover topics of published systematic reviews and we were able to extend
the included papers in a number of these. We have also explored additional groups of interventions, for
example in relation to the level of supervision and specification of the exercise component. Although we
would have liked to undertake indirect comparisons to explore individual or groups of components further,
this was not possible due to the heterogeneity of populations, interventions and comparators.
Heterogeneity was apparent in most meta-analyses but the causes of heterogeneity were difficult to
identify due to the small number of studies in most meta-analyses and the potential for trial-level
confounding when exploring heterogeneity. Therefore, to help summarise the heterogeneity more clearly,
when five or more studies were included in the meta-analysis we reported 95% prediction intervals. These
revealed the range of possible intervention effects caused by unexplained heterogeneity. However, this
interval may also reflect heterogeneity caused by small-study effects and low-quality primary studies rather
than just clinical causes of heterogeneity.
Limitations of studies within the review
The main limitations of our review result from the heterogeneity of both the interventions and the
comparison groups, and the general poor standard of reporting and conduct in many of the identified
trials. The included trials were often small, with 46% having < 50 participants; few included a power
calculation; and the reporting of method of randomisation, allocation concealment and blinding of
outcome assessment was often absent or poorly described. When undertaking risk of bias assessment we
did not use explicit cut-offs for a certain attrition or imbalance between study groups because so many
studies had small sample sizes and these thresholds were easily crossed by one or two more participants
lost to follow-up in one study arm compared with the other.
As many of the trials used a ‘UC’ comparator, it was not possible to blind participants to their allocation.
This is likely to lead to an attention effect, when the participants in the active intervention arm have a
more positive experience and often more social support through group-based activities. As most of the
trials reported HRQoL which often includes a mental or social component and follow-up was frequently
only undertaken at the end of the intervention period, attention bias is likely.
Limitations of our review methods
In defining SM interventions we took a very broad perspective but tried to exclude those interventions
when the intervention was largely provided by a professional. Thus hospital-at-home interventions were
included only if they expressly described a SM or educational component. Disease management
programmes were excluded if they were telemonitoring without an educational or SM element. Some
exercise programmes that were delivered by physiotherapists were short term and appeared to describe
something ‘done to’ the patient rather than teaching them to self-manage; these were excluded. Owing to
the large number of papers identified and a number of people reviewing abstracts and papers for eligibility,
there will inevitably be some inconsistencies in relation to inclusion/exclusion. We tried to minimise this
through regular team discussions about papers that we were unsure of including.
SYSTEMATIC REVIEW 4
NIHR Journals Library www.journalslibrary.nihr.ac.uk
190
We planned to undertake full independent double data extraction on all papers but, owing to the large
number of eligible papers, only one person extracted the characteristics and outcomes, with a 20% check
of the outcome data and a 100% check for key characteristics such as number of participants, duration of
intervention and duration of follow-up. To ensure consistency the same person categorised the
components in all trials.
In extracting HRQoL outcome data we focused on the disease-specific measures (SGRQ and CRQ) and
have not reported the generic HRQoL outcomes, as a wide variety of these were reported in a small
number of trials. We decided not to combine the findings of the SGRQ and CRQ in meta-analysis, as they
report different domains. In addition, the reporting of the actual point differences in meta-analysis on the
original scales, rather than a standardised MD, makes interpretation easier.
The admission results were reported in several different ways, for example first admission, mean
admissions, etc. Although ideally we would like to be able to capture all of this information, especially
because some patients may have multiple admissions, current methodologies are inadequate to do so. We
chose rate of first admission because there were more data available; however, it is not clear how the
effect of the interventions would vary if all admissions could be considered.
The trials reported a large number of outcomes, and trials that met our inclusion criteria in relation to
population and intervention – but did not report one of our three primary outcomes (HRQoL, hospital
admissions and exacerbations) – are listed but not described. Although we acknowledge the importance of
other outcomes, such as exercise capacity, the focus of this review was health service utilisation and patient
QoL. Mortality was rarely reported as an outcome but can be obtained from the reasons for loss to
follow-up. Papers often did not report the cause of death (respiratory or other cause) and we cannot be
sure about completeness, given that few trials specified mortality as an outcome measure. Therefore,
we did not include mortality in our analyses.
We have undertaken a large number of comparisons, with the associated risk of identifying significant
effects due to chance. However, this review was planned to be exploratory in nature and we are cautious
in the interpretation of our findings.
We had planned to undertake indirect comparisons of clusters of intervention components but did not
do this owing to considerable heterogeneity of the UC arms and difficulties in identifying potential
comparison groups. The heterogeneity and low-quality studies led us to conclude that the consistency
assumption (which is required to undertake a mixed-treatment comparison) was unlikely to be plausible,
and thus indirect comparisons were not considered.107
Generalisability
Our trials were set in 21 different countries, suggesting that our findings can be generalised across a range
of different health-care settings. We did not explore the effect of location, and thus the standard level of
COPD care as a potential cause of heterogeneity but it may be an important factor. In particular, we did
not focus on studies undertaken only in the UK. Most of the trial participants were recruited from
secondary care settings – usually hospital outpatients – and < 6% were from primary care. In addition,
the participants generally had moderate or severe COPD, as defined by GOLD criteria. Thus our findings
may not be generalised well to populations with milder COPD managed in primary care. In addition,
trials may recruit participants who are more affluent or have a higher educational level than the general
population. Given the fundamental role of self-efficacy in many SM interventions, the representativeness of
the participants is key. Comparisons of the characteristics of recruited participants and people who decline
to take part in a trial are rarely reported, so we are unable to comment on the generalisability of the trial
participants in these aspects.
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Chapter 8 Overall discussion
Introduction
This report had two aims: to evaluate the effectiveness and cost-effectiveness of SM commencing within
6 weeks of hospital discharge for an exacerbation of COPD, and to explore which components or
mechanisms of delivery appear most promising in terms of the effectiveness of SM interventions for
COPD in general.
Main findings
The review of SM post discharge identified no evidence of benefit of early SM support on admissions,
mortality and most other health outcomes, although a modest, but possibly biased, improvement in
HRQoL. However, the direction of the effect for many of the outcomes (including admissions) favoured the
SM intervention. A speculative economic model was developed to explore the cost-effectiveness of such an
intervention – if it were truly effective at reducing hospital admissions. The main drivers of the model were
the effect on hospital readmission, the duration of the effect and the cost of a SM programme. To be
cost-effective, a SM programme post admission for an acute exacerbation would need to cost no more
than £2200 if there was an 18% reduction in readmissions. The sensitivity analysis suggested that SM had
a probability of 68% of being cost-effective at a threshold incremental cost-effectiveness ratio of £20,000
per quality-adjusted life-year, demonstrating the uncertainty around the impact of SM on readmissions.
The second study was an exploratory review of the broad SM and PR literature to try to determine the
components and mechanisms of delivery that are associated with better outcomes. Multicomponent
(at least three individual components) SM interventions are likely to be effective, but the degree of
heterogeneity suggests that there are important features of these interventions that need to be
established; those with supervised exercise (as in a PR programme) or structured, unsupervised exercise
(as in a home rehabilitation programme) appear effective. SM programmes that provide an enhanced level
of care and support may reduce hospital admissions in the medium term (6 months).
Except for exercise-only interventions, there were surprisingly few trials of individual SM components, and
few for which the difference between study groups was only one component. Notably, there was no
evidence that action plans were effective by themselves.
Overall conclusion
It is difficult to recommend any type of SM support to be provided immediately after discharge with the
evidence available, as there is no clear evidence of effect across most of the outcomes. Notwithstanding,
the point estimate is consistent with ≈20% reduction in admissions, which has been observed in other
systematic reviews of COPD SM interventions.
Although some components of SM interventions are associated with positive effects of HRQoL, such as
structured exercise (either within a supervised group or home based), enhanced care and multicomponent
interventions, it was not possible to establish the relative roles of the individual components in reducing
hospital admissions and improving HRQoL.
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Recommendations for future research
1. Current interventions to support patient SM that is delivered post discharge cannot currently be
recommended because interventions are heterogeneous and methodology is problematic, and, despite
there being potential benefit in terms of HRQoL, there is not enough good evidence to be sure that
clinical outcomes could be improved. Therefore:
i. High-quality studies should be undertaken among patients with COPD disease post discharge.
ii. This should include qualitative work to explore barriers and facilitators to SM when patients have
recently had an exacerbation, exploration of novel approaches to affect behaviour change, and
exploration of approaches tailored to the individual and their circumstances.
iii. New approaches should be evaluated by properly designed and conducted trials, with special
attention to reducing loss to follow-up.
2. Owing to the heterogeneity and complexity of interventions, it was not possible to unpick the most
important components of SM interventions in general or to confirm whether they improve clinical
outcomes. It is clear that action plans alone do not seem to work in their present form, but that
structured exercise and more heavily supported interventions (which may not usually be defined as SM)
might work better. Therefore:
i. Further in-depth work using individual patient data (e.g. an Individual Patient Data meta-analysis)
should be carried out to try to identify which are the most effective components of interventions and
identify patient-specific factors that may modify this. This work is ongoing by other researchers.
ii. Future studies might try to identify the characteristics of patients who are more likely to be able to
self-manage, and consider a more targeted approach.
iii. Further qualitative work is needed to explore patients’ barriers and facilitators to SM interventions.
iv. Novel approaches to influence behaviour change and to help patients manage or prevent
exacerbations should be explored, first using qualitative studies and then properly designed and
conducted randomised controlled trials (RCTs). Most trials include a mixture of components; more
trials teasing out the individual elements, either as lone interventions, or with the addition of one
component, would be useful.
3. Recommendations for the design and conduct of future RCTs of interventions to support patient SM:
i. In general, new trials should adhere to modern standards of design, conduct and reporting in order
to reduce risks of bias, for example blinding of outcome assessment, attempts to maximise follow-up
or methods to impute this, and reporting of the characteristics of all randomised patients.
ii. The behaviour change theories and strategies that underpin COPD SM interventions need to be
better characterised and described.
iii. A clear framework for describing and classifying SM interventions and their comparators is required.
iv. Trials need to be adequately powered to detect a clinically relevant difference and long enough to
assess changing effects over time. There should be clear reporting of outcomes to include
self-efficacy, behaviour change and clinical outcomes such as hospital admissions and exacerbations.
v. Given the wide range of HRQoL outcomes available, it would be useful to standardise their use
within COPD research and ensure that they are reported accurately within publications.
Statistical analysis methods should be improved: in particular (1) analysis of HRQoL outcomes should
routinely adjust for baseline values to overcome baseline imbalance, account for correlation between final
score and baseline score, and increase statistical power; and (2) time-to-event outcomes (such as
admissions, mortality, etc.) should be analysed using suitable analyses that allow for differential patient
follow-up, and summarised using HRs (rather than odds ratios).
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Appendix 1 Search strategies for clinical
effectiveness evidence: reviews 1, 2 and 4
MEDLINE (via Ovid)
URL: https://ovid.sp.com
Date range searched: 1946 to April Week 4 2012.
Date of search: 2 May 2012.
Search strategy
1. chronic obstructive pulmonary disease.mp. or exp Pulmonary Disease, Chronic Obstructive/
2. copd.ti,ab.
3. chronic obstructive lung disease.ti,ab.
4. chronic obstructive airway disease.ti,ab.
5. chronic respiratory disorder$.ti,ab.
6. smoking-related lung disease$.ti,ab.
7. Pulmonary Emphysema/
8. exp Bronchitis/
9. emphysema.ti,ab.
10. or/1-9
11. exp Self Care/
12. self care.ti,ab.
13. self manage$.ti,ab.
14. self caring.ti,ab.
15. (self adj2 (support$ or care or caring or manage$)).ti,ab.
16. post discharge.ti,ab.
17. early discharge.ti,ab.
18. home care.ti,ab.
19. home care services/ or home nursing/
20. patient centred care.ti,ab.
21. patient education/ or patient education.ti,ab.
22. patient participation.ti,ab.
23. post hospital care.ti,ab.
24. action planning.ti,ab.
25. discharge planning.ti,ab.
26. continuity of patient care/
27. (support$ adj2 discharge).ti,ab.
28. (support$ adj2 manag$).ti,ab.
29. patient focus$.ti,ab.
30. management plan$.ti,ab.
31. management program$.ti,ab.
32. rehabilitation.mp. or exp Rehabilitation/
33. or/11-32
34. 10 and 33
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MEDLINE In-Process & Other Non-Indexed Citations (via Ovid)
URL: https://ovidsp.ovid.com
Date range searched: inception to 2 May 2012.
Date of search: 2 May 2012.
Search strategy
1. chronic obstructive pulmonary disease.ti,ab.
2. copd.ti,ab.
3. chronic obstructive lung disease.ti,ab.
4. chronic obstructive airway disease.ti,ab.
5. chronic respiratory disorder$.ti,ab.
6. smoking-related lung disease$.ti,ab.
7. emphysema.ti,ab.
8. bronchitis.ti,ab.
9. or/1-8
10. (self adj2 (support$ or care or caring or manage$)).ti,ab.
11. post discharge.ti,ab.
12. early discharge.ti,ab.
13. home care.ti,ab.
14. home nursing.ti,ab.
15. patient centred care.ti,ab.
16. patient centered care.ti,ab.
17. patient education.mp.
18. patient participation.ti,ab.
19. post hospital care.ti,ab.
20. action planning.ti,ab.
21. discharge planning.ti,ab.
22. (continuity adj2 care).ti,ab.
23. (support$ adj2 (discharge or manage$)).ti,ab.
24. patient focus$.ti,ab.
25. management plan$.ti,ab.
26. management program$.ti,ab.
27. rehabilitation.ti,ab.
28. or/10-27
29. 9 and 28
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EMBASE (via Ovid)
URL: https://ovidsp.ovid.com
Date range searched: 1980 to 2012 Week 17.
Date of search: 2 May 2012.
Search strategy
1. chronic obstructive pulmonary disease.mp. or exp chronic obstructive lung disease/
2. copd.ti,ab.
3. chronic obstructive lung disease.ti,ab.
4. chronic obstructive airway disease.ti,ab.
5. chronic respiratory disorder$.ti,ab.
6. smoking-related lung disease$.ti,ab.
7. pulmonary emphysema.mp. or exp lung emphysema/
8. emphysema.ti,ab.
9. bronchitis.mp. or exp bronchitis/
10. or/1-9
11. self care.mp. or exp self care/
12. (self adj2 (support$ or care or caring or manage$)).ti,ab.
13. post discharge.ti,ab.
14. early discharge.ti,ab.
15. exp home care/
16. home nursing.ti,ab.
17. patient centred care.ti,ab.
18. patient centered care.ti,ab.
19. patient education/
20. patient education.ti,ab.
21. patient participation.ti,ab.
22. post hospital care.ti,ab.
23. action planning.ti,ab.
24. discharge planning.ti,ab.
25. continuity of patient care.ti,ab.
26. (support$ adj2 discharge).ti,ab.
27. (support$ adj2 manage$).ti,ab.
28. patient focus$.ti,ab.
29. management plan$.ti,ab.
30. management program$.ti,ab.
31. rehabilitation.mp. or exp rehabilitation/
32. or/11-31
33. 10 and 32
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PsycINFO (via Ovid)
URL: https://ovidsp.ovid.com
Date ranged searched: 1806 to May week 1 2012.
Date of search: 2 May 2012.
Search strategy
1. chronic obstructive pulmonary disease.mp. or exp Chronic Obstructive Pulmonary Disease/
2. copd.ti,ab.
3. chronic obstructive lung disease.ti,ab.
4. chronic obstructive airway disease.ti,ab.
5. chronic respiratory disorder$.ti,ab.
6. smoking-related lung disease$.ti,ab.
7. exp Pulmonary Emphysema/ or emphysema.ti,ab.
8. bronchitis.ti,ab.
9. or/1-8
10. (self adj2 (support$ or care or caring or manage$)).ti,ab.
11. post discharge.ti,b.
12. early discharge.ti,ab.
13. home care.mp. or exp Home Care/
14. patient centred care.ti,ab.
15. patient centered care.ti,ab.
16. client education/
17. patient education.ti,ab.
18. patient participation.ti,ab.
19. post hospital care.ti,ab.
20. action planning.ti,ab.
21. discharge planning.ti,ab.
22. ‘continuum of care’/
23. continuity of patient care.ti,ab.
24. (support$ adj2 discharge).ti,ab.
25. (support$ adj manage$).ti,ab.
26. patient focus$.ti,ab.
27. management plan$.ti,ab.
28. management program$.ti,ab.
29. exp Rehabilitation/ or rehabilitation.mp.
30. or/10-29
31. 9 and 30
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The Cochrane Library (Wiley) 2012; Cochrane Central Register of
Controlled Trials (CENTRAL); Cochrane Database of Systematic
Reviews (CDSR) Issue 4 of 12; Database of Abstracts of Reviews
of Effects (DARE); NHS EED issue 4 of 12
URL: www.cochranelibrary.com
Date range searched: inception to 8 May 2012.
Date of search: 8 May 2012.
Search strategy
#1 copd
#2 chronic next obstructive next pulmonary disease
#3 MeSH descriptor Pulmonary Disease, Chronic Obstructive explode all trees
#4 chronic next obstructive next airway next disease
#5 chronic next respiratory next disorder*
#6 smoking next related next lung next disease*
#7 emphysema
#8 MeSH descriptor Pulmonary Emphysema explode all trees
#9 MeSH descriptor Bronchitis explode all trees
#10 bronchitis
#11 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10)
#12 self next care
#13 MeSH descriptor Self Care explode all trees
#14 self near/2 ( support* or care or caring or manage*)
#15 post next discharge
#16 early next discharge
#17 MeSH descriptor Home Care Services explode all trees
#18 home next nursing
#19 patient next centred next care
#20 patient next centered next care
#21 MeSH descriptor Patient Education as Topic explode all trees
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#22 patient next education
#23 patient next participation
#24 post next hospital next care
#25 action next planning
#26 discharge next planning
#27 continuity near/1 patient
#28 support* near/2 discharge
#29 support* near/2 manage*
#30 patient next focus*
#31 management next plan*
#32 management next program*
#33 rehabilitation
#34 MeSH descriptor Rehabilitation explode all trees
#35 (#12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR
#24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34)
#36 (#11 AND #35)
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Physiotherapy Evidence Database (PEDro)
URL: www.pedro.org.au
Date range searched: 1929 to 8 May 2012.
Date of search: 8 May 2012.
Search strategy
Terms used: self-management and copd or chronic obstructive pulmonary disease.
Science Citation Index (SCI) (Web of Science)
URL: http://thompsonreuters.com/en/products-services/scholarly-scientific-research/scholarly-search-and-
discovery/web-of-science.html
Date range searched: 1964 to 8 May 2012.
Date of search: 8 May 2012.
Search strategy
Topic= (copd or (chronic obstructive pulmonary disease) or bronchitis or emphysema or (smoking related
lung disease) or (chronic obstructive lung disease) or (chronic obstructive airway disease)) AND Topic=
((self management) or (self support*) or (self care) or (home care) or (home nursing) or (patient cent*) or
(patient education) or (patient participation) or (post hospital) or (action planning) or (discharge planning)
or continuity or (support* discharge) or (support* manage*) or (patient focus*) or (management plan*) or
(management program*) or (rehabilitation))
Refined by: Web of Science Categories= ( RESPIRATORY SYSTEM )
Timespan=All Years. Databases= SCI-EXPANDED.
Zetoc (Mimas)
URL: http://zetoc.mimas.ac.uk
Date range searched: 1993 to 8 May 2012.
Date of search: 8 May 2012.
Search strategy
Terms used: COPD and rehabilitation; Patient education; COPD and self-management; Pulmonary and
self-management.
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Conference Proceedings Citation Index (CPCI) (Web of Science)
URL: http://thompsonreuters.com/en/products-services/scholarly-scientific-research/scholarly-search-and-
discovery/conference-proceedings-citation-index.html
Date range searched: 1990 to 8 May 2012.
Date of search: 8 May 2012.
Search strategy
Topic= (copd or (chronic obstructive pulmonary disease) or bronchitis or emphysema or (smoking related
lung disease) or (chronic obstructive lung disease) or (chronic obstructive airway disease)) AND Topic=
((self management) or (self support*) or (self care) or (home care) or (home nursing) or (patient cent*) or
(patient education) or (patient participation) or (post hospital) or (action planning) or (discharge planning)
or continuity or (support* discharge) or (support* manage*) or (patient focus*) or (management plan*) or
(management program*) or (rehabilitation))
Timespan=All Years. Databases=CPCI-S.
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Appendix 2 List of excluded papers, with reasons
for exclusion: reviews 1 and 4
Excluded article
Reasons for exclusion
Review 1 Review 4
Abad-Corp, Carrillo-Alcaraz A, Royo-Morales T, Perez-Garcia MC,
Rodriguez-Mondejar JJ, Saez-Soto A, et al. Effectiveness of planning hospital
discharge and follow-up in primary care for patients with chronic obstructive
pulmonary disease: research protocol. J Adv Nurs 2010;66:1365–70
Intervention Intervention
Adams SG, Melo J, Luther M, Anzueto A. Antibiotics are associated with lower
relapse rates in outpatients with acute exacerbations of COPD. Chest
2000;117:1345–52
Intervention Intervention
Ahmed S, Bourbeau J, Maltais F, Mansour A. The Oort structural equation
modeling approach detected a response shift after a COPD self-management
program not detected by the Schmitt technique. J Clin Epidemiol
2009;62:1165–72
Time point Study design
Aiken LS, Butner J, Lockhart CA, Volk-Craft BE, Hamilton G, Williams FG.
Outcome evaluation of a randomized trial of the PhoenixCare intervention:
program of case management and coordinated care for the seriously chronically
ill. J Palliat Med 2006;9:111–26
Population Population
Aimonino RN, Tibaldi V, Leff B, Scarafiotti C, Marinello R, Zanocchi M, et al.
Substitutive ‘hospital at home’ versus inpatient care for elderly patients
with exacerbations of chronic obstructive pulmonary disease: a prospective
randomized, controlled trial. J Am Geriatr Soc 2008;56:493–500
Time point –
Akinci AC, Olgun N. The effectiveness of nurse-led, home-based pulmonary
rehabilitation in patients with COPD in Turkey. Rehabil Nurs J 2011;36:159–65
Time point Study design
Al-Showair RA, Tarsin WY, Assi KH, Pearson SB, Chrystyn H. Can all patients
with COPD use the correct inhalation flow with all inhalers and does training
help? Respir Med 2007;101:2395–401
Time point Outcome
Alexander JL, Phillips WT, Wagner CL. The effect of strength training on
functional fitness in older patients with chronic lung disease enrolled in
pulmonary rehabilitation. Rehabil Nurs J 2008;33:91–7
Time point –
Ambrosino N, Paggiaro PL, Macchi M, Filieri M, Toma G, Lombardi FA, et al.
A study of short-term effect of rehabilitative therapy in chronic obstructive
pulmonary disease. Respiration 1981;41:40–4
Time point –
Antonana J, Sobradillo V, De MD, Chic S, Galdiz J, Iriberri M. [Early discharge
and home health care program for patients with exacerbated COPD and
asthma.] Arch Bronconeumol 2001;37:489–94
Population Population
Antoniu SA. Self-management programs in chronic obstructive pulmonary
disease: are they worthy? Exp Rev Pharmacoecon Outcome Res 2003;3:681–3
Publication type Publication type
Antoniu SA. Self-management programs in chronic obstructive pulmonary
disease: do they have a sustained effect on health resource utilization? Exp Rev
Pharmacoecon Outcome Res 2006;6:155–7
Publication type Publication type
Arbane G, Douiri A, Enright L, Haggis L, Poulter T, Garrod R. Effects of physical
activity top up ‘pat on the back’ programme on exercise capacity and
healthcare utilisation for people with chronic obstructive pulmonary disease
(COPD). British Thoracic Society Winter Meeting, 1–3 December 2010, London.
Thorax 2010; conference publication:A96
Time point Publication type
Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, Krass I, et al.
Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the
community. Thorax 2007;62:496–502
Population Population
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Excluded article
Reasons for exclusion
Review 1 Review 4
Arnardottir RH, Sorensen S, Ringqvist I, Larsson K. Two different training
programmes for patients with COPD: a randomised study with 1-year follow-up.
Respir Med 2006;100:130–9
Time point –
Arnardottir RH, Boman G, Larsson K, Hedenstrom H, Emtner M. Interval training
compared with continuous training in patients with COPD. Respir Med
2007;101:1196–204
Time point –
Ashida C, Fukata Y, Shiota M, Hayashi Y, Yoshida Y. [Acute exacerbation of
chronic obstructive lung diseases and self management: observation of the early
symptoms and their management.] Kango Gijutsu 1988;34:1777–81
Study design Study design
Ashikaga T, Vacek PM, Lewis SO. Evaluation of a community-based education
program for individuals with chronic obstructive pulmonary disease. J Rehabil
1980;46:23–7
Population Population
Ashikaga T, Vacek PM, Lewis SO, Seckerwalker R. Impact of a COPD patient
self-management program. Am Rev Respir Dis 1983;127:152
Time point Study design
Atkins CJ, Kaplan RM, Timms RM, Reinsch S, Lofback K. Behavioral exercise
programs in the management of chronic obstructive pulmonary disease.
J Consult Clin Psychol 1984;52:591–603
Population Population
Baarends EM, Schols AM, Slebos DJ, Mostert R, Janssen PP, Wouters EF.
Metabolic and ventilatory response pattern to arm elevation in patients with
COPD and healthy age-matched subjects. Eur Respir J 1995;8:1345–51
Population Population
Bagnall P, Heslop A. Chronic respiratory disease: educating patients at home.
Prof Nurse 1987;2:293–6
Outcome Outcome
Baker S, Davenport P, Sapienza C. Examination of strength training and
detraining effects in expiratory muscles. J Speech Lang Hear Res
2005;48:1325–3
Population Population
Baltzan MA, Kamel H, Alter A, Rotaple M, Wolkove N. Pulmonary rehabilitation
improves functional capacity in patients 80 years of age or older. Can Respir J
2004;11:407–13
Intervention Study design
Barakat S, Michele G, George P, Nicole V, Guy A. Outpatient pulmonary
rehabilitation in patients with chronic obstructive pulmonary disease. Int J Chron
Obstruct Pulmon Dis 2008;3:155–62
Time point –
Barbanel D, Eldridge S, Griffiths C. Can a self-management programme
delivered by a community pharmacist improve asthma control? A randomised
trial. Thorax 2003;58:851–4
Population Population
Barber CM, Bradshaw LM, Buttery P, Fishwick D, Whyte MK, Higenbottam TW.
Assisted discharge for patients with exacerbations of COPD. Thorax
2001;56:417–18
Publication type Publication type
Barnestein-Fonseca P, Leiva-Fernandez J, Vidal-Espana F, Garcia-Ruiz A,
Prados-Torres D, Leiva-Fernandez F. Efficacy and safety of a multifactor
intervention to improve therapeutic adherence in patients with chronic
obstructive pulmonary disease (COPD): protocol for the ICEPOC study.
Trials 2011;12:40
Publication type Publication type
Baron K. COPD intervention investigation: Comparing the effect of an
outpatient counseling session after discharge to an educational counseling
session on admission day 2 on hospitalization rates in patients with COPD.
50th Annual Assembly of the New York State Council of Health-System
Pharmacists, NYSCHP 2011 Verona, NY, USA, 29 April to 1 May 2011.
J Pharm Pract 2011:354
Publication type Publication type
Bass H, Whitcomb JF, Forman R. Exercise training: therapy for patients with
chronic obstructive pulmonary disease. Chest 1970;57:116–21
Time point Study design
Battaglia E, Fulgenzi A, Ferrero ME. Rationale of the combined use of
inspiratory and expiratory devices in improving maximal inspiratory pressure and
maximal expiratory pressure of patients with chronic obstructive pulmonary
disease. Arch Phys Med Rehabil 2009;90:913–18
Time point Outcome
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Excluded article
Reasons for exclusion
Review 1 Review 4
Battersby MW, Harris M, Reed RL, Harvey PW, Woodman RJ, Frith P.
A randomised trial of the Flinders Program to improve patient self-management
competencies in a range of chronic conditions: study rationale and protocol.
Australasian Med J 2010;1:198–204
Publication type Publication type
Bauldoff GS, Hoffman LA, Sciurba F, Zullo TG. Home-based, upper-arm exercise
training for patients with chronic obstructive pulmonary disease. Heart Lung
1996;25:288–94
Time point –
Bauldoff GS, Hoffman LA, Zullo TG, Sciurba FC. Exercise maintenance following
pulmonary rehabilitation: effect of distractive stimuli. Chest 2002;122:948–54
Time point –
Bauldoff GS, Rittinger M, Nelson T, Doehrel J, Diaz PT. Feasibility of distractive
auditory stimuli on upper extremity training in persons with chronic obstructive
pulmonary disease. J Cardiopulm Rehabil 2005;25:50–5
Time point –
Bausewein C, Booth S, Gysels M, Kuhnbach R, Higginson IJ. Effectiveness of a
hand-held fan for breathlessness: a randomised phase II trial. BMC Palliat Care
2010;9:22
Population Population
Beaulieu-Genest L, Chretien D, Maltais F, Pelletier K, Parent JG, Lacasse Y.
Self-administered prescriptions of oral steroids and antibiotics in chronic
obstructive pulmonary disease: are we doing more harm than good?
Chron Respir Dis 2007;4:143–7
Time point Study design
Beckerman M, Magadle R, Weiner M, Weiner P. The effects of 1 year of specific
inspiratory muscle training in patients with COPD. Chest 2005;128:3177–82
Time point –
Bellone A, Lascioli R, Raschi S, Guzzi L, Adone R. Chest physical therapy in
patients with acute exacerbation of chronic bronchitis: Effectiveness of
three methods. Arch Phys Med Rehabil 2000;81:558–60
Intervention Intervention
Bellone A, Spagnolatti L, Massobrio M, Bellei E, Vinciguerra R, Barbieri A, et al.
Short-term effects of expiration under positive pressure in patients with acute
exacerbation of chronic obstructive pulmonary disease and mild acidosis
requiring non-invasive positive pressure ventilation. Intensive Care Med
2002;28:581–85
Intervention Intervention
Belman MJ, Kendregan BA. Physical training fails to improve ventilatory muscle
endurance in patients with chronic obstructive pulmonary disease. Chest
1982;81:440–3
Time point Study design
Belman MJ, Shadmehr R. Targeted resistive ventilatory muscle training in
chronic obstructive pulmonary disease. J Appl Physiol 1988;65:2726–35
Time point –
Bendstrup KE, Ingemann JJ, Holm S, Bengtsson B. Out-patient rehabilitation
improves activities of daily living, quality of life and exercise tolerance in chronic
obstructive pulmonary disease. Eur Respir J 1997;10:2801–6
Time point –
Bernard S, Whittom F, LeBlanc P, Jobin J, Belleau R, Berube C, et al. Aerobic
and strength training in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med 1999;159:896–901
Time point –
Berry MJ, Adair NE, Sevensky KS, Quinby A, Lever HM. Inspiratory muscle
training and whole-body reconditioning in chronic obstructive pulmonary
disease. Am J Respir Crit Care Med 1996;153:1812–16
Time point –
Berry MJ, Rejeski WJ, Adair NE, Ettinger J, Zaccaro DJ, Sevick MA.
A randomized, controlled trial comparing long-term and short-term exercise in
patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil
2003;23:60–8
Time point –
Berry MJ, Rejeski WJ, Miller ME, Adair NE, Lang W, Foy CG, et al. A lifestyle
activity intervention in patients with chronic obstructive pulmonary disease.
Respir Med 2010;104:829–39
Time point –
Bestall JC, Paul EA, Garrod R, Garnham R, Jones RW, Wedzicha AJ. Longitudinal
trends in exercise capacity and health status after pulmonary rehabilitation in
patients with COPD. Respir Med 2003;97:173–80
Time point –
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Excluded article
Reasons for exclusion
Review 1 Review 4
[Better quality of life by early diagnosis and patient education in COPD.] MMW
Fortschr Med 2003;145:4–8
Publication type Publication type
Bianchi R, Gigliotti F, Romagnoli I, Lanini B, Castellani C, Grazzini M, et al.
Chest wall kinematics and breathlessness during pursed-lip breathing in patients
with COPD. Chest 2004;125:459–65
Time point Study design
Bird S, Noronha M, Sinnott H. An integrated care facilitation model improves
quality of life and reduces use of hospital resources by patients with chronic
obstructive pulmonary disease and chronic heart failure. Aust J Prim Health
2010;16:326–33
Population Population
Bissonnette J, Logan J, Davies B, Graham ID. Methodological issues encountered
in a study of hospitalized COPD patients. Clin Nurs Res 2005;14:81–97
Study design Study design
Bjerre-Jepsen K, Secher NH, Kok-Jensen A. Inspiratory resistance training in
severe chronic obstructive pulmonary disease. Eur J Respir Dis 1981;62:405–11
Time point –
Bjornshave B, Korsgaard J. Comparison of two different levels of physical
training in patients with moderate to severe COPD. Lung 2005;183:101–8
Time point –
Blake RL, Jr, Vandiver TA, Braun S, Bertuso DD, Straub V. A randomized
controlled evaluation of a psychosocial intervention in adults with chronic lung
disease. Fam Med 1990;22:365–70
Time point –
Blumenthal JA, Keefe FJ, Babyak MA, Fenwick VC, Johnson JM, Stott K, et al.
Caregiver-assisted coping skills training for patients with COPD: background,
design, and methodological issues for the INSPIRE-II study. Clin Trials
2009;6:172–84
Publication type Publication type
Bonilha AG, Onofre F, Vieira ML, Prado MY, Martinez JA. Effects of singing
classes on pulmonary function and quality of life of COPD patients. Int J Chron
Obstruct Pulmon Dis 2009;4:1–8
Time point –
Borghi-Silva A, Arena R, Castello V, Simoes RP, Martins LE, Catai AM, et al.
Aerobic exercise training improves autonomic nervous control in patients with
COPD. Respir Med 2009;103:1503–10
Time point –
Borycki E, Kushniruk A. Development of a virtual self-management tool for
COPD patients: towards a user needs ontology. AMIA Annu Symp Proc
2007;879
Time point Study design
Bosch D, Feierabend M, Becker A. [COPD outpatient education programme
(ATEM) and BODE index.] Pneumologie 2007;61:629–35
Time point –
Bosma H, Lamers F, Jonkers CC, van Eijk JT. Disparities by education level in
outcomes of a self-management intervention: the DELTA trial in The Netherlands.
Psychiatr Serv 2011;62:793–95
Population Population
Bosnic-Anticevich SZ, Sinha H, So S, Reddel HK. Metered-dose inhaler
technique: the effect of two educational interventions delivered in community
pharmacy over time. J Asthma 2010;47:251–6
Population Population
Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupre A, Begin R, et al.
Reduction of hospital utilization in patients with chronic obstructive pulmonary
disease: a disease-specific self-management intervention. Arch Intern Med
2003;163:585–91
Time point –
Bourbeau J, Nault D, Ng-Tan T. Self-management and behaviour modification in
COPD. Patient Educ Couns 2004;52:271–7
Publication type Publication type
Bourbeau J, Collet JP, Schwartzman K, Ducruet T, Nault D, Bradley C. Economic
benefits of self-management education in COPD. Chest 2006;130:1704–11
Time point –
Bourbeau J. Disease management for COPD: avoiding hospitalizations and
controlling cost? COPD 2011;8:143–4
Publication type Publication type
Bourbeau J. Inhaled corticosteroids and survival in chronic obstructive
pulmonary disease. Eur Respir J 2003;21:202–3
Publication type Publication type
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Excluded article
Reasons for exclusion
Review 1 Review 4
Bourjeily-Habr G, Rochester CL, Palermo F, Snyder P, Mohsenin V. Randomised
controlled trial of transcutaneous electrical muscle stimulation of the lower
extremities in patients with chronic obstructive pulmonary disease. Thorax
2002;57:1045–9
Intervention Intervention
Bower P, Kennedy A, Reeves D, Rogers A, Blakeman T, Chew-Graham C, et al.
A cluster randomised controlled trial of the clinical and cost-effectiveness of a
‘whole systems’ model of self-management support for the management of
long-term conditions in primary care: trial protocol. Implement Sci 2012;7:7
Population Population
Bowles KH, Baugh AC. Applying research evidence to optimize telehomecare.
J Cardiovasc Nurs 2007;22:5–15
Publication type Publication type
Boxall AM, Barclay L, Sayers A, Caplan GA. Managing chronic obstructive
pulmonary disease in the community. A randomized controlled trial of
home-based pulmonary rehabilitation for elderly housebound patients.
J Cardiopulm Rehabil 2005;25:378–85
Time point –
Bredin M, Corner J, Krishnasamy M, Plant H, Bailey C, A’Hern R. Multicentre
randomised controlled trial of nursing intervention for breathlessness in patients
with lung cancer. BMJ 1999;318:901–4
Population Population
Breslin EH. Breathing retraining in chronic obstructive pulmonary disease.
J Cardiopulm Rehabil 1995;15:25–33
Publication type Publication type
Breyer MK, Breyer-Kohansal R, Funk GC, Dornhofer N, Spruit MA, Wouters EF,
et al. Nordic walking improves daily physical activities in COPD: a randomised
controlled trial. Respir Res 2010;11:112
Time point –
Brooks D, Krip B, Mangovski-Alzamora S, Goldstein RS. The effect of
postrehabilitation programmes among individuals with chronic obstructive
pulmonary disease. Eur Respir J 2002;20:20–9
Time point –
Brooks D, Sidani S, Graydon J, McBride S, Hall L, Weinacht K. Evaluating the
effects of music on dyspnea during exercise in individuals with chronic
obstructive pulmonary disease: a pilot study. Rehabil Nurs J 2003;28:192–6
Time point Study design
Brough FK, Schmidt CD, Rasmussen T, Boyer M. Comparison of two teaching
methods for self-care training for patients with chronic obstructive pulmonary
disease. Patient Couns Health Educ 1982;4:111–16
Time point Outcome
Brown L, Donaghy D, Jones P, Whelan R, McCormack N, Callanan I, et al.
Implementation of a bundle of care reduced median hospital length of stay for
patients with Chronic Obstructive Pulmonary Disease (COPD). Irish Thoracic
Society Annual Scientific Meeting, 11–12 November 2011, Co. Dublin, Ireland.
Ir J Med Sci 2011; conference publication: S456
Time point Study design
Brundage DJ, Swearengen P, Woody JW. Self-care instruction for patients with
COPD. Rehabil Nurs J 1993;18:321–5
Outcome Study design
Busch AJ, McClements JD. Effects of a supervised home exercise program on
patients with severe chronic obstructive pulmonary disease. Phys Ther
1988;68:469–74
Time point –
Cabedo Garcia VR, Garces Asemany CR, Cortes Berti A, Oteo Elso JT,
Ballester Salvador FJ. [Effectiveness of the correct use of inhalation devices in
patients with COPD: randomized clinical trial.] Med Clin (Barc) 2010;135:586–91
Time point –
Cai S, Chen P, Chen Y, Liu ZJ. [Effect of health education on the lung function
and life quality in patients with stable chronic obstructive pulmonary diseases.]
Zhong Nan Da Xue Xue Bao Yi Xue Ban 2006;31:189–93
Time point –
Callaghan S. ACTRITE: Acute Chest Triage Rapid Intervention Team.
Accid Emerg Nurs 1999;7:42–6
Study design Study design
Cambach W, Chadwick-Straver RVM, Wagenaar RC, van Keimpema AR.
Efficacy of a rehabilitation programme in patients with asthma and chronic
obstructive pulmonary disease (COPD). Ned Tijdschr Fysiotherapie 1996;2:26–36
Unavailable Unavailable
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Cambach W, Chadwick-Straver RV, Wagenaar RC, van Keimpema AR, Kemper HC.
The effects of a community-based pulmonary rehabilitation programme on exercise
tolerance and quality of life: a randomized controlled trial. Eur Respir J
1997;10:104–13
Population Population
Cambach W, Chadwick-Straver RVM, Wagenaar RC, van Keimpema AR.
Effectiveness of a rehabilitation programme for patients with asthma and COPD
carried out in the first line health care. Ned Tijdschr Fysiotherapie 1998;108:26–36
Time point Study design
Cambach W. [Rehabilitation of patients with asthma and mild to moderate
chronic obstructive lung disease.] Geneesk Sport 1999;32:27–30
Population Population
Cao Z, Ong KC, Eng P, Tan WC, Ng TP. Frequent hospital readmissions for
acute exacerbation of COPD and their associated factors. Respirology
2006;11:188–95
Study design Study design
Caplan GA, Ward JA, Brennan NJ, Coconis J, Board N, Brown A. Hospital in the
home: a randomised controlled trial. Med J Aust 1999;170:156–60
Intervention Intervention
Cardozo L, Steinberg J. Telemedicine for recently discharged older patients.
Telemed J E Health 2010;16:49–55
Population Population
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Participation in treatment decisions in patients with COPD and recurrent
bronchitis: a qualitative study. Thorax 2004;59:100
Time point Study design
Carone M, Bertolotti G, Cerveri I, De BF, Fogliani V, Nardini S, et al. EDU-CARE,
a randomised, multicentre, parallel group study on education and quality of life
in COPD. Monaldi Arch Chest Dis 2002;57:25–9
Publication type Publication type
Carr SJ, Hill K, Brooks D, Goldstein RS. Pulmonary rehabilitation after acute
exacerbation of chronic obstructive pulmonary disease in patients who
previously completed a pulmonary rehabilitation program. J Cardiopulm Rehabil
Prev 2009;29:318–24
Time point –
Carre PC, Roche N, Neukirch F, Radeau T, Perez T, Terrioux P, et al. The effect
of an information leaflet upon knowledge and awareness of COPD in potential
sufferers. A randomized controlled study. Respiration 2008;76:53–60
Population Population
Carrieri-Kohlman G. Internet-based and established dyspnea self-management
programs in chronic obstructive pulmonary (COPD) patients; 2005.
URL: www.clinicaltrials.gov (accessed 27 January 2015)
Publication type Publication type
Carrieri-Kohlman V, Gormley JM, Douglas MK, Paul SM, Stulbarg MS. Exercise
training decreases dyspnea and the distress and anxiety associated with it.
Monitoring alone may be as effective as coaching. Chest 1996;110:1526–35
Time point –
Carrieri-Kohlman V, Gormley JM, Eiser S, mir-Deviren S, Nguyen H, Paul SM,
et al. Dyspnea and the affective response during exercise training in obstructive
pulmonary disease. Nurs Res 2001;50:136–46
Time point –
Carrieri-Kohlman V, Nguyen HQ, Donesky-Cuenco D, mir-Deviren S, Neuhaus J,
Stulbarg MS. Impact of brief or extended exercise training on the benefit
of a dyspnea self-management program in COPD. J Cardiopulm Rehabil
2005;25:275–84
Time point –
Casaburi R, Bhasin S, Cosentino L, Porszasz J, Somfay A, Lewis MI, et al. Effects
of testosterone and resistance training in men with chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 2004;170:870–8
Time point –
Casciari RJ, Fairshter RD, Harrison A. Effects of breathing retraining in patients
with chronic obstructive pulmonary disease. Chest 1981;79:393–8
Time point Study design
Casey D, Murphy K, Cooney A, Mee L. Developing a structured education
programme for clients with COPD. Br J Community Nurs 2011;16:231–7
Publication type Publication type
Chan AW, Lee A, Suen LK, Tam WW. Effectiveness of a Tai chi Qigong program
in promoting health-related quality of life and perceived social support in
chronic obstructive pulmonary disease clients. Qual Life Res 2010;19:653–64
Time point –
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Chan AW, Lee A, Suen LK, Tam WW. Tai chi Qigong improves lung functions
and activity tolerance in COPD clients: a single blind, randomized controlled
trial. Complement Ther Med 2011;19:3–11
Time point –
Chang AT, Haines T, Jackson C, Yang I, Nitz J, Low CN, et al. Rationale and
design of the PRSM study: pulmonary rehabilitation or self management for
chronic obstructive pulmonary disease (COPD), what is the best approach?
Contemp Clin Trials 2008;29:796–800
Publication type Publication type
Chang CL, Sullivan GD, Karalus NC, Hancox RJ, McLachlan JD, Mills GD. Audit
of acute admissions of chronic obstructive pulmonary disease: inpatient
management and outcome. Intern Med J 2007;37:236–41
Study design Study design
Chen H, Dukes R, Martin BJ. Inspiratory muscle training in patients with chronic
obstructive pulmonary disease. Am Rev Respir Dis 1985;131:251–5
Time point –
Chen KH, Chen ML, Lee S, Cho HY, Weng LC. Self-management behaviours
for patients with chronic obstructive pulmonary disease: a qualitative study.
J Adv Nurs 2008;64:595–604
Time point Study design
Christensen EF, Nedergaard T, Dahl R. Long-term treatment of chronic
bronchitis with positive expiratory pressure mask and chest physiotherapy.
Chest 1990;97:645–50
Intervention Intervention
Chuang C, Levine SH, Rich J. Enhancing cost-effective care with a patient-centric
coronary obstructive pulmonary disease program. Popul Health Manag
2011;14:133–6
Time point Study design
Clark CJ, Cochrane L, Mackay E. Low intensity peripheral muscle conditioning
improves exercise tolerance and breathlessness in COPD. Eur Respir J
1996;9:2590–6
Time point –
Clark CJ, Cochrane LM, Mackay E, Paton B. Skeletal muscle strength and
endurance in patients with mild COPD and the effects of weight training.
Eur Respir J 2000;15:92–7
Time point –
Cockcroft AE, Saunders MJ, Berry G. Randomised controlled trial of
rehabilitation in chronic respiratory disability. Thorax 1981;36:200–3
Population Population
Cockcroft A, Berry G, Brown EB, Exall C. Psychological changes during a
controlled trial of rehabilitation in chronic respiratory disability. Thorax
1982;37:413–16
Population Population
Cockcroft A, Bagnall P, Heslop A, Andersson N, Heaton R, Batstone J, et al.
Controlled trial of respiratory health worker visiting patients with chronic
respiratory disability. Br Med J (Clin Res Ed) 1987;294:225–8
Time point –
Coffin SE. Bronchiolitis: in-patient focus. Pediatr Clin North Am 2005;52:1047–57 Publication type Publication type
Collins EG, Langbein WE, Fehr L, O’Connell S, Jelinek C, Hagarty E, et al. Can
ventilation-feedback training augment exercise tolerance in patients with
chronic obstructive pulmonary disease? Am J Respir Crit Care Med
2008;177:844–52
Intervention Intervention
Connolly MJ, Lowe D, Anstey K, Hosker HS, Pearson MG, Roberts CM, et al.
Admissions to hospital with exacerbations of chronic obstructive pulmonary
disease: Effect of age related factors and service organisation. Thorax
2006;61:843–8
Study design Study design
Cooper CB. Desensitization to dyspnea in COPD with specificity for exercise
training mode. Int J Chron Obstruct Pulmon Dis 2009;4:33–43
Time point –
Coppoolse R, Schols AMWJ, Baarends EM, Mostert R, Akkermans MA,
Janssen PP, et al. Interval versus continuous training in patients with severe
COPD: a randomized clinical trial. Eur Respir J 1999;14:258–63
Time point –
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reduces dyspnea perception in patients with COPD. Monaldi Archr Chest Dis
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Time point Study design
Costes F, Roche F, Pichot V, Vergnon JM, Garet M, Barthelemy JC. Influence of
exercise training on cardiac baroreflex sensitivity in patients with COPD.
Eur Respir J 2004;23:396–401
Time point Study design
Costi S, Brooks D, Goldstein RS. Perspectives that influence action plans for
chronic obstructive pulmonary disease. Can Respir J 2006;13:362–8
Time point Study design
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unsupported upper extremity exercise training in patients with COPD:
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Time point –
Costi S, Di BM, Pillastrini P, D’Amico R, Crisafulli E, Arletti C, et al. Short-term
efficacy of upper-extremity exercise training in patients with chronic airway
obstruction: a systematic review. Phys Ther 2009;89:443–55
Publication type Publication type
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et al. Early discharge for patients with exacerbations of chronic obstructive
pulmonary disease: a randomized controlled trial. Thorax 2000;55:902–6
Intervention Intervention
Coultas D, Frederick J, Barnett B, Singh G, Wludyka P. A randomized trial of
two types of nurse-assisted home care for patients with COPD. Chest
2005;128:2017–24
Time point –
Couser J, Martinez FJ, Celli BR. Pulmonary rehabilitation that includes arm
exercise reduces metabolic and ventilatory requirements for simple arm
elevation. Chest 1993;103:37–41
Time point Study design
Coventry PA, Hind D. Comprehensive pulmonary rehabilitation for anxiety and
depression in adults with chronic obstructive pulmonary disease: systematic
review and meta-analysis. J Psychosom Res 2007;63:551–65
Publication type Publication type
Covey MK, Larson JL. Exercise and COPD. Am J Nurs 2004;104:40–3 Study design Study design
Covey MK, Larson JL, Wirtz SE, Berry JK, Pogue NJ, Alex CG, et al.
High-intensity inspiratory muscle training in patients with chronic obstructive
pulmonary disease and severely reduced function. J Cardiopulm Rehabil
2001;21:231–40
Time point –
Cox NJ, Hendricks JC, Binkhorst RA, van Herwaarden CL. A pulmonary
rehabilitation program for patients with asthma and mild chronic obstructive
pulmonary diseases (COPD). Lung 1993;171:235–44
Population Population
Creutzberg EC, Wouters EF, Mostert R, Weling-Scheepers CA, Schols AM.
Efficacy of nutritional supplementation therapy in depleted patients with
chronic obstructive pulmonary disease. Nutrition 2003;19:120–7
Time point Study design
Crisafulli E, Costi S, de BF, Biscione G, Americi F, Penza S, et al. Effects
of a walking aid in COPD patients receiving oxygen therapy. Chest
2007;131:1068–74
Intervention Intervention
Cummings E, Turner P. Patient self-management and chronic illness: evaluating
outcomes and impacts of information technology. Stud Health Technol Inform
2009;143:229–34
Study design Study design
Cummings JE, Hughes SL, Weaver FM, Manheim LM, Conrad KJ, Nash K, et al.
Cost-effectiveness of Veterans Administration hospital-based home care.
A randomized clinical trial. Arch Intern Med 1990;150:1274–80
Population Population
Cummings E, Robinson A, Pratt HC, Cameron-Tucker H, Wood-Baker R,
Walters EH, et al. Pathways Home: comparing voluntary IT and non-IT users
participating in a mentored self-management project. Stud Health Technol
Inform 2010;160:23–7
Study design Study design
Currie GP, Miller D. Action plans for patients with chronic obstructive
pulmonary disease. BMJ 2012;344:e1164
Publication type Publication type
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Cuvelier A. [Education for the early recognition of exacerbations at home.
Importance of a personalized action plan.] Rev Mal Respir
2006;23:15S39–15S43
Publication type Publication type
Cydulka RK, Rowe BH, Clark S, Emerman CL, Camargo CA Jr. Emergency
department management of acute exacerbations of chronic obstructive
pulmonary disease in the elderly: the Multicenter Airway Research
Collaboration. J Am Geriatr Soc 2003;51:908–16
Study design Study design
Datta D, Zuwallack R. High versus low intensity exercise training in pulmonary
rehabilitation: is more better? Chron Respir Dis 2004;1:143–9
Publication type Publication type
Davies L, Angus RM, Calverley PM. Oral corticosteroids in patients admitted to
hospital with exacerbations of chronic obstructive pulmonary disease:
a prospective randomised controlled trial. Lancet 1999;354:456–60
Intervention Intervention
Davies L, Wilkinson M, Bonner S, Calverley PM, Angus RM. ‘Hospital at home’
versus hospital care in patients with exacerbations of chronic obstructive
pulmonary disease: prospective randomised controlled trial. BMJ 2000;321:1265–8
Intervention Intervention
Davis AH. Exercise adherence in patients with chronic obstructive pulmonary
disease: an exploration of motivation and goals. Rehabil Nurs J 2007;32:104–10
Time point Study design
Davis AH, Carrieri-Kohlman V, Janson SL, Gold WM, Stulbarg MS. Effects of
treatment on two types of self-efficacy in people with chronic obstructive
pulmonary disease. J Pain Symptom Manage 2006;32:60–70
Time point –
De Blaquiere P, Christensen DB, Carter WB, Martin TR. Use and misuse of
metered-dose inhalers by patients with chronic lung disease: a controlled,
randomized trial of two instruction methods. Am Rev Respir Dis 1989;140:910–16
Population Population
de Blasio F. A Doubting Thomas dealing with pulmonary rehabilitation. Chest
2000;117:929–31
Publication type Publication type
De Blok BM, de Greef MH, Ten Hacken NH, Sprenger SR, Postema K,
Wempe JB. The effects of a lifestyle physical activity counseling program with
feedback of a pedometer during pulmonary rehabilitation in patients with
COPD: a pilot study. Patient Educ Couns 2006;61:48–55
Time point –
De Godoy DV, de Godoy RF. A randomized controlled trial of the effect of
psychotherapy on anxiety and depression in chronic obstructive pulmonary
disease. Arch Phys Med Rehabil 2003;84:1154–7
Time point –
De Lucas RP, Rodríguez González-Moro JM, de García PJ, Santacruz SA,
Tatay ME, Cubillo Marcos JM. [Training of inspiratory muscles in chronic
obstructive lung disease. Its impact on functional changes and exercise
tolerance.] Arch Bronconeumol 1998;34:64–70
Time point Study design
De Toledo P, Jimenez S, del PF, Roca J, Alonso A, Hernandez C. Telemedicine
experience for chronic care in COPD. IEEE Trans Inf Technol Biomed
2006;10:567–73
Study design Study design
De Tullio PL, Corson ME. Effect of pharmacist counseling on ambulatory
patients’ use of aerosolized bronchodilators. Am J Hosp Pharm 1987;44:1802–6
Time point Study design
DeBisschop M, Robitaille B. Can a patient information sheet reduce antibiotic
use in adult outpatients with acute bronchitis? J Fam Pract 2002;51:381
Population Population
Dechman G, Wilson CR. Evidence underlying breathing retraining in people
with stable chronic obstructive pulmonary disease. Phys Ther 2004;84:1189–97
Publication type Publication type
Dekhuijzen PN, Folgering HT, van Herwaarden CL. Target-flow inspiratory
muscle training during pulmonary rehabilitation in patients with COPD. Chest
1991;99:128–33
Time point –
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Derom E, Marchand E, Troosters T. [Rehabilitation of patients with chronic
obstructive lung disease.] Ann Readapt Med Phys 2007;50:602–14
Study design Study design
Devine EC, Pearcy J. Meta-analysis of the effects of psychoeducational care in
adults with chronic obstructive pulmonary disease. Patient Educ Couns
1996;29:167–78
Publication type Publication type
Dewan NA, Rafique S, Kanwar B, Satpathy H, Ryschon K, Tillotson GS, et al.
Acute exacerbation of COPD: factors associated with poor treatment outcome.
Chest 2000;117:662–71
Time point Study design
Dewan NA, Rice KL, Caldwell M, Hilleman DE. Economic evaluation of a disease
management program for chronic obstructive pulmonary disease. COPD
2011;8:153–9
Time point Publication type
Dhein Y, Munks-Lederer C, Worth H. [Evaluation of a structured education
programme for patients with COPD under outpatient conditions – a pilot study.]
Pneumologie 2003;57:591–7
Time point Study design
Dickenson J. An exploratory study of patient interventions and nutritional advice
for patients with chronic obstructive pulmonary disease, living in the community.
Int J Disabil Hum Dev 2009;8:43–9
Time point Study design
Disler RT, Gallagher RD, Davidson PM. Factors influencing self-management in
chronic obstructive pulmonary disease: an integrative review. Int J Nurs Stud
2012;49:230–42
Publication type Publication type
Dolmage TE, Maestro L, Avendano MA, Goldstein RS. The ventilatory response
to arm elevation of patients with chronic obstructive pulmonary disease.
Chest 1993;104:1097–100
Time point Study design
Donald KJ, McBurney H, Teichtahl H, Irving L. A pilot study of telephone based
asthma management. Aust Fam Physician 2008;37:170–3
Population Population
Donesky-Cuenco D, Janson S, Neuhaus J, Neilands TB, Carrieri-Kohlman V.
Adherence to a home-walking prescription in patients with chronic obstructive
pulmonary disease. Heart Lung 2007;36:348–63
Time point Study design
Donesky-Cuenco D, Nguyen HQ, Paul S, Carrieri-Kohlman V. Yoga therapy
decreases dyspnea-related distress and improves functional performance in
people with chronic obstructive pulmonary disease: a pilot study. J Altern
Complement Med 2009;15:225–34
Time point –
Dourado VZ, Tanni SE, Antunes LC, Paiva SA, Campana AO, Renno AC, et al.
Effect of three exercise programs on patients with chronic obstructive
pulmonary disease. Braz J Med Biol Res 2009;42:263–71
Time point –
Dowson CA, Kuijer RG, Town IG, Mulder RT. Impact of panic disorder upon
self-management educational goals in chronic obstructive pulmonary disease?
Chron Respir Dis 2010;7:83–90
Study design Study design
Dugan D, Walker R, Monroe DA. The effects of a 9-week program of aerobic
and upper body exercise on the maximal voluntary ventilation of chronic
obstructive pulmonary disease patients. J Cardiopulm Rehabil 1995;15:130–3
Time point Study design
du Moulin M, Taube K, Wegscheider K, Behnke M, van den Bussche H.
Home-based exercise training as maintenance after outpatient pulmonary
rehabilitation. Respiration 2009;77:139–45
Time point –
Duschek S, Schandry R, Werner B. [Changes in quality of life in patients with
chronic airway diseases participating in a pilot project on home-telecare.]
Pravention und Rehabilitation 2006;18:57–67
Study design Study design
Duwoos H, Naze D, Labbey JL, Deschamps D, Pingard R, Guyonnaud CD, et al.
Evaluation of a method of pulmonary rehabilitation with physiotherapy and
exercise training in patients with Chronic Obstructive Lung-Disease (Cold).
Clin Respir Physiol Bull 1980;16:266–7
Time point Study design
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Eaton T, Young P, Fergusson W, Moodie L, Zeng I, O’Kane F, et al. Does early
pulmonary rehabilitation reduce acute health-care utilization in COPD patients
admitted with an exacerbation? A randomized controlled study. Respirology
2009;14:230–8
Intervention –
Effing T, Kerstjens H, van der Valk P, Zielhuis G, van der Palen J.
(Cost)-effectiveness of self-treatment of exacerbations on the severity of
exacerbations in patients with COPD: the COPE II study. Thorax 2009;64:956–62
Time point –
Effing T, Zielhuis G, Kerstjens H, van der Valk P, van der Palen J. Community
based physiotherapeutic exercise in COPD self-management: a randomised
controlled trial. Respir Med 2011;105:418–26
Time point –
Effing T. Action plans and case manager support may hasten recovery of
symptoms following an acute exacerbation in patients with chronic obstructive
pulmonary disease (COPD). J Physiother 2012;58:60
Publication type Publication type
Efraimsson EO, Hillervik C, Ehrenberg A. Effects of COPD self-care management
education at a nurse-led primary health care clinic. Scand J Caring Sci
2008;22:178–85
Time point –
Eiser N, West C, Evans S, Jeffers A, Quirk F. Effects of psychotherapy in
moderately severe COPD: a pilot study. Eur Respir J 1997;10:1581–4
Time point Study design
Ekman I, Andersson B, Ehnfors M, Matejka G, Persson B, Fagerberg B. Feasibility
of a nurse-monitored, outpatient-care programme for elderly patients with
moderate-to-severe, chronic heart failure. Eur Heart J 1998;19:1254–60
Population Population
Elci A, Borekci S, Ovayolu N, Elbek O. The efficacy and applicability of a
pulmonary rehabilitation programme for patients with COPD in a
secondary-care community hospital. Respirology 2008;13:703–7
Time point –
Elliott M, Watson C, Wilkinson E, Musk AW, Lake FR. Short- and long-term
hospital and community exercise programmes for patients with chronic
obstructive pulmonary disease. Respirology 2004;9:345–51
Time point –
Elzen H, Slaets JPJ, Snijders TAB, Steverink N. The effect of a self-management
intervention on health care utilization in a sample of chronically ill older patients
in the Netherlands. J Eval Clin Pract 2008;14:159–61
Population Population
Emery CF, Schein RL, Hauck ER, MacIntyre NR. Psychological and cognitive
outcomes of a randomized trial of exercise among patients with chronic
obstructive pulmonary disease. Health Psychol 1998;17:232–40
Time point –
Engstrom CP, Persson LO, Larsson S, Sullivan M. Long-term effects of a
pulmonary rehabilitation programme in outpatients with chronic obstructive
pulmonary disease: a randomized controlled study. Scand J Rehabil Med
1999;31:207–13
Time point –
Epstein SK, Celli BR, Martinez FJ, Couser JI, Roa J, Pollock M, et al. Arm training
reduces the VO2 and VE cost of unsupported arm exercise and elevation in
chronic obstructive pulmonary disease. J Cardiopulm Rehabil 1997;17:171–7
Time point –
Esteve F, Blanc-Gras N, Gallego J, Benchetrit G. The effects of breathing pattern
training on ventilatory function in patients with COPD. Biofeedback Self Regul
1996;21:311–21
Time point –
Falk P, Eriksen AM, Kolliker K, Andersen JB. Relieving dyspnea with an
inexpensive and simple method in patients with severe chronic airflow
limitation. Eur J Respir Dis 1985;66:181–6
Time point –
Fan VS, Giardino ND, Blough DK, Kaplan RM, Ramsey SD, NETT Research
Group. Costs of pulmonary rehabilitation and predictors of adherence in the
National Emphysema Treatment Trial. COPD 2008;5:105–16
Population Population
Farkas J, Kadivec S, Kosnik M, Lainscak M. Effectiveness of
discharge-coordinator intervention in patients with chronic obstructive
pulmonary disease: study protocol of a randomized controlled clinical trial.
Respir Med 2011;105(Suppl. 1):26–30
Publication type Publication type
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Farrero E, Escarrabill J, Prats E, Maderal M, Manresa F. Impact of a hospital-based
home-care program on the management of COPD patients receiving long-term
oxygen therapy. Chest 2001;119:364–9
Intervention Intervention
Fehrenbach C, Neville E, Holmes WF. Using a private sector partnership to
provide supported early discharge for acute exacerbations of COPD in a district
general hospital. Thorax 2002;57
Publication type Publication type
Fernandez AM, Pascual J, Ferrando C, Arnal A, Vergara I, Sevila V. Home-based
pulmonary rehabilitation in very severe COPD: is it safe and useful?
J Cardiopulm Rehabil Prev 2009;29:325–31
Time point –
Fernandez J, Martãn M, Moreno LF. Evaluation of a home-based rehabilitation
program controlled with pulse-meter in COPD. Neumosur 1998;10:54–5
Unavailable Unavailable
Fernandez L, Benedicto J, Siasoco MB, Medina BJ. A randomized controlled trial
on the long-term effects of multiple exposures to pulmonary rehabilitation on
stable COPD patients. Philipp J Chest Dis 2000;7:40–5
Unavailable Unavailable
Finkelstein SM, Speedie SM, Potthoff S. Home telehealth improves clinical
outcomes at lower cost for home healthcare. Telemed J E Health
2006;12:128–36
Population Population
Finnerty JP, Keeping I, Bullough I, Jones J. The effectiveness of outpatient
pulmonary rehabilitation in chronic lung disease: a randomized controlled trial.
Chest 2001;119:1705–10
Time point –
Fitzsimmons DA, Thompson J, Hawley M, Mountain GA. Preventative tele-health
supported services for early stage chronic obstructive pulmonary disease: a protocol
for a pragmatic randomized controlled trial pilot. Trials 2011;12:6
Publication type Publication type
Flanigan UM, Irwin A, Dagg K. An acute respiratory assessment service.
Profes Nurse 1999;14:839–42
Intervention Intervention
Foglio K, Bianchi L, Ambrosino N. Is it really useful to repeat outpatient
pulmonary rehabilitation programs in patients with chronic airway obstruction?
A 2-year controlled study. Chest 2001;119:1696–704
Population Population
Foglio K, Bianchi L, Bruletti G, Battista L, Pagani M, Ambrosino N. Long-term
effectiveness of pulmonary rehabilitation in patients with chronic airway
obstruction. Eur Respir J 1999;13:125–32
Time point Study design
Foy CG, Rejeski WJ, Berry MJ, Zaccaro D, Woodard CM. Gender moderates
the effects of exercise therapy on health-related quality of life among COPD
patients. Chest 2001;119:70–6
Time point –
Francis PB, Jr, Petty TL, Winterbauer RH. Helping the COPD patient help himself.
Patient Care 1984;18:177–80
Publication type Publication type
Franssen FM, Wouters EF, Baarends EM, Akkermans MA, Schols AM. Arm
mechanical efficiency and arm exercise capacity are relatively preserved in
chronic obstructive pulmonary disease. Med Sci Sports Exerc 2002;34:1570–6
Time point Study design
Gadoury MA, Schwartzman K, Rouleau M, Maltais F, Julien M, Beaupre A, et al.
Self-management reduces both short- and long-term hospitalisation in COPD.
Eur Respir J 2005;26:853–7
Time point –
Gallefoss F. The effects of patient education in COPD in a 1-year follow-up
randomised, controlled trial. Patient Educ Couns 2004;52:259–66
Time point –
Gallefoss F, Bakke PS. How does patient education and self-management
among asthmatics and patients with chronic obstructive pulmonary disease
affect medication? Am J Respir Crit Care Med 1999;160:2000–5
Time point –
Gallefoss F, Bakke PS. Impact of patient education and self-management on
morbidity in asthmatics and patients with chronic obstructive pulmonary
disease. Respir Med 2000;94:279–87
Time point –
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Gallefoss F, Bakke PS. Patient satisfaction with healthcare in asthmatics and
patients with COPD before and after patient education. Respir Med
2000;94:1057–64
Time point Outcome
Gallefoss F, Bakke PS. Cost-benefit and cost-effectiveness analysis of
self-management in patients with COPD: a 1-year follow-up randomized,
controlled trial. Respir Med 2002;96:424–31
Time point –
Gallefoss F, Bakke PS, Rsgaard PK. Quality of life assessment after patient
education in a randomized controlled study on asthma and chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 1999;159:812–17
Time point –
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Patients hospitalized for COPD have a high prevalence of modifiable risk factors
for exacerbation (EFRAM study). Eur Respir J 2000;16:1037–42
Intervention Intervention
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et al. Risk factors for hospitalization for a chronic obstructive pulmonary disease
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Study design Study design
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et al. Risk factors of readmission to hospital for a COPD exacerbation:
a prospective study. Thorax 2003;58:100–5
Study design Study design
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controlled trial of hospital out-patient pulmonary rehabilitation in moderate
COPD: early effects. Physiotherapy 1997;83:367
Publication type Publication type
Garrod R, Dallimore K, Cook J, Davies V, Quade K. An evaluation of the acute
impact of pursed lips breathing on walking distance in nonspontaneous pursed
lips breathing chronic obstructive pulmonary disease patients. Chron Respir Dis
2005;2:67–72
Intervention Intervention
Geddes EL, Reid WD, Crowe J, O’Brien K, Brooks D. Inspiratory muscle training
in adults with chronic obstructive pulmonary disease: a systematic review. Respir
Med 2005;99:1440–58
Publication type Publication type
Geddes EL, O’Brien K, Reid WD, Brooks D, Crowe J. Inspiratory muscle training
in adults with chronic obstructive pulmonary disease: an update of a systematic
review. Respir Med 2008;102:1715–29
Publication type Publication type
Ghanem M, Elaal EA, Mehany M, Tolba K. Home-based pulmonary rehabilitation
program: effect on exercise tolerance and quality of life in chronic obstructive
pulmonary disease patients. Ann Thorac Med 2010;5:18–25
Intervention –
Gibbons D. A nurse-led pulmonary rehabilitation programme for patients with
COPD. Profes Nurse 2001;17:185–8
Study design Study design
Gift AG, Moore T, Soeken K. Relaxation to reduce dyspnea and anxiety in
COPD patients. Nurs Res 1992;41:242–6
Time point –
Gilmore TW, Walter RE, Davis TC, Wissing DR. Educational strategies to improve
health-related quality of life in patients with COPD. Respir Care Educ Annu
2010;19:13–31
Time point –
Gimenez M, Servera E, Vergara P, Bach JR, Polu JM. Endurance training in
patients with chronic obstructive pulmonary disease: a comparison of high
versus moderate intensity. Arch Phys Med Rehabil 2000;81:102–9
Time point Study design
Gimeno OF, Smith ANA, Steenhuis EJ. [Follow-up study of effect of pulmonary
rehabilitation in males with COPD.] Ned Tijdschr Geneeskd 1986;130:351–3
Time point Study design
Gohl O, Linz H, Schonleben T, Otte B, Weineck J, Worth H. [Benefits of a
multimodular outpatient training program for patients with COPD.]
Pneumologie 2006;60:529–36
Time point –
Goldstein RS, Gort EH, Stubbing D, Avendano MA, Guyatt GH. Randomised
controlled trial of respiratory rehabilitation. Lancet 1994;344:1394–7
Time point –
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Goldstein RS, Gort EH, Guyatt GH, Feeny D. Economic analysis of respiratory
rehabilitation. Chest 1997;112:370–9
Time point –
Golmohammadi K, Jacobs P, Sin DD. Economic evaluation of a community-based
pulmonary rehabilitation program for chronic obstructive pulmonary disease.
Lung 2004;182:187–96
Time point Study design
Gomez A, Roman M, Larraz C, Esteva M, Mir I, Thomas V, et al. [Efficacy of
respiratory rehabilitation on patients with moderate COPD in primary care and
maintenance of benefits at 2 years.] Aten Prim 2006;38:230–3. [Erratum
published in Aten Prim 2006;38:369.]
Publication type Publication type
Gormley JM, Carrieri-Kohlman V, Douglas MK, Stulbarg MS. Treadmill
self-efficacy and walking performance in patients with COPD. J Cardiopulm
Rehabil 1993;13:424–31
Time point –
Gort EH, Goldstein R, Guyatt G, Stubbing D, Avendano M. Randomized
controlled trial of respiratory rehabilitation. Can J Rehabil 1993;7:13–14
Unavailable Unavailable
Gosselink R, De VJ, van den Heuvel SP, Segers J, Decramer M, Kwakkel G.
Impact of inspiratory muscle training in patients with COPD: what is the
evidence? Eur Respir J 2011;37:416–25
Publication type Publication type
Gottlieb V, Lyngso AM, Nybo B, Frolich A, Backer V. Pulmonary rehabilitation
for moderate COPD (GOLD 2) – does it have an effect? COPD 2011;8:380–6
Time point Study design
Gourley GA, Portner TS, Gourley DR, Rigolosi EL, Holt JM, Solomon DK, et al.
Humanistic outcomes in the hypertension and COPD arms of a multicenter
outcomes study. J Am Pharm Assoc (Wash) 1998;38:586–97
Time point –
Gravil JH, Al-Rawas OA, Cotton MM, Flanigan U, Irwin A, Stevenson RD. Home
treatment of exacerbations of chronic obstructive pulmonary disease by an
acute respiratory assessment service. Lancet 1998;351:1853–5
Intervention Intervention
Green RH, Singh SJ, Williams J, Morgan MDL. A randomised controlled trial of
four weeks versus seven weeks pulmonary rehabilitation in chronic obstructive
pulmonary disease (COPD). Thorax 2001;56:143–5
Time point –
Greenstone M. Self-monitored, home-based pulmonary rehab was non-inferior
to outpatient, hospital-based rehab for COPD. Evid Based Med 2009;14:75
Publication type Publication type
Griffiths C, Motlib J, Azad A, Ramsay J, Eldridge S, Feder G, et al.
Randomised controlled trial of a lay-led self-management programme for
Bangladeshi patients with chronic disease. Br J Gen Pract 2005;55:831–7
Population Population
Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, et al.
Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation:
a randomised controlled trial. Lancet 2000;355:362–8. [Erratum published
in Lancet 2000;355:1280.]
Population Population
Griffiths TL, Phillips CJ, Davies S, Burr ML, Campbell IA. Cost-effectiveness of
an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax
2001;56:779–84
Population Population
Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related
factors after hospitalization for acute exacerbation of COPD. Chest
2003;124:459–67
Study design Study design
Gruffydd-Jones K, Langley-Johnson C, Dyer C, Badlan K, Ward S. What are the
needs of patients following discharge from hospital after an acute exacerbation
of chronic obstructive pulmonary disease (COPD)? Prim Care Resp J
2007;16:363–8
Time point Study design
Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, et al.
Risk factors for rehospitalisation in COPD: role of health status, anxiety and
depression. Eur Respir J 2005;26:414–19
Study design Study design
Güell R, Casan P, Sangenis M, Morante F, Belda J, Guyatt GH. Quality of life in
patients with chronic respiratory disease: the Spanish version of the Chronic
Respiratory Questionnaire (CRQ). Eur Respir J 1998;11:55–60
Time point Outcome
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Güell R, Casan P, Belda J, Sangenis M, Morante F, Guyatt GH, et al. Long-term
effects of outpatient rehabilitation of COPD: a randomized trial. Chest
2000;117:976–83
Time point –
Güell R, Morante F, Sangenis M, Casan P. Effects of respiratory rehabilitation on
quality of life of patients with chronic obstructive pulmonary disease. Annals de
Medicina 1995;81:9
Unavailable Unavailable
Güell R, Resqueti V, Sangenis M, Morante F, Martorell B, Casan P, et al.
Impact of pulmonary rehabilitation on psychosocial morbidity in patients with
severe COPD. Chest 2006;129:899–904. [Erratum published in Chest
2007;132:738.]
Publication type Publication type
Güell R, Resqueti V, Sangenis M, Morante F, Martorell B, Casan P, et al.
Impact of pulmonary rehabilitation on psychosocial morbidity in patients
with severe COPD. Chest 2006;129:899–904. [Erratum published in Chest
2007;132:738.]
Time point –
Guyatt G, Keller J, Singer J, Halcrow S, Newhouse M. Controlled trial of
respiratory muscle training in chronic airflow limitation. Thorax
1992;47:598–602
Time point –
Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS. Generic and specific
measurement of health-related quality of life in a clinical trial of respiratory
rehabilitation. J Clin Epidemiol 1999;52:187–92
Time point –
Haas A, Cardon H. Rehabilitation in chronic obstructive pulmonary disease:
a 5-year study of 252 male patients. Med Clin North Am 1969;53:593–606
Time point Study design
Haas A, Dani A. Rehabilitation of patients with chronic obstructive pulmonary
disease. AAGP 1965;31:92–8
Time point Study design
Haas A, Luczak A. The importance of rehabilitation in the treatment of chronic
pulmonary emphysema. Arch Phys Med Rehabil 1961;42:733–9
Time point Study design
Haas A, Luczak AK, Kernisant R, Zotowicz V. [Studies on the use of physical
therapy and rehabilitation in patients with chronic obstructive pulmonary
emphysema.] Polski Tygodnik Lekarski 1963;18:1834–7
Time point Study design
Haave E. Writing About Disease: Effect on Rehabilitation; 2005.
URL: www.clinicaltrials.gov (accessed 27 January 2015)
Population Population
Habraken JM, Pols J, Bindels PJ, Willems DL. The silence of patients with
end-stage COPD: a qualitative study. Br J Gen Pract 2008;58:844–9
Intervention Intervention
Haggerty MC, Stockdale-Woolley R, Nair S. Respi-Care. An innovative home
care program for the patient with chronic obstructive pulmonary disease.
Chest 1991;100:607–12
Intervention Intervention
Han SJ. [The effects of a pulmonary rehabilitation program for chronic
obstructive pulmonary disease patients.] Daehan Ganho Haghoeji
2003;33:1008–17
Time point Study design
Harver A, Mahler DA, Daubenspeck JA. Targeted inspiratory muscle training
improves respiratory muscle function and reduces dyspnea in patients with
chronic obstructive pulmonary disease. Ann Intern Med 1989;111:117–24
Time point –
Harvey PA, Murphy MC, Dornom E, Berlowitz DJ, Lim WK, Jackson B.
Implementing evidence-based guidelines: inpatient management of chronic
obstructive pulmonary disease. Intern Med J 2005;35:151–5
Study design Study design
Health related quality of life changes in community based pulmonary
rehabilitation for people with COPD. Data eighteen months post rehab. 07;
Switzerland: Lausanne; 2007
Study design Study design
Heijdra YF, Dekhuijzen PNR, van Herwaarden CLA, Folgering HT. Nocturnal
saturation improves by target-flow inspiratory muscle training in patients with
COPD. Am J Respir Crit Care Med 1996;153:260–5
Time point –
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Hellem E, Bruusgaard KA, Bergland A. Exercise maintenance: COPD patients’
perception and perspectives on elements of success in sustaining long-term
exercise. Physiother Theory Pract 2012;28:206–20
Time point Study design
Herala M, Stalenheim G, Boman G. Effects of positive expiratory pressure (PEP),
continuous positive airway pressure (CPAP) and hyperventilation in COPD
patients with chronic hypercapnea. Ups J Med Sci 1995;100:223–32
Intervention Intervention
Herborg H, Soendergaard B, Froekjaer B, Fonnesbaek L, Jorgensen T, Hepler CD,
et al. Improving drug therapy for patients with asthma. Part 1: Patient Outcomes.
J Am Pharm Assoc (Wash) 2001;41:539–50
Population Population
Hernandez MT, Rubio TM, Ruiz FO, Riera HS, Gil RS, Gomez JC. Results of a
home-based training program for patients with COPD. Chest 2000;118:106–14
Time point –
Heslop AP, Bagnall P. A study to evaluate the intervention of a nurse visiting
patients with disabling chest disease in the community. J Adv Nurs 1988;13:71–7
Time point Study design
Hesselink AE, Penninx BW, van der Windt DA, van Duin BJ, de Vries P,
Twisk JW, et al. Effectiveness of an education programme by a general
practice assistant for asthma and COPD patients: results from a randomised
controlled trial. Patient Educ Couns 2004;55:121–8
Population Population
Hill K, Jenkins SC, Philippe DL, Cecins N, Shepherd KL, Green DJ, et al.
High-intensity inspiratory muscle training in COPD. Eur Respir J
2006;27:1119–28
Time point –
Hoberty RJ, Craig MW. ‘Living up to par’: a golf tournament for persons with
COPD. Respir Care 1983;28:1480–3
Population Population
Hochstetter JK, Lewis J, Soares-Smith L. An investigation into the immediate
impact of breathlessness management on the breathless patient: randomised
controlled trial. Physiotherapy 2005;91:178–85
Population Population
Hoff J, Tjonna AE, Steinshamn S, Hoydal M, Richardson RS, Helgerud J.
Maximal strength training of the legs in COPD: a therapy for mechanical
inefficiency. Med Sci Sports Exerc 2007;39:220–6
Time point –
Hogan MT. Effect of pulmonary rehabilitation on quality of life in individuals
with chronic obstructive pulmonary disease. Aus Health Rev 1992;52:3155
Unavailable Unavailable
Holden DA, Stelmach KD, Curtis PS, Beck GJ, Stoller JK. The impact of a
rehabilitation program on functional status of patients with chronic lung
disease. Respir Care 1990;35:332–41
Time point Study design
Holland AE, Hill CJ, Nehez E, Ntoumenopoulos G. Does unsupported upper
limb exercise training improve symptoms and quality of life for patients with
chronic obstructive pulmonary disease? J Cardiopulm Rehabil 2004;24:422–7
Time point –
Holle RHO, Williams DV, Vandree JC, Starks GL, Schoene RB. Increased muscle
efficiency and sustained benefits in an outpatient community hospital-based
pulmonary rehabilitation program. Chest 1988;94:1161–8
Time point Study design
Holm SM, Rodgers WM, Haennel RG, Bhutani M, MacDonald GF, Wong E.
Physiological responses to treadmill and cycle ergometer exercise testing
in chronic obstructive pulmonary disease. Am J Respir Crit Care Med
2011;183:A3965
Publication type Publication type
Honeyman P, Barr P, Stubbing DG. Effect of a walking aid on disability,
oxygenation, and breathlessness in patients with chronic airflow limitation.
J Cardiopulm Rehabil 1996;16:63–7
Intervention Intervention
Hoogendoorn M, van Wetering CR, Schols AM, Rutten-van Mölken MP.
Self-report versus care provider registration of healthcare utilization: impact on
cost and cost-utility. Int J Technol Assess Health Care 2009;25:588–95
Time point –
Hoogendoorn M, van Wetering CR, Schols AM, Rutten-van Mölken MP.
Is INTERdisciplinary COMmunity-based COPD management (INTERCOM)
cost-effective? Eur Respir J 2010;35:79–87
Time point –
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Hospes G, Bossenbroek L, Ten Hacken NH, van Hengel P, de Greef MH.
Enhancement of daily physical activity increases physical fitness of outclinic
COPD patients: results of an exercise counseling program. Patient Educ Couns
2009;75:274–8
Time point –
Houchen L, Deacon S, Sandland C, Collier R, Steiner M, Morgan M, et al.
Preservation of lower limb strength after a short course of pulmonary
rehabilitation with no maintenance: a 6-month follow-up study. Physiotherapy
2011;97:264–6
Time point Study design
Howard JE, Davies JL, Roghmann KJ. Respiratory teaching of patients: how
effective is it? J Adv Nurs 1987;12:207–14
Time point Study design
Howland J, Nelson EC, Barlow PB, McHugo G, Meier FA, Brent P, et al. Chronic
obstructive airway disease. Impact of health education. Chest 1986;90:233–8
Time point Study design
Hsiao SF, Wu YT, Wu HD, Wang TG. Comparison of effectiveness of pressure
threshold and targeted resistance devices for inspiratory muscle training in
patients with chronic obstructive pulmonary disease. J Formosan Med Assoc
2003;102:240–5
Time point –
Hsieh MJ, Lan CC, Chen NH, Huang CC, Wu YK, Cho HY, et al. Effects of
high-intensity exercise training in a pulmonary rehabilitation programme
for patients with chronic obstructive pulmonary disease. Respirology
2007;12:381–8
Time point Study design
Hsu HC. [Respiratory rehabilitation in patients with chronic obstructive
pulmonary disease.] Hu Li Tsa Chih 1997;44:87–92
Publication type Publication type
Huang C-H, Yang G-G, Wu Y-T, Lee C-W. Comparison of inspiratory muscle
strength training effects between older subjects with and without chronic
obstructive pulmonary disease. J Formosan Med Assoc 2011;110:518–26
Time point Study design
Hudson LD, Tyler ML, Petty TL. Hospitalization needs during an outpatient
rehabilitation program for severe chronic airway obstruction. Chest
1976;70:606–10
Study design Study design
Hughes SL, Cummings J, Weaver F, Manheim L, Braun B, Conrad K. A
randomized trial of the cost-effectiveness of VA hospital-based home care for
the terminally ill. Health Serv Res 1992;26:801–17
Population Population
Hughes SL, Weaver FM, Giobbie-Hurder A, Manheim L, Henderson W,
Kubal JD, et al. Effectiveness of team-managed home-based primary care:
a randomized multicenter trial. JAMA 2000;284:2877–85
Population Population
Hui KP, Hewitt AB. A simple pulmonary rehabilitation program improves health
outcomes and reduces hospital utilization in patients with COPD. Chest
2003;124:94–7
Time point Study design
Hung SH, Tseng HC, Tsai WH, Lin HH, Cheng JH, Chang YM. COPD: endurance
training via mobile phone. AMIA Ann Symp Proc 2007;2007:985
Time point Publication type
Hunter J, Singh SJ, Morgan MDL. Objective monitoring of adherence with home
exercise training during pulmonary rehabilitation for chronic obstructive
pulmonary disease. Physiotherapy 2006;92:50–4
Time point Study design
Hunter SM. Educating clients with COPD. Home Healthc Nurse 1987;5:41–3 Publication type Publication type
Hunter SM, Hall SS. The effect of an educational support program on dyspnea
and the emotional status of COPD clients. Rehabil Nurs J 1989;14:200–2
Time point Study design
Hurst JR, Fitzgerald-Khan F, Quint JK, Goldring JJ, Mikelsons C, Dilworth JP, et al.
Use and utility of a 24-hour Telephone Support Service for ‘high risk’ patients with
COPD. Prim Care Resp J 2010;19:260–5
Time point Study design
Hynninen MJ, Bjerke N, Pallesen S, Bakke PS, Nordhus IH. A randomized
controlled trial of cognitive behavioral therapy for anxiety and depression in
COPD. Respir Med 2010;104:986–94
Time point –
DOI: 10.3310/hta19360 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 36
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Jordan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
247
Excluded article
Reasons for exclusion
Review 1 Review 4
Ige OM, Olarewaju RK, Lasebikan VO, Adeniyi YO. Outpatient pulmonary
rehabilitation in severe chronic obstructive pulmonary disease. Indian J Chest Dis
Allied Sci 2010;52:197–201
Time point Study design
Ilayaraja A, Shawesh A. A comparative study on effectiveness of autogenic
drainage (AD) versus postural drainage (PD) in improving pulmonary function
(FEV1, FVC) in chronic obstructive pulmonary disease (COPD). Jamahiriya Med J
2010;10:106–10
Unavailable Unavailable
Incalzi RA, Corsonello A, Trojano L, Pedone C, Acanfora D, Spada A, et al.
Cognitive training is ineffective in hypoxemic COPD: a six-month randomized
controlled trial. Rejuvenation Res 2008;11:239–50
Time point –
Incorvaia C, Riario-Sforza GG. Effect of patient education on adherence to drug
treatment for chronic obstructive pulmonary disease. Ann Thorac Med
2011;6:242–3
Publication type Publication type
Innocenti F, Fabbri A, Guerrini M, Fonseca D, Lippi P. Results of an outpatient
pulmonary rehabilitation program in patients with COPD. Eur Respir J
2000;16(Suppl. 31):46
Unavailable Unavailable
Inoue M, Ohtsu I, Tomioka S, Hagiya M, Sumi M, Aoki H, et al. [Effects of
pulmonary rehabilitation on vital capacity in patients with chronic pulmonary
emphysema.] Nihon Kyobu Shikkan Gakkai Zasshi 1996;34:1182–8
Time point Study design
Inoue M, Ohtsu I, Tomioka S, Sumi M, Nakayama M, Hagiya M, et al. [One year
follow-up of pulmonary rehabilitation in patients with pulmonary emphysema:
physiological outcome.] Nihon Kokyuki Gakkai Zasshi 1998;36:756–62
Time point Study design
Ip SP, Leung YF, Choy KL. Short-stay in-patient rehabilitation of elderly patients
with chronic obstructive pulmonary disease: prospective study. Hong Kong Med
J 2004;10:312–18
Intervention Study design
Ito M, Kakizaki F, Tsuzura Y, Yamada M. Immediate effect of respiratory muscle
stretch gymnastics and diaphragmatic breathing on respiratory pattern.
Respiratory Muscle Conditioning Group. Intern Med 1999;38:126–32
Time point Study design
Izumizaki M, Satake M, Takahashi H, Sugawara K, Shioya T, Homma I. Effects
of inspiratory muscle thixotropy on the 6-minute walk distance in COPD. Respir
Med 2008;102:970–7
Time point –
Janaudis-Ferreira T, Hill K, Goldstein R, Robles-Ribeiro P, Beauchamp M,
Dolmage T. Resistance arm training in patients with COPD: a randomized
controlled trial. European Respiratory Society Annual Congress, 18–22
September 2010, Barcelona, Spain, abstract no. 1936
Time point Publication type
Janaudis-Ferreira T, Hill K, Goldstein RS, Robles-Ribeiro P, Beauchamp MK,
Dolmage T, et al. Resistance arm training in patients with COPD: a randomized
controlled trial. Chest 2011;139:151–8
Time point –
Jang HJ, Jung YK. [The effects of self-efficacy promoting pulmonary
rehabilitation program in out-patients with chronic obstructive pulmonary
disease.] Tuberc Respir Dis 2006;61:533–46
Time point –
Janos V, Krisztina B, Attila S. [The effect of controlled and uncontrolled dynamic
lower extremity training in the rehabilitation of patients with chronic obstructive
pulmonary disease.] Orvosi Hetilap 2005;146:2249–55
Time point Study design
Jans MP, Schellevis FG, Le Coq EM, Bezemer PD, van Eijk JT. Health outcomes
of asthma and COPD patients: the evaluation of a project to implement
guidelines in general practice. Int J Qual Health Care 2001;13:17–25
Time point Study design
Jarab AS, Alqudah SG, Khdour M, Shamssain M, Mukattash TL. Impact of
pharmaceutical care on health outcomes in patients with COPD. Int J Clin
Pharm 2012;34:53–62
Time point –
Jeffs KJ, Lim WK, Lim M, Berlowitz DJ, Jackson B. The effect of a post acute
respiratory outreach service for patients with chronic obstructive pulmonary
disease on hospital readmission rates. Respirology 2005;10:239–43
Study design Study design
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Jeng C, Tsao LI, Ho CH, Chang PC. Experiences of daily activities within two
weeks after hospital discharge among Taiwanese elderly patients with chronic
obstructive pulmonary disease. J Nurs Res 2002;10:168–76
Intervention Study design
Jensen PS. Risk, protective factors, and supportive interventions in chronic
airway obstruction. Arch Gen Psychiatry 1983;40:1203–7
Population Population
Jerant A, Moore M, Lorig K, Franks P. Perceived control moderated the
self-efficacy-enhancing effects of a chronic illness self-management
intervention. Chron Illness 2008;4:173–82
Population Population
Jette DU, Bourgeois MC, Buchbinder R. Pulmonary rehabilitation following
acute exacerbation of chronic obstructive pulmonary disease. Phys Ther
2010;90:9–12
Publication type Publication type
Jin X-Q, Hao L-S, Chen W-H. [The influence of pulmonary rehabilitation on
dyspnea, pulmonary function test and exercise tolerance in chronic obstructive
pulmonary disease patients.] Chin J Clin Rehabil 2002;6:662–3
Time point –
Johnston B, Wheeler L, Deuser J, Sousa KH. Outcomes of the Kaiser
Permanente Tele-Home Health Research Project. Arch Fam Med 2000;9:40–5
Population Population
Jones AY, Dean E, Chow CC. Comparison of the oxygen cost of breathing
exercises and spontaneous breathing in patients with stable chronic obstructive
pulmonary disease. Phys Ther 2003;83:424–31
Time point Study design
Jones DT, Thomson RJ, Sears MR. Physical exercise and resistive breathing
training in severe chronic airways obstruction. Are they effective? Eur J Respir
Dis 1985;67:159–66
Time point –
Jones RC, Hyland ME, Hanney K, Erwin J. A qualitative study of compliance
with medication and lifestyle modification in Chronic Obstructive Pulmonary
Disease (COPD). Prim Care Resp J 2004;13:149–54
Time point Study design
Jones RC, Wang X, Harding S, Bott J, Hyland M. Educational impact of
pulmonary rehabilitation: Lung Information Needs Questionnaire. Respir Med
2008;102:1439–45
Time point Study design
Jonkers CC, Lamers F, Bosma H, Metsemakers JF, van Eijk JT. The effectiveness
of a minimal psychological intervention on self-management beliefs and
behaviors in depressed chronically ill elderly persons: a randomized trial.
Int Psychogeriatr 2012;24:288–97
Population Population
Jonsdottir H. Life patterns of people with chronic obstructive pulmonary disease:
isolation and being closed in. Nurs Sci Q 1998;11:160–6
Intervention Intervention
Jordhoy MS, Fayers P, Saltnes T, Ehlner-Elmqvist M, Jannert M, Kaasa S. A
palliative-care intervention and death at home: a cluster randomised trial.
Lancet 2000;356:888–93
Population Population
Joseph AM. Care coordination and telehealth technology in promoting
self-management among chronically ill patients. Telemed J E Health
2006;12:156–9
Population Population
Kaelin ME, Swank AM, Barnard KL, Adams KJ, Beach P, Newman J. Physical
fitness and quality of life outcomes in a pulmonary rehabilitation program
utilizing symptom limited interval training and resistance training. J Exerc Physiol
Online 2001;4:30–7
Time point Study design
Kagaya H, Takahashi H, Sugawara K, Kasai C, Kiyokawa N, Shioya T. Effective
home-based pulmonary rehabilitation in patients with restrictive lung diseases.
Tohoku J Exp Med 2009;218:215–19
Population Population
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Kakizaki F, Shibuya M, Yamazaki T, Yamada M, Suzuki H, Homma I. Preliminary
report on the effects of respiratory muscle stretch gymnastics on chest wall
mobility in patients with chronic obstructive pulmonary disease. Respir Care
1999;44:409–14
Time point Study design
Kalter-Leibovici O. Comprehensive Disease Management Program in Chronic
Obstructive Pulmonary Disease (COPD) Patients in the Community (COPD_CDM);
2009. URL: www.clinicaltrials.gov (accessed 27 January 2015)
Publication type Publication type
Kamahara K, Homma T, Naito A, Matsumura T, Nakayama M, Kadono K, et al.
Circuit training for elderly patients with chronic obstructive pulmonary disease:
a preliminary study. Arch Gerontol Geriatr 2004;39:103–10
Time point Study design
Kanamori K, Okubo K. [Effects of pulmonary rehabilitation in patients with
chronic respiratory failure.] Nihon Kyobu Shikkan Gakkai Zasshi
1996;34:397–403
Time point Study design
Kanervisto M, Kaistila T, Paavilainen E. Severe chronic obstructive pulmonary
disease in a family’s everyday life in Finland: perceptions of people with chronic
obstructive pulmonary disease and their spouses. Nurs Health Sci 2007;9:40–7
Time point Study design
Kapella MC, Herdegen JJ, Perlis ML, Shaver JL, Larson JL, Law JA, et al.
Cognitive behavioral therapy for insomnia comorbid with COPD is feasible with
preliminary evidence of positive sleep and fatigue effects. Int J Chron Obstruct
Pulmon Dis 2011;6:625–35
Time point Study design
Kaplan RM. Randomized trial of rehabilitation in chronic obstructive pulmonary
disease. J Rehabil Res Dev 1991;28:268
Time point Publication type
Kaplan RM, Atkins CJ, Reinsch S. Specific efficacy expectations mediate exercise
compliance in patients with COPD. Health Psychol 1984;3:223–42
Population Population
Kara M. Using the Roper, Logan and Tierney model in care of people with
COPD. J Clin Nurs 2007;16:223–33
Intervention Intervention
Kara M, Asti T. Effect of education on self-efficacy of Turkish patients with
chronic obstructive pulmonary disease. Patient Educ Couns 2004;55:114–20
Time point Outcome
Karapolat H, Atasever A, Atamaz F, Kirazli Y, Elmas F, Erdinc E. Do the benefits
gained using a short-term pulmonary rehabilitation program remain in COPD
patients after participation? Lung 2007;185:221–5
Time point –
Kasikci MK. Using self-efficacy theory to educate a patient with chronic
obstructive pulmonary disease: a case study of 1-year follow-up. Int J Nurs Pract
2011;17:1–8
Time point Study design
Katiyar SK, Bihari S. Role of pranayama in rehabilitation of COPD patients: a
randomized controlled study. Indian J Allergy Asthma Immunol 2006;20:98–104
Time point –
Kayahan B, Karapolat H, Atyntoprak E, Atasever A, Ozturk O. Psychological
outcomes of an outpatient pulmonary rehabilitation program in patients with
chronic obstructive pulmonary disease. Respir Med 2006;100:1050–7
Time point –
Keating A, Lee AL, Holland AE. Lack of perceived benefit and inadequate
transport influence uptake and completion of pulmonary rehabilitation in
people with chronic obstructive pulmonary disease: a qualitative study.
J Physiother 2011;57:183–90
Time point Study design
Kelly MG, Elborn JS. Admissions with chronic obstructive pulmonary disease
after publication of national guidelines. Ir J Med Sci 2002;171:16–19
Study design Study design
Kennedy S. Caring for a patient newly diagnosed with COPD: a reflective
account. Nurs Stand 2011;25:43–8
Study design Study design
Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors
of hospitalization for acute exacerbation in a series of 64 patients with chronic
obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:158–64
Study design Study design
APPENDIX 2
NIHR Journals Library www.journalslibrary.nihr.ac.uk
250
Excluded article
Reasons for exclusion
Review 1 Review 4
Ketelaars CA, Huyer Abu-Saad H, Halfens RJ, Schlosser MA, Mostert R,
Wouters EF. Effects of specialized community nursing care in patients with
chronic obstructive pulmonary disease. Heart Lung 1998;27:109–20
Time point Study design
Khdour MR, Agus AM, Kidney JC, Smyth BM, Elnay JC, Crealey GE. Cost–utility
analysis of a pharmacy-led self-management programme for patients with
COPD. Int J Clin Pharm 2011;33:665–73
Time point –
Khdour MR, Kidney JC, Smyth BM, McElnay JC. Clinical pharmacy-led disease
and medicine management programme for patients with COPD. Br J Clin
Pharmacol 2009;68:588–98
Time point –
Kheirabadi GR, Keypour M, Attaran N, Bagherian R, Maracy MR. Effect of
add-on ‘Self management and behavior modification’ education on severity of
COPD. Tanaffos 2008;7:23–30
Time point –
Kim MJ, Larson JL, Covey MK, Vitalo CA, Alex CG, Patel M. Inspiratory muscle
training in patients with chronic obstructive pulmonary disease. Nurs Res
1993;42:356–62
Time point –
Kim S, Emerman CL, Cydulka RK, Rowe BH, Clark S, Camargo CA. Prospective
multicenter study of relapse following emergency department treatment of
COPD exacerbation. Chest 2004;125:473–81
Study design Study design
Kinney M. Rehabilitation of patients with COLD. Am J Nurs 1967;67:2528–35 Study design Study design
Kirsten DK, Taube C, Lehnigk B, Jörres RA, Magnussen H. Exercise training
improves recovery in patients with COPD after an acute exacerbation. Respir
Med 1998;92:1191–8
Time point –
Kiser K, Jonas D, Warner Z, Scanlon K, Shilliday BB, DeWalt DA. A randomized
controlled trial of a literacy-sensitive self-management intervention for chronic
obstructive pulmonary disease patients. J Gen Intern Med 2012;27:190–5
Time point Outcome
Ko FW, Dai DL, Ngai J, Tung A, Ng S, Lai K, et al. Effect of early pulmonary
rehabilitation on health care utilization and health status in patients hospitalized
with acute exacerbations of COPD. Respirology 2011;16:617–24
Intervention –
Koff PB, Jones RH, Cashman JM, Voelkel NF, Vandivier RW. Proactive integrated
care improves quality of life in patients with COPD. Eur Respir J 2009;33:1031–8
Time point –
Kokosov AN, Potashov DA. [Rehabilitation treatment of patients with chronic
bronchitis with initial manifestations of obstruction at a specialized department.]
Klin Med (Mosk) 1989;67:45–9
Unavailable Unavailable
Kongsgaard M, Backer V, Jorgensen K, Kjaer M, Beyer N. Heavy resistance
training increases muscle size, strength and physical function in elderly male
COPD-patients: a pilot study. Respir Med 2004;98:1000
Time point –
Koppers RJH, Vos PJE, Boot CRL, Folgering HT. Exercise performance improves
in patients with COPD due to respiratory muscle endurance training. Chest
2006;129:886–92
Time point –
Koshioka T, Kataoka K, Ichihara S, Sawamoto A, Sawada T. [Self control of
respiratory rehabilitation by patients with chronic obstructive lung diseases:
group sessions on instructions in respiratory rehabilitation.] Kango gijutsu
1988;34:1773–6
Study design Study design
Kovacevic A, Schmidt KG, Nicolai T, Wisbauer M, Schuster A. Two further cases
supporting nonsurgical management in congenital lobar emphysema. Klin
Padiatr 2009;221:232–6
Population Population
Kuehn BM. Education key to treating airway disease: focus on inhaler users,
rescue workers, athletes. JAMA 2007;298:2601–8
Study design Study design
Kunik ME, Veazey C, Cully JA, Souchek J, Graham DP, Hopko D, et al. COPD
education and cognitive behavioral therapy group treatment for clinically
significant symptoms of depression and anxiety in COPD patients: a randomized
controlled trial. Psychol Med 2008;38:385–96
Time point –
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Kurabayashi H, Machida I, Tamura K, Iwai F, Tamura J, Kubota K. Breathing out
into water during subtotal immersion: a therapy for chronic pulmonary
emphysema. Am J Phys Med Rehabil 2000;79:150–3
Time point –
Kurch TK. [Therapeutico-rehabilitation process using graded physical loads in
recurrent bronchitis.] Vrach Delo 1984;6:59–61
Population Population
Kurch TK. [Effectiveness of using therapeutic and rehabilitation complexes in
recurrent bronchitis.] Vrach Delo 1987;12:40–3
Population Population
Kurihara N, Shirai S. [Rehabilitation of patients with chronic obstructive lung
diseases.] Kango gijutsu 1988;34:1807–11
Study design Study design
Kuver C, Beyer M, Gensichen J, Ludt S, Schmitz A, Szecsenyi J, et al.
[An assessment of patient education programmes for patients with type 1 and
2 diabetes, asthma and COPD, coronary heart disease, hypertension, congestive
heart failure, and breast cancer in Germany.] Z Arztl Fortbild Qualitatssich
2004;98:393–402
Study design Study design
Kyung KA, Chin PA. The effect of a pulmonary rehabilitation programme on
older patients with chronic pulmonary disease. J Clin Nurs 2008;17:118–25
Population Population
Labrecque M, Rabhi K, Laurin C, Favreau H, Moullec G, Lavoie K, et al. Can a
self-management education program for patients with chronic obstructive
pulmonary disease improve quality of life? Can Respir J 2011;18:e77–81
Time point Study design
Lacasse Y, Wong E, Guyatt GH, King D, Cook DJ, Goldstein RS. Meta-analysis
of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet
1996;348:1115–19
Publication type Publication type
Lake FR, Henderson K, Briffa T, Openshaw J, Musk AW. Upper-limb and
lower-limb exercise training in patients with chronic airflow obstruction. Chest
1990;97:1077–82
Time point –
Lamers F, Jonkers CC, Bosma H, Chavannes NH, Knottnerus JA, van Eijk JT.
Improving quality of life in depressed COPD patients: effectiveness of a minimal
psychological intervention. COPD 2010;7:315–22
Time point –
Lamers F, Jonkers CC, Bosma H, Kempen GI, Meijer JA, Penninx BW, et al.
A minimal psychological intervention in chronically ill elderly patients with
depression: a randomized trial. Psychother Psychosomat 2010;79:217–26
Population Population
Lan CC, Yang MC, Lee CH, Huang YC, Huang CY, Huang KL, et al. Pulmonary
rehabilitation improves exercise capacity and quality of life in underweight
patients with chronic obstructive pulmonary disease. Respirology
2011;16:276–83
Time point Study design
Lange P, Brondum E, Bolton S, Martinez G. [Rehabilitation of patients with
chronic obstructive pulmonary disease.] Ugeskr Laeger 2005;167:274–9
Time point Study design
Laros CD, Swierenga J. [Rehabilitation program in patients with
obstructive-destructive lung disease (author’s translation).] Acta Tuberc
PneumolBelg 1975;66:207–21
Publication type Publication type
Larraz C, Esteva M, Ripoll J, Mir I, Gomez A, Romãn M, et al. Efficacy of a
rehabilitation program on moderate COPD conducted in primary care and the
maintenance of benefits during two years. Prim Care Resp J 2010;19:A22.
Publication type Publication type
Larson JL, Kim MJ, Sharp JT, Larson DA. Inspiratory muscle training with a
pressure threshold breathing device in patients with chronic obstructive
pulmonary disease. Am Rev Respir Dis 1988;138:689–96
Time point –
Larson JL, Covey MK, Wirtz SE, Berry JK, Alex CG, Langbein WE, et al. Cycle
ergometer and inspiratory muscle training in chronic obstructive pulmonary
disease. Am J Respir Crit Care Med 1999;160:500–7
Time point –
Larson M, Kim MJ. Respiratory muscle training with the incentive spirometer
resistive breathing device. Heart Lung 1984;13:341–5
Time point Study design
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Lathlean T, Cafarella P, Rowett D, Frith P, Lawrence J. Combining chronic
condition self management and pulmonary rehabilitation for COPD patients.
Respirology 2008;13(Suppl. 5):A172
Publication type Publication type
Lau AC, Yam LY, Poon E. Hospital re-admission in patients with acute
exacerbation of chronic obstructive pulmonary disease. Respir Med
2001;95:876–84
Intervention Intervention
Laviolette L, Bourbeau J, Bernard S, Lacasse Y, Pepin V, Breton MJ, et al.
Assessing the impact of pulmonary rehabilitation on functional status in COPD.
Thorax 2008;63:115–21
Time point Study design
Laviolette L, Lands LC, Dauletbaev N, Saey D, Milot J, Provencher S, et al.
Combined effect of dietary supplementation with pressurized whey and exercise
training in chronic obstructive pulmonary disease: a randomized, controlled,
double-blind pilot study. J Med Food 2010;13:589–98
Intervention Intervention
Lawlor M, Kealy S, Agnew M, Korn B, Quinn J, Cassidy C, et al. Early discharge
care with ongoing follow-up support may reduce hospital readmissions in
COPD. Int J Chron Obstruct Pulmon Dis 2009;4:55–60.
Study design Study design
Leal HM, Abellan AJ, Martinez CJ, Nicolas BA. [Written information on the use
of aerosols in COPD patients. Can we improve their use?] Aten Prim
2004;33:6–10
Time point Outcome
Lee CY, Yeh LL, Chen CZ, Lin PY, Hsiue TR, Wang WL. [Exploring
self-management in patients with chronic obstructive pulmonary disease.]
Hu Li Tsa Chih 2008;55:45–55
Time point Study design
Lee DK. Pulmonary rehabilitation and readmissions in COPD: hospital
readmissions did not fall. BMJ 2005;330:480
Publication type Publication type
Leff B, Burton L, Guido S, Greenough WB, Steinwachs D, Burton JR. Home
Hospital program: a pilot study. J Am Geriatr Soc 1999;47:697–702
Intervention Intervention
Leidy NK, Haase JE. Functional performance in people with chronic obstructive
pulmonary disease: a qualitative analysis. Adv Nurs Sci 1996;18:77–89
Time point Study design
Leidy NK, Haase JE. Functional status from the patient’s perspective: the
challenge of preserving personal integrity. Res Nurs Health 1999;22:67–77
Time point Study design
Lertzman MM, Cherniack RM. Rehabilitation of patients with chronic
obstructive pulmonary disease. Am Rev Respir Dis 1976;114:1145–65
Publication type Publication type
Leung RW, Alison JA, McKeough ZJ, Peters MJ. Ground walk training improves
functional exercise capacity more than cycle training in people with chronic
obstructive pulmonary disease (COPD): a randomised trial. J Physiother
2010;56:105–12
Time point –
Leung RWM, Alison JA, McKeough ZJ, Peters MJ. A study design to investigate
the effect of short-form Sun-style Tai Chi in improving functional exercise
capacity, physical performance, balance and health related quality of life in
people with Chronic Obstructive Pulmonary Disease (COPD). Contemp Clin
Trials 2011;32:267–72
Publication type Publication type
Levine S, Weiser P, Gillen J. Evaluation of a ventilatory muscle endurance
training program in the rehabilitation of patients with chronic obstructive
pulmonary disease. Am Rev Respir Dis 1986;133:400–6
Time point –
Lewczuk J, Piszko P. [Rehabilitation of patients with chronic obstructive
pulmonary diseases.] Pneumonol Alergol Pol 1997;65:691–9
Publication type Publication type
Lewczuk J, Piszko P, Kowalska-Superlak M, Wrabec K, Knap J, Palka P, et al.
[Respiratory rehabilitation of patients with chronic obstructive lung diseases in
the subjective and objective evaluation.] Pneumonol Alergol Pol 1991;59:132–6
Time point Study design
Lewczuk J, Piszko P, Kowalska-Superlak M, Jagas J, Wojciak S, Wrabec K.
[The impact of 2-year rehabilitation on exercise tolerance and transcutaneous
oxygen saturation during exercise in patients with chronic obstructive
pulmonary disease.] Pol Arch Med Wewn 1998;100:331–6
Time point Study design
DOI: 10.3310/hta19360 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 36
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Jordan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
253
Excluded article
Reasons for exclusion
Review 1 Review 4
Lewczuk J, Piszko P, Wojciak S, Kowalska-Superlak M, Wrabec K.
[Comparison of 14-day rehabilitation and oxygen therapy on exercise
tolerance and percutaneous oxygen saturation in patients with advanced
COPD.] Pneumonol Alergol Pol 1998;66:464–7
Intervention Intervention
Lewis MI, Fournier M, Storer TW, Bhasin S, Porszasz J, Ren SG, et al. Skeletal
muscle adaptations to testosterone and resistance training in men with COPD.
J Appl Physiol 2007;103:1299–310
Outcome Outcome
Li Y-L. [Nutritional supplementation and respiratory gym in patients with chronic
obstructive pulmonary disease.] Chin J Clin Rehabil 2002;6:1260–2
Time point –
Liddell F, Webber J. Pulmonary rehabilitation for chronic obstructive pulmonary
disease: a pilot study evaluating a once-weekly versus twice-weekly supervised
programme. Physiotherapy 2010;96:68–74
Time point –
Lindenauer PK, Pekow P, Gao S, Crawford AS, Gutierrez B, Benjamin EM.
Quality of care for patients hospitalized for acute exacerbations of chronic
obstructive pulmonary disease. Ann Intern Med 2006;144:894–903
Study design Study design
Lindsay M, Lee A, Chan K, Poon P, Han LK, Wong WC, et al. Does pulmonary
rehabilitation give additional benefit over tiotropium therapy in primary care
management of chronic obstructive pulmonary disease? Randomized controlled
clinical trial in Hong Kong Chinese. J Clin Pharm Ther 2005;30:567–73
Time point –
Linneberg A, Rasmussen M, Buch TF, Wester A, Malm L, Fannikke G, et al.
A randomised study of the effects of supplemental exercise sessions after a
7-week chronic obstructive pulmonary disease rehabilitation program.
Clin Respir J 2012;6:112–19
Time point –
Lisansky DP, Clough DH. A cognitive–behavioral self-help educational program
for patients with COPD. A pilot study. Psychother Psychosomat 1996;65:97–101
Time point Study design
Lisboa C, Munoz V, Beroiza T, Leiva A, Cruz E. Inspiratory muscle training in
chronic airflow limitation: comparison of two different training loads with a
threshold device. Eur Respir J 1994;7:1266–74
Time point Study design
Lisboa C, Villafranca C, Pertuze J, Leiva A, Repetto P. [Clinical effects of
inspiratory muscle training in patients with chronic airflow limitation.] Rev Med
Chil 1995;123:1108–15
Time point –
Lisboa C, Villafranca C, Leiva A, Cruz E, Pertuze J, Borzone G. Inspiratory muscle
training in chronic airflow limitation: Effect on exercise performance. Eur Respir
J 1997;10:537–42
Time point –
Lisboa C, Villafranca C, Caiozzi G, Berrocal C, Leiva A, Pinochet R, et al.
[Quality of life in patients with chronic obstructive pulmonary disease and the
impact of physical training.] Rev Med Chil 2001;129:359–66
Time point Study design
Littlejohns P, Baveystock CM, Parnell H, Jones PW. Randomised controlled trial of
the effectiveness of a respiratory health worker in reducing impairment, disability,
and handicap due to chronic airflow limitation. Thorax 1991;46:559–64
Time point –
Liu WT, Wang CH, Lin HC, Lin SM, Lee KY, Lo YL, et al. Efficacy of a cell
phone-based exercise programme for COPD. Eur Respir J 2008;32:651–9
Time point –
Liu Y-F. [Effects of the comprehensive pulmonary rehabilitation programme on
the quality of life of the patients with COPD in recovery period.] Chin J Clin
Rehabil 2002;6:3170–1
Time point Study design
Livermore N, Sharpe L, McKenzie D. Prevention of panic attacks and panic
disorder in COPD. Eur Respir J 2010;35:557–63
Time point –
Lolak S, Connors GL, Sheridan MJ, Wise TN. Effects of progressive muscle
relaxation training on anxiety and depression in patients enrolled in an
outpatient pulmonary rehabilitation program. Psychother Psychosomat
2008;77:119–25
Population Population
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Lomundal BK, Steinsbekk A. Observational studies of a one year
self-management program and a two year pulmonary rehabilitation program
in patients with COPD. Int J Chron Obstruct Pulmon Dis 2007;2:617–24
Time point Study design
Lomundal BK, Steinsbekk A. Five-year follow-up of a one-year self-management
program for patients with COPD. Int J Chron Obstruct Pulmon Dis
2012;7:87–93
Time point Study design
Conference proceedings. Long-Term Benefits of Pulmonary Rehabilitation on
the Exercise Capacity and Shortness of Breath in Patient With Chronic
Obstructive Pulmonary Disease (COPD). Series: Diseases of the Chest. The
College; 1996. Vol. 110, no. 4, p. 159S
Unavailable Unavailable
Lopez ME, Jara PM, Diaz EA, Gonzalez SM, Servian Carroquino RM, Vera VM.
[Evaluation of an educational intervention for the use of inhalers in Primary
Health Care.] MEDIFAM – Revista de Medicina Familiar y Comunitaria
2000;10:290–5
Time point Study design
Lord VM, Cave P, Hume VJ, Flude EJ, Evans A, Kelly JL, et al. Singing teaching
as a therapy for Chron Respir Dis: a randomised controlled trial and qualitative
evaluation. BMC Pulm Med 2010;10:41
Time point –
Lorenzi CM, Cilione C, Rizzardi R, Furino V, Bellantone T, Lugli D, et al.
Occupational therapy and pulmonary rehabilitation of disabled COPD patients.
Respiration 2004;71:246–51
Time point Study design
Lorig KR, Ritter P, Stewart AL, Sobel DS, Brown BW, Jr, Bandura A, et al.
Chronic disease self-management program: 2-year health status and health care
utilization outcomes. Med Care 2001;39:1217–23
Population Population
Lorig KR, Ritter PL, Gonzalez VM. Hispanic chronic disease self-management:
a randomized community-based outcome trial. Nurs Res 2003;52:361–9
Population Population
Lotters F, van Tol B, Kwakkel G, Gosselink R. Effects of controlled inspiratory
muscle training in patients with COPD: a meta-analysis. Eur Respir J
2002;20:570–6
Publication type Publication type
Louie SW. The effects of guided imagery relaxation in people with COPD.
Occup Ther Int 2004;11:145–59
Time point –
Lox CL, Freehill AJ. Impact of pulmonary rehabilitation on self-efficacy, quality of
life, and exercise tolerance. Rehabil Psychol 1999;44:208–21
Time point Study design
Lucioni C, Donner CF, De BF, Lusuardi M, Mazzi S, Paggiaro PL, et al. [The costs
of COPD.] Pharmacoecon 2005;7:119–34
Intervention Intervention
Macfarlane J, Holmes W, Gard P, Thornhill D, Macfarlane R, Hubbard R.
Reducing antibiotic use for acute bronchitis in primary care: blinded,
randomised controlled trial of patient information leaflet. BMJ 2002;324:91–4
Population Population
Mackay L. Health education and COPD rehabilitation: a study. Nurs Stand
1996;10:34–9
Time point Study design
Madariaga VB, Iturri JB, Manterola AG, Buey JC, Sebastian NT, Pena VS.
[Comparison of 2 methods for inspiratory muscle training in patients with
chronic obstructive pulmonary disease.] Arch Bronconeumol 2007;43:431–8
Time point –
Mador MJ, Bozkanat E, Aggarwal A, Shaffer M, Kufel TJ. Endurance and
strength training in patients with COPD. Chest 2004;125:2036–45
Time point –
Mador MJ, Deniz O, Aggarwal A, Shaffer M, Kufel TJ, Spengler CM. Effect of
respiratory muscle endurance training in patients with COPD undergoing
pulmonary rehabilitation. Chest 2005;128:1216–24. [Erratum published in
Chest 2006;129:216.]
Time point –
Mador MJ, Krawza M, Alhajhusian A, Khan AI, Shaffer M, Kufel TJ. Interval
training versus continuous training in patients with chronic obstructive
pulmonary disease. J Cardiopulm Rehabil Prev 2009;29:126–32
Time point –
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Madsen H. Nurse Tele-Consultations with Discharged COPD Patients Reduce the
Numbers of Readmissions; 2009. URL: www.clinicaltrials.gov (accessed 27
January 2015)
Study design Study design
Magadle R, McConnell AK, Beckerman M, Weiner P. Inspiratory muscle training
in pulmonary rehabilitation program in COPD patients. Respir Med
2007;101:1500–5
Time point –
Maixner J. [Effect of respiratory rehabilitation in patients with pulmonary
emphysema.] Cesk Zdrav 1963;11:486–93
Time point Study design
Malicdem MG, Cruz BOD, Punzal P, De GT. Outcome of pulmonary
rehabilitation among difficult to wean patients admitted at the Philippine heart
center – a randomized controlled study. 15th Congress of the Asian Pacific
Society of Respirology, 22–25 November 2010, Manila, The Philippines.
Respirology 2010;99
Population Population
Malik SK. Aerosol therapy and rehabilitation in chronic obstructive pulmonary
disease (COPD). Indian J Chest Dis 1968;10:142–8
Time point Study design
Maltais F, LeBlanc P, Simard C, Jobin J, Berube C, Bruneau J, et al. Skeletal
muscle adaptation to endurance training in patients with chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 1996;154:442–7
Time point Study design
Maltais F, LeBlanc P, Jobin J, Berube C, Bruneau J, Carrier L, et al. Intensity of
training and physiologic adaptation in patients with chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 1997;155:555–61
Time point Study design
Maltais F, Bourbeau J, Lacasse Y, Shapiro S, Perrault H, Penrod JR, et al. A
Canadian, multicentre, randomized clinical trial of home-based pulmonary
rehabilitation in chronic obstructive pulmonary disease: rationale and methods.
Can Respir J 2005;12:193–8
Publication type Publication type
Maltais F, Bourbeau J, Shapiro S, Lacasse Y, Perrault H, Baltzan M, et al. Effects
of home-based pulmonary rehabilitation in patients with chronic obstructive
pulmonary disease: a randomized trial. Ann Intern Med 2008;149:869–78.
[Summary for patients in Ann Intern Med 2008;149:I56.]
Time point –
Maltais F. Pulmonary Rehabilitation at Home Versus at the Gymnasium; 2005.
URL: www.clinicaltrials.gov (accessed 27 January 2015)
Publication type Publication type
Man WD, Polkey MI, Donaldson N, Gray BJ, Moxham J. Community pulmonary
rehabilitation after hospitalisation for acute exacerbations of chronic obstructive
pulmonary disease: randomised controlled study. BMJ 2004;329:1209
Intervention –
Man WDC, Soliman MGG, Gearing J, Radford SG, Rafferty GF, Gray BJ, et al.
Symptoms and quadriceps fatigability after walking and cycling in chronic
obstructive pulmonary disease. Am J Respir Crit Care Med 2003;168:562–7
Time point Study design
Mandigout S, Antonini M-T, Laforge Q, Lemaire F, Dalmay F, Bouteille B. Effects
of training rehabilitation on the physical capacity of patients suffering from
chronic obstructive pulmonary disease. Sci Sports 2007;22:300–1
Time point Study design
Mapel DW. Estimating the cost of COPD: a matter of perspective. COPD
2006;3:177–8
Publication type Publication type
Mapel DW, McMillan GP, Frost FJ, Hurley JS, Picchi MA, Lydick E, et al.
Predicting the costs of managing patients with chronic obstructive pulmonary
disease. Respir Med 2005;99:1325–33
Time point Study design
Marchioro JC, Belmonte G, Pradela C, Maia MN, Nascimento OA, Jardim JR.
Effects of home-based pulmonary rehabilitation in COPD patients: adaptation to
patient’s real life. Am J Respir Crit Care Med 2011;183:A6438
Time point Publication type
Marrara KT, Marino DM, de Held PA, de Oliveira Junior AD, Jamami M, Di L, V.
Different physical therapy interventions on daily physical activities in chronic
obstructive pulmonary disease. Respir Med 2008;102:505–11
Time point –
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Martin IR, McNamara D, Sutherland FR, Tilyard MW, Taylor DR. Care plans for
acutely deteriorating COPD: a randomized controlled trial. Chron Respir Dis
2004;1:191–5
Time point –
Martinez FJ, Vogel PD, Dupont DN, Stanopoulos I, Gray A, Beamis JF. Supported
arm exercise vs unsupported arm exercise in the rehabilitation of patients with
severe chronic airflow obstruction. Chest 1993;103:1397–402
Time point –
Martins JA, de Andrade AD, Britto RR, Lara R, Parreira VF. Effect of slow
expiration with glottis opened in lateral posture (ELTGOL) on mucus clearance in
stable patients with chronic bronchitis. Respir Care 2012;57:420–6
Time point Study design
Mattke S, Seid M, Ma S. Evidence for the effect of disease management: is $1
billion a year a good investment? Am J Manag Care 2007;13:670–6
Publication type Publication type
McBride S. Patients with chronic obstructive pulmonary disease: their beliefs
about measures that increase activity tolerance. Rehabil Nurs J 1994;19:37–41
Time point Study design
McBride S, Graydon J, Sidani S, Hall L. The therapeutic use of music for dyspnea
and anxiety in patients with COPD who live at home. J Holist Nurs
1999;17:229–50
Time point Study design
McCrory DC, Brown C, Gelfand SE, Bach PB. Management of acute
exacerbations of COPD: a summary and appraisal of published evidence. Chest
2001;119:1190–209
Publication type Publication type
McGavin CR, Gupta SP, Lloyd EL, McHardy GJ. Physical rehabilitation for the
chronic bronchitic: results of a controlled trial of exercises in the home. Thorax
1977;32:307–11
Time point Study design
McGeoch GR, Willsman KJ, Dowson CA, Town GI, Frampton CM, McCartin FJ,
et al. Self-management plans in the primary care of patients with chronic
obstructive pulmonary disease. Respirology 2006;11:611–18
Time point –
McKeon JL, Turner J, Kelly C. The effect of inspiratory resistive training on
exercise capacity in optimally treated patients with severe chronic airflow
limitation. Aust NZ J Med 1986;16:648–52
Time point –
McKinstry A, Tranter M, Sweeney J. Outcomes of dysphagia intervention in a
pulmonary rehabilitation program. Dysphagia 2010;25:104–11
Time point Study design
McLean W, Gillis J, Waller R. The BC Community Pharmacy Asthma Study: a
study of clinical, economic and holistic outcomes influenced by an asthma care
protocol provided by specially trained community pharmacists in British
Columbia. Can Respir J 2003;10:195–202
Population Population
Mehri SN, Khoshnevis MA, Zarrehbinan F, Hafezi S, Ghasemi A, Ebadi A. Effect
of treadmill exercise training on VO2 peak in chronic obstructive pulmonary
disease. Tanaffos 2007;6:18–24
Time point –
Mehuys E, Van Bortel L, De Bolle L, Van Tongelen, I, Annemans L, Remon JP,
et al. Effectiveness of pharmacist intervention for asthma control improvement.
Eur Respir J 2008;31:790–9
Population Population
Mendes De Oliveira JC, Studart Leitao Filho FS, Malosa Sampaio LM, Negrinho
De Oliveira AC, Hirata RP, Costa D, et al. Outpatient vs. home-based pulmonary
rehabilitation in COPD: a randomized controlled trial. Multidiscip Respir Med
2010;5:401–8
Time point –
Menn P, Holle R. Markov model for health-economic evaluations of COPD in
Germany. 12th Annual European Congress, 24–27 October 2009, Paris, France.
Value Health 2009;A303
Publication type Publication type
Menon B, Kumar S, Vishal B, V, Vijayan VK. Effect of pulmonary rehabilitation
on systemic inflammation, functional parameters and muscle cross section area
in COP. European Respiratory Society Annual Congress, 18–22 September 2010,
Barcelona, Spain, abstract E3540
Publication type Publication type
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Mercken EM, Hageman GJ, Schols AM, Akkermans MA, Bast A, Wouters EF.
Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 2005;172:994–1001
Population Population
Mertens DJ, Shephard RJ, Kavanagh T. Long-term exercise therapy for chronic
obstructive lung disease. Respiration 1978;35:96–107
Time point Study design
Meulepas MA, Jacobs JE, Smeenk FWJM, Smeele I, Lucas AEM, Bottema BJAM,
et al. Effect of an integrated primary care model on the management of
middle-aged and old patients with obstructive lung diseases. Scand J Prim
Health Care 2007;25:186–92
Time point Study design
Miller MB, Conrad WF. Pharmacist involvement in an education program for
patients with chronic obstructive pulmonary disease. Am J Hosp Pharm
1975;32:909–11
Publication type Publication type
Minoguchi H, Shibuya M, Miyagawa T, Kokubu F, Yamada M, Tanaka H, et al.
Cross-over comparison between respiratory muscle stretch gymnastics and
inspiratory muscle training. Intern Med 2002;41:805–12
Time point Study design
Miravitlles M, Guerrero T, Mayordomo C, Sanchez-Agudo L, Nicolau F, Segu JL.
Factors associated with increased risk of exacerbation and hospital admission in
a cohort of ambulatory COPD patients: a multiple logistic regression analysis.
Respiration 2000;67:495–501
Intervention Intervention
Miravitlles M, Murio C, Guerrero T. Factors associated with relapse after
ambulatory treatment of acute exacerbations of chronic bronchitis. DAFNE
Study Group. Eur Respir J 2001;17:928–33
Study design Study design
Miravitlles M, Calle M, varez-Gutierrez F, Gobartt E, Lopez F, Martin A.
Exacerbations, hospital admissions and impaired health status in chronic
obstructive pulmonary disease. Qual Life Res 2006;15:471–80
Time point Study design
Mochizuki A, Tomohisa H, Nakayama S, Kashiwazaki T, Komuro T.
[Promotion of self care and organization of a social network for patients
with chronic obstructive lung diseases.] Kango Gijutsu 1988;34:1786–90
Study design Study design
Molina PJ, Molina PC, de Lucas RP, Lobo Alvarez MA, Calvo CE, Lumbreras GG.
[Effectiveness of a recuperative primary care intervention in patients with
chronic obstructive pulmonary disease.] Aten Prim 2005;36:39–44
Unavailable Unavailable
Monninkhof E, van der Valk P, van der Palen J, van Herwaarden C, Zielhuis G.
Effects of a comprehensive self-management programme in patients with
chronic obstructive pulmonary disease. Eur Respir J 2003;22:815–20
Time point –
Monninkhof E, van der Aa M, van der Valk P, van der Palen J, Zielhuis G,
Koning K, et al. A qualitative evaluation of a comprehensive self-management
programme for COPD patients: effectiveness from the patients’ perspective.
Patient Educ Couns 2004;55:177–84
Time point Study design
Monninkhof E, van der Valk P, Schermer T, van der Palen J, van Herwaarden C,
Zielhuis G. Economic evaluation of a comprehensive self-management
programme in patients with moderate to severe chronic obstructive pulmonary
disease. Chron Respir Dis 2004;1:7–16
Time point –
Monninkhof E, van der Valk P, van der Palen J, Mulder H, Pieterse M,
van Herr waarden C, et al. The effect of a minimal contact smoking cessation
programme in out-patients with chronic obstructive pulmonary disease: a
pre-post-test study. Patient Educ Couns 2004;52:231–6
Time point Study design
Montemayor T, Ortega F. [Strategies for muscular training in chronic obstructive
pulmonary disease. Training of resistance, strength, of both?] Arch Bronconeumol
2001;37:279–85
Publication type Publication type
Montes de OM, Torres SH, Gonzalez Y, Romero E, Hernandez N, Talamo C.
[Changes in exercise tolerance, health related quality of life, and peripheral
muscle characteristics of chronic obstructive pulmonary disease patients after
6 weeks’ training.] Arch Bronconeumol 2005;41:413–18
Time point Study design
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Moody LE, Fraser M, Yarandi H. Effects of guided imagery in patients with
chronic bronchitis and emphysema. Clin Nurs Res 1993;2:478–86
Time point Study design
Moore J, Fiddler H, Seymour J, Grant A, Jolley C, Johnson L, et al. Effect of a
home exercise video programme in patients with chronic obstructive pulmonary
disease. J Rehabil Med 2009;41:195–200
Time point –
Mota S, Güell R, Barreiro E, Solanes I, Ramirez-Sarmiento A, Orozco-Levi M, et al.
Clinical outcomes of expiratory muscle training in severe COPD patients. Respir
Med 2007;101:516–24
Time point –
Moullec G, Favreau H, Lavoie KL, Labrecque M. Does a self-management
education program have the same impact on emotional and functional
dimensions of HRQoL? COPD 2012;9:36–45
Time point Study design
Mousing CA, Lomborg K. Self-care 3 months after attending chronic obstructive
pulmonary disease patient education: a qualitative descriptive analysis. Patient
Prefer Adherence 2012;6:19–25
Time point Study design
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Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
[NCT00557115.] 2007. URL: www.clinicaltrials.gov (accessed 27 January 2015)
Publication type Publication type
Moxham J. The Effects of a Home Exercise Video Programme for Patients With
COPD; 2007. URL: www.clinicaltrials.gov (accessed 27 January 2015)
Publication type Publication type
Mularski RA, Munjas BA, Lorenz KA, Sun S, Robertson SJ, Schmelzer W, et al.
Randomized controlled trial of mindfulness-based therapy for dyspnea in
chronic obstructive lung disease. J Altern Complement Med 2009;15:1083–90
Time point –
Muller C, Heinl KW. [Patient training reduces the fear of cortisone in chronic
obstructive respiratory tract diseases.] Prav Rehabil 1996;8:45
Outcome Outcome
Mungall IP, Hainsworth R. An objective assessment of the value of exercise
training to patients with chronic obstructive airways disease. Q J Med
1980;49:77–85
Time point Study design
Murphy K, Casey D, Devane D, Cooney A, McCarthy B, Mee L, et al. A cluster
randomised controlled trial evaluating the effectiveness of a structured
pulmonary rehabilitation education programme for improving the health status
of people with chronic obstructive pulmonary disease (COPD): The PRINCE
Study protocol. BMC Pulm Med 2011;11:4
Publication type Publication type
Murphy K, Casey D, Devane D, Cooney A, McCarthy B, Mee L, et al. The
effectiveness of a structured education pulmonary rehabilitation programme for
improving the health status of people with Chronic Obstructive Pulmonary
Disease (COPD): The PRINCE study. Irish Thoracic Society Annual Scientific
Meeting, 11–12 November 2011, Co. Dublin, Ireland. Ir J Med Sci 2011:S457
Time point Publication type
Murphy M, Campbell M, Saunders J, Jackson B, Rangan N, Zimmerman F, et al.
A randomised, controlled trial of pulmonary rehabilitation, weekly exercise and
better health self-management in COPD. Respirology 2004;9(Suppl. 2):A48
Publication type Publication type
Murphy N, Bell C, Costello RW. Extending a home from hospital care programme
for COPD exacerbations to include pulmonary rehabilitation. Respir Med
2005;99:1297–302
Time point –
Muzembo NJ, Nkakudulu BH, Frans A. [Respiratory rehabilitation in patients
with bronchial asthma and chronic obstructive pulmonary disease (COPD) in
Kinshasa.] Rev Pneumol Clin 2001;57:209–18
Population Population
Na JO, Kim DS, Yoon SH, Jegal YJ, Kim WS, Kim ES, et al. A simple and easy
home-based pulmonary rehabilitation programme for patients with chronic lung
diseases. Monaldi Arch Chest Dis 2005;63:30–6
Time point Study design
Nakamura Y, Tanaka K, Shigematsu R, Nakagaichi M, Lnoue M, Homma T.
Effects of aerobic training and recreational activities in patients with chronic
obstructive pulmonary disease. Int J Rehabil Res 2008;31:275–83
Time point –
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Nalbant O, Nur H, Ogus C, Toraman NF. [Effects of long-term aerobic exercise
program in chronic obstructive pulmonary disease.] Turkiye Fiziksel Tip ve
Rehabilitasyon Dergisi 2011;57:8–13
Unavailable Unavailable
Nasis IG, Vogiatzis I, Stratakos G, Athanasopoulos D, Koutsoukou A, Daskalakis A,
et al. Effects of interval-load versus constant-load training on the BODE index in
COPD patients. Respir Med 2009;103:1392–8
Time point –
Nava S. Rehabilitation of patients admitted to a respiratory intensive care unit.
Arch Phys Med Rehabil 1998;79:849–54
Time point –
Navarre M, Patel H, Johnson CE, Durance A, McMorris M, Bria W, et al.
Influence of an interactive computer-based inhaler technique tutorial on patient
knowledge and inhaler technique. Ann Pharmacother 2007;41:216–21
Population Population
Navrotskii VV, Siurin SA. [Comparative efficacy of several types of physical
training in restoring the physical work capacity of chronic bronchitis patients.]
Vopr Kurortol Fizioter Lech Fiz Kult 1985;5:64–6
Time point Study design
Neff DF, Madigan E, Narsavage G. APN-directed transitional home care model:
achieving positive outcomes for patients with COPD. Home Healthc Nurse
2003;21:543–50
Intervention Intervention
Newton DA, Bevans HG. Physiotherapy and intermittent positive-pressure
ventilation of chronic bronchitis. Br Med J 1978;2:1525–8
Intervention Intervention
Ng BH, Tsang HW, Jones AY, So CT, Mok TY. Functional and psychosocial
effects of health qigong in patients with COPD: a randomized controlled trial.
J Altern Complement Med 2011;17:243–51
Time point –
Nguyen HQ, Carrieri-Kohlman V, Rankin SH, Slaughter R, Stulbarg MS. Is
internet-based support for dyspnea self-management in patients with chronic
obstructive pulmonary disease possible? Results of a pilot study. Heart Lung
2005;34:51–62
Time point Study design
Nguyen HQ, Carrieri-Kohlman V. Dyspnea self-management in patients with
chronic obstructive pulmonary disease: moderating effects of depressed mood.
Psychosomatics 2005;46:402–10
Time point Study design
Nguyen HQ, Donesky-Cuenco D, Wolpin S, Reinke LF, Benditt JO, Paul SM,
et al. Randomized controlled trial of an internet-based versus face-to-face
dyspnea self-management program for patients with chronic obstructive
pulmonary disease: pilot study. J Med Internet Res 2008;10:e9
Time point –
Nguyen HQ, Gill DP, Wolpin S, Steele BG, Benditt JO. Pilot study of a cell
phone-based exercise persistence intervention post-rehabilitation for COPD.
Int J Chron Obstruct Pulmon Dis 2009;4:301–13
Time point –
Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, et al.
American Thoracic Society/European Respiratory Society statement on
pulmonary rehabilitation. Am J Respir Crit Care Med 2006;173:1390–413
Study design Study design
Nield MA, Soo Hoo GW, Roper JM, Santiago S. Efficacy of pursed-lips
breathing: a breathing pattern retraining strategy for dyspnea reduction.
J Cardiopulm Rehabil Prev 2007;27:237–44
Time point –
Ninot G, Moullec G, Picot MC, Jaussent A, Hayot M, Desplan M, et al.
Cost-saving effect of supervised exercise associated to COPD self-management
education program. Respir Med 2011;105:377–85
Time point –
Nissen I, Jensen MS. [Nurse-supported discharge of patients with exacerbation
of chronic obstructive pulmonary disease.] Ugeskr Laeger 2007;169:2220–3
Intervention Intervention
Nissen I, Jensen MS. [Randomised controlled trial of nurse-supported discharge
of patients with exacerbation of chronic obstructive pulmonary disease.] Ugeskr
Laeger 2007;169:2220–3
Duplicate Duplicate
Normandin EA, McCusker C, Connors M, Vale F, Gerardi D, Zuwallack RL.
An evaluation of two approaches to exercise conditioning in pulmonary
rehabilitation. Chest 2002;121:1085–91
Time point –
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Norweg AM, Whiteson J, Malgady R, Mola A, Rey M. The effectiveness of
different combinations of pulmonary rehabilitation program components: a
randomized controlled trial. Chest 2005;128:663–72
Time point –
Noseda A, Carpiaux JP, Vandeput W, Prigogine T, Schmerber J. Resistive
inspiratory muscle training and exercise performance in COPD patients.
A comparative study with conventional breathing retraining. Bull Eur
Physiopathol Respir 1987;23:457–63
Time point –
Nosworthy J, Barter C, Thomas S, Flynn M. An evaluation of the three elements
of pulmonary rehabilitation. Aust Physiother 1993;38:189–93
Time point –
O’Bey KA, Jim LK, Gee JP, Cowen ME, Quigley AE. An education program that
improves the psychomotor skills needed for metaproterenol inhaler use. Drug
Intell Clin Pharm 1982;16:945–8
Population Population
O’Donnell DE, McGuire M, Samis L, Webb KA. General exercise training
improves ventilatory and peripheral muscle strength and endurance in chronic
airflow limitation. Am J Respir Crit Care Med 1998;157:1489–97
Time point Study design
O’Donnell DE, McGuire M, Samis L, Webb KA. The impact of exercise
reconditioning on breathlessness in severe chronic air-flow limitation. Am J
Respir Crit Care Med 1995;152:2005–13
Time point Study design
Oga T, Nishimura K, Tsukino M, Sato S. Exercise responses during endurance
testing at different intensities in patients with COPD. Respir Med
2004;98:515–21
Time point Study design
Oh EG. The effects of home-based pulmonary rehabilitation in patients with
chronic lung disease. Int J Nurs Stud 2003;40:873–9
Time point –
O’Hara WJ, Lasachuk KE, Matheson PC. Weight training and backpacking in
chronic obstructive pulmonary disease. Respir Care 1984;29:1202–10
Time point Study design
Ojoo JC, Moon T, McGlone S, Martin K, Gardiner ED, Greenstone MA, et al.
Patients’ and carers’ preferences in two models of care for acute exacerbations
of COPD: results of a randomised controlled trial. Thorax 2002;57:167–9
Intervention Intervention
Oka T. [Self-care and guidance of patients: nursing of patients with chronic
obstructive lung diseases. Actions by self-help groups and the significance of
their activities.] Kango gijutsu 1988;34:1756–60
Study design Study design
Olséni L, Midgren B, Hörnblad Y, Wollmer P. Chest physiotherapy in chronic
obstructive pulmonary disease: forced expiratory technique combined with
either postural drainage or positive expiratory pressure breathing. Respir Med
1994;88:435–40
Time point Study design
O’Neill B, McKevitt A, Rafferty S, Bradley JM, Johnston D, Bradbury I, et al.
A comparison of twice- versus once-weekly supervision during pulmonary
rehabilitation in chronic obstructive pulmonary disease. Arch Phys Med Rehabil
2007;88:167–72
Time point –
O’Neill ES. Illness representations and coping of women with chronic
obstructive pulmonary disease: a pilot study. Heart Lung 2002;31:295–302
Time point Study design
Onodera A, Yazaki K. [Effects of a short-term pulmonary rehabilitation program
on patients with chronic respiratory failure due to pulmonary emphysema.]
Nihon Kokyuki Gakkai Zasshi 1998;36:679–83
Time point Study design
Ortega F, Toral J, Cejudo P, Villagomez R, Sanchez H, Castillo J, et al.
Comparison of effects of strength and endurance training in patients with
chronic obstructive pulmonary disease. Am J Respir Crit Care Med
2002;166:669–74
Time point –
O’Shea SD, Taylor NF, Paratz JD. A predominantly home-based progressive
resistance exercise program increases knee extensor strength in the short-term
in people with chronic obstructive pulmonary disease: a randomised controlled
trial. Aust J Physiother 2007;53:229–37
Time point –
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O’Shea SD, Taylor NF, Paratz JD. Qualitative outcomes of progressive resistance
exercise for people with COPD. Chron Respir Dis 2007;4:135–42
Time point Study design
Otsuka T, Kurihara N, Fujii T, Fujimoto S, Yoshikawa J. Effect of exercise training
and detraining on gas exchange kinetics in patients with chronic obstructive
pulmonary disease. Clin Physiol 1997;17:287–97
Time point Study design
Ozdemir EP, Solak O, Fidan F, Demirdal US, Evcik D, Unlu M, et al. [The effect
of water-based pulmonary rehabilitation on anxiety and quality of life in
chronic pulmonary obstructive disease patients.] Turkiye Klinikleri J Med Sci
2010;30:880–7
Time point –
Paget T, Jones C, Davies M, Evered C, Lewis C. Using home telehealth to
empower patients to monitor and manage long term conditions. Nurs Times
2010;106:17–19
Population Population
Panton LB, Golden J, Broeder CE, Browder KD, Cestaro-Seifer DJ, Seifer FD. The
effects of resistance training on functional outcomes in patients with chronic
obstructive pulmonary disease. Eur J Appl Physiol 2004;91:443–9
Time point Study design
Pardy RL, Rivington RN, Despas PJ, Macklem PT. Inspiratory muscle training
compared with physiotherapy in patients with chronic airflow limitation.
Am Rev Respir Dis 1981;123:421–5
Time point Study design
Park K, Robbins RA. ACP Journal Club. A COPD disease management program
reduced a composite of hospitalizations or emergency department visits. Ann
Intern Med 2011;154:JC3–5
Publication type Publication type
Pascual-Pape T, Badia JR, Marrades RM, Hernandez C, Ballester E, Fornas C,
et al. [Results of a preventive program and assisted hospital discharge for COPD
exacerbation. A feasibility study.] Med Clin 2003;120:408–11
Study design Study design
Paz-Diaz H, Montes de OM, Lopez JM, Celli BR. Pulmonary rehabilitation
improves depression, anxiety, dyspnea and health status in patients with COPD.
Am J Phys Med Rehabil 2007;86:30–6
Time point –
Pereira AM, Santa-Clara H, Pereira E, Simoes S, Remedios I, Cardoso J, et al.
Impact of combined exercise on chronic obstructive pulmonary patients’ state of
health. Rev Port Pneumol 2010;16:737–57
Time point Study design
Perry JA. Effectiveness of teaching in the rehabilitation of patients with chronic
bronchitis and emphysema. Nurs Res 1981;30:219–22
Time point Study design
Petersen AM, Mittendorfer B, Magkos F, Iversen M, Pedersen BK. Physical
activity counteracts increased whole-body protein breakdown in chronic
obstructive pulmonary disease patients. Scand J Med Sci Sports
2008;18:557–64
Time point –
Petty TL, Nett LM, Finigan MM, Brink GA, Corsello PR. A comprehensive care
program for chronic airway obstruction. Methods and preliminary evaluation of
symptomatic and functional improvement. Ann Intern Med 1969;70:1109–20
Time point Study design
Petty TL, Nett LM. Patient education and emphysema care. Med Times
1969;97:117–30
Publication type Publication type
Petty TL, Dempsey EC, Collins T, Pluss W, Lipkus I, Cutter GR, et al. Impact of
customized videotape education on quality of life in patients with chronic
obstructive pulmonary disease. J Cardiopulm Rehabil 2006;26:112–17
Time point –
Pfister T, Berrol C, Caplan C. Effects of music on exercise and perceived
symptoms in patients with chronic obstructive pulmonary disease. J Cardiopulm
Rehabil 1998;18:228–32
Time point Study design
Phillips WT, Benton MJ, Wagner CL, Riley C. The effect of single set resistance
training on strength and functional fitness in pulmonary rehabilitation patients.
J Cardiopulm Rehabil 2006;26:330–7
Time point –
Pilotto LS, Smith BJ, Heard AR, McElroy HJ, Weekley J, Bennett P. Trial of
nurse-run asthma clinics based in general practice versus usual medical care.
Respirology 2004;9:356–62
Population Population
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Pinnock H, Hanley J, Lewis S, MacNee W, Pagliari C, van der Pol M, et al. The
impact of a telemetric chronic obstructive pulmonary disease monitoring service:
randomised controlled trial with economic evaluation and nested qualitative
study. Prim Care Resp J 2009;18:233–5
Publication type Publication type
Pison C, Cano N, Cherion C, Roth H, Pichard C. [Effects of home pulmonary
rehabilitation in patients with chronic respiratory failure and nutritional
depletion.] Rev Mal Respir 2004;21:573–82
Publication type Publication type
Pison CM, Cano NJ, Cherion C, Caron F, Court-Fortune I, Antonini MT, et al.
Multimodal nutritional rehabilitation improves clinical outcomes of
malnourished patients with chronic respiratory failure: a randomised controlled
trial. Thorax 2011;66:953–60
Intervention Intervention
Piszko P, Lewczuk J, Jagas J, Kowalska-Superlak K, Wrabec K. Oxygen
saturation at rest, on exercise and during sleep in non oxygenated rehabilitation
patients with COPD. Eur Respir J 2002;20(Suppl. 38):235
Publication type Publication type
Piszko P, Lewczuk J, Kowalska-Superlak M, Jagas J, Ludwik B, Wrabec K.
[Effect of a 2-year pulmonary rehabilitation on the 7-year prognosis in patients
with advanced chronic obstructive pulmonary disease.] Pol Arch Med Wewn
2004;111:57–62
Time point Study design
Pitta F, Brunetto AF, Padovani CR, Godoy I. Effects of isolated cycle ergometer
training on patients with moderate-to-severe chronic obstructive pulmonary
disease. Respiration 2004;71:477–83
Time point Study design
Pitta F, Takaki MY, Oliveira NH, Sant’anna TJ, Fontana AD, Kovelis D, et al.
Relationship between pulmonary function and physical activity in daily life in
patients with COPD. Respir Med 2008;102:1203–07
Time point Study design
Pomidori L, Contoli M, Mandolesi G, Cogo A. A simple method for home
exercise training in patients with chronic obstructive pulmonary disease:
one-year study. J Cardiopulm Rehabil Prev 2012;32:53–7
Time point –
Poole PJ, Chase B, Frankel A, Black PN. Case management may reduce length
of hospital stay in patients with recurrent admissions for chronic obstructive
pulmonary disease. Respirology 2001;6:37–42
Time point Study design
Porszasz J, Emtner M, Goto S, Somfay A, Whipp BJ, Casaburi R. Exercise
training decreases ventilatory requirements and exercise-induced hyperinflation
at submaximal intensities in patients with COPD. Chest 2005;128:2025–34
Time point Study design
Porta R, Vitacca M, Gile LS, Clini E, Bianchi L, Zanotti E, et al. Supported arm
training in patients recently weaned from mechanical ventilation. Chest
2005;128:2511–20
Intervention Intervention
Porto EF, Castro AA, Velloso M, Nascimento O, Dal MF, Jardim JR. Exercises
using the upper limbs hyperinflate COPD patients more than exercises using the
lower limbs at the same metabolic demand. Monaldi Archr Chest Dis
2009;71:21–6
Time point Study design
Potashov DA, Kokosov AN. [Characteristics and results of rehabilitation of
patients with chronic obstructive bronchitis at a specialized department.] Probl
Tuberk 1990;3:62–6
Time point Study design
Pouw EM, Ten Velde GP, Croonen BH, Kester AD, Schols AM, Wouters EF. Early
non-elective readmission for chronic obstructive pulmonary disease is associated
with weight loss. Clin Nutr 2000;19:95–9
Study design Study design
Premaratne U, Sterne J, Marks G, Webb J, Azima H, Burney P. Clustered
randomised trial of an intervention to improve the management of asthma:
Greenwich asthma study. BMJ 1999;318:1251–5
Population Population
Preusser BA, Winningham ML, Clanton TL. High- vs low-intensity inspiratory
muscle interval training in patients with COPD. Chest 1994;106:110–17
Time point –
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Prigmore S. Does an Individualised Self-management Plan Help Patients with
Chronic Obstructive Pulmonary Disease (COPD) Initiate Early Treatment for
Infective Exacerbations? ISRCTN Register 2004. URL: www.isrctn.org
(accessed 27 January 2015)
Publication type Publication type
Prince KL, Helm M. Effectiveness of a rehabilitation programme in chronic
bronchitis and emphysema. Clin Rehabil 1989;3:211–14
Time point –
Prior H. Randomized Controlled Trial of Home Telemonitoring for Elderly People
(Dreaming); 2009. URL: www.clinicaltrials.gov (accessed 27 January 2015)
Population Population
Probst VS, Troosters T, Coosemans I, Spruit MA, Pitta FO, Decramer M, et al.
Mechanisms of improvement in exercise capacity using a rollator in patients
with COPD. Chest 2004;126:1102–7
Time point Study design
Probst VS, Troosters T, Pitta F, Decramer M, Gosselink R. Cardiopulmonary stress
during exercise training in patients with COPD. Eur Respir J 2006;27:1110–18
Time point Study design
Probst VS, Kovelis D, Hernandes NA, Camillo CA, Cavalheri V, Pitta F. Effects of
2 exercise training programs on physical activity in daily life in patients with
COPD. Respir Care 2011;56:1799–807
Time point –
Puente-Maestu L, Sanz ML, Sanz P, Cubillo JM, Mayol J, Casaburi R. Comparison
of effects of supervised versus self-monitored training programmes in patients
with chronic obstructive pulmonary disease. Eur Respir J 2000;15:517–25
Time point –
Puente-Maestu L, Sanz ML, Sanz P, Ruiz De Ona JM, Rodriguez-Hermosa JL,
Whipp BJ. Effects of two types of training on pulmonary and cardiac responses
to moderate exercise in patients with COPD. Eur Respir J 2000;15:1026–32
Time point –
Puente-Maestu L, SantaCruz A, Vargas T, Martinez-Abad Y, Whipp BJ. Effects
of training on the tolerance to high-intensity exercise in patients with severe
COPD. Respiration 2003;70:367–70
Time point Study design
Puente-Maestu L, Luisa SM, Sanz P, de Ona RJ, Arnedillo A, Casaburi R.
Long-term effects of a maintenance program after supervised or self-monitored
training programs in patients with COPD. Lung 2003;181:67–78
Time point –
Puente-Maestu L, Abad YM, Pedraza F, Sanchez G, Stringer WW. A controlled
trial of the effects of leg training on breathing pattern and dynamic hyperinflation
in severe COPD. Lung 2006;184:159–67
Time point Study design
Puhan M, Spaar A, Frey M, Turk A, Brandli O, Ritscher D, et al. Timing of
pulmonary rehabilitation – Swiss trial on pulmonary rehabilitation after COPD
exacerbation (SOPRE). Joint Annual Meeting of the Swiss Respiratory Society,
Swiss Society of Oto-Rhino-Laryngology, Head and Neck Surgery, Swiss
Paediatric Respiratory Society and Swiss Society for Thoracic Surgery,
4–5 May 2011, Interlaken, Switzerland. Respiration 2011:92
Intervention Publication type
Puhan MA, Busching G, Schunemann HJ, van Oort E, Zaugg C, Frey M. Interval
versus continuous high-intensity exercise in chronic obstructive pulmonary
disease: a randomized trial. [Summary for patients in Ann Intern Med
2006;145:I49.] Ann Intern Med 2006;145:816–25
Time point –
Puhan MA, Schunemann HJ, Buesching G, van Oort E, Spaar A, Frey M.
COPD patients’ ability to follow exercise influences short-term outcomes of
rehabilitation. Eur Respir J 2008;31:304–10
Time point Study design
Punzal PA, Ries AL, Kaplan RM, Prewitt LM. Maximum intensity exercise
training in patients with chronic obstructive pulmonary disease. Chest
1991;100:618–23
Time point Study design
Pushparajah S, McClellan R, Henry A, Kuitert LM. Use of a chronic disease
management programme in COPD to reduce hospital admissions. Chron Respir
Dis 2006;3:187–93
Study design Study design
Putt MT, Watson M, Seale H, Paratz JD. Muscle stretching technique increases
vital capacity and range of motion in patients with chronic obstructive
pulmonary disease. Arch Phys Med Rehabil 2008;89:1103–7
Time point Study design
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Ramirez-Sarmiento A, Orozco-Levi M, Güell R, Barreiro E, Hernandez N, Mota S,
et al. Inspiratory muscle training in patients with chronic obstructive pulmonary
disease: structural adaptation and physiologic outcomes. Am J Respir Crit Care
Med 2002;166:1491–7
Time point –
Rasekaba TM, Williams E, Hsu-Hage B. Can a chronic disease management
pulmonary rehabilitation program for COPD reduce acute rural hospital
utilization? Chron Respir Dis 2009;6:157–63
Time point Study design
Rea H, McAuley S, Stewart A, Lamont C, Roseman P, Didsbury P. A chronic
disease management programme can reduce days in hospital for patients with
chronic obstructive pulmonary disease. Intern Med J 2004;34:608–14
Time point –
Reardon J, Awad E, Normandin E, Vale F, Clark B, Zuwallack RL. The effect of
comprehensive outpatient pulmonary rehabilitation on dyspnea. Chest
1994;105:1046–52
Time point –
Reema T, Adepu R, Sabin T. Impact of clinical pharmacist intervention on
knowledge, attitude and practice (KAP) of patients with chronic obstructive
pulmonary disease. Int J Pharm Pharm Sci 2010;2:54–7
Time point Study design
Rees PJ. A disease-specific self-management program reduced hospital
utilization and improved health status in COPD. ACP J Club 2012;139:65
Publication type Publication type
Regiane R, V, Gorostiza A, Galdiz JB, Lopez de Santa ME, Casan CP, Güell RR.
[Benefits of a home-based pulmonary rehabilitation program for patients
with severe chronic obstructive pulmonary disease.] Arch Bronconeumol
2007;43:599–604
Time point –
Reid WD, Samrai B. Respiratory muscle training for patients with chronic
obstructive pulmonary-disease. Phys Ther 1995;75:996–1005
Publication type Publication type
Rejbi IB, Trabelsi Y, Chouchene A, Ben TW, Ben SH, Zbidi A, et al. Changes in
six-minute walking distance during pulmonary rehabilitation in patients with
COPD and in healthy subjects. Int J Chron Obstruct Pulmon Dis 2010;5:209–15
Population Population
Ren L, Li Q-Y, Du J-B, Zhou J-M, Weng Q-L, Chen X-H. Comparison of different
strategies of pulmonary rehabilitation for patients with COPD of different
severity. J Shanghai Jiaotong Uni (Med Sci) 2011;31:620–4
Time point –
Renfroe KL. Effect of progressive relaxation on dyspnea and state anxiety in
patients with chronic obstructive pulmonary disease. Heart Lung 1988;17:408–13
Population Population
Renzi G, Renzi P. [Role of respiratory muscle training in a rehabilitation program
for patients with chronic obstructive pulmonary disease.] Union Medicale de
Canada 1985;114:897–901
Time point Study design
Resnikoff PM, Ries AL. Pulmonary rehabilitation for chronic lung disease. J Heart
Lung Transpl 1998;17:643–50
Publication type Publication type
Riario-Sforza GG, Incorvaia C, Paterniti F, Pessina L, Caligiuri R, Pravettoni C,
et al. Effects of pulmonary rehabilitation on exercise capacity in patients with
COPD: a number needed to treat study. Int J Chron Obstruct Pulmon Dis
2009;4:315–19
Time point Study design
Rice KL, Dewan N, Bloomfield HE, Grill J, Schult TM, Nelson DB, et al. Disease
management program for chronic obstructive pulmonary disease: a randomized
controlled trial. Am J Respir Crit Care Med 2010;182:890–6
Time point –
Richards S, Coast J, Gunnell D, Peters T, Poundsford J, Darlow M-A.
Randomised controlled trial comparing effectiveness and acceptability of
an early discharge, hospital at home scheme with acute hospital care. BMJ
1998;316:1796–806
Population Population
Richardson J, Dunn L, Pardy R. Inspiratory resistive endurance training in
patients with chronic obstructive pulmonary disease: a pilot study. Physiother
Can 1989;41:85–92
Time point Study design
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Riera HS, Rubio TM, Ruiz FO, Ramos PC, Del Castillo OD, Hernandez TE, et al.
Inspiratory muscle training in patients with COPD: effect on dyspnea, exercise
performance, and quality of life. Chest 2001;120:748–56
Time point –
Ries AL, Archibald CJ. Endurance exercise training at maximal targets in
patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil
1987;7:594–601
Time point Study design
Ries AL, Moser KM. Comparison of isocapnic hyperventilation and walking
exercise training at home in pulmonary rehabilitation. Chest 1986;90:285–9
Time point –
Ries AL, Ellis B, Hawkins RW. Upper extremity exercise training in chronic
obstructive pulmonary disease. Chest 1988;93:688–92
Time point –
Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effect of pulmonary rehabilitation
program on hospital days of COPD patients. Ann Intern Med 1995;122:823–32
Unavailable Unavailable
Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation
on physiologic and psychosocial outcomes in patients with chronic obstructive
pulmonary disease. Ann Intern Med 1995;122:823–32
Time point –
Ries AL, Kaplan RM, Myers R, Prewitt LM. Maintenance after pulmonary
rehabilitation in chronic lung disease: a randomized trial. Am J Respir Crit Care
Med 2003;167:880–8
Population Population
Ries AL, Make BJ, Lee SM, Krasna MJ, Bartels M, Crouch R, et al. The effects of
pulmonary rehabilitation in the national emphysema treatment trial. Chest
2005;128:3799–809
Time point Study design
Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, et al.
Pulmonary rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice
Guidelines. Chest 2007;131(Suppl. 5):4–42S
Publication type Publication type
Ringbaek TJ, Broendum E, Hemmingsen L, Lybeck K, Nielsen D, Andersen C,
et al. Rehabilitation of patients with chronic obstructive pulmonary disease.
Exercise twice a week is not sufficient! Respir Med 2000;94:150–4
Time point –
Ringbaek TJ, Nielsen LL, Admasu H, Lange P. [Early supported discharge for
patients with exacerbations of chronic obstructive pulmonary disease.] Ugeskr
Laeger 2008;170:47–50
Intervention Intervention
Ringbaek T, Brondum E, Martinez G, Lange P, Pulmonary Rehabilitation
Research Group. Rehabilitation in COPD: the long-term effect of a supervised
7-week program succeeded by a self-monitored walking program. Chron Respir
Dis 2008;5:75–80
Time point Study design
Ringbaek T, Brondum E, Martinez G, Thogersen J, Lange P. Long-term effects of
1-year maintenance training on physical functioning and health status in
patients with COPD: a randomized controlled study. J Cardiopulm Rehabil Prev
2010;30:47–52
Intervention Intervention
Roberts CM, Ryland I, Lowe D, Kelly Y, Bucknall CE, Pearson MG. Audit of
acute admissions of COPD: standards of care and management in the hospital
setting. Eur Respir J 2001;17:343–9
Study design Study design
Roberts MM, Leeder SR, Robinson TD. Nurse-led 24-h hotline for patients with
chronic obstructive pulmonary disease reduces hospital use and is safe. Intern
Med J 2008;38:334–40
Time point Study design
Roberts SE, Kettle G, Rogers S, Segal A, Purcell S, Fabris G, et al. Piloting and
evaluating post-pulmonary rehabilitation (PR) long-term exercise (LTE) for COPD
patients. British Thoracic Society Winter Meeting, 7–9 November 2011, London,
UK. Thorax 2011:A127–8
Time point Study design
Roberts SE, Schreuder FM, Watson T, Stern M. A randomised control trial to
investigate the effectiveness of PLB in the clinical setting. British Thoracic Society
Winter Meeting, 7–9 November 2011, London, UK. Thorax 2011:A175–6
Time point Publication type
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Robinson S, Fletcher C, Parrington J, Norell J, Mabbett S. COPD and me:
The development and implementation of an individual patient management
plan and hand-held record. British Thoracic Society Winter Meeting,
1–3 December 2010, London, UK. Thorax 2010; A174–5
Time point Study design
Robinson T. Living with severe hypoxic COPD: the patients’ experience. Nurs
Times 2005;101:38–42
Time point Study design
Rodgers S, Dyas J, Molyneux AW, Ward MJ, Revill SM. Evaluation of the
information needs of patients with chronic obstructive pulmonary disease
following pulmonary rehabilitation: a focus group study. Chron Respir Dis
2007;4:195–203
Time point Study design
Romagnoli M, Dell’Orso D, Lorenzi C, Crisafulli E, Costi S, Lugli D, et al.
Repeated pulmonary rehabilitation in severe and disabled COPD patients.
Respiration 2006;73:769–76
Time point –
Roomi J, Yohannes AM, Connolly MJ. The effect of walking aids on exercise
capacity and oxygenation in elderly patients with chronic obstructive pulmonary
disease. Age Ageing 1998;27:703–6
Time point Study design
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COPD patients at a respiratory outpatient clinic: results from a double blind,
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Population Population
Rooyackers JM, Berkeljon DA, Folgering HT. Eccentric exercise training in
patients with chronic obstructive pulmonary disease. Int J Rehabil Res
2003;26:47–4
Time point –
Rosser R, Denford J, Heslop A, Kinston W, Macklin D, Minty K, et al.
Breathlessness and psychiatric morbidity in chronic bronchitis and emphysema:
a study of psychotherapeutic management. Psychol Med 1983;13:93–110
Intervention Intervention
Rozman A, Butorac-Petanjek B, Plesko N, Sarajlic N, Crc M, Krstic-Buric M.
[Education and training in COPD patients in Croatia.] Prav Rehabil
2001;13:125–7
Population Population
Ruiz de Ona Lacasta JM, Garcia de PJ, Puente ML, Llorente ID, Celdran GJ,
Cubillo Marcos JM. [Effects of muscle training on breathing pattern in patients
with severe chronic obstructive pulmonary disease.] Arch Bronconeumol
2004;40:20–3.
Time point –
Ruzicka J, Zvonar J, Kolesar J, Redhammer R, Kristufek P, Karpatiova A, et al.
[Effectiveness of load training in the rehabilitation of patients with chronic
obstructive lung disease.] Studia Pneumologica et Phtiseologica Cechoslovaca
1989;49:544–8
Time point Study design
Ruzicka J, Zvonar J, Kolesar J, Redhammer R, Kristufek P, Karpatiova A, et al.
[Resisted inspiration training and re-education of respiration in the rehabilitation
programme on patients with chronic pulmonary obstructive disease.] Studia
Pneumologica et Phtiseologica Cechoslovaca 1989;49:538–43
Time point Study design
Sabapathy S, Kingsley RA, Schneider DA, Adams L, Morris NR. Continuous and
intermittent exercise responses in individuals with chronic obstructive pulmonary
disease. Thorax 2004;59:1026–31
Time point Study design
Sala E, Alegre L, Carrera M, Ibars M, Orriols FJ, Blanco ML, et al. Supported
discharge shortens hospital stay in patients hospitalized because of an
exacerbation of COPD. Eur Respir J 2001;17:1138–42
Intervention Study design
Sala E, Roca J, Marrades RM, Alonso J, Gonzalez De Suso JM, Moreno A, et al.
Effects of endurance training on skeletal muscle bioenergetics in chronic
obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1726–34
Population Population
Sandland CJ, Morgan MD, Singh SJ. Detecting oxygen desaturation in patients
with COPD: incremental versus endurance shuttle walking. Respir Med
2008;102:1148–52
Intervention Intervention
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Santiworakul A, Jarungjitaree S, Jalayondeja W, Chantarothorn S, Supaibulpipat S.
Effect of lower extremity exercise on muscle strength and physical capacity in
COPD patients. J Med Assoc Thailand 2009;92:556–63
Time point Study design
Santos C, Santos J, Morais L, Rodrigues F, Rbara C. Pulmonary rehabilitation in
COPD: Effects of two aerobic exercise intensity in patient-centered outcomes:
a randomized study. European Respiratory Society Annual Congress, 18–22
September 2010, Barcelona, Spain, p. 2835
Publication type Publication type
Santos C, Santos J, Morais L, Rodrigues F, Barbara C. Pulmonary rehabilitation
in COPD: effects of two aerobic exercise intensity in patient-centered outcomes:
a randomized study. CHEST conference, 22–26 November 2011, Honolulu, HI,
USA. Chest 2011:(var. pagings)
Time point Publication type
Sasaki Y. [Pulmonary rehabilitation.] Hokkaido igaku zasshi 1986;61:340–3 Study design Study design
Sassi-Dambron DE, Eakin EG, Ries AL, Kaplan RM. Treatment of dyspnea in
COPD. A controlled clinical trial of dyspnea management strategies. Chest
1995;107:724–9
Time point –
Satake M, Shioya T, Takahashi H, Kawatani M. Ventilatory responses to
six-minute walk test, incremental shuttle walking test, and cycle ergometer
test in patients with chronic obstructive pulmonary disease. Biomed Res
2003;24:309–16
Time point Study design
Saudny-Unterberger H, Martin JG, Gray-Donald K. Impact of nutritional support
on functional status during an acute exacerbation of chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 1997;156:794–9
Intervention Intervention
Saunders KB, White JE. Controlled trial of breathing exercises. Br Med J
1965;2:680–2
Time point –
Savci S, Ince DI, Arikan H. A comparison of autogenic drainage and the active
cycle of breathing techniques in patients with chronic obstructive pulmonary
diseases. J Cardiopulm Rehabil 2000;20:37–43
Time point –
Scherer TA, Spengler CM, Owassapian D, Imhof E, Boutellier U. Respiratory
muscle endurance training in chronic obstructive pulmonary disease: impact on
exercise capacity, dyspnea, and quality of life. Am J Respir Crit Care Med
2000;162:1709–14
Time point –
Scherer YK, Janelli LM, Schmieder LE. Chronic obstructive pulmonary disease:
does participating in a Help Yourself to Better Breathing Program make a
difference? J Cardiopulm Rehabil 1989;9:492–6
Time point Study design
Scherer YK, Janelli LM, Schmieder LE. A time-series perspective on effectiveness
of a health teaching program on chronic obstructive pulmonary disease.
J Healthc Educ Train 1992;6:7–13
Time point Study design
Scherer YK, Schmieder LE. The effect of a pulmonary rehabilitation program on
self-efficacy, perception of dyspnea, and physical endurance. Heart Lung
1997;26:15–22
Time point Study design
Scherer YK, Schmieder LE, Shimmel S. The effects of education alone and in
combination with pulmonary rehabilitation on self-efficacy in patients with
COPD. Rehabil Nurs J 1998;23:71–7
Time point Study design
Schlozman DL. Rehabilitation of patients with chronic obstructive lung disease.
Pneumonologia Polska 1986;54:217–21
Publication type Publication type
Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF. Physiologic effects
of nutritional support and anabolic steroids in patients with chronic obstructive
pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care
Med 1995;152:1268–74
Intervention Intervention
Schomberg LEE, Garner JL, Porter JW, Bahadur K, Ross L, Kosky CA, et al.
Does the provision of a rescue pack keep patients with chronic obstructive
pulmonary disease (COPD) at home? British Thoracic Society Winter Meeting,
7–9 November 2011, London, UK. Thorax 2011:A174
Conference abstract Publication type
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Schonlau M, Mangione-Smith R, Chan KS, Keesey J, Rosen M, Louis TA, et al.
Evaluation of a quality improvement collaborative in asthma care: does it
improve processes and outcomes of care? Ann Fam Med 2005;3:200–8
Population Population
Schucher B, Criee C-P. [Respiratory muscle training.] Atemweg Lungenkrank
2009;35:312–17
Study design Study design
Schultz K, Schwiersch M, Petro W, Muhlig S, Petermann F. [Individualized,
modular structured patient behavioral training in obstructive airway diseases
during inpatient rehabilitation.] Pneumologie 2000;54:296–305
Publication type Publication type
Schultz K, Stark HJ, Petro W. [New educational tasks in the rehabilitation of
respiratory diseases.] Atemwegs- und Lungenkrankheiten 1996;22:38–44
Time point Study design
Schulz M, Verheyen F, Muhlig S, Muller JM, Muhlbauer K, Knop-Schneickert E,
et al. Pharmaceutical care services for asthma patients: a controlled intervention
study. J Clin Pharmacol 2001;41:668–76
Population Population
Sedeno MF, Nault D, Hamd DH, Bourbeau J. A written action plan for early
treatment of COPD exacerbations: an important component to the reduction of
hospitalizations. Proc ATS 2006;3:A603
Publication type Publication type
Sedeno MF, Nault D, Hamd DH, Bourbeau J. A self-management education
program including an action plan for acute COPD exacerbations. COPD
2009;6:352–8
Time point Study design
Seron P, Riedemann P, Munoz S, Doussoulin A, Villarroel P, Cea X. [Effect of
inspiratory muscle training on muscle strength and quality of life in patients
with chronic airflow limitation: A randomized controlled trial.] Arch
Bronconeumol 2005;41:601–6
Population Population
Serres I, Varray A, Vallet G, Micallef JP, Prefaut C. Improved skeletal muscle
performance after individualized exercise training in patients with chronic
obstructive pulmonary disease. J Cardiopulm Rehabil 1997;17:232–8
Time point Study design
Sewell L, Singh SJ, Williams JE, Collier RJ, Morgan MDL. Goal directed
pulmonary rehabilitation does not significantly improve health status and
domestic function. Eur Respir J 2001;18(Suppl. 33):187s
Time point Publication type
Sewell L, Singh SJ, Williams JE, Collier R, Morgan MD. Can individualized
rehabilitation improve functional independence in elderly patients with COPD?
Chest 2005;128:1194–200
Time point –
Sewell L, Singh SJ, Williams JE, Collier R, Morgan MD. How long should
outpatient pulmonary rehabilitation be? A randomised controlled trial of
4 weeks versus 7 weeks. Thorax 2006;61:767–71
Time point –
Seymour JM, Moore L, Jolley CJ, Ward K, Creasey J, Steier JS, et al. Outpatient
pulmonary rehabilitation following acute exacerbations of COPD. Thorax
2010;65:423–8
Intervention –
Shahin B, Germain M, Kazem A, Annat G. Benefits of short inspiratory muscle
training on exercise capacity, dyspnea, and inspiratory fraction in COPD
patients. Int J Chron Obstruct Pulmon Dis 2008;3:423–7
Time point Study design
Shakur H. A COPD self management programme reduced hospital use and
improved health status. Evid Based Nurs 2003;6:111
Publication type Publication type
Shao L-Z. [Effects of the behavioral intervention on the life quality of the
patients with chronic obstructive pulmonary disease in remission period.] Chin J
Clin Rehabil 2003;7:4078–9
Time point –
Shepperd S, Harwood D, Gray A, Vessey M, Morgan P. Randomised controlled
trial comparing hospital at home care with inpatient hospital care. II: cost
minimisation analysis. BMJ 1998;316:1791–6
Intervention Intervention
Sheridan N, Kenealy T, Salmon E, Rea H, Raphael D, Schmidt-Busby J.
Helplessness, self blame and faith may impact on self management in COPD:
a qualitative study. Prim Care Resp J 2001;20:307–14
Time point Study design
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Conference proceedings. Short-Term In-hospital Rehabilitation Program (SRP) in
COPD Patients. Functional and Clinical Effectiveness. Series: Diseases of the
chest. The College; 1996. Vol. 110, no. 4. p. 137S
Unavailable Unavailable
Silverman M, Musa D, Kirsch B, Siminoff LA. Self care for chronic illness: older
African Americans and whites. J Cross Cult Gerontol 1999;14:169–89
Time point Study design
Simpson K, Killian K, McCartney N, Stubbing DG, Jones NL. Randomised
controlled trial of weightlifting exercise in patients with chronic airflow
limitation. Thorax 1992;47:70–5
Time point –
Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management
of chronic obstructive pulmonary disease: scientific review. JAMA
2003;290:2301–12
Publication type Publication type
Sinclair DJ, Ingram CG. Controlled trial of supervised exercise training in chronic
bronchitis. BMJ 1980;280:519–21
Study design Study design
Sindhwani G, Verma A, Biswas D, Srivastava M, Rawat J. A pilot study on
domiciliary pulmonary rehabilitation programme in the management of severe
chronic obstructive pulmonary disease. Singapore Med J 2011;52:689–93
Time point Study design
Singh V, Khandelwal DC, Khandelwal R, Abusaria S. Pulmonary rehabilitation in
patients with chronic obstructive pulmonary disease. Indian J Chest Dis Allied Sci
2003;45:13–17
Time point –
Singh VP, Rao V, Prem V, Sahoo RC, Kenshav Pai K. Comparison of the
effectiveness of music and progressive muscle relaxation for anxiety in COPD: a
randomized controlled pilot study. Chron Respir Dis 2009;6:209–16
Time point –
Sirey JA, Raue PJ, Alexopoulos GS. An intervention to improve depression care
in older adults with COPD. Int J Geriatr Psychiatry 2007;22:154–9
Intervention Intervention
Sirinoglu Y, Sancar M, Karagoz T, Izzettin FV. The effect of pharmacist-led
education on skills of patients with chronic obstructive pulmonary disease in
using inhaler device. 39th ESCP European Symposium on Clinical Pharmacy and
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27 January 2015)
Publication type Publication type
Varga J, Porszasz J, Boda K, Casaburi R, Somfay A. Supervised high intensity
continuous and interval training vs. self-paced training in COPD. Respir Med
2007;101:2297–304
Time point –
Vargas F, Boyer A, Bui HN, Salmi LR. Intrapulmonary percussive ventilation in
acute exacerbations of COPD patients with mild respiratory acidosis: a
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Publication type Publication type
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Wang QX, Zhang XY, Li QA. Effects of a flutter mucus-clearance device on
pulmonary function test results in healthy people 85 years and older in China.
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Wang Z, Zeng H, Chen H. [Rehabilitative treatment in patients with chronic
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Wanke T, Formanek D, Lahrmann H, Brath H, Wild M, Wagner C, et al. Effects
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education program ‘Lebensrhythmus Atmen’: a prospective, randomized,
controlled study for COPD patients: a pilot study.] Pravention und Rehabilitation
2006;18:68–79
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Warm D, Lewis K. A New Model for Continuous Care of Chronic Patients: eCare
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controlled trial of pulmonary rehabilitation in severe chronic obstructive
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Weekes CE, Emery PW, Elia M. Dietary counselling and food fortification in
stable COPD: a randomised trial. Thorax 2009;64:326–31
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care reduce hospital readmissions? N Engl J Med 1996;334:1441–7
Intervention Intervention
Weinberger M, Murray MD, Marrero DG, Brewer N, Lykens M, Harris LE, et al.
Effectiveness of pharmacist care for patients with reactive airways disease: a
randomized controlled trial. JAMA 2002;288:1594–602
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Weiner P, Azgad Y, Ganam R. Inspiratory muscle training combined with
general exercise reconditioning in patients with COPD. Chest 1992;102:1351–6
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Weiner P, Azgad Y, Ganam R, Weiner M. Inspiratory muscle training in patients
with bronchial asthma. Chest 1992;102:1357–61
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Weiner P, Magadle R, Berar-Yanay N, Davidovich A, Weiner M. The cumulative
effect of long-acting bronchodilators, exercise, and inspiratory muscle training
on the perception of dyspnea in patients with advanced COPD. Chest
2000;118:672–8
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Weiner P, Magadle R, Beckerman M, Weiner M, Berar-Yanay N. Comparison of
specific expiratory, inspiratory, and combined muscle training programs in
COPD. Chest 2003;124:1357–64
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Weiner P, Magadle R, Beckerman M, Weiner M, Berar-Yanay N. Specific
expiratory muscle training in COPD. Chest 2003;124:468–73
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Weiner P, Magandle R, Beckerman M, Weiner M, Berar-Yanay N. Maintenance
of inspiratory muscle training in COPD patients: one year follow-up. Eur Respir J
2004;23:61–5
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Weiner P, Weiner M. Inspiratory muscle training may increase peak inspiratory
flow in chronic obstructive pulmonary disease. Respiration 2006;73:151–6
Time point –
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medical follow-up. A negative randomized trial. Eff Clin Pract 2000;3:123–30
Population Population
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Wen H, Gao Y, An JY. [Comparison of high-intensity and anaerobic threshold
programs in rehabilitation for patients with moderate to severe chronic
obstructive pulmonary disease.] Chung-Hua Chieh Ho Ho Hu Hsi Tsa Chih
2008;31:571–6
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Wen Y-L, Huang D-F, Huang M, Huang Y-P. [Evaluation on the effect of
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perceptions. J Telemed Telecare 2007;13:69–73
Population Population
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Study design Study design
Wijkstra PJ, ten Vergert EM, van Altena R, Otten V, Kraan J, Postma DS, et al.
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Appendix 3 Conference abstracts, relevant to
review 1, between 2010 and 2012
American Thoracic Society 2012
Controlled trial of short term (3 weeks) pulmonary rehabilitation in COPD following acute exacerbation
MS Ali, D Talwar, RK Singh, D Pabreja
India
European Respiratory Society 2012
Do telephone interventions of patients with COPD prevent readmission?
M Lavesen, R Overgaard, S Mazurek, A Just, D Overgaard
Denmark
Effect on prevention of readmissions of a home-based education and exercise program implemented early after
a severe exacerbation of COPD
R Coll-Fernandez, N Martínez, M Arranz, H Prados, X Pomares, A Moreno, M Teixidó, F Epelde, F Caballero,
E Monsó
Spain
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Appendix 4 List of ongoing trials relevant to
reviews 1–4
Citation
Relevant to review
1 2 3 4
Optimizing the effect of COPD rehabilitation – – – Y
A multi-center study of rehabilitation to stable chronic obstructive pulmonary disease (COPD) patients – – – Y
Effectiveness of incorporating tai chi in pulmonary rehabilitation program for patients with chronic
obstructive pulmonary disease in primary health care
– – – Y
Long-term respiratory rehabilitation programs in chronic obstructive pulmonary disease (COPD)
patients: study of cost-effectiveness
– – – Y
Early pulmonary rehabilitation following acute COPD exacerbation – – – Y
Benefits and costs of home-based pulmonary rehabilitation in chronic obstructive pulmonary disease – – – Y
Effects of home-based pulmonary rehabilitation in patients with severe or very severe chronic
obstructive pulmonary disease (COPD)
– – – Y
Home-based in chronic obstructive pulmonary disease – – – Y
Nutritional rehabilitation in chronic obstructive pulmonary disease (COPD) patients with muscle
atrophy
– – – Y
Effects of inspiratory muscle training on dyspnea in subjects with chronic obstructive pulmonary
disease
– – – Y
Eccentric exercise training as novel rehabilitation for chronic obstructive pulmonary disease (COPD) – – – Y
Physical activity counseling during pulmonary rehabilitation – – – Y
Long-term physical training in chronic obstructive pulmonary disease – – – Y
Multicomponent intervention to decrease chronic obstructive pulmonary disease (COPD)-related
hospitalizations
– – – Y
Impact of a hospital physical therapy program on chronic obstructive pulmonary disease (COPD)
patients
Y – Y Y
Comprehensive disease management program in chronic obstructive pulmonary disease (COPD)
patients in the community
– – – Y
Nurse managed sequential strength training and bicycle training in chronic obstructive pulmonary
disease (COPD)
– – – Y
Effects of mud bath therapy in chronic obstructive pulmonary disease – – – Y
Randomized trial of physical activity self-management intervention for patients with COPD – – – Y
Validation of an exercise DVD for maintenance after pulmonary rehabilitation – – – Y
Effects of respiratory muscle training and respiratory exercise in exercise tolerance, performing daily
life activities and quality of life of patients with chronic obstructive pulmonary disease
– – – Y
Balance training in patients with chronic obstructive pulmonary disease (COPD) – – – Y
A comprehensive care programme for patients with chronic obstructive pulmonary disease Y – Y Y
Problem-solving therapy for people with major depression and chronic obstructive pulmonary disease – – – Y
Life-long monitoring of COPD in veneto region – – – Y
Breathing control in patients with chronic obstructive pulmonary disease (COPD) – – – Y
Randomized trial of physical activity self-management intervention for patients with COPD – – – Y
Multicomponent intervention to decrease chronic obstructive pulmonary disease (COPD)-related
hospitalizations
– – – Y
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Citation
Relevant to review
1 2 3 4
Effectiveness of Interventions to Teach Respiratory Inhaler Technique (E-TRaIN) – – – Y
The COPD on Oxygen Patient Management European Trial (COMET) – – – Y
A randomized controlled trial to determine outcome and cost effectiveness of case management of
chronic obstructive pulmonary disease (COPD) patients
– – – Y
Home telehealth follow-up after hospital discharge for chronic obstructive pulmonary disease (COPD)
patients
Y Y Y Y
Effectiveness of incorporating tai chi in pulmonary rehabilitation program for patients with chronic
obstructive pulmonary disease in primary health care
– – – Y
Educational intervention for managing inhalers in chronic obstructive pulmonary disease (COPD)
patients
– – – Y
Disease management in asthma or chronic obstructive pulmonary disease (COPD) patients – – – Y
Stepping up to health – for veterans with chronic obstructive pulmonary disease (COPD) – – – Y
Coping skills for patients with chronic obstructive pulmonary disease (COPD) and their caregivers – – – Y
Prigmore S. Does an individualised self-management plan help patients with chronic obstructive
pulmonary disease (COPD) initiate early treatment for infective exacerbations? ISRCTN Register 2012
– – – Y
Educational interventions for chronic obstructive pulmonary disease (COPD) self-management in
ethno-cultural communities. Clinicaltrials.gov 2012
– – – Y
Y, yes for inclusion.
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randomised controlled trials: review 1
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Appendix 17 Search strategies for
cost-effectiveness studies: review 3
MEDLINE (via Ovid)
URL: https://ovid.sp.com
Date range searched: 1946 to May week 1 2012.
Date of search: 15 May 2012.
Search strategy
1. chronic obstructive pulmonary disease.mp. or exp Pulmonary Disease, Chronic Obstructive/
2. copd.ti,ab.
3. chronic obstructive lung disease.ti,ab.
4. chronic obstructive airway disease.ti,ab
5. chronic respiratory disorder$.ti,ab.
6. smoking-related lung disease$.ti,ab.
7. Pulmonary Emphysema/
8. exp Bronchitis/
9. emphysema.ti,ab.
10. or/1-9
11. exp Self Care/
12. (self adj2 (support$ or care or caring or manage$)).ti,ab.
13. post discharge.ti,ab.
14. early discharge.ti,ab.
15. home care.ti,ab.
16. home care services/ or home nursing/
17. patient centred care.ti,ab.
18. patient centered care.ti,ab.
19. patient education/ or patient education.ti,ab.
20. patient participation.ti,ab.
21. post hospital care.ti,ab.
22. action planning.ti,ab.
23. discharge planning.ti,ab.
24. continuity of patient care/
25. (support$ adj2 discharge).ti,ab.
26. (support$ adj2 manag$).ti,ab.
27. patient focus$.ti,ab.
28. management plan$.ti,ab.
29. management program$.ti,ab.
30. rehabilitation.mp. or exp Rehabilitation/
31. or/11-30
32. 10 and 31
33. economics/
34. exp ‘costs and cost analysis’/
35. cost of illness/
36. exp health care costs/
37. economic value of life/
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38. exp economics medical/
39. exp economics hospital/
40. economics pharmaceutical/
41. exp ‘fees and charges’/
42. (econom$ or cost or costs or costly or costing or price or pricing or pharmacoeconomic$).tw.
43. (expenditure$ not energy).tw.
44. (value adj1 money).tw.
45. budget$.tw.
46. or/33-45
47. 32 and 46
EMBASE (via Ovid)
URL: https://ovidsp.ovid.com
Date range searched: 1980 to 2012 week 19.
Date of search: 15 May 2012.
Search strategy
1. chronic obstructive pulmonary disease.mp. or exp chronic obstructive lung disease/
2. copd.ti,ab.
3. chronic obstructive lung disease.ti,ab.
4. chronic obstructive airway disease.ti,ab.
5. chronic respiratory disorder$.ti,ab.
6. smoking-related lung disease$.ti,ab.
7. pulmonary emphysema.mp. or exp lung emphysema/
8. emphysema.ti,ab.
9. bronchitis.mp. or exp bronchitis/
10. or/1-9
11. self care.mp. or exp self care/
12. (self adj2 (support$ or care or caring or manage$)).ti,ab.
13. post discharge.ti,ab.
14. early discharge.ti,ab.
15. exp home care/
16. home nursing.ti,ab.
17. patient centred care.ti,ab.
18. patient centered care.ti,ab.
19. patient education/
20. patient education.ti,ab.
21. patient participation.ti,ab.
22. post hospital care.ti,ab.
23. action planning.ti,ab.
24. discharge planning.ti,ab.
25. continuity of patient care.ti,ab.
26. (support$ adj2 discharge).ti,ab.
27. (support$ adj2 manage$).ti,ab.
28. patient focus$.ti,ab.
29. management plan$.ti,ab.
30. management program$.ti,ab.
31. rehabilitation.mp. or exp rehabilitation/
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32. or/11-31
33. 10 and 32
34. cost benefit analysis/
35. cost effectiveness analysis/
36. cost minimization analysis/
37. cost utility analysis/
38. economic evaluation/
39. (cost or costs or costed or costly or costing).tw.
40. (economic$ or pharmacoeconomic$ or price$ or pricing).tw.
41. (technology adj assessment$).tw.
42. or/34-41
43. 33 and 42
The Cochrane Library Cochrane (Wiley) NHS Economic
Evaluation Database
URL: https://cochranelibrary.com
Date range searched: 1993–2012 issue 4 of 12.
Date of search: 15 May 2012.
Search strategy
#1 copd
#2 chronic next obstructive next pulmonary disease
#3 MeSH descriptor Pulmonary Disease, Chronic Obstructive explode all trees
#4 chronic next obstructive next airway next disease
#5 chronic next respiratory next disorder*
#6 smoking next related next lung next disease*
#7 emphysema
#8 MeSH descriptor Pulmonary Emphysema explode all trees
#9 MeSH descriptor Bronchitis explode all trees
#10 bronchitis
#11 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10)
#12 self next care
#13 MeSH descriptor Self Care explode all trees
#14 self near/2 ( support* or care or caring or manage*)
#15 post next discharge
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#16 early next discharge
#17 MeSH descriptor Home Care Services explode all trees
#18 home next nursing
#19 patient next centred next care
#20 patient next centered next care
#21 MeSH descriptor Patient Education as Topic explode all trees
#22 patient next education
#23 patient next participation
#24 post next hospital next care
#25 action next planning
#26 discharge next planning
#27 continuity near/1 patient
#28 support* near/2 discharge
#29 support* near/2 manage*
#30 patient next focus*
#31 management next plan*
#32 management next program*
#33 rehabilitation
#34 MeSH descriptor Rehabilitation explode all trees
#35 (#12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR
#24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34)
#36 (#11 AND #35)
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MEDLINE (via Ovid)
URL: https://ovidsp.ovid.com
Date range searched: 1946 to May week 1 2012.
Date of search: 15 May 2012.
Search strategy
1. chronic obstructive pulmonary disease.mp. or exp Pulmonary Disease, Chronic Obstructive/
2. copd.ti,ab.
3. chronic obstructive lung disease.ti,ab.
4. chronic obstructive airway disease.ti,ab.
5. chronic respiratory disorder$.ti,ab.
6. smoking-related lung disease$.ti,ab.
7. Pulmonary Emphysema/
8. exp Bronchitis/
9. emphysema.mp.
10. or/1-9
11. exp Self Care/
12. (self adj2 (support$ or care or caring or manage$)).ti,ab.
13. post discharge.ti,ab.
14. early discharge.ti,ab.
15. home care.ti,ab.
16. home care services/ or home nursing/
17. patient centred care.ti,ab.
18. patient centered care.ti,ab.
19. patient education/ or patient education.ti,ab.
20. patient participation.ti,ab.
21. post hospital care.ti,ab.
22. action planning.ti,ab.
23. discharge planning.ti,ab.
24. continuity of patient care/
25. (support$ adj2 discharge).ti,ab.
26. (support$ adj2 manag$).ti,ab.
27. patient focus$.ti,ab.
28. management plan$.ti,ab.
29. management program$.ti,ab.
30. rehabilitation.mp. or exp Rehabilitation/
31. or/11-30
32. 10 and 31
33. decision support techniques/
34. markov.ti,ab.
35. exp models economic/
36. decision analysis.ti,ab.
37. cost benefit analysis/
38. or/33-37
39. 32 and 38
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Appendix 18 Chronic obstructive pulmonary
disease-adjusted all-cause mortality rates by age and
sex: review 3
Appendix 18 lists the COPD-adjusted all-cause mortality rates applied in the economic model. Thesewere derived from all-cause and COPD-related mortality rates by sex and age for a UK population,
obtained from the Office for National Statistics.
Age (years)
All-cause mortality (%) Deaths caused by COPD (%) COPD-adjusted mortality (%)
Male Female Male Female Male Female
60 0.8342 0.5361 4.205241 5.111524 0.7828 0.509483
61 0.8871 0.581 0.8325 0.552154
62 0.9507 0.6165 0.8921 0.585891
63 1.0509 0.6812 0.9862 0.647379
64 1.1558 0.7478 1.0846 0.710672
65 1.2725 0.8201 6.184986 7.25799 1.1941 0.779383
66 1.4205 0.9119 1.333 0.866625
67 1.5369 0.9737 1.4422 0.925356
68 1.7243 1.0949 1.6181 1.040539
69 1.9125 1.2158 1.7947 1.155436
70 2.1149 1.3856 1.9846 1.316806
71 2.3225 1.4768 2.1794 1.403478
72 2.5652 1.6469 2.4072 1.565133
73 2.7907 1.8063 2.6188 1.716619
74 3.1141 2.0492 2.9223 1.947459
75 3.3999 2.2567 6.654892 6.476441 3.1905 2.144656
76 3.8443 2.5538 3.6075 2.427006
77 4.2217 2.8839 3.9616 2.740716
78 4.7005 3.2547 4.4109 3.093106
79 5.2482 3.6732 4.9249 3.490828
80 5.944 4.1742 5.5778 3.966954
81 6.6343 4.662 6.2256 4.430535
82 7.4283 5.3215 6.9707 5.057291
83 8.1907 6.0585 7.6861 5.7577
84 9.2142 6.7739 8.6466 6.437581
85 10.2895 7.5849 5.575312 3.413472 9.6556 7.208315
86 11.2992 8.5749 10.6031 8.149162
87 12.7193 9.5838 11.9358 9.107971
88 14.0875 10.779 13.2197 10.24383
89 16.0713 12.1602 15.0813 11.55645
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Age (years)
All-cause mortality (%) Deaths caused by COPD (%) COPD-adjusted mortality (%)
Male Female Male Female Male Female
90 16.6367 13.5352 15.6118 12.86319
91 17.8196 14.6525 16.7219 13.92501
92 18.8878 16.0748 17.7243 15.2767
93 21.4681 18.0517 20.1456 17.15545
94 23.7662 20.2789 22.3021 19.27207
95 25.6292 22.3947 24.0504 21.28282
96 27.5704 24.0167 25.872 22.82429
97 29.48 25.97 27.67 24.68
98 31.56 27.82 29.61 26.44
99 32.73 29.69 30.71 28.22
100 34.46 31.82 32.34 30.24
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Appendix 19 Annual disease progression risks by
age and smoking status: review 3
Appendix 19 lists the annual disease progression rates applied in the economic model. These wereobtained from a published COPD Markov model by Atsou et al.86
Age
GOLD stage 2 to 3 GOLD stage 3 to 4 GOLD stage 2 to 3 GOLD stage 3 to 4
Ex-smoker (%) Ex-smoker (%) Smoker (%) Smoker (%)
60 5.803 5.12 9.338 7.823
61 5.926 5.229 9.535 7.989
62 6.049 5.338 9.733 8.155
63 6.104 5.386 9.822 8.229
64 6.159 5.434 9.912 8.304
65 6.213 5.482 10.001 8.379
66 6.268 5.53 10.091 8.454
67 6.322 5.579 10.18 8.529
68 6.367 5.618 10.252 8.589
69 6.412 5.658 10.324 8.65
70 6.457 5.698 10.396 8.71
71 6.502 5.737 10.468 8.77
72 6.547 5.777 10.54 8.831
73 6.561 5.789 10.562 8.849
74 6.575 5.801 10.584 8.868
75 6.589 5.814 10.607 8.887
76 6.603 5.826 10.629 8.905
77 6.617 5.838 10.651 8.924
78 6.638 5.857 10.686 8.953
79 6.659 5.876 10.72 8.982
80 6.681 5.895 10.755 9.011
81 6.702 5.914 10.789 9.04
82 6.724 5.933 10.824 9.069
83 6.792 5.993 10.935 9.161
84 6.861 6.054 11.045 9.254
85 6.93 6.114 11.156 9.347
86 6.998 6.175 11.266 9.439
87 7.067 6.236 11.377 9.532
88 7.136 6.296 11.487 9.624
89 7.204 6.357 11.598 9.717
90 7.273 6.417 11.708 9.81
91 7.342 6.478 11.819 9.902
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Age
GOLD stage 2 to 3 GOLD stage 3 to 4 GOLD stage 2 to 3 GOLD stage 3 to 4
Ex-smoker (%) Ex-smoker (%) Smoker (%) Smoker (%)
92 7.41 6.538 11.929 9.995
93 7.479 6.599 12.04 10.088
94 7.547 6.659 12.15 10.18
95 7.616 6.72 12.261 10.273
96 7.685 6.781 12.372 10.365
97 7.753 6.841 12.482 10.458
98 7.822 6.902 12.593 10.551
99 3.61 7.891 12.703 10.643
100 3.61 7.891 12.703 10.643
APPENDIX 19
NIHR Journals Library www.journalslibrary.nihr.ac.uk
336
Appendix 20 Cost of other self-management
programmes in populations with chronic obstructive
pulmonary disease: review 3
Appendix 20 lists cost estimates extracted from SM programmes targeted at patients with COPD, notprovided within 6 weeks of discharge. Costs are listed in the year and currency they were reported
and also 2012 GB pound sterling (£) prices. Costs were converted using mid-year exchange rates for the
reporting year and inflated assuming an average inflation rate of 3.5%.
Author Type of programme Main activities
Cost, year,
currency
(as reported)
Costs 2012, GB£
(estimated)
Khdour 2011279 Pharmacy-led SM
programme
A consultation with a pharmacist,
lasting 1 hour
Two follow-up telephone calls lasting
20 minutes
Two follow-up consultations
381, 2006, GB£ 458
Sridhar 2008155 Nurse-led
intermediate care
programme
A 1-hour group session
A home visit by a respiratory nurse
A follow-up telephone call
107, 2006, GB£ 129
Dewan 2012299 Disease management
programme
A group session lasting 1.5 hours
Development of an action plan
Provision of a refillable prescriptions
Access to helpline
Series of follow-up telephone calls
849, 2011, US$ 544
Monninkhof
2004300
SM programme Five group sessions lasting 2 hours
Provision of education booklet
Two group training sessions lasting
1 hour
642, 2002,
euros
508
Tinkelman
2003301
Disease management
programme
A telephone education session
Ongoing access to case management
support via telephone service
Series of follow-up telephone calls
Reassessment at 6 months
635, 2002, US$ 573
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Appendix 21 Outcomes as reported by studies
included for review 4 but not included in analyses
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Appendix 22 Summary of characteristics of
population and study information: review 4
DOI: 10.3310/hta19360 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 36
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Jordan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
345
Author, year,
setting
Sample
size
Age,
mean
(SD) Males%
FEV1%
(SD)
Recruited
from Intervention details Control details
Follow-up
(weeks)
Aimonino Ricauda
2008 Italy75
104 79.7
(3.2)
65 42.5 ED Hospital at home Inpatient care 26
Arnardottir 2006
Sweden216
63 66. 6 (2) 50 37.5
(2.5)
Secondary
care
outpatient
Endurance, resistance training
and calisthenics
Resistance
training and
calisthenics
52
Arnardottir 2007
Sweden217
100 64.5
(7.6)
15 33.4
(11.5)
PR
programme
Interval training Continuous
training
16
Barakat 2008
France249
80 64.8
(11.1)
84 42.6
(3.1)
Secondary
care
outpatient
PR Control 14
Bauldoff 2002 USA108 24 68.1
(8.0)
17 41.3
(13.0)
PR
programme
Music (distractive auditory
stimulation)
Control 8
Bauldoff 2005 USA109 30 63.0
(11)
43 41.3
(18)
Secondary
care
outpatient
(1) Moderate distractive
auditory stimulation during
exercise; and (2) slow
distractive auditory
stimulation during exercise
Attention
control
4
Beckerman 2005
Israel253
42 67.3
(15.8)
76 42.5
(11.7)
Community IMT Sham training 52
Behnke 2000,
Behnke 2003,
Germany64,65
46 66.0
(2.1)
77 36.0
(7.0)
Secondary
care inpatient
Home-based exercise Control 26, 78
Bendstrup 1997
Denmark222
47 64.5
(2.5)
88 NR Secondary
care
PR Control 24
Bernard 1999
Canada191
45 65.3
(7.9)
78 42.5
(13.8)
NR Aerobic and strength training Aerobic training 12
Berry 2010 USA110 176 66.0
(10.0)
50 51.8
(19.4)
Mixed Lifestyle activity intervention Traditional
exercise therapy
52
Bestall 2003 UK141 66 68.7
(7.5)
NR 37.5
(11.5)
PR
programme
Exercise Control 52
Bjornshave 2005
Denmark223
31 62.6 35 34.8 Secondary
care
Middle intensity training Low-intensity
training
4
Blake Jr 1990 USA111 94 63.4 81 NR Secondary
care
outpatient
Psychosocial intervention Control 52
Bonilha 2009 Brazil232 43 71.7
(7.5)
75 51.1
(20.5)
Mixed Singing classes Control 25
Bourbeau 2003,
Bourbeau 2006,
Gadoury 2005
Canada192,270,271
191 69.5
(7.0)
57 NR Secondary
care
SM programme UC 52, 104, 52
Boxall 2005
Australia160
60 76.7
(7.9)
57 39.1
(15.5)
Secondary
care
outpatient
Home-based PR Control 26
Breyer 2010
Austria245
60 60.3
(8.5)
45 46.3
(17.6)
NR Nordic walking Control 39
Brooks 2002
Canada193
109 68.0
(7.4)
59 32.0
(12.0)
PR
programme
Enhanced follow-up Conventional
follow-up
52
Bucknall 2012 UK63 464 69.1
(9.3)
37 40.5
(13.6)
Mixed Supported SM UC 52
Busch 1988
Canada194
20 65.1
(15.5)
79 26.3
(10.0)
Unclear Home exercise Control 18
Cai 2006 China199 82 61.0
(9.0)
95 NR Secondary
care
Education Control 26
Carr 2009 Canada195 34 68.0
(8.1)
44 NR Primary and
secondary
care
Repeat PR UC 52
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Author, year,
setting
Sample
size
Age,
mean
(SD) Males%
FEV1%
(SD)
Recruited
from Intervention details Control details
Follow-up
(weeks)
Casas 2006,
Garcia-Aymerich
2007
Spain and Belgium71,72
155 71.2
(9.0)
83 41.8
(17.3)
Secondary
care inpatient
Integrated care UC 52
Chan 2010, 2011
Hong Kong212,272
206 73.0
(7.7)
91 NR Secondary
care
outpatient
(a) T’ai chi qigong; (b) exercise Control 13
Cockcroft 1987 UK142 75 69.8 68 NR Primary and
secondary
care
Respiratory health worker Control NR
Coultas 2005 USA112 217 69.0
(8.2)
62 NR Primary care (a) Nurse-assisted
collaborative management;
and (b) nurse-assisted medical
management
UC 26
Covey 2001 USA113 37 66.1
(8.5)
67 37.8
(10.2)
NR IMT Education 16
de Blok 2006
The Netherlands181
21 64.0
(11.4)
43 46.8
(17.8)
PR
programme
Lifestyle physical activity
counselling
Control 9
Dheda 2004 UK73 33 70.2
(7.5)
NR 41.3
(16.5)
Secondary
care inpatient
Outpatient follow up Primary care
follow-up
26
Donesky-Cuenco
2009 USA114
41 69.9
(9.5)
28 47.7
(15.6)
Community Yoga therapy UC 12
Dourado 2009
Brazil233
47 63.1
(87.2)
74 58.8
(25.0)
Secondary
care inpatient
(a) Strength training with
low-intensity general training;
and (b) low-intensity general
training
Strength
training
12
du Moulin 2009
Germany206
20 65.9 70 60.6 PR
programme
Home-based exercise Control 26
Eaton 2009
New Zealand227
97 69. 9
(9.6)
44 35.5
(16)
Secondary
care inpatient
Early PR UC 13
Effing 2009, 2011
Australia161,278
142 63.4
(8.0)
59 50.1
(15.8)
Secondary
care
outpatient
SM sessions plus COPE-active
(community-based
physiotherapeutic exercise)
SM 52
Efraimsson 2008
Sweden218
52 67.0
(10.6)
50 n/a Primary care Self-care management
education
Control 13
Egan 2002 Australia69 66 52.5 48 NR Secondary
care inpatient
Nursing-based case
management
Control 13
Elci 2008 Turkey236 78 58.9
(10.1)
81 47 Secondary
care
PR Control 13
Elliott 2004
Australia162
43 66.2
(8.1)
54 45.1
(18.3)
Secondary
care
(a) Hospital- and home-based
rehabilitation; and
(b) hospital- and
community-based rehabilitation
Community
rehabilitation
52
Emery 1998 USA115 79 66.6
(6.5)
47 42.0
(17.0)
Mixed (a) Exercise, education and
stress management; and
(b) education and stress
management
Waiting list
control
10
Engstrom 1999
Sweden219
50 66.4
(5.4)
52 32.3
(10.8)
Secondary
care
outpatient
PR UC 52
Fernandez 2009
Spain171
49 67 (8) 100 59.76
(14.14)
Secondary
care
Home-based PR Control 52
Finnerty 2001 UK143 100 69.5
(9.2)
68 41.0
(18.5)
Secondary
care
outpatient
PR Control 26
Foy 2001 USA116 140 67.7
(5.9)
56 58.4
(17.8)
Mixed Long-term exercise Short-term
exercise
78
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Author, year,
setting
Sample
size
Age,
mean
(SD) Males%
FEV1%
(SD)
Recruited
from Intervention details Control details
Follow-up
(weeks)
Gallefoss 1999,
2000, 2002, 2004
Norway255,280,281,391
62 57.5
(9.5)
50 53.5
(9.5)
Secondary
care
outpatient
Education Control 52
Ghanem 2010
Egypt264
39 56.8
(10.8)
NR NR Secondary
care inpatient
Home-based PR UC 9
Gilmore 2010 USA117 37 59.2
(8.3)
35 45.0
(15.8)
Secondary
care
outpatient
(a) COPD education guide and
structured home visit;
(b) COPD education guide; and
(c) structured home visit
Control NR
Gohl 2006
Germany207
34 62.8
(7.7)
68% 53.5
(8.7)
Mixed Training programme UC 52
Goldstein 1994,
1997; Guyatt 1999,
Canada196,392,393
89 65.5
(7.5)
49 36.5
(13.2)
NR PR Control 26
Green 2001 UK144 44 68.5
(9.0)
64 NR NR 7 weeks PR 4 weeks PR 7
Güell 2000 Spain172 60 65.0
(7.0)
100 35.0
(14.0)
Secondary
care
outpatient
PR Control 104
Güell 2006 Spain173 40 65.0
(8.0)
83 35.0
(13.0)
Secondary
care
PR Control 17
Guyatt 1992 USA118 93 66.4
(7.6)
NR NR Secondary
care
Respiratory muscle training Sham training 26
Hermiz 2002
Australia67
177 66.9 46 n/a Secondary
care
Home-based care Control 13
Hernandez 2000
Spain282
60 63.8
(7.7)
NR 40.9
(16.0)
NR Home-based training
programme
Control 12
Hernandez 2003
Spain68
222 71.0
(10.0)
97 42.0 Secondary
care
Hospital at home UC 8
Hill 2006 Australia163 35 68.0
(8.6)
67 36.9
(12.0)
NR IMT Sham IMT 8
Holland 2004
Australia164
40 67.8
(7.7)
63 36.6
(10.3)
Secondary
care
outpatient
Upper limb and lower limb
training
Lower limb plus
sham training
6
Hoogendoorn 2009;
Van Wetering 2010;
Hoogendoorn 2010
The Netherlands182,273,274
199 66.5
(8.9)
71 58.8
(16.1)
Secondary
care
INTERCOM: Interdisciplinary
community-based COPD
management programme
UC 104
Hospes 2009
The Netherlands183
39 62.18
(8.7)
60 64.7
(16.1)
Secondary
care inpatient
Exercise counselling UC 12
Hsiao 2003 Taiwan259 42 69.9
(5.3)
87 51.4
(13.0)
Secondary
care
(a) Targeted, resistive IMT; and
(b) pressure threshold IMT
Control 8
Hynninen 2010
Norway256
51 61.0
(8.9)
49 58.8
(23.62)
Mixed Cognitive–behavioural
therapy
UC 35
Janaudis-Ferreira
2011 Canada197
36 66.0
(9.0)
58 35.0
(15.1)
Secondary
care
Unsupported upper extremity
resistance training
Sham training 6
Jang 2006 Korea267 36 NR 100 48.7
(16.52)
Unclear PR Education
control
8
Jarab 2012 Jordan266 133 62.5
(14.5)
41 53.3
(16.9)
Secondary
care
outpatient
Pharmacist intervention Control 26
Karapolat 2007
Turkey237
54 65.8
(9.0)
88 54.9
(16.0)
NR PR Control 12
Katiyar 2006 India240 48 52.2
(2.85)
84 48
(2.77)
NR Pranayama (yogic breathing) Control 14
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Author, year,
setting
Sample
size
Age,
mean
(SD) Males%
FEV1%
(SD)
Recruited
from Intervention details Control details
Follow-up
(weeks)
Kayahan 2006
Turkey238
45 65.8
(8.4)
87 NR Secondary
care
outpatient
PR Control 9
Khdour 2009, 2011
Ireland251,279
173 64.5
(9.7)
44 52.0
(16.9)
Secondary
care
outpatient
Pharmacy-led disease
management programme
Control 52
Kim 1993 USA119 129 64.8
(7.4)
76 40.0
(13.4)
NR IMT Control 26
Ko 2011
Hong Kong213
60 73.6
(7.10)
98 54.6
(18.5)
Secondary
care inpatient
Early pulmonary rehabilitation UC 52
Koff 2009 USA120 40 65.8
(8.7)
48 32.4
(9.7)
Secondary
care
outpatient
Integrated care UC 13
Koppers 2006
The Netherlands184
39 55.7
(8.1)
47 54.0
(14.5)
PR
programme
Respiratory muscle endurance
training
Sham training 5
Kunik 2008 USA121 238 66.3
(10.3)
96 46.0
(17.2)
Mixed Cognitive–behavioural
therapy
Education 52
Kwok 2004
Hong Kong70
157 74.7
(6.4)
71 NR Secondary
care
Community nursing
programme
Control 26
Lamers 2010
The Netherlands185
187 71 (6.7) 60 NR Primary care Minimal psychological
intervention plus UC
UC 39
Larson 1988 USA122 22 64.4
(4.6)
91 31.1
(15.7)
Mixed IMT 30% load IMT 15% load 8
Larson 1999 USA123 130 65.0
(6.0)
66 50.3
(17.3)
Mixed (a) IMT; (b) cycle ergometry
training; and (c) IMT and cycle
ergometry training
Health
education
17
Lee 2002
Hong Kong66
112 80.4
(6.3)
53 NR
(severe)
Secondary
care inpatient
Care protocol nurse follow-up Control 26
Leung 2010
Australia165
36 71.5
(7.5)
70 54.5
(17.5)
PR
programme
Walking Cycling 8
Li 2002 China200 74 NR NR 61.8
(17.3)
Secondary
care
Nutritional support Control 13
Liddell 2010 UK145 30 69 (8.1) 67 51
(21.2)
PR
programme
Twice-weekly PR Once-weekly PR 8
Lindsay 2005
Hong Kong214
50 69.7
(9.8)
76 NR Secondary
care
outpatient
PR (plus tiotropium) UC (plus
tiotropium)
13
Linneberg 2012
Denmark224
118 NR 38 42.2 PR
programme
Supplemental exercise post
PR programme
No
supplemental
exercise post-PR
45
Littlejohns 1991
UK146
152 62.7
(7.7)
65 47.8
(22.7)
Secondary
care
outpatient
Respiratory health worker UC 52
Liu 2008 Taiwan260 60 72.1
(7.4)
100 45.6
(13.9)
NR Cell phone-based exercise
programme
Control 52
Livermore 2010
Australia166
41 73.4
(7.3)
44 54.1
(20.8)
Secondary
care
Cognitive–behavioural
therapy
UC 78
Lord 2010 UK147 36 63.7
(8.1)
NR 37.2
(18.6)
Secondary
care
outpatient
Singing Control 7
Madariaga 2007
Spain174
34 63.2
(10.4)
NR 46.9
(9.5)
Secondary
care
outpatient
(a) RMT with a threshold
device; and (b) RMT with a
resistive device
Control 6
Mador 2004 USA126 32 70.8
(6.9)
NR 41.8
(13.9)
Secondary
care
outpatient
Endurance, strength training
and education
Endurance
training and
education
8
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Author, year,
setting
Sample
size
Age,
mean
(SD) Males%
FEV1%
(SD)
Recruited
from Intervention details Control details
Follow-up
(weeks)
Mador 2005 USA125 38 70.3
(2.0)
NR 44.4
(4.7)
PR
programme
Endurance training plus
hyperpneic (combined)
training)
Endurance
training
8
Mador 2009 USA124 48 71.8
(7.4)
NR 44.6
(13.9)
Mixed Interval training Continuous
training
8
Magadle 2007
Israel254
34 65.6
(13.0)
74 45.5
(10.0)
PR
programme
General exercise
reconditioning programme
plus IMT
General exercise
reconditioning
programme plus
sham IMT
26
Maltais 2008
Canada198
252 66.0
(9.0)
56 44.5
(13.0)
Secondary
care
outpatient
Home-based PR Hospital-based
PR
52
Man 2004 UK148 42 70.2
(9.3)
41 39.2
(17.0)
Secondary
care inpatient
Early PR UC 13
Martin 2004
New Zealand228
96 70.1
(15.6)
50 34.8
(12.0)
Primary care Individualised care plans UC 52
McGeoch 2006
New Zealand229
159 70.9
(10.9)
65 53.9
(18.4)
Primary care SM plan UC 52
Monninkhof 2003,
2004
The Netherlands186,300
248 65.0
(7.0)
68 57.0
(15.0)
Secondary
care
outpatient
SM programme UC 52
Moore 2009 UK284 20 70.0 50 40.8 Mixed Home exercise video
programme
Control 6
Mota 2007 Spain175 18 63.5
(6.7)
NR 28.0
(8.0)
NR EMT Sham training 5
Mularski 2009 USA127 86 67.4
(2.2)
99 NR Mixed Mindfulness-based breathing
therapy
Support group
control
8
Murphy 2005
Ireland252
26 66.0
(10.4)
74 40.0
(12.0)
Secondary
care inpatient
Home-based exercise Control 26
Nakamura 2008
Japan261
42 68.9
(6.8)
NR 51.5
(19.7)
Secondary
care
outpatient
(a) Aerobic and strength
training; and (b) aerobic training
and recreational activities
Control 12
Ng 2011
Hong Kong215
80 72.4
(7.6)
89 36.9
(13.7)
Secondary
care
outpatient
Health qigong Control 26
Nguyen 2008 USA128 50 69.3
(8.8)
50 50.3
(17.3)
Community Face-to-face dyspnoea
SM programme
Internet-based
dyspnoea SM
programme
26
Nguyen 2009 USA129 17 68.2
(10.5)
94 40.9
(17.1)
Secondary
care
Mobile coached Mobile
self-monitored
26
Nield 2007 USA130 40 65.0
(9.0)
95 39.0
(13.0)
Secondary
care
outpatient
(a) Pursed lips breathing; and
(b) EMT
Control 12
Ninot 2011 France250 45 63.1 84 55.1 Secondary
care
SM education programme
and exercise
UC 52
Normandin 2002
USA131
54 68.0
(8.1)
53 49.5
(18.1)
PR
programme
High intensity endurance Low intensity
calisthenics
8
Norweg 2005 USA132 43 75.3
(7.0)
30 55.9
(17.8)
Secondary
care
outpatient
(a) Exercise training and
activity training; and (b) exercise
training and lecture series
Exercise training
alone
24
Oh 2003
South Korea283
34 65.5
(9.6)
61 43.1
(16.0)
Secondary
care
outpatient
Home-based PR Control 8
O’Neill 2007 UK150 91 68.5
(7.9)
67 41.3
(17.8)
PR
programme
Twice-weekly PR Once-weekly PR 26
Ortega 2002 Spain176 54 64.2
(7.7)
87 38.3
(12.5)
NR (a) Strength training and
endurance training; and
(b) endurance training
Strength
training
24
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Author, year,
setting
Sample
size
Age,
mean
(SD) Males%
FEV1%
(SD)
Recruited
from Intervention details Control details
Follow-up
(weeks)
O’Shea 2007
Australia167
54 67.7
(8.6)
39 50.5
(23.6)
Mixed Progressive resistance exercise Control 24
Ozdemir 2010
Turkey239
50 62.5
(8.9)
100 54.3
(12.7)
Secondary
care
outpatient
Water-based PR Control 4
Paz-Diaz 2007
Venezuela269
24 64.1
(6.3)
75 31.7
(9.9)
Secondary
care
outpatient
PR Control 9
Petersen 2008
Denmark225
19 66.0
(2.0)
32 31.0
(3.0)
NR Lifestyle training Control 7
Petty 2006 USA133 214 68.8
(9.4)
56 NR Mixed (a) Customised video; and
(b) standardised video
Control 16
Pomidori 2012
Italy243
36 72.0
(8.0)
75 48.5
(12.5)
Secondary
care
outpatient
Paced speed walking Walking (known
distance, fixed
time)
52
Prince 1989
Edinburgh151
39 67.5 64 NR Secondary
care
outpatient
Rehabilitation Control 6
Probst 2011
Brazil234
63 66.0
(8.6)
54 39.5
(13.5)
NR High-intensity endurance and
strength training
Low-intensity
calisthenics and
breathing
12
Puente-Maestu 2000,
2003 Spain177,275
49 64.4
(4.5)
NR 40.6
(6.2)
PR
programme
Supervised exercise Self-monitored
exercise
8, 56
Puhan 2006
Switzerland257
100 69.0
(9.2)
66 34.3
(8.5)
PR
programme
Interval exercise High-intensity
continuous
exercise
5
Rea 2004 New
Zealand230
135 68.0 42 51.1 Primary care Disease management
programme
UC 52
Regiane Resqueti
2007 Spain178
38 67.7
(4.3)
92 28.6
(8.5)
Secondary
care
outpatient
Home-based PR Control 26
Ren 2011 China201 89 NR NR NR Secondary
care
(a) PR strategy group 1; and
(b) PR strategy group 2
Control 52
Rice 2010 USA140 743 69.9
(9.6)
98 37.1
(14.5)
Secondary
care
Disease management
programme
UC 52
Riera 2001 Spain179 20 67.3
(4.5)
90 39.8
(12.0)
Secondary
care
outpatient
IMT Sham training 26
Ringbaek 2000
Denmark226
45 63.1
(7.2)
16 47.1
(15.8)
Secondary
care
outpatient
PR Control 8
Romagnoli 2006
Italy244
35 69.5
(8.0)
66 36.5
(8.0)
PR
programme
Two repeat PR sessions One repeat PR
session
52
Rooyackers 2003
The Netherlands187
24 59.0
(11.6)
83 41.5
(12)
NR General exercise training and
eccentric exercise training
General exercise
training
10
Sassi-Dambron 1995
USA134
98 67.4
(8.0)
61 50.0
(22.0)
Mixed Dyspnoea management
strategy
Attention
control
26
Scherer 2000
Zurich258
34 69.0
(1.9)
63 51.3
(4.0)
Secondary
care
outpatient
RMT Control 9
Sewell 2005 UK152 180 68.3
(8.6)
62 NR PR
programme
Individually targeted exercise
programme
General exercise
training
7
Sewell 2006 UK153 100 70.1
(8.0)
56 NR PR
programme
7-week PR 4-week PR 26
Seymour 2010 UK154 60 66.0
(10.0)
55 52.0
(17.1)
Secondary
care inpatient
Post-exacerbations pulmonary
rehabilitation
UC 13
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Author, year,
setting
Sample
size
Age,
mean
(SD) Males%
FEV1%
(SD)
Recruited
from Intervention details Control details
Follow-up
(weeks)
Shao 2003 China202 38 63.4
(5.1)
85 NR Secondary
care
Rehabilitation (behavioural
intervention)
Control 52
Simpson 1992 USA135 34 71.5
(7.6)
54 38.0 Secondary
care
outpatient
Weight training Control 8
Singh 2003 India241 40 59.4
(6.4)
80 27.0
(7.3)
NR PR Control 4
Sívori 1998
Argentina263
28 64.6
(9.33)
NR 36.1
(14.6)
Secondary
care
outpatient
Upper limb and lower limb
training
Lower limb
training
8
Smith 1999
Australia168
96 69.9
(8.3)
62 NR Secondary
care
Home nurse Control 52
Soler 2006 Spain180 26 73.5
(8.1)
NR 42.8
(15.7)
Secondary
care
Education and monitoring
programme
UC 52
Solomon 1998,
Gourley 1998
USA136,285
98 69.3
(7.9)
100 NR Secondary
care
Pharmaceutical care Conventional
care
26
Spencer 2010
Australia169
59 66.4
(8.0)
46 56.9
(19.5)
PR
programme
Supervised out-patient
exercise (plus PR)
Unsupervised
home-based
exercise (plus
PR)
52
Spruit 2002
Belgium247
48 63.5
(7.6)
87 38.0
(17.0)
Secondary
care
outpatient
Endurance training Resistance
training
12
Sridhar 2008 UK155 122 69.8
(10.0)
49 42.0
(16.3)
Secondary
care
outpatient
Nurse-led intermediate care
programme
Control 104
Stulbarg 2002,
Carrieri-Kohlman
2005, Davis 2006
USA137,394,395
115 66.0
(8.0)
55 44.8
(14.0)
Mixed (a) Dyspnoea SM programme
with 24 training sessions; and
(b) dyspnoea SM programme
with four training sessions
Dyspnoea SM
programme
52
Subin 2010 India242 30 58.7
(8.4)
NR 41.7
(9.5)
Secondary
care
Upper and lower limb training Upper limb
training
4
Theander 2009
Sweden220
30 64.9
(2.0)
50 33.6
(8.7)
Secondary
care
outpatient
PR Control 12
Toshima 1990,
Ries 1995 USA138,276
129 62.6
(7.2)
74 52.0 Secondary
care
PR Control 26, 312
Trappenburg 2011
The Netherlands188
233 65.7
(10.8)
69 55.7
(21.0)
Primary and
secondary
care
Individualised action plan UC 26
Troosters 2000
Belgium248
100 61.5
(8.1)
87 42.0
(14.0)
Secondary
care
outpatient
Training programme Control 78
Van Gestel 2012
Germany208
43 66.1
(6.4)
43 45.9
(17.4)
Secondary
care
outpatient
Respiratory biofeedback
training
Control 4
Vogiatzis 2002
Greece265
45 68.0
(2.0)
83 45.0
(4.0)
Secondary
care
outpatient
Interval training Continuous
training
13
Vonbank 2012
Austria246
43 60.2
(6.5)
69 55.8
(16.4)
Secondary
care
outpatient
(a) Strength and endurance
training; and (b) endurance
training
Strength
training
12
Wadell 2004
Sweden221
30 66.1
(8.1)
30 54.6
(11.5)
Secondary
care
outpatient
a) Water physical aerobic
training; and (b) land physical
aerobic training
Control 12
Wakabayashi 2011
Japan262
102 71.7
(7.6)
86 60.3
(21.0)
Secondary
care
outpatient
Integrated care UC 52
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Author, year,
setting
Sample
size
Age,
mean
(SD) Males%
FEV1%
(SD)
Recruited
from Intervention details Control details
Follow-up
(weeks)
Wang 2004 China203 100 NR 87 NR Secondary
care
Resistance breathing exercises Breathing
exercises
13
Warlies 2006
Germany209
60 63.3 67 NR Secondary
care
Education UC 26
Waterhouse 2010
UK277
240 68.9
(7.9)
52 46.8
(18.0)
Mixed Hospital rehabilitation Community
rehabilitation
78
Watson 1997
New Zealand231
69 67.5
(9.0)
65 37.5
(15.0)
Primary care SM plan Control 26
Wedzicha 1998 UK157 126 70.5
(7.0)
51 37.3
(13.1)
Secondary
care
outpatient
PR Control 8
Weekes 2009 UK158 66 69.1 51 31.75
(13.7)
Secondary
care
outpatient
Dietary counselling and food
fortification
Control 52
White 2002 UK159 103 67.0
(9.0)
69 26.9
(7.8)
Secondary
care
outpatient
PR Brief advice 13
Wijkstra 1994
The Netherlands189
45 63.3
(5.0)
91 44.4
(10.4)
NR Home rehabilitation Control 12
Wijkstra 1995
The Netherlands190
45 62.7
(5.0)
83 43.8
(10.8)
PR
programme
(a) Rehabilitation with weekly
visits to a physiotherapist; and
(b) rehabilitation with
monthly visits to a
physiotherapist
Control 78
Wittmann 2007
Germany210
212 53.9
(6.9)
80 NR Secondary
care
PR plus education PR 52
Wong 2005 China74 60 73.6
(7.8)
78 NR Secondary
care inpatient
Nurse-initiated telephone
follow-up
UC 13
Wood-Baker 2006
Australia170
139 70.0
(8.1)
84 45.0
(16.0)
Primary care Action plan UC 52
Wright 2003
Germany211
28 55.7
(6.9)
43 55.9
(12.8)
NR Resistance training Control 12
Xu 2010 China204 80 57.1
(7.6)
53 NR Secondary
care
(a) Integrative rehabilitation
(traditional and modern);
(b) modern rehabilitation; and
(c) traditional rehabilitation
UC 52
Yamaguti 2012
Brazil235
30 66.5
(22.6)
73 42.9
(52.9)
Secondary
care
Diaphragmatic breathing Control 4
Yeh 2010 USA139 10 65.5
(6.0)
60 50.0
(7.0)
Secondary
care
T’ai chi plus UC UC 12
Zhang 2008 China205 60 69.5
(3.3)
85 NR Secondary
care
(a) PR plus PLB; and (b) PR Control 8
n/a, not applicable; NR, not reported; PLB, pursed lip breathing.
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Intervention
Author, year
Disease
knowledge
Unspecified
SM RMT
Action
planning Breathing Smoking Medication
Bronchial
hygiene
Aimonino Ricauda 200875 1 – – 1 1 1 1 –
Arnardottir 2006216 – – – – 1 – – –
Arnardottir 2007217 – – – – 1 – – –
Barakat 2008249 – – – – 1 – – –
Bauldoff 2002108 – – – – – – – –
Bauldoff 2005109 A – – – – – – – –
Bauldoff 2005109 B – – – – – – – –
Bauldoff 2005109 C – – – – – – – –
Beckerman 2005253 – – 1 – – – – –
Behnke 200064 – – – – 1 – – –
Bendstrup 1997222 1 – – – 1 1 1 –
Bernard 1999191 – – – – – – – –
Berry 2010110 1 – – – – – – –
Bestall 2003141 1 – – 1 1 1 1 1
Bjornshave 2005223 – – – – – – – –
Blake Jr 1990111 1 – – – 1 – – –
Bonilha 2009232 – 1 – – 1 – – –
Bourbeau 2003192 1 1 – 1 1 1 – 1
Boxall 2005160 1 – – – 1 – 1 1
Breyer 2010245 1 – – – 1 1 1 1
Brooks 2002193 1 – – – 1 – – –
Bucknall 201263 1 – – 1 1 – 1 –
Busch 1988194 – – – – 1 – – –
Cai 2006199 1 – – 1 1 1 1 –
Carr 2009195 1 – – – 1 – 1 –
Casas 200671 1 1 – 1 1 1 1 –
Chan 2010212 A 1 – – – 1 – – –
Chan 2010212 B 1 – – – 1 – – –
Chan 2010212 C 1 – – – 1 – – –
Cockcroft 1987142 – 1 – 1 – – – –
Coultas 2005112 A 1 1 – 1 – 1 1 –
Coultas 2005112 B 1 1 – 1 – 1 1 –
Coultas 2005112 C 1 1 – 1 – 1 1 –
Covey 2001113 – – 1 – – – – –
de Blok 2006181 – – – – – – – –
Dheda 200473 – – – – – 1 1 –
Donesky-Cuenco 2009114 1 – – – 1 – – –
Dourado 2009233 A – – – – – – – –
Dourado 2009233 B – – – – – – – –
Dourado 2009233 C – – – – – – – –
du Moulin 2009206 1 – – – 1 1 – –
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Nutrition Psychological Preventative Inhaler
Energy
conservation
Support
groups Exercise
Enhanced
access Other
Total
number
1 – – – 1 – 1 1 – 9
– – – – – – 1 – – 2
– – – – – – 1 – – 2
1 – – – – – 1 – – 3
– – – – – – 1 – 1 2
– – – – – – 1 – – 1
– – – – – – 1 – – 1
– – – – – – 1 – – 1
– – – – – – – – – 1
– – – – – – 1 1 – 3
1 1 – 1 – – 1 – 1 9
– – – – – – 1 – – 1
– – – – – – 1 – 1 3
1 1 – 1 1 – 1 – – 11
– – – – – – 1 – – 1
– 1 – – – – 1 1 – 5
– 1 – – – – – – 1 4
1 1 – 1 1 – 1 1 – 12
– 1 – 1 1 – 1 – – 8
1 – – – – – 1 – – 7
– 1 – – – – 1 1 – 5
– – – – – 1 – 1 – 6
– – – – – – 1 – – 2
– – – 1 – – – – – 6
– 1 – – 1 – 1 – – 6
1 – – 1 – – 1 1 – 10
– 1 – – – – 1 – – 4
– – – – – – 1 – – 3
– 1 – – – – 1 – – 4
– – – – – – – 1 – 3
– – – – – – – – – 5
– – – – – – – – – 5
– – – – – – – – – 5
– – – – – – – – – 1
1 1 – – – – 1 – – 3
1 – – 1 – 1 1 – – 6
– 1 – – – – 1 – – 4
– – – – – – 1 – – 1
– – – – – – 1 – – 1
– – – – – – 1 – – 1
1 1 – – – – 1 1 – 7
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Intervention
Author, year
Disease
knowledge
Unspecified
SM RMT
Action
planning Breathing Smoking Medication
Bronchial
hygiene
Eaton 2009227 1 – – 1 1 – 1 1
Effing 2009161 1 1 – 1 1 1 1 1
Efraimsson 2008218 1 1 – 1 1 1 1 1
Egan 200269 1 – – – – – 1 –
Elci 2008236 1 – – – 1 – 1 1
Elliott 2004162 A 1 – – – – – 1 –
Elliott 2004162 B 1 – – – – – 1 –
Elliott 2004162 C 1 – – – – – 1 –
Emery 1998115 A 1 – – – – – 1 –
Emery 1998115 B 1 – – – – – 1 –
Emery 1998115 C 1 – – – – – 1 –
Engstrom 1999219 1 – – – 1 1 1 –
Fernandez 2009171 1 – 1 1 1 – – –
Finnerty 2001143 1 – – 1 1 – – –
Foy 2001116 – – – – – – – –
Gallefoss 1999255 1 1 – 1 1 1 1 1
Ghanem 2010264 1 – – – 1 – 1 –
Gilmore 2010117 A 1 – – 1 1 1 1 –
Gilmore 2010117 B 1 – – 1 1 1 1 –
Gilmore 2010117 C 1 – – – – – 1 –
Gilmore 2010117 D 1 – – 1 1 1 1 –
Gilmore 2010117 E 1 – – 1 1 1 1 –
Gilmore 2010117 F 1 – – 1 1 1 1 –
Gohl 2006207 – – – – 1 – – –
Goldstein 1994196 – – – – 1 – – –
Green 2001144 1 – – – – – – –
Güell 2000172 1 – – – 1 – – 1
Güell 2006173 1 – – – 1 – – 1
Guyatt 1992118 – – 1 – 1 – – –
Hermiz 200267 1 – – 1 1 1 1 –
Hernandez 2000282 1 – – 1 1 1 1 –
Hernandez 200368 – – – – – – – –
Hill 2006163 – – 1 – – – – –
Holland 2004164 – – – – – – – –
Hoogendoorn 2009182 1 – – – – 1 – –
Hospes 2009183 – – – – 1 – – –
Hsiao 2003259 A – – 1 – 1 – – –
Hsiao 2003259 B – – 1 – 1 – – –
Hsiao 2003259 C – – 1 – 1 – – –
Hynninen 2010256 – – – – 1 – – –
Janaudis-Ferreira 2011197 – 1 – – 1 – – –
Jang 2006267 1 – 1 – 1 – – –
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Nutrition Psychological Preventative Inhaler
Energy
conservation
Support
groups Exercise
Enhanced
access Other
Total
number
1 1 1 – 1 – 1 1 – 11
1 1 – – – – 1 1 – 11
1 1 1 1 – – 1 1 – 13
– – – – – 1 – 1 1 5
1 1 – – – – 1 – – 7
– – – – – – 1 – – 3
– – – – – – 1 – – 3
– – – – – – 1 – – 3
– 1 – – – – 1 – – 4
– 1 – – – – – – – 3
– 1 – – – – 1 – – 4
1 – – – 1 – 1 – – 7
– – – 1 – – 1 1 – 7
1 1 – – – 1 1 – – 7
– – – – – – 1 – – 1
– – 1 1 – – 1 – – 10
1 – 1 1 – – 1 – – 7
– – – 1 – – 1 1 – 8
– – – 1 – – 1 – – 7
– – – 1 – – – 1 – 4
– – – 1 – – 1 1 – 8
– – – 1 – – 1 1 – 8
– – – 1 – – 1 – – 7
– – – – – – 1 – – 2
– 1 – – – – 1 1 – 4
– – – – – – 1 – – 2
– 1 – 1 – – 1 – – 6
– 1 – – – – 1 – – 5
– – – – – – – – – 2
– – – – 1 – 1 1 – 8
1 – – – 1 1 1 1 – 10
– – – – – – 1 – 1 2
– – – – – – – – – 1
– – – – – – 1 – – 1
1 – – – – – 1 – – 4
– – – – – – 1 – – 2
– – 1 – – – – – – 3
– – 1 – – – – – – 3
– – 1 – – – – – – 3
– 1 – – – – – – 1 3
– 1 – – – – 1 – – 4
1 1 – – – – 1 – – 6
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Intervention
Author, year
Disease
knowledge
Unspecified
SM RMT
Action
planning Breathing Smoking Medication
Bronchial
hygiene
Jarab 2012266 1 – – – – 1 1 1
Karapolat 2007237 1 – – – 1 – 1 1
Katiyar 2006240 – – – – 1 – – –
Kayahan 2006238 1 – – – 1 – 1 1
Khdour 2009251 1 – – 1 1 1 1 1
Kim 1993119 – – 1 – – – – –
Ko 2011213 – – – – 1 1 – –
Koff 2009120 1 1 – – 1 – 1 –
Koppers 2006184 – – 1 – – – – –
Kunik 2008121 – – – – 1 – – –
Kwok 200470 – – – – – – 1 –
Lamers 2010185 – 1 – 1 1 – – –
Larson 1988122 – – 1 – – – – –
Larson 1999123 A – – 1 – – – – –
Larson 1999123 B – – – – – – – –
Larson 1999123 C – – 1 – – – – –
Larson 1999123 D – – 1 – – – – –
Larson 1999123 E – – 1 – – – – –
Larson 1999123 F – – 1 – – – – –
Lee 200266 – – – – 1 – 1 –
Leung 2010165 – – – – 1 – – –
Li 2002200 – – – – 1 – – –
Liddell 2010145 1 – – – 1 – 1 –
Lindsay 2005214 1 1 – – 1 – – –
Linneberg 2012224 1 1 – – – 1 1 1
Littlejohns 1991146 1 – – 1 – – 1 –
Liu 2008260 1 – – – 1 – – –
Livermore 2010166 – – – 1 1 – – –
Lord 2010147 1 – – – 1 – – –
Madariaga 2007174 A – – 1 – – – – –
Madariaga 2007174 B – – 1 – – – – –
Madariaga 2007174 C – – 1 – – – – –
Mador 2004126 1 – – – 1 – – –
Mador 2005125 1 – – – – – – –
Mador 2009124 1 – – – – – – –
Magadle 2007254 – – 1 – 1 – – –
Maltais 2008198 1 – – – 1 – – –
Man 2004148 – 1 – – 1 1 1 –
Martin 2004228 – – – 1 – – 1 –
McGeoch 2006229 – – – 1 1 – – –
Monninkhof 2003186 1 1 – 1 1 – – –
Moore 2009284 1 – – – 1 1 1 –
APPENDIX 24
NIHR Journals Library www.journalslibrary.nihr.ac.uk
390
Nutrition Psychological Preventative Inhaler
Energy
conservation
Support
groups Exercise
Enhanced
access Other
Total
number
– – – – – – 1 – – 5
1 1 – – 1 – 1 – – 8
– – – – – – 1 – – 2
1 1 – – – – 1 – – 7
– 1 – 1 – – 1 1 – 10
– – – – – – – – – 1
– 1 – 1 1 – 1 – – 6
1 – – – – – – 1 – 6
– – – – – – – – – 1
– 1 – – – – – – – 2
1 1 1 1 1 – 1 1 – 8
– 1 – – – – – – – 4
– – – – – – – – – 1
– – – – – – – 1 – 2
– – – – – – 1 1 – 2
– – – – – – 1 1 – 3
– – – – – – – 1 – 2
– – – – – – 1 1 – 3
– – – – – – 1 1 – 3
1 – – 1 – – – 1 – 5
– – – – – – 1 – – 2
1 – – – – – – – – 2
1 1 – – – – 1 – – 6
– 1 – 1 1 1 1 – – 8
– – – – – – 1 – – 6
– – – 1 – – – 1 – 5
– – – – – – 1 1 1 5
– 1 – – – – – – – 3
– 1 – – – – 1 – 1 5
– – – – – – – – – 1
– – – – – – – – – 1
– – – – – – – – – 1
– – – – – – 1 – – 3
– – – – – – 1 – 1 3
– – – – – – 1 – – 2
– – – – – – 1 – – 3
– – – – – – 1 1 – 4
1 – – – – – 1 – – 6
– – – – – – – – – 2
– – – – – – – – – 2
1 1 – – 1 – 1 1 1 10
– 1 1 – – – 1 1 – 8
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Intervention
Author, year
Disease
knowledge
Unspecified
SM RMT
Action
planning Breathing Smoking Medication
Bronchial
hygiene
Mota 2007175 – – 1 – 1 – – 1
Mularski 2009127 – – – – – – – –
Murphy 2005252 – – – – – – – –
Nakamura 2008261 A – – – – 1 – – 1
Nakamura 2008261 B – – – – – – – –
Nakamura 2008261 C – – – – 1 – – 1
Ng 2011215 1 – – – 1 – – –
Nguyen 2008128 – 1 – 1 1 – – –
Nguyen 2009129 – – – – 1 – 1 –
Nield 2007130 A – – – – 1 – – –
Nield 2007130 B – – 1 – – – – –
Nield 2007130 C – – 1 – – – – –
Ninot 2011250 – – – 1 1 1 – 1
Normandin 2002131 1 – – – – – – –
Norweg 2005132 A – – – – 1 – – –
Norweg 2005132 B 1 – – – – – 1 –
Norweg 2005132 C – – – – 1 – – –
Oh 2003283 1 – 1 – 1 – 1 1
O’Neill 2007150 1 – – – 1 – – –
Ortega 2002176 A – – – – – – – –
Ortega 2002176 B – – – – – – – –
Ortega 2002176 C – – – – – – – –
O’Shea 2007167 – – – – 1 – – –
Ozdemir 2010239 – – – – – – – –
Paz-Diaz 2007269 – – – – 1 – – –
Petersen 2008225 1 – – – 1 – 1 –
Petty 2006133 A 1 – – – – – – –
Petty 2006133 B 1 – – – – – – –
Petty 2006133 C 1 – – – – – – –
Pomidori 2012243 – – – – – – – –
Prince 1989151 1 – – – 1 1 – –
Probst 2011234 – – – – – – – –
Puente-Maestu 2000177 – – – – – – 1 –
Puhan 2006257 1 – – – 1 – – –
Rea 2004230 – – – 1 – 1 1 –
Regiane Resqueti 2007178 – – – – 1 – – –
Ren 2011201 A – – – – 1 – – –
Ren 2011201 B – – – – 1 – – –
Ren 2011201 C 1 – 1 – 1 – – 1
Rice 2010140 1 – – 1 1 1 1 –
Riera 2001179 – – 1 – – – – –
APPENDIX 24
NIHR Journals Library www.journalslibrary.nihr.ac.uk
392
Nutrition Psychological Preventative Inhaler
Energy
conservation
Support
groups Exercise
Enhanced
access Other
Total
number
– 1 – – – – – – – 4
– 1 – – – – – – – 1
– – – – – – 1 – – 1
– 1 – – – – 1 – – 4
– – – – – – 1 – – 1
– 1 – – – – 1 – – 4
– 1 – – – – 1 – 1 5
– – – – – – 1 – – 4
– 1 1 – – – 1 1 – 6
– – – – – – – – – 1
– – – – – – – – – 1
– – – – – – – – – 1
1 – – 1 – – 1 – – 7
– – – – – – 1 – – 2
– – – – – – 1 – – 2
1 1 1 – – – 1 – – 6
– – – – – – 1 – – 2
1 1 – 1 1 – 1 1 – 11
– – – – – – 1 – – 3
– – – – – – 1 – – 1
– – – – – – 1 – – 1
– – – – – – 1 – – 1
– – – – – – 1 – – 2
– – – – – – 1 – – 1
– – – – – – 1 – – 2
1 1 – – – – 1 – – 6
– – – – – – 1 – – 2
– – – – – – 1 – – 2
– – – – – – 1 – – 2
– – – – – – 1 – 1 2
1 1 – – – – 1 – – 6
– – – – – – 1 – – 1
1 – – – – – 1 – – 3
– 1 – – – – 1 – – 4
– – 1 1 – – – 1 1 7
– – – – – – – – – 1
– – – – – – 1 – – 2
– – – – – – 1 – – 2
– – – – – – 1 1 – 6
– – 1 1 – – 1 1 – 9
– 1 – – – – – – – 2
DOI: 10.3310/hta19360 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 36
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Jordan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
393
Intervention
Author, year
Disease
knowledge
Unspecified
SM RMT
Action
planning Breathing Smoking Medication
Bronchial
hygiene
Ringbaek 2000226 1 – – – 1 – – –
Romagnoli 2006244 1 – – – 1 – – –
Rooyackers 2003187 – – – – – – – –
Sassi-Dambron 1995134 1 – – – 1 – – –
Scherer 2000258 – – 1 – – – – –
Sewell 2005152 1 – – – 1 – 1 1
Sewell 2006153 1 – – – 1 – 1 1
Seymour 2010154 1 – – – 1 – – –
Shao 2003202 – – – – 1 1 – –
Simpson 1992135 – – – – 1 – – –
Singh 2003241 – – – – 1 – – 1
Sívori 1998263 – – – – – – – –
Smith 1999168 1 – – 1 – 1 1 –
Soler 2006180 1 – – – 1 1 – –
Solomon 1998136 1 – – – – – 1 –
Spencer 2010169 – – – – 1 – – –
Spruit 2002247 – – – – – – – –
Sridhar 2008155 1 1 – 1 1 1 1 –
Stulbarg 2002137 A 1 1 – – 1 – 1 –
Stulbarg 2002137 B 1 1 – – 1 – 1 –
Stulbarg 2002137 C 1 1 – – 1 – 1 –
Subin 2010242 A – – – – 1 – – –
Subin 2010242 B – – – – 1 – – –
Subin 2010242 C – – – – 1 – – –
Theander 2009220 1 1 – – 1 1 1 –
Toshima 1990138 1 – – – 1 1 1 1
Trappenburg 2011188 – – – 1 1 1 1 –
Troosters 2000248 – – – – – – – –
Van Gestel 2012208 – – – – 1 – – –
Vogiatzis 2002265 1 – – – 1 – 1 1
Vonbank 2012246 A – – – – – – – –
Vonbank 2012246 B – – – – – – – –
Vonbank 2012246 C – – – – – – – –
Wadell 2004221 A – – – – – – – –
Wadell 2004221 B – – – – – – – –
Wadell 2004221 C – – – – – – – –
Wakabayashi 2011262 1 – – 1 – 1 1 –
Wang 2004203 – – – – 1 – – –
Warlies 2006209 – – – – – – – –
Waterhouse 2010277 1 – – – 1 – 1 –
Watson 1997231 1 – – 1 – – – –
Wedzicha 1998157 1 – – 1 1 1 1 1
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394
Nutrition Psychological Preventative Inhaler
Energy
conservation
Support
groups Exercise
Enhanced
access Other
Total
number
1 1 – – – – 1 – – 5
1 1 – – – – 1 – – 5
– – – – – – 1 – – 1
– 1 – – 1 – – – – 4
– – – – – – – – – 1
1 1 – – 1 – 1 – – 8
1 1 – – 1 – 1 – – 8
– – – – – – 1 – – 3
1 1 – – – – 1 – – 5
– – – – – – 1 – – 2
– – – – 1 – 1 – – 4
– – – – – – 1 – – 1
– – – 1 – – 1 1 – 7
1 – – 1 – – 1 1 – 7
– – – – – – – 1 – 3
– – – – – – 1 – – 2
– – – – – – 1 – – 1
– – – – – – 1 1 – 8
– 1 – – – – 1 – – 6
– 1 – – – – 1 – – 6
– 1 – – – – 1 – – 6
– – – – – – 1 – – 2
– – – – – – 1 – – 2
– – – – – – 1 – – 2
1 – – – 1 – 1 – – 8
1 1 1 – 1 – 1 – 1 11
1 – 1 1 – – 1 1 – 9
– – – – – – 1 – – 1
– – – – – – 1 – – 2
1 1 – – – – 1 – – 7
– – – – – – 1 – – 1
– – – – – – 1 – – 1
– – – – – – 1 – – 1
– – – – – – 1 – – 1
– – – – – – 1 – – 1
– – – – – – 1 – – 1
1 – 1 1 – – 1 – – 8
– – – – – – 1 – – 2
– – – – – – 1 – – 1
– 1 – – 1 – 1 – – 6
– – – – – – – – – 2
1 1 – 1 – – 1 – – 10
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395
Intervention
Author, year
Disease
knowledge
Unspecified
SM RMT
Action
planning Breathing Smoking Medication
Bronchial
hygiene
Weekes 2009158 – – – – 1 – – –
White 2002159 1 – – 1 1 – 1 1
Wijkstra 1994189 1 – 1 – 1 – 1 –
Wijkstra 1995190 A 1 – 1 – 1 – 1 –
Wijkstra 1995190 B 1 – 1 – 1 – 1 –
Wijkstra 1995190 C 1 – 1 – 1 – 1 –
Wittmann 2007210 1 1 – 1 1 – 1 –
Wong 200574 1 – – – – – – –
Wood-Baker 2006170 1 – – 1 1 1 1 1
Wright 2003211 – – – – 1 – – –
Xu 2010204 A – – – – 1 – – –
Xu 2010204 B – – – – 1 – – –
Xu 2010204 C – – – – – – – –
Xu 2010204 D – – – – 1 – – –
Xu 2010204 E – – – – 1 – – –
Xu 2010204 F – – – – 1 – – –
Yamaguti 2012235 – – – – 1 – – –
Yeh 2010139 – – – – 1 – – –
Zhang 2008205 A – – – – 1 – – –
Zhang 2008205 B – – – – – – – –
Zhang 2008205 C – – – – 1 – – –
Total number 108 24 32 43 140 44 77 30
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396
Nutrition Psychological Preventative Inhaler
Energy
conservation
Support
groups Exercise
Enhanced
access Other
Total
number
1 – – – – – – – – 2
1 1 – 1 – – 1 – – 9
– 1 – – – – 1 – – 6
– 1 – – – – 1 1 – 7
– 1 – – – – 1 1 – 7
– 1 – – – – 1 1 – 7
1 1 1 1 – – 1 – – 10
– – – – – – – 1 – 2
1 1 1 1 – 1 1 – – 12
– – – – – – 1 – – 2
– 1 – – – – 1 – – 3
– – – – – – 1 – – 2
– 1 – – – – 1 – – 2
– 1 – – – – 1 – – 3
– 1 – – – – 1 – – 3
– – – – – – 1 – – 2
– – – – – – – – – 1
– 1 – – – – 1 – – 3
– – – – – – – – 1 2
– – – – – – – – 1 1
– – – – – – – – 1 2
51 77 18 36 22 7 176 50 18 953
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397
Comparator
Author, year
Disease
knowledge
Unspecified
SM RMT
Action
planning Breathing Smoking Medication
Bronchial
hygiene
Aimonino Ricauda 200875 – – – – – – – –
Arnardottir 2006216 – – – – 1 – – –
Arnardottir 2007217 – – – – 1 – – –
Barakat 2008249 – – – – – – – –
Bauldoff 2002108 – – – – – – – –
Bauldoff 2005109 A – – – – – – – –
Bauldoff 2005109 B – – – – – – – –
Bauldoff 2005109 C – – – – – – – –
Beckerman 2005253 – – 1 – – – – –
Behnke 200064 – – – – 1 – – –
Bendstrup 1997222 – – – – – – – –
Bernard 1999191 – – – – 1 – – 1
Berry 2010110 1 – – – – – – –
Bestall 2003141 1 – – 1 1 1 1 1
Bjornshave 2005223 – – – – – – – –
Blake Jr 1990111 – – – – – – – –
Bonilha 2009232 – – – – – – – –
Bourbeau 2003192 – – – – – – – –
Boxall 2005160 – – – – – – – –
Breyer 2010245 1 – – – 1 1 1 1
Brooks 2002193 1 – – – 1 – – –
Bucknall 201263 – – – – – – – –
Busch 1988194 – – – – – – – –
Cai 2006199 – – – – – – – –
Carr 2009195 1 – – – 1 – 1 –
Casas 200671 – – – – – – – –
Chan 2010212 A – – – – – – – –
Chan 2010212 B – – – – – – – –
Chan 2010212 C 1 – – – 1 – – –
Cockcroft 1987142 – – – – – – – –
Coultas 2005112 A 1 – – – – – – –
Coultas 2005112 B 1 – – – – – – –
Coultas 2005112 C 1 1 – 1 – 1 1 –
Covey 2001113 – – – – 1 1 1 –
de Blok 2006181 – – – – – – – –
Dheda 200473 – – – – – – – –
Donesky-Cuenco 2009114 1 – – – – – – –
Dourado 2009233 A – – – – – – – –
Dourado 2009233 B – – – – – – – –
Dourado 2009233 C – – – – – – – –
du Moulin 2009206 1 – – – 1 1 – –
Eaton 2009227 – – – – – – – –
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398
Nutrition Psychological Preventative Inhaler
Energy
conservation
Support
groups Exercise
Enhanced
access Other
Total
number
– – – – – – – – – 0
– – – – – – 1 – – 2
– – – – – – 1 – – 2
– – – – – – – – – 0
– – – – – – 1 – – 1
– – – – – – 1 – – 1
– – – – – – 1 – – 1
– – – – – – 1 – – 1
– – – – – – – – – 1
– – – – – – 1 – – 2
– – – – – – – – – 0
– 1 – – – – 1 – – 4
– – – – – – 1 – – 2
1 1 – 1 1 – – – – 10
– – – – – – 1 – – 1
– – – – – – – – – 0
– 1 – – – – – – 1 2
– – – – – – – – – 0
– – – – – – – – – 0
1 – – – – – – – – 6
– 1 – – – – 1 – – 4
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 0
– 1 – – 1 – 1 – – 6
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – 1 – – 3
– – – – – – – – – 0
– – – – – – – – – 1
– – – – – – – – – 1
– – – – – – – – – 5
1 1 – – 1 – – – – 6
1 1 – – – – 1 – – 3
– – – – – – – – – 0
– – – – – – – – – 1
– – – – – – 1 – – 1
– – – – – – 1 – – 1
– – – – – – 1 – – 1
1 1 – – – – 1 – – 6
– – – – – – 1 – – 1
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399
Comparator
Author, year
Disease
knowledge
Unspecified
SM RMT
Action
planning Breathing Smoking Medication
Bronchial
hygiene
Effing 2009161 1 1 – 1 1 1 1 1
Efraimsson 2008218 – – – – – – – –
Egan 200269 – – – – – – – –
Elci 2008236 – – – – – – – –
Elliott 2004162 A 1 – – – – – 1 –
Elliott 2004162 B 1 – – – – – 1 –
Elliott 2004162 C 1 – – – – – 1 –
Emery 1998115 A – – – – – – – –
Emery 1998115 B – – – – – – – –
Emery 1998115 C 1 – – – – – 1 –
Engstrom 1999219 – – – – – – – –
Fernandez 2009171 1 – – 1 – – – –
Finnerty 2001143 – – – – – – – –
Foy 2001116 – – – – – – – –
Gallefoss 1999255 – – – – – – – –
Ghanem 2010264 – – – – – – – –
Gilmore 2010117 A 1 – – – – – 1 –
Gilmore 2010117 B 1 – – – – – 1 –
Gilmore 2010117 C 1 – – – – – 1 –
Gilmore 2010117 D 1 – – 1 1 1 1 –
Gilmore 2010117 E 1 – – – – – 1 –
Gilmore 2010117 F 1 – – – – – 1 –
Gohl 2006207 – – – – – – – –
Goldstein 1994196 – – – – – – – –
Green 2001144 1 – – – – – – –
Güell 2000172 – – – – – – – –
Güell 2006173 – – – – – – – –
Guyatt 1992118 – – 1 – 1 – – –
Hermiz 200267 – – – – – – – –
Hernandez 2000282 – – – – – – – –
Hernandez 200368 – – – – – – – –
Hill 2006163 – – 1 – – – – –
Holland 2004164 – – – – – – – –
Hoogendoorn 2009182 – – – – – 1 – –
Hospes 2009183 – – – – – – – –
Hsiao 2003259 A – – 1 – 1 – – –
Hsiao 2003259 B – – – – 1 – – –
Hsiao 2003259 C – – – – 1 – – –
Hynninen 2010256 – – – – – – – –
Janaudis-Ferreira 2011197 – – – – – – – –
Jang 2006267 1 – – – – – – –
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400
Nutrition Psychological Preventative Inhaler
Energy
conservation
Support
groups Exercise
Enhanced
access Other
Total
number
1 1 – – – – 1 1 – 11
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – 1 – – 3
– – – – – – 1 – – 3
– – – – – – 1 – – 3
– – – – – – – – – 0
– – – – – – – – – 0
– 1 – – – – – – – 3
– – – – – – – – – 0
– – – 1 – – – – – 3
– – – – – – – – – 0
– – – – – – 1 – – 1
– – – – – – – – – 0
– – – – – – – – – 0
– – – 1 – – – – – 3
– – – 1 – – – – – 3
– – – 1 – – – – – 3
– – – 1 – – 1 – – 7
– – – 1 – – – 1 – 4
– – – 1 – – – 1 – 4
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – 1 – – 2
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 2
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 1
– – – – – – 1 – – 1
1 – – – – – – – – 2
– – – – – – – – – 0
– – 1 – – – – – – 3
– – 1 – – – – – – 2
– – 1 – – – – – – 2
– – – – – – – 1 – 1
– – – – – – 1 – – 1
– – – – – – – – – 1
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401
Comparator
Author, year
Disease
knowledge
Unspecified
SM RMT
Action
planning Breathing Smoking Medication
Bronchial
hygiene
Jarab 2012266 – – – – – – – –
Karapolat 2007237 – – – – – – – –
Katiyar 2006240 – – – – – – – –
Kayahan 2006238 – – – – – – – –
Khdour 2009251 – – – – – – – –
Kim 1993119 – – 1 – – – – –
Ko 2011213 – – – – – 1 – –
Koff 2009120 – – – – – – – –
Koppers 2006184 – – – – 1 – – –
Kunik 2008121 1 – – – 1 1 1 1
Kwok 200470 – – – – – – – –
Lamers 2010185 – – – – – – – –
Larson 1988122 – – 1 – – – – –
Larson 1999123 A 1 – – – – – – –
Larson 1999123 B 1 – – – – – – –
Larson 1999123 C 1 – – – – – – –
Larson 1999123 D – – – – – – – –
Larson 1999123 E – – 1 – – – – –
Larson 1999123 F – – – – – – – –
Lee 200266 – – – – – – – –
Leung 2010165 – – – – – – – –
Li 2002200 – – – – – – – –
Liddell 2010145 1 – – – 1 – 1 –
Lindsay 2005214 – – – – – – – –
Linneberg 2012224 1 1 – – – 1 1 1
Littlejohns 1991146 – – – – – – – –
Liu 2008260 1 – – – – – – –
Livermore 2010166 – – – – – – – –
Lord 2010147 1 – – – 1 – – –
Madariaga 2007174 A – – – – – – – –
Madariaga 2007174 B – – – – – – – –
Madariaga 2007174 C – – 1 – – – – –
Mador 2004126 1 – – – – – – –
Mador 2005125 1 – – – – – – –
Mador 2009124 1 – – – – – – –
Magadle 2007254 – – – – – – – –
Maltais 2008198 1 – – – – – – –
Man 2004148 – – – – – – – –
Martin 2004228 – – – – – – – –
McGeoch 2006229 – – – – 1 1 – –
Monninkhof 2003186 – – – – – – – –
Moore 2009284 1 – – – 1 1 1 –
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402
Nutrition Psychological Preventative Inhaler
Energy
conservation
Support
groups Exercise
Enhanced
access Other
Total
number
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 1
– 1 – 1 – – 1 – – 4
– – – – – – – – – 0
– – – – – – – – – 1
1 – 1 – – – 1 – – 8
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 1
– – – – – – – – – 1
– – – – – – – – – 1
– – – – – – – – – 1
– – – – – – 1 1 – 2
– – – – – – – 1 – 2
– – – – – – 1 1 – 2
– – – – – – – – – 0
– – – – – – 1 – – 1
– – – – – – 1 – – 1
1 1 – – – 1 1 – – 7
– – – – – – – – – 0
– – – – – – 1 – – 6
– – – – – – – – – 0
– – – – – – 1 1 – 3
– – – – – – – – – 0
– – – – – – – – – 2
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 1
– – – – – – 1 – – 2
– – – – – – 1 – – 2
– – – – – – 1 – – 2
– – – – – – 1 – – 1
– – – – – – 1 1 – 3
– – – – – – – – – 0
– – – – – – – – – 0
1 – 1 1 – – 1 – – 6
– – – – – – – 1 – 1
– 1 1 – – – 1 – 1 8
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403
Comparator
Author, year
Disease
knowledge
Unspecified
SM RMT
Action
planning Breathing Smoking Medication
Bronchial
hygiene
Mota 2007175 – – 1 – – – – 1
Mularski 2009127 1 – – – 1 – – –
Murphy 2005252 – – – – – – – –
Nakamura 2008261 A – – – – – – – –
Nakamura 2008261 B – – – – – – – –
Nakamura 2008261 C – – – – – – – –
Ng 2011215 1 – – – 1 – – –
Nguyen 2008128 – 1 – 1 1 – – –
Nguyen 2009129 – – – – 1 – 1 –
Nield 2007130 A – – – – – – – –
Nield 2007130 B – – – – – – – –
Nield 2007130 C – – – – 1 – – –
Ninot 2011250 – – – – – – – –
Normandin 2002131 1 – – – – – – –
Norweg 2005132 A – – – – – – – –
Norweg 2005132 B – – – – – – – –
Norweg 2005132 C 1 – – – – – 1 –
Oh 2003283 1 – – – 1 – 1 1
O’Neill 2007150 1 – – – – – – –
Ortega 2002176 A – – – – – – – –
Ortega 2002176 B – – – – – – – –
Ortega 2002176 C – – – – – – – –
O’Shea 2007167 – – – – – – – –
Ozdemir 2010239 – – – – – – – –
Paz-Diaz 2007269 – – – – – – – –
Petersen 2008225 1 – – – – – 1 –
Petty 2006133 A – – – – – – – –
Petty 2006133 B – – – – – – – –
Petty 2006133 C 1 – – – – – – –
Pomidori 2012243 – – – – – – – –
Prince 1989151 1 – – – – – – –
Probst 2011234 – – – – 1 – – –
Puente-Maestu 2000177 – – – – – – 1 –
Puhan 2006257 1 – – – 1 – – –
Rea 2004230 – – – – – – – –
Regiane Resqueti 2007178 – – – – – – – –
Ren 2011201 A – – – – – – – –
Ren 2011201 B – – – – 1 – – –
Ren 2011201 C 1 – – – 1 – – 1
Rice 2010140 1 – – – – – – –
Riera 2001179 – – 1 – – – – –
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404
Nutrition Psychological Preventative Inhaler
Energy
conservation
Support
groups Exercise
Enhanced
access Other
Total
number
– 1 – – – – – – – 3
– – – – – 1 – – – 3
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – 1 – – 1
– – – – – – 1 – 1 4
– – – – – – 1 – – 4
– 1 1 – – – 1 1 – 6
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 1
– – – – – – – 1 – 1
– – – – – – 1 – – 2
– – – – – – 1 – – 1
– – – – – – 1 – – 1
1 1 1 – – – 1 – – 6
1 – – 1 1 – – – – 7
– – – – – – 1 – – 2
– – – – – – 1 – – 1
– – – – – – 1 – – 1
– – – – – – 1 – – 1
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – 1 – 1
1 1 – – – – – – – 4
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – 1 – – 2
– – – – – – 1 – – 1
– – – – – – – – – 1
– – – – – – 1 – – 2
1 – – – – – 1 – – 3
– 1 – – – – 1 – – 4
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 1
– – – – – – 1 – – 4
– – – – – – – 1 – 2
– 1 – – – – – – – 2
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Comparator
Author, year
Disease
knowledge
Unspecified
SM RMT
Action
planning Breathing Smoking Medication
Bronchial
hygiene
Ringbaek 2000226 – – – – – – – –
Romagnoli 2006244 1 – – – – – – –
Rooyackers 2003187 – – – – – – – –
Sassi-Dambron 1995134 – – – – – – 1 –
Scherer 2000258 – – – – 1 – – –
Sewell 2005152 1 – – – 1 – 1 1
Sewell 2006153 1 – – – 1 – 1 1
Seymour 2010154 1 – – – – – – –
Shao 2003202 – – – – – – – –
Simpson 1992135 – – – – – – – –
Singh 2003241 – – – – – – – –
Sívori 1998263 – – – – – – – –
Smith 1999168 1 – – – – – – –
Soler 2006180 1 – – – – – – –
Solomon 1998136 – – – – – – – –
Spencer 2010169 – – – – – – – –
Spruit 2002247 – – – – – – – –
Sridhar 2008155 1 – – 1 – – 1 –
Stulbarg 2002137 A 1 1 – – 1 – 1 –
Stulbarg 2002137 B 1 1 – – 1 – 1 –
Stulbarg 2002137 C 1 1 – – 1 – 1 –
Subin 2010242 A – – – – 1 – – –
Subin 2010242 B – – – – 1 – – –
Subin 2010242 C – – – – 1 – – –
Theander 2009220 – – – – – – – –
Toshima 1990138 1 – – – 1 – 1 1
Trappenburg 2011188 – – – – 1 1 1 –
Troosters 2000248 – – – – – – – –
Van Gestel 2012208 – – – – – – – –
Vogiatzis 2002265 1 – – – 1 – 1 1
Vonbank 2012246 A – – – – – – – –
Vonbank 2012246 B – – – – – – – –
Vonbank 2012246 C – – – – – – – –
Wadell 2004221 A – – – – – – – –
Wadell 2004221 B – – – – – – – –
Wadell 2004221 C – – – – – – – –
Wakabayashi 2011262 1 – – – – 1 1 –
Wang 2004203 – – – – 1 – – –
Warlies 2006209 – 1 – – – 1 1 –
Waterhouse 2010277 1 – – – – – 1 –
Watson 1997231 – – – – – – – –
Wedzicha 1998157 1 – – 1 1 1 1 1
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406
Nutrition Psychological Preventative Inhaler
Energy
conservation
Support
groups Exercise
Enhanced
access Other
Total
number
– – – – – – – – – 0
1 1 – – – – 1 – – 4
– – – – – – 1 – – 1
1 – – – – – 1 – – 3
– – – – – – – – – 1
1 1 – – 1 – 1 – – 8
1 1 – – 1 – 1 – – 8
– – – – – – – – – 1
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – 1 – – 1
– – – – – – – – – 1
1 – – 1 – – 1 – – 4
– – – – – – – – – 0
– – – – – – 1 – – 1
– – – – – – 1 – – 1
– – – – – – 1 – – 4
– 1 – – – – 1 – – 6
– 1 – – – – 1 – – 6
– 1 – – – – 1 – – 6
– – – – – – 1 – – 2
– – – – – – 1 – – 2
– – – – – – 1 – – 2
– – – – – – – – – 0
1 – – – – – 1 – – 6
1 – 1 1 – – 1 – – 7
– – – – – – – – – 0
– – – – – – 1 – – 1
1 1 – – – – 1 – – 7
– – – – – – 1 – – 1
– – – – – – 1 – – 1
– – – – – – 1 – – 1
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – 1 – – 1
1 – 1 1 – – 1 – – 7
– – – – – – – – – 1
– – – 1 – – – – – 4
– 1 – – 1 – 1 – – 5
– – – – – – – – – 0
1 1 – 1 – – – – – 9
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Comparator
Author, year
Disease
knowledge
Unspecified
SM RMT
Action
planning Breathing Smoking Medication
Bronchial
hygiene
Weekes 2009158 – – – – – – – –
White 2002159 1 – – 1 1 – 1 1
Wijkstra 1994189 – – – – – – – –
Wijkstra 1995190 A – – – – – – – –
Wijkstra 1995190 B – – – – – – – –
Wijkstra 1995190 C 1 – 1 – 1 – 1 –
Wittmann 2007210 – 1 – – 1 – 1 –
Wong 200574 – – – – – – – –
Wood-Baker 2006170 1 – – – 1 1 1 1
Wright 2003211 – – – – – – – –
Xu 2010204 A – – – – – – – –
Xu 2010204 B – – – – – – – –
Xu 2010204 C – – – – – – – –
Xu 2010204 D – – – – 1 – – –
Xu 2010204 E – – – – – – – –
Xu 2010204 F – – – – – – – –
Yamaguti 2012235 – – – – – – – –
Yeh 2010139 – – – – – – – –
Zhang 2008205 A – – – – – – – –
Zhang 2008205 B – – – – – – – –
Zhang 2008205 C – – – – – – – –
Total number 68 9 11 9 52 18 43 16
1, component present.
APPENDIX 24
NIHR Journals Library www.journalslibrary.nihr.ac.uk
408
Nutrition Psychological Preventative Inhaler
Energy
conservation
Support
groups Exercise
Enhanced
access Other
Total
number
1 – – – – – – – – 1
1 1 – 1 – – 1 – – 9
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 0
– 1 – – – – 1 1 – 7
1 1 – 1 – – 1 – – 7
– – – – – – – – – 0
1 1 1 1 – 1 1 – – 11
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – 1 – – 2
– 1 – – – – 1 – – 2
– 1 – – – – 1 – – 2
– – – – – – – – – 0
– – – – – – 1 – – 1
– – – – – – – – – 0
– – – – – – – – – 0
– – – – – – – – 1 1
28 34 11 19 7 3 96 15 4 443
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Appendix 25 Direction of effects for hospital
admissions, exacerbation and health-related
quality-of-life outcomes at last follow-up: review 4
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First author QoL
Hospital
(re)
admissions Exacerbations
Follow-up
(weeks)
Hospital
admissions Exacerbations
SGRQ CRQ
Total Symptoms Activity Impact Total Dyspnoea Fatigue
Aimonino Ricauda
2008
75
1 1 0 26 ↑
Arnardottir 2006
216
1 0 0 16 ↔
Arnardottir 2007
217
1 0 0 52 ↔ ↔ ↔ ↔
Barakat 2008
249
1 0 0 14 ↑ • • •
Bauldoff 2002
108
1 0 0 8 ↔ ↔ ↔ ↔
Bauldoff 2005
109
A 1 0 0 4 ↔ ↔ ↔ ↔
Bauldoff 2005
109
B 1 0 0 4 ↔ ↔ ↔ ↔
Bauldoff 2005
109
C 1 0 0 4 ↔ ↔ ↔ ↔
Beckerman 2005
253
1 1 0 52 ↔ ↔
Behnke 2000
64
1 1 0 78 ↑ ↑ ↑
Bendstrup 1997
222
1 0 0 24 ↑
Bernard 1999
191
1 0 0 12 ↔ ↔
Berry 2010
110
1 0 0 52 ↔
Bestall 2003
141
1 0 0 52 ↔ ↔
Bjornshave 2005
223
1 0 0 4
Blake Jr 1990
111
1 0 0 52
Bonilha 2009
232
1 0 0 25 ↔
Bourbeau 2003
192
1 1 1 52 ↑ ↔ ↔ ↔ ↔ ↔
Boxall 2005
160
1 1 0 12 ↔ ↑ ↔ ↔ ↑
Breyer 2010
245
1 0 0 39
Brooks 2002
193
1 0 0 52 ↔ ↔ ↔
Bucknall 2012
63
1 1 0 52 ↔ ↔ ↔ ↔ ↑
Busch 1988
194
1 0 0 18 ↔
Cai 2006
199
1 0 1 26 ↑ • • • •
Carr 2009
195
1 0 0 12 ↑ ↔
Casas 2006
71
1 1 0 52 ↑ ↔ ↔ ↔ ↔
Chan 2010
212
A 1 1 1 13 ↔ ↔ ↔ • • •
Chan 2010
212
B 1 1 1 13 ↔ ↔ ↔ • • •
Chan 2010
212
C 1 1 1 13 ↔ ↔ ↔ • • •
Cockcroft 1987
142
0 1 0 ↔
Coultas 2005
112
A 1 1 0 26 ↔ ↔ ↔ ↔ ↔
Coultas 2005
112
B 1 1 0 26 ↔ ↔ ↔ ↔ ↔
Coultas 2005
112
C 1 1 0 26 ↔ ↔ ↔ ↔ ↔
Covey 2001
113
1 0 0 16 ↔
de Blok 2006
181
1 0 0 9 ↔ ↔ ↔ ↔
Dheda 2004
73
1 1 1 26 ↔ ↔ ↑ ↑ ↔ ↑
Donesky-Cuenco
2009
114
1 0 0 12 ↔ ↔
Dourado 2009
233
A 1 0 0 12 ↔ • • •
Dourado 2009
233
B 1 0 0 12 ↔ • • •
Dourado 2009
233
C 1 0 0 12 ↔ • • •
du Moulin 2009
206
1 0 0 26 ↔ ↑ ↑ ↑
Eaton 2009
227
1 1 0 13 ↔ ↔ ↑
Effing 2009
161
1 1 1 52 ↔ ↔ ↔ ↔
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SF-36
EQ-5D Other
Other
effect
Emotional
function Mastery PCS MCS
Physical
functioning
Role
physical
Bodily
pain
General
health Vitality
Social
functioning
Role
emotional
Mental
health
Change
in
health
↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔ NHP ↑
↑ ↑
YQLQ ↔
↔ ↔
↔ ↔
• •
SIP physical ↑
↑ ↔
↔ ↔ • • •
↔
↔ ↔
↔
↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔
↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔
↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔
↔ ↔ ↔ ↔
↔ ↔ ↔ ↔
AQ20
AQ20
AQ20
↔ ↔
↔ ↔ ↑ ↔
↔ ↔
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First author QoL
Hospital
(re)
admissions Exacerbations
Follow-up
(weeks)
Hospital
admissions Exacerbations
SGRQ CRQ
Total Symptoms Activity Impact Total Dyspnoea Fatigue
Efraimsson 2008
218
1 0 0 ↑
Egan 2002
69
1 1 0 ↔
Elci 2008
236
1 0 0 13 ↑
Elliott 2004
162
A 1 0 0 13 ↑
Elliott 2004
162
B 1 0 0 13 •
Elliott 2004
162
C 1 0 0 13 •
Emery 1998
115
A 1 0 0 10
Emery 1998
115
B 1 0 0 10
Emery 1998
115
C 1 0 0 10
Engstrom 1999
219
1 0 0 52 ↔ ↔ ↔ ↔
Fernandez 2009
171
1 0 0 52 ↑ • • •
Finnerty 2001
143
1 0 0 26 ↑ • • •
Foy 2001
116
1 0 0 78 ↑ ↑
Gallefoss 1999
255
1 1 0 52 ↔ ↔ ↔ ↔ ↔
Ghanem 2010
264
1 0 0 9 ↑ ↑
Gilmore 2010
117
A 1 0 0 ? • • • •
Gilmore 2010
117
B 1 0 0 ? • • • •
Gilmore 2010
117
C 1 0 0 ? • • • •
Gilmore 2010
117
D 1 0 0 ? • • • •
Gilmore 2010
117
E 1 0 0 ? • • • •
Gilmore 2010
117
F 1 0 0 ? • • • •
Gohl 2006
207
1 0 0 52 ↔ • • •
Goldstein 1994
196
1 0 0 24 ↑ ↑
Green 2001
144
1 0 0 7 ↑ ↑ ↔
Güell 2000
172
1 0 0 17 ↑ ↔
Güell 2006
173
1 1 1 104 ↔ ↑ ↑ ↔
Guyatt 1992
118
1 0 0 26 ↔
Hermiz 2002
67
1 1 0 13 ↔ ↔ ↔ ↔ ↔
Hernandez 2000
282
1 1 0 8 ↑ ↑ ↔ ↔ ↑
Hernandez 2003
68
1 0 0 12 ↔ ↑ ↑ ↑
Hill 2006
163
1 0 0 8 ↔ ↑ ↑
Holland 2004
164
1 0 0 6 ↔ ↔
Hoogendoorn
2009
182
1 1 1 104 • ↔ ↑
Hospes 2009
183
1 0 0 12 ↑ ↔ ↔ ↔
Hsiao 2003
259
A 1 0 0
Hsiao 2003
259
B 1 0 0
Hsiao 2003
259
C 1 0 0
Hynninen 2010
256
1 0 0 35 ↔
Janaudis-Ferreira
2011
197
1 0 0 6 ↔ ↔
Jang 2006
267
1 0 0 8
Jarab 2012
266
1 1 1 26 ↑ ↔ ↔ ↔ ↔ ↔
Karapolat 2007
237
1 0 0 12 ↑ ↑ ↑ ↑
Katiyar 2006
240
1 0 0 13 ↑ • • •
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SF-36
EQ-5D Other
Other
effect
Emotional
function Mastery PCS MCS
Physical
functioning
Role
physical
Bodily
pain
General
health Vitality
Social
functioning
Role
emotional
Mental
health
Change
in
health
SF-36 total ↑
SIP total ↔
SIP total ↑
SIP total ↔
SIP total ↔
↑ ↑
↑ ↑ ↑ ↑ • • • • • • • • •
• • • • • • • • • •
↑ ↑ QWB & SIP ↔
↑ ↑
↔ ↑
↑ ↑
↔
SF-12
↑ ↑
• •
↔ ↔
↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔ CCQ ↔
SF-36 ns
SF-36 ns
SF-36 •
QoL ↑
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First author QoL
Hospital
(re)
admissions Exacerbations
Follow-up
(weeks)
Hospital
admissions Exacerbations
SGRQ CRQ
Total Symptoms Activity Impact Total Dyspnoea Fatigue
Kayahan 2006
238
1 0 0 9 ↑
Khdour 2009
251
1 1 1 52 ↑ • ↔ ↑ ↔ ↑
Kim 1993
119
1 0 0 26
Ko 2011
213
1 1 1 52 ↔ ↔ ↔ ↔ ↔ ↔
Koff 2009
120
1 1 1 13 • ↔ ↑ ↔ ↔ ↔
Koppers 2006
184
1 0 0 5 ↔
Kunik 2008
121
1 0 0 52 ↔ ↔ ↔
Kwok 2004
70
0 1 0 ↔
Lamers 2010
185
1 0 0 39 ↑ ↔ ↔ ↑
Larson 1988
122
1 0 0
Larson 1999
123
A 1 0 0 17 • •
Larson 1999
123
B 1 0 0 17 • •
Larson 1999
123
C 1 0 0 17 • •
Larson 1999
123
D 1 0 0 17 • •
Larson 1999
123
E 1 0 0 17 • •
Larson 1999
123
F 1 0 0 17 • •
Lee 2002
66
0 1 0 26 ↔
Leung 2010
165
1 0 0 8 ↔ ↔ ↔
Li 2002
200
1 0 0 13
Liddell 2010
145
1 0 0 8 •
Lindsay 2005
214
1 0 0 13 ↔ ↔
Linneberg 2012
224
1 0 0 52 ↔
Littlejohns 1991
146
1 0 0 52 ↔
Liu 2008
260
1 1 1 52 ↑ •
Livermore 2010
166
1 1 0 ↔ ↔
Lord 2010
147
1 0 0 7 ↔
Madariaga 2007
174
A 1 0 0 8 ↔ ↔
Madariaga 2007
174
B 1 0 0 8 ↔ ↔
Madariaga 2007
174
C 1 0 0 8 ↔ ↔
Mador 2004
126
1 0 0 8 ↑ ↑ ↑
Mador 2005
125
1 0 0 8 ↔ ↔ ↔
Mador 2009
124
1 0 0 8 ↔ ↔
Magadle 2007
254
1 0 0 39 ↑
Maltais 2008
198
1 1 1 52 • • • ↔ ↔
Man 2004
148
1 1 0 13 ↔ ↑ ↔ ↔ ↑ ↑ ↑
Martin 2004
228
1 1 0 52 ↔
McGeoch 2006
229
1 1 0 52 ↔ ↔ ↔ ↔ ↔
Monninkhof 2003
186
1 0 0 52 ↔ ↔ ↔ ↔
Moore 2009
284
1 0 0 6 ↔
Mota 2007
175
1 0 0 5 • • • •
Mularski 2009
127
1 0 0 8 ↔ ↔ ↔ ↔
Murphy 2005
252
1 0 1 6 ↔ ↔ • • •
Nakamura 2008
261
A 1 0 0 12
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SF-36
EQ-5D Other
Other
effect
Emotional
function Mastery PCS MCS
Physical
functioning
Role
physical
Bodily
pain
General
health Vitality
Social
functioning
Role
emotional
Mental
health
Change
in
health
SIP total •
↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔
SIP ↔
↔ ↔
ADL, social
activities
↑
↔ ↔
SIP physical
functioning
↑
↑
↑ ↔
↔ ↔
↔ ↔
↔ ↔
↑ ↑
↔ ↔
↔ ↔
↔ ↔
↑ ↑ ↑ ↑
↔
QoL
↑ ↔
•
↑ ↔ ↔ ↔ ↔ ↔ ↔ ↔
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First author QoL
Hospital
(re)
admissions Exacerbations
Follow-up
(weeks)
Hospital
admissions Exacerbations
SGRQ CRQ
Total Symptoms Activity Impact Total Dyspnoea Fatigue
Nakamura 2008
261
B 1 0 0 12
Nakamura 2008
261
C 1 0 0 12
Ng 2011
215
1 0 0 26 ↔ ↔
Nguyen 2008
128
1 0 0 26 ↔
Nguyen 2009
129
1 0 1 26 • ↔ ↔
Nield 2007
130
A 1 0 0 12
Nield 2007
130
B 1 0 0 12
Nield 2007
130
C 1 0 0 12
Ninot 2011
250
1 1 0 52 ↔ ↔
Normandin 2002
131
1 0 0 8 ↔ ↔
Norweg 2005
132
A 1 0 0 24 ↔ ↔ ↔
Norweg 2005
132
B 1 0 0 24 ↔ ↔ ↔
Norweg 2005
132
C 1 0 0 24 ↑ ↔ ↔
Oh 2003
283
1 0 0 8 ↑ ↔ ↑
O’Neill 2007
150
1 0 0 26 ↔ ↔ ↔
Ortega 2002
176
A 1 0 0 24 ↔ ↔
Ortega 2002
176
B 1 0 0 24 ↔ ↔
Ortega 2002
176
C 1 0 0 24 ↔ ↔
O’Shea 2007
167
1 0 0 24 ↔ ↔
Ozdemir 2010
239
1 0 0 4 • • •
Paz-Diaz 2007
269
1 0 0 9 ↑ • • •
Petersen 2008
225
1 0 0 7 ↑ ↔ ↔ ↔
Petty 2006
133
A 1 0 0 16
Petty 2006
133
B 1 0 0 16
Petty 2006
133
C 1 0 0 16
Pomidori 2012
243
1 0 0 52 •
Prince 1989
151
1 0 0 6
Probst 2011
234
1 0 0 12
Puente-Maestu
2000
177
1 0 0 52 • •
Puhan 2006
257
1 0 0 5 ↔ ↔ ↔
Rea 2004
230
1 1 0 52 ↔ ↔ ↑
Regiane Resqueti
2007
178
0 0 1 •
Ren 2011
201
A 0 0 1 •
Ren 2011
201
B 0 0 1 •
Ren 2011
201
C 1 0 0 26 • ↑ ↑
Rice 2010
140
1 1 0 52 ↑ ↑ ↑
Riera 2001
179
1 0 0 26 ↑ ↔
Ringbaek 2000
226
1 0 0 8 ↔
Romagnoli 2006
244
1 1 0 56 ↔ ↔ ↑ ↔ •
Rooyackers 2003
187
1 0 0 10 ↓
Sassi-Dambron
1995
134
1 0 0 26
Scherer 2000
258
1 0 0 8
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SF-36
EQ-5D Other
Other
effect
Emotional
function Mastery PCS MCS
Physical
functioning
Role
physical
Bodily
pain
General
health Vitality
Social
functioning
Role
emotional
Mental
health
Change
in
health
↔ ↔ ↔ ↔ ↔ ↔ ↔ ↑
↔ ↔ ↔ ↔ ↔ ↔ ↔ •
↔ ↔ ↔ ↔ ↔ ↔
↔ ↔
↔ ↔ ↔ ↔
•
•
•
↔ ↔
↔ ↔
↔ ↔
↔ ↔
↑ ↑
↔ ↔
↔ ↔
↔ ↔
↔ ↔
↔ ↔
• •
SOLDQ •
SOLDQ •
SOLDQ •
VAS •
GHQ •
• •
↔ ↔
↔ ↑ ↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔
↔ ↔
↔ ↔
PGWB
index
↔
QWB total ↔
↑ ↔
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First author QoL
Hospital
(re)
admissions Exacerbations
Follow-up
(weeks)
Hospital
admissions Exacerbations
SGRQ CRQ
Total Symptoms Activity Impact Total Dyspnoea Fatigue
Sewell 2005
152
1 0 0 7 ↔ ↔
Sewell 2006
153
1 0 0 7 ↔ ↔ ↔
Seymour 2010
154
1 1 1 13 ↑ ↑ ↑ ↔ ↑ ↔ ↑ ↔
Shao 2003
202
1 0 0 52
Simpson 1992
135
1 0 0 8 ↑ ↔ ↔
Singh 2003
241
1 0 0 4 ↑ ↑
Sívori 1998
263
1 1 0 8 • • • •
Smith 1999
168
1 1 0 52 ↔
Soler 2006
180
1 1 1 52 ↑ • ↔ ↔ ↔ ↔
Solomon 1998
136
1 1 0 26 ↔
Spencer 2010
169
1 1 1 52 ↔ ↔ ↔ ↑ ↔ ↔
Spruit 2002
247
1 0 0 12 ↔ ↔
Sridhar 2008
155
1 1 0 104 ↔ ↑ • •
Stulbarg 2002
137
A 1 0 0 9 ↑ ↔
Stulbarg 2002
137
B 1 0 0 9 ↔ ↔
Stulbarg 2002
137
C 1 0 0 9 ↔ ↔
Subin Rao 2010
242
A 1 0 0 4 • •
Subin Rao 2010
242
B 1 0 0 4 • •
Subin Rao 2010
242
C 1 0 0 4 • •
Theander 2009
220
1 0 0 12 ↔ ↔ ↔ ↔
Toshima 1990
138
1 1 0 26 ↔
Trappenburg 2011
188
1 1 1 26 ↔ ↔ ↔ ↔ ↔ ↔
Troosters 2000
248
1 0 0 78 ↔ ↔ ↔
Van Gestel 2012
208
1 0 0 4 ↔
Vogiatzis 2002
265
1 0 0 13 ↔ ↔ ↔
Vonbank 2012
246
A 1 0 0 12 ↔ • • •
Vonbank 2012
246
B 1 0 0 12 ↔ • • •
Vonbank 2012
246
C 1 0 0 12 ↔ • • •
Wadell 2004
221
A 1 0 0 12 ↔ ↔ ↑ ↔
Wadell 2004
221
B 1 0 0 12 ↔ ↔ ↔ ↔
Wadell 2004
221
C 1 0 0 12 ↔ ↔ ↑ ↔
Wakabayashi 2011
262
1 0 0 52 ↔ ↔
Wang 2004
203
1 0 0 15
Warlies 2006
209
1 0 0 26 ↔ • • •
Waterhouse 2010
277
1 0 0 78 ↔ ↔ ↔
Watson 1997
231
1 0 0 26 ↔ ? ? ?
Wedzicha 1998
157
1 0 0 8 ↔ ↔
Weekes 2009
158
1 0 0 52 ↑ ↔ ↔ ↑
White 2002
159
1 0 0 13 ↔ ↔ ↔
Wijkstra 1994
189
1 0 0 12 ↑ ↔
Wijkstra 1995
190
A 1 0 0 78 ↔ ↔
Wijkstra 1995
190
B 1 0 0 78 ↑ ↔
Wijkstra 1995
190
C 1 0 0 78 ↓ ↔
Wittmann 2007
210
1 1 0 52 • ↔ • • •
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SF-36
EQ-5D Other
Other
effect
Emotional
function Mastery PCS MCS
Physical
functioning
Role
physical
Bodily
pain
General
health Vitality
Social
functioning
Role
emotional
Mental
health
Change
in
health
↔ ↔
↔ ↔
↑ ↔ ↔
ADL, social
activities
↔ ↔
↑ ↑
CO-OP •
↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔
• •
↔ ↑ ↔ ↔ ↔ ↔ ↔ ↔ ↑ ↔ ↔ ↔ ↑
↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔
↔ ↑ ↔ ↔ ↔ ↔ ↔ ↔ ↑ ↔ ↔ ↔ ↔
• •
• •
• •
↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔
QWB total •
↔ ↔
↔ ↔
↑ ↔
↔ ↔
↑ ↔
QoL •
↔ ↔ ↔ ↔ ↔
↑
↔ ↔ ↔ ↔
↑ ↑
↔ ↔
↔ ↑
↔ ↔
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First author QoL
Hospital
(re)
admissions Exacerbations
Follow-up
(weeks)
Hospital
admissions Exacerbations
SGRQ CRQ
Total Symptoms Activity Impact Total Dyspnoea Fatigue
Wong 2005
74
0 1 0 13 ↔
Wood-Baker 2006
170
1 1 0 52 ↔ ↔ ↔ ↔ ↔
Wright 2003
211
1 0 0 12 •
Xu 2010
204
A 1 0 0 52 ↑
Xu 2010
204
B 1 0 0 52 ↑
Xu 2010
204
C 1 0 0 52 ↑
Xu 2010
204
D 1 0 0 52 ↑
Xu 2010
204
E 1 0 0 52 ↑
Xu 2010
204
F 1 0 0 52 ↔
Yamaguti 2012
235
1 0 0 4 ↑ ↑ ↔ ↑
Yeh 2010
139
1 0 0 ↑ ↔ ↑
Zhang 2008
205
A 1 0 0 8
Zhang 2008
205
B 1 0 0 8
Zhang 2008
205
C 1 0 0 8
ADL, activities of daily living; AQ20, airways questionnaire 20; CCQ, Clinical COPD Questionnaire; CO-OP, Dartmouth
Primary Care Co-operative Quality of Life Questionnaire; MCS, mental component summary; NHP, Nottingham Health Profile;
PCS, physical component summary; PGWB, Psychological General Wellbeing Index; QWB, quality of wellbeing; SF-12,
Short Form questionnaire-12 items; SIP, Sickness Impact Profile; SOLDQ, Seattle Obstructive Lung Disease questionnaire;
VAS, visual analogue scale; YQLQ, York Quality of Life Questionnaire.
Notes
↑ Intervention group had significantly better outcome than comparator.
↓ Intervention group had significantly worse outcome than comparator.
↔ No significant difference between study groups.
• Outcome reported, but difference between study arms not reported.
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SF-36
EQ-5D Other
Other
effect
Emotional
function Mastery PCS MCS
Physical
functioning
Role
physical
Bodily
pain
General
health Vitality
Social
functioning
Role
emotional
Mental
health
Change
in
health
↔ ↔
Mood,
dyspnoea,
social
activity,
household
activity,
headache,
appetite,
anxiety
•
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Appendix 26 Risk of bias assessment for all
included studies with primary outcomes: review 4
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Appendix 28 Funnel plot of studies for
multicomponent self-management interventions vs.
usual care: St George’s Respiratory Questionnaire
outcomes at 13 weeks’ follow-up – review 4
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FIGURE 80 Egger’s test: coefficient of bias 1.98, p-value 0.001.
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Appendix 29 Funnel plot of studies for
multicomponent self-management interventions vs.
usual care: St George’s Respiratory Questionnaire
outcomes at between 3 and 6 months’ follow-up –
review 4
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FIGURE 81 Egger’s test: coefficient of bias –1.80, p-value 0.054.
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Appendix 30 Funnel plot of studies for
multicomponent self-management interventions vs.
usual care: St George’s Respiratory Questionnaire
outcomes at ≥ 6 months’ follow-up – review 4
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FIGURE 82 Egger’s test: coefficient of bias 0.99, p-value 0.031.
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Appendix 31 Funnel plot of studies for
multicomponent self-management interventions
including supervised exercise: St George’s Respiratory
Questionnaire outcomes at ≤ 13 weeks’ follow-up –
review 4
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FIGURE 83 Egger’s test: coefficient of bias 3.91, p-value 0.006.
DOI: 10.3310/hta19360 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 36
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Jordan et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
511

Appendix 32 Funnel plot of studies for
enhanced care interventions: hospital admissions
at ≥ 6 months’ follow-up – review 4
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FIGURE 84 Egger’s test: coefficient of bias –0.43, p-value 0.749.
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Appendix 33 Funnel plot of studies for combined
strength and aerobic interventions: St George’s
Respiratory Questionnaire outcomes at ≤ 13 weeks’
follow-up – review 4
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FIGURE 85 Egger’s test: coefficient of bias 2.79, p-value 0.061.
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